{"info":{"_postman_id":"9fc3211d-64b4-4e95-98c1-9fd65571c9e3","name":"Compliance Hub Enterprise","description":"

This collection documents the APIs used to authenticate users and submit/monitor jobs on the Scitegrity Compliance Hub Enterprise platform.

\n","schema":"https://schema.getpostman.com/json/collection/v2.0.0/collection.json","toc":[],"owner":"4175425","collectionId":"9fc3211d-64b4-4e95-98c1-9fd65571c9e3","publishedId":"2sAXqwagAd","public":true,"customColor":{"top-bar":"FFFFFF","right-sidebar":"303030","highlight":"FF6C37"},"publishDate":"2024-09-26T09:08:00.000Z"},"item":[{"name":"Controlled Substances Squared","item":[{"name":"/cs2/webservice","item":[{"name":"/search/run","event":[{"listen":"test","script":{"id":"ba447bee-c037-4a4d-93db-dc9df09f398c","exec":["// parse response and set gatewayJobId as environment variable","var response = pm.response.json();","pm.environment.set(\"jobId\", response.gatewayJobId);"],"type":"text/javascript","packages":{}}}],"id":"a998e976-049f-47e8-9cdc-44db5ac0933b","protocolProfileBehavior":{"disableBodyPruning":true},"request":{"auth":{"type":"noauth","isInherited":false},"method":"POST","header":[{"key":"x-access-token","value":"{{token}}","type":"text","description":"

The authentication token obtained from the /authenticate endpoint

\n"}],"body":{"mode":"raw","raw":"{\r\n \"fileContent\" : \"O=[N+]([O-])c1cc(cc([N+]([O-])=O)c1O)[N+]([O-])=O POSTMAN_TEST_1\",\r\n \"idJurisdiction\": [2, 3],\r\n \"jurisdictions\": [\"UK\", \"USA\"],\r\n \"includePrecursors\": true,\r\n \"dangerousGoods\": false,\r\n \"autoSelectSubjurisdiction\": false,\r\n \"includeInputData\": true,\r\n \"includeCustomRules\": true,\r\n \"includeSystemRules\": true,\r\n \"useFastlookup\": true,\r\n \"fastlookupOnly\": false,\r\n\t\"useFastlookupFast\": false,\r\n \"runSimilarityWhereRequired\": true,\r\n \"similarityThreshold\": 0.75,\r\n \"controlCodeFilterGroupNames\": [\"filterGroup1\"],\r\n \"passControlCodesInFilterGroup\": true\r\n}","options":{"raw":{"language":"json"}}},"url":"https://{{host}}:{{port}}/cs2/webservice/search/run","description":"

Submit a new job to Controlled Substances Squared providing input compounds in a plain text format (SMILES, InChI or a list of compound IDs). This API call will return a gatewayJobId which can be used to monitor the job and retrieve the results using the other endpoints in this collection.

The header field x-access-token must be populated with the value of an active token. Once the job is submitted, the owner of that job will be whomever the token was created by. To obtain a value for x-access-token see GET /authenticate

Body parameters

fileContent: string
This is the list of SMILES strings, InChI strings or IDs for the compounds you would like to check. This should be in plain text format with each compound on a new line. Optionally, you can provide a compound identifier along with the SMILES/InChI which will be output in the results, add this to the same line after the SMILES/InChI string with a space between the id and SMILES/InChI. If the useFastlookup parameter is set to true, these identifiers will also be used to get pre-calculated controlled statuses from CS2 for corporate collection compounds which can improve the performance of webservice calls.

Providing the jurisdictions to be checked is optional and can be provided either using numerical jurisdiction IDs using the idJurisdiction parameter or 2-3 character jurisdiction codes using the jurisdictions parameter, see below for more information.

idJurisdiction: integer array
This parameter is optional. If not provided CS2 will search against all jurisdictions you license within CS2. If provided this should contain an array of the integer IDs of all jurisdictions for the search to consider. If provided the array must contain at least one valid jurisdiction ID.

jurisdictions: string array
This parameter is optional. If not provided CS2 will search against all jurisdictions you license within CS2. If provided this should contain an array of the jurisdictions codes for the search to consider. If provided the array must contain at least one valid jurisdiction code. A list of these codes can be found using the /jurisdictions endpoint.

includePrecursors: bool
If this parameter is set to true precursor legislation will be included in the check. When set to false CS2 will not check the provided compounds against precursor legislation. If this parameter is not provided, precursor legislation will be included by default.

dangerousGoods: bool
If this parameter is set to true and you have an active subscription to Scitegrity's Dangerous Goods Assessor application the input compounds will also be checked against the UN Dangerous Goods shipping guidelines. If this is set to true and you do not have an active subcription Dangerous Goods data will not be returned.

autoSelectSubjurisdiction: bool
This parameter is optional and is only used when the idJurisdiction parameter has been specified. If not provided CS2 will use use default value of false. If set to true, any subjurisidictions of the jurisidictions specified will be also be considered in the search.

includeInputData: bool
This parameter is optional. If not provided CS2 will use use default value of false. This parameter determines whether CS2 includes through other data fields that are attached to the input records. If set to true any additional fields in the SDF file will be returned in the results. If set to false these additional fields will not be returned in the results.

includeCustomRules: bool
This parameter is optional. If not provided CS2 will use the default set on the server. If set to true CS2 searches against custom rules your orginisation has set up. If set to false CS2 does not return hits from any customer defined rules.

includeSystemRules: bool
This parameter is optional. If not provided CS2 will use the default set on the server. If set to true CS2 searches against system legislation (legislation added by Scitegrity). If set to false CS2 does not return hits for any system legislation and only returns matches to customer defined rules.

useFastLookup: bool
This parameter is optional. If not provided CS2 will use the default set on the server. Whether to check the fastlookup table for precalculated results (recommended).. If set to true, precalculated results will be used if present which speeds up the search (recommended). If set to false no precalculated results are used an all compounds are analysed in real time.

fastlookupOnly: bool
This parameter is optional. If not provided CS2 will use the default value of false. This parameter selects whether to only check the fastlookup table. If the result is not in the fastlookup table nothing will be returned, however search speed will be 100Ks of compounds per minute. You must provide a corporateID in the same format as used in the fastlookup table, as it will only attempt to do an exact string match of the corporateID (case sensitive).

useFastlookupFast: bool
This parameter is optional and is only used when the fastlookupOnly parameter is set to true. If not provided CS2 will use the default value of false. When set to true, more concise results are returned omitting non-important fields (such as links to legislation and control code documents). This further increases the speed of a search.

runSimilarityWhereRequired: bool
This parameter is optional. If not provided CS2 will use the default set on the server. Determines whether analogue hits (Possibly controlled) compounds are shown. If set to true analogue hits will be shown.

similarityThreshold: float
This parameter is optional. If not provided CS2 will use the default set on the server. Sets the Threshold value for Similarity cut off and controls at what level something is decalred an analogue (Possibly controlled). Requires a value between 0 and 1. This parameter is not used if the useFastlookup parameter is set to true.

controlCodeFilterGroupNames: string array
This parameter is optional. Allows you to specify a predefined filter group which can be used to filter in / out control codes. This filter group needs to be created by a CS2 admin before use.

passControlCodesInFilterGroup: bool
This parameter is only required if the controlCodeFilterGroupNames parameter has been specified. It defines whether records with control codes listed in the filter group should be excluded from the results or should be the only ones that are shown in the result. true: Only records which have a control code in the specified filter group are displayed. false: Only records that DO NOT have a control code specified filter group are displayed.

\n","urlObject":{"protocol":"https","port":"{{port}}","path":["cs2","webservice","search","run"],"host":["{{host}}"],"query":[],"variable":[]}},"response":[{"id":"0f1e06d1-f353-4d1b-a765-1aa1c2953041","name":"single compound","originalRequest":{"method":"POST","header":[{"key":"x-access-token","value":"{{token}}","description":"The authentication token obtained from the /authenticate endpoint"}],"body":{"mode":"raw","raw":"{\r\n \"fileContent\" : \"CCOCC POSTMAN_TEST_1\",\r\n \"idJurisdiction\": [2, 3, 4, 5 ],\r\n \"includePrecursors\": true,\r\n \"useFastlookup\": true\r\n}","options":{"raw":{"language":"json"}}},"url":"https://{{host}}:{{port}}/cs2/webservice/search/run"},"status":"Created","code":201,"_postman_previewlanguage":"json","header":[{"key":"Date","value":"Tue, 28 Jan 2025 10:18:39 GMT"},{"key":"Content-Type","value":"application/json; charset=utf-8"},{"key":"Content-Length","value":"59"},{"key":"Connection","value":"keep-alive"},{"key":"X-Frame-Options","value":"SAMEORIGIN"},{"key":"Strict-Transport-Security","value":"max-age=63072000; includeSubDomains; preload"},{"key":"ETag","value":"W/\"3b-42qvZyc+wiZsup2kD2ev9HmxboU\""}],"cookie":[],"responseTime":null,"body":"{\n \"gatewayJobId\": \"GWJ-3df5cd60-dd61-11ef-af4a-3b55feddd1e5\"\n}"},{"id":"5e436b10-12ac-4796-9221-b68f52b75d3f","name":"multiple compounds","originalRequest":{"method":"POST","header":[{"key":"x-access-token","value":"{{token}}","description":"The authentication token obtained from the /authenticate endpoint"}],"body":{"mode":"raw","raw":"{\r\n \"fileContent\" : \"CCOCC POSTMAN_TEST_1\\nCCNCC POSTMAN_TEST_2\",\r\n \"idJurisdiction\": [2, 3, 4, 5],\r\n \"includePrecursors\": true,\r\n \"useFastlookup\": true\r\n}","options":{"raw":{"language":"json"}}},"url":"https://{{host}}:{{port}}/cs2/webservice/search/run"},"status":"Created","code":201,"_postman_previewlanguage":"json","header":[{"key":"Date","value":"Tue, 28 Jan 2025 10:20:33 GMT"},{"key":"Content-Type","value":"application/json; charset=utf-8"},{"key":"Content-Length","value":"59"},{"key":"Connection","value":"keep-alive"},{"key":"X-Frame-Options","value":"SAMEORIGIN"},{"key":"Strict-Transport-Security","value":"max-age=63072000; includeSubDomains; preload"},{"key":"ETag","value":"W/\"3b-ktfPRXtcO6xe+BaLo7yVeWZqYYc\""}],"cookie":[],"responseTime":null,"body":"{\n \"gatewayJobId\": \"GWJ-81f30b90-dd61-11ef-af4a-3b55feddd1e5\"\n}"}],"_postman_id":"a998e976-049f-47e8-9cdc-44db5ac0933b"},{"name":"/search/run/b64","event":[{"listen":"test","script":{"id":"ce54d3d7-20c0-4753-a904-51e30835d1cf","exec":["// parse response and set gatewayJobId as environment variable\r","var response = pm.response.json();\r","pm.environment.set(\"jobId\", response.gatewayJobId);"],"type":"text/javascript","packages":{}}}],"id":"346a6c1f-5ff4-4b84-9ac8-7de3815631a7","protocolProfileBehavior":{"disableBodyPruning":true},"request":{"auth":{"type":"noauth","isInherited":false},"method":"POST","header":[{"key":"x-access-token","value":"{{token}}","type":"text","description":"

The authentication token obtained from the /authenticate endpoint

\n"}],"body":{"mode":"raw","raw":"{\r\n \"idJurisdiction\": [2, 3],\r\n \"jurisdictions\": [\"UK\", \"USA\"],\r\n \"includePrecursors\": true,\r\n \"dangerousGoods\": false,\r\n \"autoSelectSubjurisdiction\": false,\r\n \"includeInputData\": true,\r\n \"includeCustomRules\": true,\r\n \"includeSystemRules\": true,\r\n \"useFastlookup\": true,\r\n \"fastlookupOnly\": false,\r\n\t\"useFastlookupFast\": false,\r\n \"runSimilarityWhereRequired\": true,\r\n \"similarityThreshold\": 0.75,\r\n \"controlCodeFilterGroupNames\": [\"filterGroup1\"],\r\n \"passControlCodesInFilterGroup\": true, \r\n \"fileContent\" : \"
  SciTegic11061411402D

  6  6  0  0  0  0            999 V2000
    4.9992    6.0386    0.0000 O   0  0
    5.7838    5.7839    0.0000 C   0  0
    6.4510    6.2685    0.0000 O   0  0
    7.1185    5.7839    0.0000 C   0  0
    6.8636    4.9992    0.0000 C   0  0
    6.0385    4.9992    0.0000 C   0  0
  1  2  2  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  2  1  0
M  END
> <corporateID>
Example_1

$$$$

  SciTegic11061411402D

 29 32  0  0  0  0            999 V2000
    5.0000    8.8643    0.0000 C   0  0
    5.1714    8.0573    0.0000 O   0  0
    5.9560    7.8023    0.0000 C   0  0
    6.5692    8.3543    0.0000 C   0  0
    7.3538    8.0992    0.0000 C   0  0
    7.5252    7.2923    0.0000 C   0  0
    8.3098    7.0372    0.0000 C   0  0
    8.9230    7.5892    0.0000 C   0  0
    9.7076    7.3342    0.0000 N   0  0
   10.3207    7.8862    0.0000 C   0  0
   10.1493    8.6931    0.0000 O   0  0
   11.1053    7.6311    0.0000 C   0  0
   11.7185    8.1831    0.0000 S   0  0
   12.5031    7.9281    0.0000 C   0  0
   13.1705    8.4129    0.0000 N   0  0
   13.8380    7.9280    0.0000 N   0  0
   13.5830    7.1434    0.0000 C   0  0
   13.9954    6.4290    0.0000 C   0  0
   13.5829    5.7145    0.0000 C   0  0
   13.9954    5.0000    0.0000 C   0  0
   12.7579    5.7145    0.0000 C   0  0
   12.3454    5.0000    0.0000 C   0  0
   11.5204    5.0000    0.0000 C   0  0
   11.1079    5.7145    0.0000 C   0  0
   11.5204    6.4289    0.0000 C   0  0
   12.3454    6.4290    0.0000 C   0  0
   12.7579    7.1434    0.0000 N   0  0
    6.9121    6.7403    0.0000 C   0  0
    6.1275    6.9953    0.0000 C   0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  2  0
 10 12  1  0
 12 13  1  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  2  0
 19 20  1  0
 19 21  1  0
 21 22  2  0
 22 23  1  0
 23 24  2  0
 24 25  1  0
 25 26  2  0
 26 21  1  0
 26 27  1  0
 27 14  1  0
 27 17  1  0
  6 28  1  0
 28 29  2  0
 29  3  1  0
M  END
> <corporateID>
Example_2

$$$$

  SciTegic11061411402D

 22 25  0  0  1  0            999 V2000
    4.1486   -1.0341    0.0000 C   0  0
    4.1487   -1.8528    0.0000 N   0  0
    3.4834   -2.3364    0.0000 C   0  0
    3.7383   -3.1219    0.0000 C   0  0  2  0  0  0
    4.5600   -3.1187    0.0000 C   0  0  1  0  0  0
    4.8143   -2.3364    0.0000 C   0  0
    5.0785   -3.7622    0.0000 C   0  0
    5.8586   -3.5060    0.0000 C   0  0
    6.4698   -4.0602    0.0000 C   0  0
    7.2492   -3.8092    0.0000 Cl  0  0
    6.2974   -4.8653    0.0000 C   0  0
    5.5138   -5.1161    0.0000 C   0  0
    4.9062   -4.5672    0.0000 C   0  0
    4.1649   -4.9279    0.0000 O   0  0
    3.4167   -4.5768    0.0000 C   0  0
    2.8165   -5.1469    0.0000 C   0  0
    2.0205   -4.9057    0.0000 C   0  0
    1.8301   -4.0977    0.0000 C   0  0
    2.4359   -3.5310    0.0000 C   0  0
    3.2263   -3.7689    0.0000 C   0  0
    4.0964   -3.8583    0.0000 H   0  0
    5.3654   -2.9705    0.0000 H   0  0
  1  2  1  0
  2  6  1  0
  2  3  1  0
  3  4  1  0
  4 20  1  0
  4  5  1  0
  5  6  1  0
  5  7  1  0
  7 13  2  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
  9 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  1  0
 14 15  1  0
 15 20  2  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  2  0
 19 20  1  0
  4 21  1  1
  5 22  1  6
M  END
> <corporateID>
Example_3

$$$$

  SciTegic11061411402D

 21 21  0  0  0  0            999 V2000
    2.7361    0.7608    0.0000 C   0  0
    1.9291    0.5892    0.0000 N   0  0
    1.6742   -0.1954    0.0000 C   0  0
    1.3770    1.2023    0.0000 C   0  0
    0.5701    1.0308    0.0000 C   0  0
    0.3151    0.2462    0.0000 C   0  0
    0.8001   -0.4213    0.0000 C   0  0
    0.3151   -1.0887    0.0000 N   0  0
   -0.4696   -0.8338    0.0000 C   0  0
   -1.1840   -1.2464    0.0000 C   0  0
   -1.8985   -0.8338    0.0000 C   0  0
   -1.8985   -0.0088    0.0000 C   0  0
   -2.6130    0.4037    0.0000 O   0  0
   -1.1840    0.4037    0.0000 C   0  0
   -0.4696   -0.0088    0.0000 C   0  0
    4.9142    0.8252    0.0000 O   0  0
    5.2318    0.2751    0.0000 C   0  0
    5.8671    0.2751    0.0000 O   0  0
    4.9142   -0.2751    0.0000 C   0  0
    5.2318   -0.8252    0.0000 O   0  0
    4.2789   -0.2751    0.0000 O   0  0
  1  2  1  0
  2  3  1  0
  2  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  2  0
  6 15  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
  9 15  2  0
 10 11  2  0
 11 12  1  0
 12 13  1  0
 12 14  2  0
 14 15  1  0
 16 17  1  0
 17 18  2  0
 17 19  1  0
 19 20  1  0
 19 21  2  0
M  END
> <corporateID>
Example_4

$$$$

  SciTegic11061411402D

 24 26  0  0  0  0            999 V2000
    4.2867   -1.2375    0.0000 C   0  0
    3.5722   -1.6500    0.0000 C   0  0
    2.8579   -1.2375    0.0000 C   0  0
    2.8579   -0.5775    0.0000 O   0  0
    2.1434   -1.6500    0.0000 N   0  0
    2.1434   -2.4749    0.0000 C   0  0
    1.4289   -2.8874    0.0000 C   0  0
    1.4289   -3.7124    0.0000 C   0  0
    2.1434   -4.1249    0.0000 N   0  0
    2.8579   -3.7124    0.0000 C   0  0
    2.8579   -2.8874    0.0000 C   0  0
    2.1434   -4.9498    0.0000 C   0  0
    2.8579   -5.3623    0.0000 C   0  0
    3.5722   -4.9498    0.0000 C   0  0
    3.8089   -4.1596    0.0000 C   0  0
    4.6337   -4.1405    0.0000 C   0  0
    4.9067   -4.9190    0.0000 C   0  0
    4.2507   -5.4193    0.0000 S   0  0
    1.4289   -1.2375    0.0000 C   0  0
    1.4289   -0.4125    0.0000 C   0  0
    0.7145    0.0000    0.0000 C   0  0
    0.0001   -0.4124    0.0000 C   0  0
    0.0000   -1.2375    0.0000 C   0  0
    0.7145   -1.6500    0.0000 C   0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  3  5  1  0
  5  6  1  0
  5 19  1  0
  6  7  1  0
  6 11  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
  9 12  1  0
 10 11  1  0
 12 13  1  0
 13 14  1  0
 14 15  2  0
 14 18  1  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 19 20  2  0
 19 24  1  0
 20 21  1  0
 21 22  2  0
 22 23  1  0
 23 24  2  0
M  END
> <corporateID>
Example_5

$$$$

  SciTegic11061411402D

 24 26  0  0  0  0            999 V2000
    0.0000   -2.8876    0.0000 C   0  0
    0.7145   -2.4750    0.0000 C   0  0
    0.7145   -1.8151    0.0000 O   0  0
    1.4289   -2.8876    0.0000 N   0  0
    2.1434   -2.4750    0.0000 C   0  0
    2.1434   -1.6500    0.0000 C   0  0
    2.8579   -1.2376    0.0000 C   0  0
    3.5723   -1.6500    0.0000 N   0  0
    3.5723   -2.4750    0.0000 C   0  0
    2.8579   -2.8876    0.0000 C   0  0
    4.2868   -1.2375    0.0000 C   0  0
    5.0013   -1.6500    0.0000 C   0  0
    5.7158   -1.2375    0.0000 C   0  0
    5.7158   -0.4125    0.0000 C   0  0
    6.4302    0.0000    0.0000 C   0  0
    7.1447   -0.4125    0.0000 C   0  0
    7.1447   -1.2375    0.0000 C   0  0
    6.4302   -1.6500    0.0000 C   0  0
    1.4289   -3.7125    0.0000 C   0  0
    0.7145   -4.1251    0.0000 C   0  0
    0.7145   -4.9501    0.0000 C   0  0
    1.4289   -5.3626    0.0000 C   0  0
    2.1434   -4.9501    0.0000 C   0  0
    2.1434   -4.1251    0.0000 C   0  0
  1  2  1  0
  2  3  2  0
  2  4  1  0
  4  5  1  0
  4 19  1  0
  5  6  1  0
  5 10  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  8 11  1  0
  9 10  1  0
 11 12  1  0
 12 13  1  0
 13 14  2  0
 13 18  1  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  2  0
 19 20  2  0
 19 24  1  0
 20 21  1  0
 21 22  2  0
 22 23  1  0
 23 24  2  0
M  END
> <corporateID>
Example_6

$$$$

  SciTegic11061411402D

 22 24  0  0  0  0            999 V2000
   -4.3225   -1.2712    0.0000 C   0  0
   -3.6080   -0.8587    0.0000 C   0  0
   -2.8935   -1.2712    0.0000 C   0  0
   -2.1790   -0.8587    0.0000 C   0  0
   -1.4646   -1.2712    0.0000 C   0  0
   -0.7501   -0.8587    0.0000 N   0  0
   -0.6639   -0.0383    0.0000 C   0  0
    0.1431    0.1333    0.0000 C   0  0
    0.5556   -0.5812    0.0000 C   0  0
    0.0036   -1.1943    0.0000 C   0  0
    1.3761   -0.6674    0.0000 C   0  0
    1.7116   -1.4211    0.0000 O   0  0
    1.8610    0.0000    0.0000 C   0  0
    1.5255    0.7537    0.0000 C   0  0
    2.0104    1.4211    0.0000 C   0  0
    2.8309    1.3349    0.0000 C   0  0
    3.1664    0.5812    0.0000 C   0  0
    3.9869    0.4950    0.0000 C   0  0
    4.3225   -0.2587    0.0000 C   0  0
    3.8375   -0.9261    0.0000 C   0  0
    3.0171   -0.8399    0.0000 C   0  0
    2.6815   -0.0862    0.0000 C   0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
  6 10  1  0
  9 11  1  0
 11 12  2  0
 11 13  1  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  2  0
 21 22  1  0
 13 22  2  0
 17 22  1  0
M  END
> <corporateID>
Example_7

$$$$
\"\r\n}","options":{"raw":{"language":"json"}}},"url":"https://{{host}}:{{port}}/cs2/webservice/search/run/b64","description":"

Submit a new job to Controlled Substances Squared providing input compounds in SDF/MOL file format. This API call will return a gatewayJobId which can be used to monitor the job and retrieve the results using the other endpoints in this collection.

Body parameters

fileContent: string
Must contain the base64 encoded content of a valid SDF/MOL file, containing the structures you wish to check. You can also provide identifiers for compounds (e.g. SCIT-1, SCIT-2) using a field named 'corporateId'. Scitegrity recommends to avoid using integers as IDs and instead use a string such as input1, input2 etc. If the useFastlookup parameter is set to true, these identifiers will also be used to get pre-calculated controlled statuses from CS2 for corporate collection compounds which can improve the performance of webservice calls.

\n","urlObject":{"protocol":"https","port":"{{port}}","path":["cs2","webservice","search","run","b64"],"host":["{{host}}"],"query":[],"variable":[]}},"response":[{"id":"06d61924-8253-4c6f-9a21-f0097ea64eb6","name":"single compound","originalRequest":{"method":"POST","header":[{"key":"x-access-token","value":"{{token}}","description":"The authentication token obtained from the /authenticate endpoint"}],"body":{"mode":"raw","raw":"{\r\n \"idJurisdiction\": [2, 3],\r\n \"fileContent\" : \"DQogIFNjaVRlZ2ljMDYyNjE4MTQxMDJEDQoNCiAxNCAxNSAgMCAgMCAgMCAgMCAgICAgICAgICAgIDk5OSBWMjAwMA0KICAgIDAuMDAwMCAgICAwLjAwMDAgICAgMC4wMDAwIEMgICAwICAwDQogICAgMC4wMDAwICAgIDAuMDAwMCAgICAwLjAwMDAgTiAgIDAgIDANCiAgICAwLjAwMDAgICAgMC4wMDAwICAgIDAuMDAwMCBDICAgMCAgMA0KICAgIDAuMDAwMCAgICAwLjAwMDAgICAgMC4wMDAwIEMgICAwICAwDQogICAgMC4wMDAwICAgIDAuMDAwMCAgICAwLjAwMDAgQyAgIDAgIDANCiAgICAwLjAwMDAgICAgMC4wMDAwICAgIDAuMDAwMCBDICAgMCAgMA0KICAgIDAuMDAwMCAgICAwLjAwMDAgICAgMC4wMDAwIEMgICAwICAwDQogICAgMC4wMDAwICAgIDAuMDAwMCAgICAwLjAwMDAgQyAgIDAgIDANCiAgICAwLjAwMDAgICAgMC4wMDAwICAgIDAuMDAwMCBDICAgMCAgMA0KICAgIDAuMDAwMCAgICAwLjAwMDAgICAgMC4wMDAwIE8gICAwICAwDQogICAgMC4wMDAwICAgIDAuMDAwMCAgICAwLjAwMDAgQyAgIDAgIDANCiAgICAwLjAwMDAgICAgMC4wMDAwICAgIDAuMDAwMCBPICAgMCAgMA0KICAgIDAuMDAwMCAgICAwLjAwMDAgICAgMC4wMDAwIEMgICAwICAwDQogICAgMC4wMDAwICAgIDAuMDAwMCAgICAwLjAwMDAgQyAgIDAgIDANCiAgMSAgMiAgMSAgMA0KICAyICAzICAxICAwDQogIDMgIDQgIDEgIDANCiAgMyAgNSAgMSAgMA0KICA1ICA2ICAxICAwDQogIDYgIDcgIDIgIDANCiAgNyAgOCAgMSAgMA0KICA4ICA5ICAyICAwDQogIDkgMTAgIDEgIDANCiAxMCAxMSAgMSAgMA0KIDExIDEyICAxICAwDQogMTIgMTMgIDEgIDANCiAxMyAgOSAgMSAgMA0KIDEzIDE0ICAyICAwDQogMTQgIDYgIDEgIDANCk0gIEVORA0KPiA8Q29ycG9yYXRlSWQ+DQpQT1NUTUFOX1RFU1RfMQ0KDQokJCQkDQo=\"\r\n}","options":{"raw":{"language":"json"}}},"url":"https://{{host}}:{{port}}/cs2/webservice/search/run/b64"},"status":"Created","code":201,"_postman_previewlanguage":"json","header":[{"key":"Date","value":"Tue, 28 Jan 2025 10:24:37 GMT"},{"key":"Content-Type","value":"application/json; charset=utf-8"},{"key":"Content-Length","value":"59"},{"key":"Connection","value":"keep-alive"},{"key":"X-Frame-Options","value":"SAMEORIGIN"},{"key":"Strict-Transport-Security","value":"max-age=63072000; includeSubDomains; preload"},{"key":"ETag","value":"W/\"3b-cDmyp5Aq/SWqd9ZJfP6dlshH/6E\""}],"cookie":[],"responseTime":null,"body":"{\n \"gatewayJobId\": \"GWJ-13972220-dd62-11ef-af4a-3b55feddd1e5\"\n}"}],"_postman_id":"346a6c1f-5ff4-4b84-9ac8-7de3815631a7"},{"name":"/search/status","event":[{"listen":"test","script":{"id":"8499a6a8-e0f9-4ff2-bec1-09231b4e964d","exec":[""],"type":"text/javascript","packages":{}}}],"id":"6c2dd279-db72-41cb-a1ca-d6fee6e34a1a","protocolProfileBehavior":{"disableBodyPruning":true},"request":{"method":"POST","header":[{"key":"x-access-token","value":"{{token}}","type":"text","description":"

The authentication token obtained from the /authenticate endpoint

\n"}],"body":{"mode":"raw","raw":"{\r\n \"gatewayJobId\": \"{{jobId}}\"\r\n}","options":{"raw":{"language":"json"}}},"url":"https://{{host}}:{{port}}/cs2/webservice/search/status","description":"

Get the status of a submitted CS2 webservice job.

Body parameters

gatewayJobId: string

The returned jobId provided when the job was started using the above /search/run endpoints.

\n","urlObject":{"protocol":"https","port":"{{port}}","path":["cs2","webservice","search","status"],"host":["{{host}}"],"query":[],"variable":[]}},"response":[{"id":"ee0beb50-8c5a-4d1c-9944-b21df94203b1","name":"job running","originalRequest":{"method":"POST","header":[{"key":"x-access-token","value":"{{token}}","description":"The authentication token obtained from the /authenticate endpoint"}],"body":{"mode":"raw","raw":"{\r\n \"gatewayJobId\": \"{{jobId}}\"\r\n}","options":{"raw":{"language":"json"}}},"url":"https://{{host}}:{{port}}/cs2/webservice/search/status"},"status":"OK","code":200,"_postman_previewlanguage":"json","header":[{"key":"Date","value":"Tue, 28 Jan 2025 10:20:36 GMT"},{"key":"Content-Type","value":"application/json; charset=utf-8"},{"key":"Content-Length","value":"101"},{"key":"Connection","value":"keep-alive"},{"key":"X-Frame-Options","value":"SAMEORIGIN"},{"key":"Strict-Transport-Security","value":"max-age=63072000; includeSubDomains; preload"},{"key":"ETag","value":"W/\"65-4RZruacXU1BldNl0MBTKF7y+B+I\""}],"cookie":[],"responseTime":null,"body":"{\n \"jobStatus\": \"running\",\n \"protocol\": \"search_CS2\",\n \"updatedAt\": \"2025-01-28T10:20:36.127Z\",\n \"message\": null\n}"},{"id":"7c94539c-f1dc-4c2f-bdd3-27f2ea83bdc5","name":"job complete","originalRequest":{"method":"POST","header":[{"key":"x-access-token","value":"{{token}}","description":"The authentication token obtained from the /authenticate endpoint"}],"body":{"mode":"raw","raw":"{\r\n \"gatewayJobId\": \"{{jobId}}\"\r\n}","options":{"raw":{"language":"json"}}},"url":"https://{{host}}:{{port}}/cs2/webservice/search/status"},"status":"OK","code":200,"_postman_previewlanguage":"json","header":[{"key":"Date","value":"Tue, 28 Jan 2025 10:20:51 GMT"},{"key":"Content-Type","value":"application/json; charset=utf-8"},{"key":"Content-Length","value":"139"},{"key":"Connection","value":"keep-alive"},{"key":"X-Frame-Options","value":"SAMEORIGIN"},{"key":"Strict-Transport-Security","value":"max-age=63072000; includeSubDomains; preload"},{"key":"ETag","value":"W/\"8b-hhVl+l9P1lTTzeI/OQIkjaclY5Y\""}],"cookie":[],"responseTime":null,"body":"{\n \"jobStatus\": \"complete\",\n \"protocol\": \"search_CS2\",\n \"updatedAt\": \"2025-01-28T10:20:40.358Z\",\n \"message\": \"CS2 search complete - preparing results\"\n}"}],"_postman_id":"6c2dd279-db72-41cb-a1ca-d6fee6e34a1a"},{"name":"/search/result","event":[{"listen":"test","script":{"id":"2755f38e-b0d2-4938-b9af-a7f9f15ea703","exec":[""],"type":"text/javascript","packages":{}}}],"id":"5222246d-1ec9-4282-a340-3268fa2a5e71","protocolProfileBehavior":{"disableBodyPruning":true},"request":{"method":"POST","header":[{"key":"x-access-token","value":"{{token}}","type":"text","description":"

The authentication token obtained from the /authenticate endpoint

\n"}],"body":{"mode":"raw","raw":"{\r\n \"gatewayJobId\": \"{{jobId}}\"\r\n}","options":{"raw":{"language":"json"}}},"url":"https://{{host}}:{{port}}/cs2/webservice/search/result","description":"

Get the results of a completed CS2 webservice job in JSON format.

Body parameters

gatewayJobId: string

The returned jobId provided when the job was started using the above /search/run endpoints.

\n","urlObject":{"protocol":"https","port":"{{port}}","path":["cs2","webservice","search","result"],"host":["{{host}}"],"query":[],"variable":[]}},"response":[{"id":"e91e3078-70ae-4bd9-9726-7ba32f05b35e","name":"job results JSON","originalRequest":{"method":"POST","header":[{"key":"x-access-token","value":"{{token}}","description":"The authentication token obtained from the /authenticate endpoint"}],"body":{"mode":"raw","raw":"{\r\n \"gatewayJobId\": \"{{jobId}}\"\r\n}","options":{"raw":{"language":"json"}}},"url":"https://{{host}}:{{port}}/cs2/webservice/search/result"},"status":"OK","code":200,"_postman_previewlanguage":"json","header":[{"key":"Date","value":"Tue, 28 Jan 2025 10:21:06 GMT"},{"key":"Content-Type","value":"application/json; charset=utf-8"},{"key":"Content-Length","value":"7493"},{"key":"Connection","value":"keep-alive"},{"key":"X-Frame-Options","value":"SAMEORIGIN"},{"key":"Strict-Transport-Security","value":"max-age=63072000; includeSubDomains; preload"},{"key":"ETag","value":"W/\"1d45-wpYuJJCNNJYLR80UtNQtnO5bfDk\""}],"cookie":[],"responseTime":null,"body":"{\n \"jobStatus\": \"complete\",\n \"jobResult\": {\n \"records\": [\n {\n \"corporateId\": \"POSTMAN_TEST_1\",\n \"controlledStatus\": \"Controlled\",\n \"resultComments\": \"Exact match.\",\n \"idJurisdiction\": 2,\n \"companyDefinedRule\": false,\n \"idSysSubstance\": 766,\n \"idLeg2Sub\": 11658,\n \"jurisdictionName\": \"United Kingdom\",\n \"legislationName\": \"EU Regulation (EC) No 273/2004 on drug precursors (UK implementation - The Controlled Drugs (Drug Precursors)(Intra-Community Trade) Regulations)\",\n \"substanceLegislationName\": \"Ethyl ether\",\n \"idSysControlledCode\": [\n 46\n ],\n \"codeName\": [\n \"UK EU Drug Precursor Category 3\"\n ],\n \"sysControlCodeDocument\": [\n \"https://staging.scitegrity.com/client/#docs/systemControlCode/2753\"\n ],\n \"nativeLink\": \"https://www.legislation.gov.uk/eur/2004/273/contents\",\n \"link\": \"https://www-legislation-gov-uk.translate.goog/eur/2004/273/contents?_x_tr_sl=auto&_x_tr_tl=en&_x_tr_hl=en&_x_tr_pto=wapp\"\n },\n {\n \"corporateId\": \"POSTMAN_TEST_1\",\n \"controlledStatus\": \"Controlled\",\n \"resultComments\": \"Exact match.\",\n \"idJurisdiction\": 2,\n \"companyDefinedRule\": false,\n \"idSysSubstance\": 766,\n \"idLeg2Sub\": 11659,\n \"jurisdictionName\": \"United Kingdom\",\n \"legislationName\": \"EU Regulation (EC) No 111/2005 on drug precursors (UK implementation - The Controlled Drugs (Drug Precursors)(Community External Trade) Regulations 2008)\",\n \"substanceLegislationName\": \"Ethyl ether\",\n \"idSysControlledCode\": [\n 46\n ],\n \"codeName\": [\n \"UK EU Drug Precursor Category 3\"\n ],\n \"sysControlCodeDocument\": [\n \"https://staging.scitegrity.com/client/#docs/systemControlCode/2753\"\n ],\n \"nativeLink\": \"https://www.legislation.gov.uk/eur/2005/111/contents\",\n \"link\": \"https://www-legislation-gov-uk.translate.goog/eur/2005/111/contents?_x_tr_sl=auto&_x_tr_tl=en&_x_tr_hl=en&_x_tr_pto=wapp\"\n },\n {\n \"corporateId\": \"POSTMAN_TEST_1\",\n \"controlledStatus\": \"Controlled\",\n \"resultComments\": \"Exact match.\",\n \"idJurisdiction\": 3,\n \"companyDefinedRule\": false,\n \"idSysSubstance\": 766,\n \"idLeg2Sub\": 35749,\n \"jurisdictionName\": \"United States of America\",\n \"legislationName\": \"Controlled Substances Act - Regulations 21 CFR, Part 1300-1399\",\n \"substanceLegislationName\": \"Ethyl ether\",\n \"idSysControlledCode\": [\n 43\n ],\n \"codeName\": [\n \"US CSA List 2 Regulated Chemical\"\n ],\n \"sysControlCodeDocument\": [\n \"https://staging.scitegrity.com/client/#docs/systemControlCode/4516\"\n ],\n \"nativeLink\": \"https://www.ecfr.gov/current/title-21/chapter-II\",\n \"link\": \"https://www-ecfr-gov.translate.goog/current/title-21/chapter-II?_x_tr_sl=auto&_x_tr_tl=en&_x_tr_hl=en-GB&_x_tr_pto=nui\",\n \"additionalInformation\": \"Citation: Pub. L. 100-690\"\n },\n {\n \"corporateId\": \"POSTMAN_TEST_1\",\n \"controlledStatus\": \"Controlled\",\n \"resultComments\": \"Exact match.\",\n \"idJurisdiction\": 4,\n \"companyDefinedRule\": false,\n \"idSysSubstance\": 766,\n \"idLeg2Sub\": 14052,\n \"jurisdictionName\": \"France\",\n \"legislationName\": \"France - Regulation (EC) No 273/2004 on drug precursors\",\n \"substanceLegislationName\": \"Ether éthylique\",\n \"idSysControlledCode\": [\n 134\n ],\n \"codeName\": [\n \"French EU Drug Precursor Category 3\"\n ],\n \"sysControlCodeDocument\": [\n \"https://staging.scitegrity.com/client/#docs/systemControlCode/4319\"\n ],\n \"nativeLink\": \"https://eur-lex.europa.eu/legal-content/FR/TXT/PDF/?uri=CELEX:32004R0273&from=EN\",\n \"link\": \"https://eur-lex.europa.eu/legal-content/EN/TXT/?uri=CELEX:32004R0273\"\n },\n {\n \"corporateId\": \"POSTMAN_TEST_1\",\n \"controlledStatus\": \"Controlled\",\n \"resultComments\": \"Exact match.\",\n \"idJurisdiction\": 4,\n \"companyDefinedRule\": false,\n \"idSysSubstance\": 766,\n \"idLeg2Sub\": 14053,\n \"jurisdictionName\": \"France\",\n \"legislationName\": \"France - Regulation (EC) No 111/2005 on drug precursors\",\n \"substanceLegislationName\": \"Ether éthylique\",\n \"idSysControlledCode\": [\n 134\n ],\n \"codeName\": [\n \"French EU Drug Precursor Category 3\"\n ],\n \"sysControlCodeDocument\": [\n \"https://staging.scitegrity.com/client/#docs/systemControlCode/4319\"\n ],\n \"nativeLink\": \"https://eur-lex.europa.eu/legal-content/FR/TXT/PDF/?uri=CELEX:32005R0111&from=EN\",\n \"link\": \"https://eur-lex.europa.eu/legal-content/EN/TXT/?qid=1430479010032&uri=CELEX:32005R0111\"\n },\n {\n \"corporateId\": \"POSTMAN_TEST_1\",\n \"controlledStatus\": \"Controlled\",\n \"resultComments\": \"Exact match.\",\n \"idJurisdiction\": 5,\n \"companyDefinedRule\": false,\n \"idSysSubstance\": 766,\n \"idLeg2Sub\": 4558,\n \"jurisdictionName\": \"Ireland\",\n \"legislationName\": \"Ireland - Regulation (EC) No 273/2004 on drug precursors\",\n \"substanceLegislationName\": \"Ethyl ether\",\n \"idSysControlledCode\": [\n 112\n ],\n \"codeName\": [\n \"Irish EU Drug Precursor Category 3\"\n ],\n \"sysControlCodeDocument\": [\n \"https://staging.scitegrity.com/client/#docs/systemControlCode/4325\"\n ],\n \"nativeLink\": \"https://eur-lex.europa.eu/legal-content/EN/TXT/PDF/?uri=CELEX:32004R0273&from=EN\",\n \"link\": \"https://eur-lex.europa.eu/legal-content/EN/TXT/?uri=CELEX:32004R0273\"\n },\n {\n \"corporateId\": \"POSTMAN_TEST_1\",\n \"controlledStatus\": \"Controlled\",\n \"resultComments\": \"Exact match.\",\n \"idJurisdiction\": 5,\n \"companyDefinedRule\": false,\n \"idSysSubstance\": 766,\n \"idLeg2Sub\": 13996,\n \"jurisdictionName\": \"Ireland\",\n \"legislationName\": \"Ireland - Regulation (EC) No 111/2005 on drug precursors\",\n \"substanceLegislationName\": \"Ethyl ether\",\n \"idSysControlledCode\": [\n 112\n ],\n \"codeName\": [\n \"Irish EU Drug Precursor Category 3\"\n ],\n \"sysControlCodeDocument\": [\n \"https://staging.scitegrity.com/client/#docs/systemControlCode/4325\"\n ],\n \"nativeLink\": \"https://eur-lex.europa.eu/legal-content/EN/TXT/PDF/?uri=CELEX:32005R0111&from=EN\",\n \"link\": \"https://eur-lex.europa.eu/legal-content/EN/TXT/?qid=1430479010032&uri=CELEX:32005R0111\"\n },\n {\n \"corporateId\": \"POSTMAN_TEST_2\",\n \"controlledStatus\": \"Controlled\",\n \"resultComments\": \"Exact match.\",\n \"idJurisdiction\": 2,\n \"companyDefinedRule\": false,\n \"idSysSubstance\": 4813,\n \"idLeg2Sub\": 46229,\n \"jurisdictionName\": \"United Kingdom\",\n \"legislationName\": \"UK Strategic Export Control Lists\",\n \"substanceLegislationName\": \"Diethylamine\",\n \"idSysControlledCode\": [\n 399,\n 400\n ],\n \"codeName\": [\n \"UK Dual Use Items - EU Cat. 1C (Materials)\",\n \"UK CWC Precursors\"\n ],\n \"sysControlCodeDocument\": [\n \"https://staging.scitegrity.com/client/#docs/systemControlCode/2921\",\n \"https://staging.scitegrity.com/client/#docs/systemControlCode/2762\"\n ],\n \"nativeLink\": \"https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/948279/uk-strategic-export-control-list.pdf\",\n \"link\": \"https://www-gov-uk.translate.goog/government/publications/uk-strategic-export-control-lists-the-consolidated-list-of-strategic-military-and-dual-use-items-that-require-export-authorisation?_x_tr_sl=auto&_x_tr_tl=en&_x_tr_hl=en-GB\",\n \"additionalInformation\": \"1C350, Chemicals, which may be used as precursors for toxic chemical agents.\"\n },\n {\n \"corporateId\": \"POSTMAN_TEST_2\",\n \"controlledStatus\": \"Controlled\",\n \"resultComments\": \"Exact match.\",\n \"idJurisdiction\": 3,\n \"companyDefinedRule\": false,\n \"idSysSubstance\": 4813,\n \"idLeg2Sub\": 34144,\n \"jurisdictionName\": \"United States of America\",\n \"legislationName\": \"Commerce Control List (United States)\",\n \"substanceLegislationName\": \"Diethylamine\",\n \"idSysControlledCode\": [\n 291,\n 217,\n 198\n ],\n \"codeName\": [\n \"US CWC Precursors\",\n \"US CCL AT\",\n \"US CCL CB2\"\n ],\n \"sysControlCodeDocument\": [\n \"https://staging.scitegrity.com/client/#docs/systemControlCode/4248\",\n \"https://staging.scitegrity.com/client/#docs/systemControlCode/4510\",\n \"https://staging.scitegrity.com/client/#docs/systemControlCode/4511\"\n ],\n \"nativeLink\": \"https://www.bis.gov/ear\",\n \"link\": \"https://www-bis-gov.translate.goog/ear?_x_tr_sl=auto&_x_tr_tl=en&_x_tr_hl=en-US&_x_tr_pto=wapp\",\n \"additionalInformation\": \"IC350 - Chemicals that may be used as precursors for toxic chemical agents. IC350 d - Australia Group-controlled precursor chemicals not also identified as Schedule 1,2 or 3 chemicals under the Chemical Weapons Convention. Includes mixtures containing at least 30% of the chemical by weight.\"\n }\n ]\n },\n \"searchQuery\": \"idJurisdiction=2&idJurisdiction=3&idJurisdiction=4&idJurisdiction=5&includePrecursors=true&useFastlookup=true\"\n}"}],"_postman_id":"5222246d-1ec9-4282-a340-3268fa2a5e71"},{"name":"/search/result/sdf","event":[{"listen":"test","script":{"id":"45485ddf-429c-48a6-8f81-82874cbbf9b8","exec":[""],"type":"text/javascript","packages":{}}}],"id":"2a805986-17ee-4c5a-96bf-071e8590a1d8","protocolProfileBehavior":{"disableBodyPruning":true},"request":{"method":"POST","header":[{"key":"x-access-token","value":"{{token}}","type":"text","description":"

The authentication token obtained from the /authenticate endpoint

\n"}],"body":{"mode":"raw","raw":"{\r\n \"gatewayJobId\": \"{{jobId}}\"\r\n}","options":{"raw":{"language":"json"}}},"url":"https://{{host}}:{{port}}/cs2/webservice/search/result/sdf","description":"

Get the results of a completed CS2 webservice job in SDF format.

Body parameters

gatewayJobId: string

The returned jobId provided when the job was started using the above /search/run endpoints.

\n","urlObject":{"protocol":"https","port":"{{port}}","path":["cs2","webservice","search","result","sdf"],"host":["{{host}}"],"query":[],"variable":[]}},"response":[{"id":"62d79094-5343-4fad-bc89-e0184c2bd4a4","name":"job results sdf","originalRequest":{"method":"POST","header":[{"key":"x-access-token","value":"{{token}}","description":"The authentication token obtained from the /authenticate endpoint"}],"body":{"mode":"raw","raw":"{\r\n \"gatewayJobId\": \"{{jobId}}\"\r\n}","options":{"raw":{"language":"json"}}},"url":"https://{{host}}:{{port}}/cs2/webservice/search/result/sdf"},"status":"OK","code":200,"_postman_previewlanguage":"raw","header":[{"key":"Date","value":"Tue, 28 Jan 2025 10:22:30 GMT"},{"key":"Content-Type","value":"chemical/x-mdl-sdfile"},{"key":"Content-Length","value":"10987"},{"key":"Connection","value":"keep-alive"},{"key":"X-Frame-Options","value":"SAMEORIGIN"},{"key":"Strict-Transport-Security","value":"max-age=63072000; includeSubDomains; preload"},{"key":"Cache-Control","value":"no-cache"},{"key":"Content-Disposition","value":"attachment; filename=results.sdf"},{"key":"ETag","value":"W/\"2aeb-J5KJehShln9/fZy0vyre+T168r8\""}],"cookie":[],"responseTime":null,"body":"\r\n SciTegic01282510202D\r\n\r\n 5 4 0 0 0 0 999 V2000\r\n 1.3000 0.7500 0.0000 C 0 0\r\n 0.2606 0.1503 0.0000 C 0 0\r\n 2.6000 0.0000 0.0000 O 0 0\r\n 3.9000 0.7500 0.0000 C 0 0\r\n 4.9394 0.1503 0.0000 C 0 0\r\n 1 2 1 0\r\n 1 3 1 0\r\n 3 4 1 0\r\n 4 5 1 0\r\nM END\r\n> \r\nPOSTMAN_TEST_1\r\n\r\n> \r\nControlled\r\n\r\n> \r\nExact match.\r\n\r\n> \r\n2\r\n\r\n> \r\nfalse\r\n\r\n> \r\n766\r\n\r\n> \r\n11658\r\n\r\n> \r\nUnited Kingdom\r\n\r\n> \r\nEU Regulation (EC) No 273/2004 on drug precursors (UK implementation - The Controlled Drugs (Drug Precursors)(Intra-Community Trade) Regulations)\r\n\r\n> \r\nEthyl ether\r\n\r\n> \r\n46\r\n\r\n> \r\nUK EU Drug Precursor Category 3\r\n\r\n> \r\nhttps://staging.scitegrity.com/client/#docs/systemControlCode/2753\r\n\r\n> \r\nhttps://www.legislation.gov.uk/eur/2004/273/contents\r\n\r\n> \r\nhttps://www-legislation-gov-uk.translate.goog/eur/2004/273/contents?_x_tr_sl=auto&_x_tr_tl=en&_x_tr_hl=en&_x_tr_pto=wapp\r\n\r\n$$$$\r\n\r\n SciTegic01282510202D\r\n\r\n 5 4 0 0 0 0 999 V2000\r\n 1.3000 0.7500 0.0000 C 0 0\r\n 0.2606 0.1503 0.0000 C 0 0\r\n 2.6000 0.0000 0.0000 O 0 0\r\n 3.9000 0.7500 0.0000 C 0 0\r\n 4.9394 0.1503 0.0000 C 0 0\r\n 1 2 1 0\r\n 1 3 1 0\r\n 3 4 1 0\r\n 4 5 1 0\r\nM END\r\n> \r\nPOSTMAN_TEST_1\r\n\r\n> \r\nControlled\r\n\r\n> \r\nExact match.\r\n\r\n> \r\n2\r\n\r\n> \r\nfalse\r\n\r\n> \r\n766\r\n\r\n> \r\n11659\r\n\r\n> \r\nUnited Kingdom\r\n\r\n> \r\nEU Regulation (EC) No 111/2005 on drug precursors (UK implementation - The Controlled Drugs (Drug Precursors)(Community External Trade) Regulations 2008)\r\n\r\n> \r\nEthyl ether\r\n\r\n> \r\n46\r\n\r\n> \r\nUK EU Drug Precursor Category 3\r\n\r\n> \r\nhttps://staging.scitegrity.com/client/#docs/systemControlCode/2753\r\n\r\n> \r\nhttps://www.legislation.gov.uk/eur/2005/111/contents\r\n\r\n> \r\nhttps://www-legislation-gov-uk.translate.goog/eur/2005/111/contents?_x_tr_sl=auto&_x_tr_tl=en&_x_tr_hl=en&_x_tr_pto=wapp\r\n\r\n$$$$\r\n\r\n SciTegic01282510202D\r\n\r\n 5 4 0 0 0 0 999 V2000\r\n 1.3000 0.7500 0.0000 C 0 0\r\n 0.2606 0.1503 0.0000 C 0 0\r\n 2.6000 0.0000 0.0000 O 0 0\r\n 3.9000 0.7500 0.0000 C 0 0\r\n 4.9394 0.1503 0.0000 C 0 0\r\n 1 2 1 0\r\n 1 3 1 0\r\n 3 4 1 0\r\n 4 5 1 0\r\nM END\r\n> \r\nPOSTMAN_TEST_1\r\n\r\n> \r\nControlled\r\n\r\n> \r\nExact match.\r\n\r\n> \r\n3\r\n\r\n> \r\nfalse\r\n\r\n> \r\n766\r\n\r\n> \r\n35749\r\n\r\n> \r\nUnited States of America\r\n\r\n> \r\nControlled Substances Act - Regulations 21 CFR, Part 1300-1399\r\n\r\n> \r\nEthyl ether\r\n\r\n> \r\n43\r\n\r\n> \r\nUS CSA List 2 Regulated Chemical\r\n\r\n> \r\nhttps://staging.scitegrity.com/client/#docs/systemControlCode/4516\r\n\r\n> \r\nhttps://www.ecfr.gov/current/title-21/chapter-II\r\n\r\n> \r\nhttps://www-ecfr-gov.translate.goog/current/title-21/chapter-II?_x_tr_sl=auto&_x_tr_tl=en&_x_tr_hl=en-GB&_x_tr_pto=nui\r\n\r\n> \r\nCitation: Pub. L. 100-690\r\n\r\n$$$$\r\n\r\n SciTegic01282510202D\r\n\r\n 5 4 0 0 0 0 999 V2000\r\n 1.3000 0.7500 0.0000 C 0 0\r\n 0.2606 0.1503 0.0000 C 0 0\r\n 2.6000 0.0000 0.0000 O 0 0\r\n 3.9000 0.7500 0.0000 C 0 0\r\n 4.9394 0.1503 0.0000 C 0 0\r\n 1 2 1 0\r\n 1 3 1 0\r\n 3 4 1 0\r\n 4 5 1 0\r\nM END\r\n> \r\nPOSTMAN_TEST_1\r\n\r\n> \r\nControlled\r\n\r\n> \r\nExact match.\r\n\r\n> \r\n4\r\n\r\n> \r\nfalse\r\n\r\n> \r\n766\r\n\r\n> \r\n14052\r\n\r\n> \r\nFrance\r\n\r\n> \r\nFrance - Regulation (EC) No 273/2004 on drug precursors\r\n\r\n> \r\nEther éthylique\r\n\r\n> \r\n134\r\n\r\n> \r\nFrench EU Drug Precursor Category 3\r\n\r\n> \r\nhttps://staging.scitegrity.com/client/#docs/systemControlCode/4319\r\n\r\n> \r\nhttps://eur-lex.europa.eu/legal-content/FR/TXT/PDF/?uri=CELEX:32004R0273&from=EN\r\n\r\n> \r\nhttps://eur-lex.europa.eu/legal-content/EN/TXT/?uri=CELEX:32004R0273\r\n\r\n$$$$\r\n\r\n SciTegic01282510202D\r\n\r\n 5 4 0 0 0 0 999 V2000\r\n 1.3000 0.7500 0.0000 C 0 0\r\n 0.2606 0.1503 0.0000 C 0 0\r\n 2.6000 0.0000 0.0000 O 0 0\r\n 3.9000 0.7500 0.0000 C 0 0\r\n 4.9394 0.1503 0.0000 C 0 0\r\n 1 2 1 0\r\n 1 3 1 0\r\n 3 4 1 0\r\n 4 5 1 0\r\nM END\r\n> \r\nPOSTMAN_TEST_1\r\n\r\n> \r\nControlled\r\n\r\n> \r\nExact match.\r\n\r\n> \r\n4\r\n\r\n> \r\nfalse\r\n\r\n> \r\n766\r\n\r\n> \r\n14053\r\n\r\n> \r\nFrance\r\n\r\n> \r\nFrance - Regulation (EC) No 111/2005 on drug precursors\r\n\r\n> \r\nEther éthylique\r\n\r\n> \r\n134\r\n\r\n> \r\nFrench EU Drug Precursor Category 3\r\n\r\n> \r\nhttps://staging.scitegrity.com/client/#docs/systemControlCode/4319\r\n\r\n> \r\nhttps://eur-lex.europa.eu/legal-content/FR/TXT/PDF/?uri=CELEX:32005R0111&from=EN\r\n\r\n> \r\nhttps://eur-lex.europa.eu/legal-content/EN/TXT/?qid=1430479010032&uri=CELEX:32005R0111\r\n\r\n$$$$\r\n\r\n SciTegic01282510202D\r\n\r\n 5 4 0 0 0 0 999 V2000\r\n 1.3000 0.7500 0.0000 C 0 0\r\n 0.2606 0.1503 0.0000 C 0 0\r\n 2.6000 0.0000 0.0000 O 0 0\r\n 3.9000 0.7500 0.0000 C 0 0\r\n 4.9394 0.1503 0.0000 C 0 0\r\n 1 2 1 0\r\n 1 3 1 0\r\n 3 4 1 0\r\n 4 5 1 0\r\nM END\r\n> \r\nPOSTMAN_TEST_1\r\n\r\n> \r\nControlled\r\n\r\n> \r\nExact match.\r\n\r\n> \r\n5\r\n\r\n> \r\nfalse\r\n\r\n> \r\n766\r\n\r\n> \r\n4558\r\n\r\n> \r\nIreland\r\n\r\n> \r\nIreland - Regulation (EC) No 273/2004 on drug precursors\r\n\r\n> \r\nEthyl ether\r\n\r\n> \r\n112\r\n\r\n> \r\nIrish EU Drug Precursor Category 3\r\n\r\n> \r\nhttps://staging.scitegrity.com/client/#docs/systemControlCode/4325\r\n\r\n> \r\nhttps://eur-lex.europa.eu/legal-content/EN/TXT/PDF/?uri=CELEX:32004R0273&from=EN\r\n\r\n> \r\nhttps://eur-lex.europa.eu/legal-content/EN/TXT/?uri=CELEX:32004R0273\r\n\r\n$$$$\r\n\r\n SciTegic01282510202D\r\n\r\n 5 4 0 0 0 0 999 V2000\r\n 1.3000 0.7500 0.0000 C 0 0\r\n 0.2606 0.1503 0.0000 C 0 0\r\n 2.6000 0.0000 0.0000 O 0 0\r\n 3.9000 0.7500 0.0000 C 0 0\r\n 4.9394 0.1503 0.0000 C 0 0\r\n 1 2 1 0\r\n 1 3 1 0\r\n 3 4 1 0\r\n 4 5 1 0\r\nM END\r\n> \r\nPOSTMAN_TEST_1\r\n\r\n> \r\nControlled\r\n\r\n> \r\nExact match.\r\n\r\n> \r\n5\r\n\r\n> \r\nfalse\r\n\r\n> \r\n766\r\n\r\n> \r\n13996\r\n\r\n> \r\nIreland\r\n\r\n> \r\nIreland - Regulation (EC) No 111/2005 on drug precursors\r\n\r\n> \r\nEthyl ether\r\n\r\n> \r\n112\r\n\r\n> \r\nIrish EU Drug Precursor Category 3\r\n\r\n> \r\nhttps://staging.scitegrity.com/client/#docs/systemControlCode/4325\r\n\r\n> \r\nhttps://eur-lex.europa.eu/legal-content/EN/TXT/PDF/?uri=CELEX:32005R0111&from=EN\r\n\r\n> \r\nhttps://eur-lex.europa.eu/legal-content/EN/TXT/?qid=1430479010032&uri=CELEX:32005R0111\r\n\r\n$$$$\r\n\r\n SciTegic01282510202D\r\n\r\n 5 4 0 0 0 0 999 V2000\r\n 1.3000 0.7500 0.0000 C 0 0\r\n 3.9000 0.7500 0.0000 C 0 0\r\n 0.2606 0.1503 0.0000 C 0 0\r\n 4.9394 0.1503 0.0000 C 0 0\r\n 2.6000 0.0000 0.0000 N 0 0\r\n 1 5 1 0\r\n 2 5 1 0\r\n 1 3 1 0\r\n 2 4 1 0\r\nM END\r\n> \r\nPOSTMAN_TEST_2\r\n\r\n> \r\nControlled\r\n\r\n> \r\nExact match.\r\n\r\n> \r\n2\r\n\r\n> \r\nfalse\r\n\r\n> \r\n4813\r\n\r\n> \r\n46229\r\n\r\n> \r\nUnited Kingdom\r\n\r\n> \r\nUK Strategic Export Control Lists\r\n\r\n> \r\nDiethylamine\r\n\r\n> \r\n399\r\n400\r\n\r\n> \r\nUK Dual Use Items - EU Cat. 1C (Materials)\r\nUK CWC Precursors\r\n\r\n> \r\nhttps://staging.scitegrity.com/client/#docs/systemControlCode/2921\r\nhttps://staging.scitegrity.com/client/#docs/systemControlCode/2762\r\n\r\n> \r\nhttps://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/948279/uk-strategic-export-control-list.pdf\r\n\r\n> \r\nhttps://www-gov-uk.translate.goog/government/publications/uk-strategic-export-control-lists-the-consolidated-list-of-strategic-military-and-dual-use-items-that-require-export-authorisation?_x_tr_sl=au\r\nto&_x_tr_tl=en&_x_tr_hl=en-GB\r\n\r\n> \r\n1C350, Chemicals, which may be used as precursors for toxic chemical agents.\r\n\r\n$$$$\r\n\r\n SciTegic01282510202D\r\n\r\n 5 4 0 0 0 0 999 V2000\r\n 1.3000 0.7500 0.0000 C 0 0\r\n 3.9000 0.7500 0.0000 C 0 0\r\n 0.2606 0.1503 0.0000 C 0 0\r\n 4.9394 0.1503 0.0000 C 0 0\r\n 2.6000 0.0000 0.0000 N 0 0\r\n 1 5 1 0\r\n 2 5 1 0\r\n 1 3 1 0\r\n 2 4 1 0\r\nM END\r\n> \r\nPOSTMAN_TEST_2\r\n\r\n> \r\nControlled\r\n\r\n> \r\nExact match.\r\n\r\n> \r\n3\r\n\r\n> \r\nfalse\r\n\r\n> \r\n4813\r\n\r\n> \r\n34144\r\n\r\n> \r\nUnited States of America\r\n\r\n> \r\nCommerce Control List (United States)\r\n\r\n> \r\nDiethylamine\r\n\r\n> \r\n291\r\n217\r\n198\r\n\r\n> \r\nUS CWC Precursors\r\nUS CCL AT\r\nUS CCL CB2\r\n\r\n> \r\nhttps://staging.scitegrity.com/client/#docs/systemControlCode/4248\r\nhttps://staging.scitegrity.com/client/#docs/systemControlCode/4510\r\nhttps://staging.scitegrity.com/client/#docs/systemControlCode/4511\r\n\r\n> \r\nhttps://www.bis.gov/ear\r\n\r\n> \r\nhttps://www-bis-gov.translate.goog/ear?_x_tr_sl=auto&_x_tr_tl=en&_x_tr_hl=en-US&_x_tr_pto=wapp\r\n\r\n> \r\nIC350 - Chemicals that may be used as precursors for toxic chemical agents. IC350 d - Australia Group-controlled precursor chemicals not also identified as Schedule 1,2 or 3 chemicals under the Chemic\r\nal Weapons Convention. Includes mixtures containing at least 30% of the chemical by weight.\r\n\r\n$$$$\r\n"}],"_postman_id":"2a805986-17ee-4c5a-96bf-071e8590a1d8"}],"id":"e16424ea-2f03-4b19-8387-2b3d6e38f0c8","description":"

Endpoints to start CS2 controlled status determination jobs, check the status of these jobs and to get job results.

\n","_postman_id":"e16424ea-2f03-4b19-8387-2b3d6e38f0c8"},{"name":"/job","item":[{"name":"/fastlookupRefresh","event":[{"listen":"test","script":{"id":"99c09a66-a1a4-4d58-91ae-ba1740ba2cf4","exec":["// parse response and set gatewayJobId as environment variable\r","var response = pm.response.json();\r","pm.environment.set(\"jobId\", response.gatewayJobId);"],"type":"text/javascript","packages":{}}}],"id":"5598b0ff-d333-4b03-8201-f4b1c1f704cd","protocolProfileBehavior":{"disableBodyPruning":true},"request":{"method":"POST","header":[{"key":"Content-Type","value":"application/json"},{"key":"x-access-token","value":"{{token}}","description":"

This header needs to have the authentication token obtained from the /authenticate API to allow requests to be sent to this endpoint

\n"}],"body":{"mode":"raw","raw":"{\r\n \"fileContent\": \"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\"\r\n}","options":{"raw":{"language":"json"}}},"url":"https://{{host}}:{{port}}/job/fastlookupRefresh","description":"

Send a batch of compounds to the CS2 fastlookup webservice to be populated in the CS2 fastlookup table. This API call will return a gatewayJobId which can be used to monitor the job and retrieve the CS2 results using the /job/fastlookupRefresh/resultendpoint.

This is a protected route - the CS2 administrator needs to permit a user to use this API.

Body parameters

fileContent: string
This is required and must contain the base64 encoded content of a valid SD file. The SD file needs to contain a field named corporateId which contains the identifier of the compound (e.g. SCITEGRITY-123). The SD file can optionally include an array field named otherIds for providing synonyms for the compound and a field named fastlookupIdSource which can be used to denote the source of the compound (e.g. CorporateDB1). NOTE: DO NOT USE INTEGERS FOR CORPORATEIDs - this can cause issues where users unintentionally use precalculated results when using an integer index for their file of compounds - always prefix or postfix this with a label (i.e. use COMP123 as corporateId not 123).

Only 1 process within your organization should be submitting to this service. It should collate all the compounds from the various compound structure stores, ensuring IDs are unique across stores. We suggest each call should have ~4000 structures in the .sdf file format, base64 encoded into JSON body of the request. CS2 will automatically split the submitted compounds across multiple cores in the background to fully utilise the server

\n","urlObject":{"protocol":"https","port":"{{port}}","path":["job","fastlookupRefresh"],"host":["{{host}}"],"query":[],"variable":[]}},"response":[{"id":"5b32f7a1-752b-4370-8a6d-2d11d4f26a20","name":"/job/fastlookupRefresh","originalRequest":{"method":"POST","header":[{"key":"Content-Type","type":"text","value":"application/json"},{"description":"This header needs to have the authenication token obtained from the /owner/authenticate API to allow jobs to be sent to this endpoint","key":"x-access-token","type":"text","value":""}],"body":{"mode":"raw","raw":"{\r\n \"fileContent\": \"DQogIFNjaVRlZ2ljMDcyNzIwMTAyMTJEDQoNCiAgNCAgMyAgMCAgMCAgMCAgMCAgICAgICAgICAgIDk5OSBWMjAwMA0KICAgIDAuMDAwMCAgICAwLjAwMDAgICAgMC4wMDAwIEMgICAwICAwDQogICAgMC4wMDAwICAgIDAuMDAwMCAgICAwLjAwMDAgQyAgIDAgIDANCiAgICAwLjAwMDAgICAgMC4wMDAwICAgIDAuMDAwMCBPICAgMCAgMA0KICAgIDAuMDAwMCAgICAwLjAwMDAgICAgMC4wMDAwIEMgICAwICAwDQogIDEgIDIgIDEgIDANCiAgMiAgMyAgMiAgMA0KICAyICA0ICAxICAwDQpNICBFTkQNCj4gPENvcnBvcmF0ZUlkPg0KU0NJVEVHUklUWS0xDQoNCj4gPEZhc3Rsb29rdXBJZFNvdXJjZT4NClNDSVRFR1JJVFlfREJfMQ0KDQokJCQkDQoNCiAgU2NpVGVnaWMwNzI3MjAxMDIxMkQNCg0KIDE0IDE1ICAwICAwICAwICAwICAgICAgICAgICAgOTk5IFYyMDAwDQogICAgMC4wMDAwICAgIDAuMDAwMCAgICAwLjAwMDAgQyAgIDAgIDANCiAgICAwLjAwMDAgICAgMC4wMDAwICAgIDAuMDAwMCBDICAgMCAgMA0KICAgIDAuMDAwMCAgICAwLjAwMDAgICAgMC4wMDAwIE4gICAwICAwDQogICAgMC4wMDAwICAgIDAuMDAwMCAgICAwLjAwMDAgQyAgIDAgIDANCiAgICAwLjAwMDAgICAgMC4wMDAwICAgIDAuMDAwMCBDICAgMCAgMA0KICAgIDAuMDAwMCAgICAwLjAwMDAgICAgMC4wMDAwIEMgICAwICAwDQogICAgMC4wMDAwICAgIDAuMDAwMCAgICAwLjAwMDAgQyAgIDAgIDANCiAgICAwLjAwMDAgICAgMC4wMDAwICAgIDAuMDAwMCBDICAgMCAgMA0KICAgIDAuMDAwMCAgICAwLjAwMDAgICAgMC4wMDAwIEMgICAwICAwDQogICAgMC4wMDAwICAgIDAuMDAwMCAgICAwLjAwMDAgTyAgIDAgIDANCiAgICAwLjAwMDAgICAgMC4wMDAwICAgIDAuMDAwMCBDICAgMCAgMA0KICAgIDAuMDAwMCAgICAwLjAwMDAgICAgMC4wMDAwIE8gICAwICAwDQogICAgMC4wMDAwICAgIDAuMDAwMCAgICAwLjAwMDAgQyAgIDAgIDANCiAgICAwLjAwMDAgICAgMC4wMDAwICAgIDAuMDAwMCBDICAgMCAgMA0KICAxICAyICAxICAwDQogIDIgIDMgIDEgIDANCiAgMyAgNCAgMSAgMA0KICAyICA1ICAxICAwDQogIDUgIDYgIDEgIDANCiAgNiAgNyAgMiAgMw0KICA3ICA4ICAxICAwDQogIDggIDkgIDIgIDMNCiAgOSAxMCAgMSAgMA0KIDEwIDExICAxICAwDQogMTEgMTIgIDEgIDANCiAgOSAxMyAgMSAgMA0KIDEzIDEyICAxICAwDQogMTMgMTQgIDIgIDMNCiAxNCAgNiAgMSAgMA0KTSAgRU5EDQo+IDxDb3Jwb3JhdGVJZD4NClNDSVRFR1JJVFktMg0KDQo+IDxGYXN0bG9va3VwSWRTb3VyY2U+DQpTQ0lURUdSSVRZX0RCXzENCg0KJCQkJA0KDQogIFNjaVRlZ2ljMDcyNzIwMTAyMTJEDQoNCiAgNSAgNSAgMCAgMCAgMCAgMCAgICAgICAgICAgIDk5OSBWMjAwMA0KICAgIDAuMDAwMCAgICAwLjAwMDAgICAgMC4wMDAwIEMgICAwICAwDQogICAgMC4wMDAwICAgIDAuMDAwMCAgICAwLjAwMDAgQyAgIDAgIDANCiAgICAwLjAwMDAgICAgMC4wMDAwICAgIDAuMDAwMCBDICAgMCAgMA0KICAgIDAuMDAwMCAgICAwLjAwMDAgICAgMC4wMDAwIE4gICAwICAwDQogICAgMC4wMDAwICAgIDAuMDAwMCAgICAwLjAwMDAgQyAgIDAgIDANCiAgMSAgMiAgMSAgMA0KICAyICAzICAxICAwDQogIDMgIDQgIDEgIDANCiAgNCAgNSAgMSAgMA0KICA1ICAxICAxICAwDQpNICBFTkQNCj4gPENvcnBvcmF0ZUlkPg0KU0NJVEVHUklUWS0zDQoNCj4gPEZhc3Rsb29rdXBJZFNvdXJjZT4NClNDSVRFR1JJVFlfREJfMQ0KDQokJCQkDQoNCiAgU2NpVGVnaWMwNzI3MjAxMDIxMkQNCg0KIDEyIDEzICAwICAwICAxICAwICAgICAgICAgICAgOTk5IFYyMDAwDQogICAgMC4wMDAwICAgIDAuMDAwMCAgICAwLjAwMDAgQyAgIDAgIDANCiAgICAwLjAwMDAgICAgMC4wMDAwICAgIDAuMDAwMCBOICAgMCAgMA0KICAgIDAuMDAwMCAgICAwLjAwMDAgICAgMC4wMDAwIEMgICAwICAwDQogICAgMC4wMDAwICAgIDAuMDAwMCAgICAwLjAwMDAgQyAgIDAgIDANCiAgICAwLjAwMDAgICAgMC4wMDAwICAgIDAuMDAwMCBDICAgMCAgMA0KICAgIDAuMDAwMCAgICAwLjAwMDAgICAgMC4wMDAwIEMgICAwICAwICAxICAwICAwICAwDQogICAgMC4wMDAwICAgIDAuMDAwMCAgICAwLjAwMDAgQyAgIDAgIDANCiAgICAwLjAwMDAgICAgMC4wMDAwICAgIDAuMDAwMCBDICAgMCAgMA0KICAgIDAuMDAwMCAgICAwLjAwMDAgICAgMC4wMDAwIEMgICAwICAwDQogICAgMC4wMDAwICAgIDAuMDAwMCAgICAwLjAwMDAgQyAgIDAgIDANCiAgICAwLjAwMDAgICAgMC4wMDAwICAgIDAuMDAwMCBOICAgMCAgMA0KICAgIDAuMDAwMCAgICAwLjAwMDAgICAgMC4wMDAwIEMgICAwICAwDQogIDEgIDIgIDEgIDANCiAgMiAgMyAgMSAgMA0KICAzICA0ICAxICAwDQogIDQgIDUgIDEgIDANCiAgNSAgNiAgMSAgMA0KICA2ICAyICAxICAwDQogIDYgIDcgIDEgIDENCiAgNyAgOCAgMiAgMw0KICA4ICA5ICAxICAwDQogIDkgMTAgIDIgIDMNCiAxMCAxMSAgMSAgMA0KIDExIDEyICAyICAzDQogMTIgIDcgIDEgIDANCk0gIEVORA0KPiA8Q29ycG9yYXRlSWQ+DQpTQ0lURUdSSVRZLTQNCg0KPiA8RmFzdGxvb2t1cElkU291cmNlPg0KU0NJVEVHUklUWV9EQl8xDQoNCiQkJCQNCg==\"\r\n}","options":{"raw":{"language":"json"}}},"url":"https://{{host}}:{{port}}/job/fastlookupRefresh"},"status":"Created","code":201,"_postman_previewlanguage":"json","header":null,"cookie":[],"responseTime":null,"body":"{\n \"gatewayJobId\": \"GWJ-2f66a630-e50e-11e9-89c4-c5fdf9927ee6\"\n}"}],"_postman_id":"5598b0ff-d333-4b03-8201-f4b1c1f704cd"},{"name":"/fastlookupRefresh/result","event":[{"listen":"test","script":{"id":"5d7cba73-10b3-4d04-bad7-d432effdfce7","exec":[""],"type":"text/javascript","packages":{}}}],"id":"8a217ff1-b3ab-4d51-b647-2a287bac30f0","protocolProfileBehavior":{"disableBodyPruning":true},"request":{"method":"POST","header":[{"key":"Content-Type","type":"text","value":"application/json"},{"description":"

This header needs to have the authenication token obtained from the /authenticate API to allow requests to be sent to this endpoint

\n","key":"x-access-token","type":"text","value":"{{token}}"}],"body":{"mode":"raw","raw":"{\r\n \"gatewayJobId\": \"{{jobId}}\"\r\n}","options":{"raw":{"language":"json"}}},"url":"https://{{host}}:{{port}}/job/fastlookupRefresh/result","description":"

Retrieve the results of a previously submitted fastlookup job. If the job is still running the request will show the status of the job. If the job has completed the CS2 results will be returned in the response.

This is a protected route - the CS2 administrator needs to permit a user to use this API.

Look at the example completed job to see the format of CS2 results returned

\n","urlObject":{"protocol":"https","port":"{{port}}","path":["job","fastlookupRefresh","result"],"host":["{{host}}"],"query":[],"variable":[]}},"response":[{"id":"62221dba-8be5-4bb8-9f44-a9d561096f94","name":"Job Running","originalRequest":{"method":"POST","header":[{"key":"Content-Type","value":"application/json","type":"text"},{"key":"x-access-token","value":"{{token}}","description":"This header needs to have the authenication token obtained from the /owner/authenticate API to allow requests to be sent to this endpoint","type":"text"}],"body":{"mode":"raw","raw":"{\r\n \"gatewayJobId\": \"GWJ-76ddf1b0-cff7-11ea-a7d7-512f81afdad9\"\r\n}","options":{"raw":{"language":"json"}}},"url":"https://{{host}}:{{port}}/job/fastlookupRefresh/result"},"status":"OK","code":200,"_postman_previewlanguage":"json","header":[{"key":"Date","value":"Mon, 27 Jul 2020 10:54:36 GMT","enabled":true},{"key":"Content-Type","value":"application/json; charset=utf-8","enabled":true},{"key":"Content-Length","value":"130","enabled":true},{"key":"Connection","value":"keep-alive","enabled":true},{"key":"X-DNS-Prefetch-Control","value":"off","enabled":true},{"key":"X-Frame-Options","value":"SAMEORIGIN","enabled":true},{"key":"Strict-Transport-Security","value":"max-age=15552000; includeSubDomains","enabled":true},{"key":"X-Download-Options","value":"noopen","enabled":true},{"key":"X-Content-Type-Options","value":"nosniff","enabled":true},{"key":"X-XSS-Protection","value":"1; mode=block","enabled":true},{"key":"ETag","value":"W/\"82-xTaMvhafWuraRsw6Tun8OgshJrk\"","enabled":true}],"cookie":[],"responseTime":null,"body":"{\n \"jobStatus\": \"running\",\n \"jobResult\": null,\n \"updatedAt\": \"2020-07-27T10:54:08.000Z\",\n \"ownerId\": \"GWU-70019290-6ea2-11ea-8147-e76818d102cf\"\n}"},{"id":"4e917dcf-bef8-4cb1-9684-37e518b6e9c4","name":"Job Complete","originalRequest":{"method":"POST","header":[{"key":"Content-Type","type":"text","value":"application/json"},{"description":"This header needs to have the authenication token obtained from the /authenticate API to allow requests to be sent to this endpoint","key":"x-access-token","type":"text","value":"{{token}}"}],"body":{"mode":"raw","raw":"{\r\n \"gatewayJobId\": \"{{jobId}}\"\r\n}","options":{"raw":{"language":"json"}}},"url":"https://{{host}}:{{port}}/job/fastlookupRefresh/result"},"status":"OK","code":200,"_postman_previewlanguage":"json","header":[{"key":"Date","value":"Thu, 21 Dec 2023 12:46:24 GMT","enabled":true},{"key":"Content-Type","value":"application/json; charset=utf-8","enabled":true},{"key":"Content-Length","value":"54626","enabled":true},{"key":"Connection","value":"keep-alive","enabled":true},{"key":"X-Frame-Options","value":"SAMEORIGIN","enabled":true},{"key":"Strict-Transport-Security","value":"max-age=63072000; includeSubDomains; preload","enabled":true},{"key":"ETag","value":"W/\"d562-oXW9TKXOUp5AJkRusZheTLThtEc\"","enabled":true}],"cookie":[],"responseTime":null,"body":"{\n \"jobStatus\": \"complete\",\n \"jobResult\": {\n \"records\": [\n {\n \"sysControlCodeDocument\": [\n \"https://staging.scitegrity.com/client/#docs/systemControlCode/2753\"\n ],\n \"idSysControlledCode\": [\n 46\n ],\n \"corporateId\": \"SCITEGRITY-1\",\n \"fastlookupIdSource\": \"SCITEGRITY_DB_1\",\n \"idLeg2Sub\": 11660,\n \"resultComments\": \"Exact match.\",\n \"controlledStatus\": \"Controlled\",\n \"checkStatus\": \"Completed\",\n \"companyDefinedRule\": false,\n \"nativeLink\": \"https://eur-lex.europa.eu/legal-content/EN/TXT/PDF/?uri=CELEX:32004R0273&from=EN\",\n \"link\": \"http://eur-lex.europa.eu/legal-content/EN/TXT/?qid=1430479110318&uri=CELEX:32004R0273\",\n \"legislationName\": \"European Union Regulation (EC) No 273/2004 on drug precursors (UK implementation - The Controlled Drugs (Drug Precursors)(Intra-Community Trade) Regulations)\",\n \"idJurisdiction\": 2,\n \"jurisdictionName\": \"United Kingdom\",\n \"substanceLegislationName\": \"Acetone\",\n \"codeName\": [\n \"UK EU Drug Precursor Category 3\"\n ]\n },\n {\n \"sysControlCodeDocument\": [\n \"https://staging.scitegrity.com/client/#docs/systemControlCode/2753\"\n ],\n \"idSysControlledCode\": [\n 46\n ],\n \"corporateId\": \"SCITEGRITY-1\",\n \"fastlookupIdSource\": \"SCITEGRITY_DB_1\",\n \"idLeg2Sub\": 11661,\n \"resultComments\": \"Exact match.\",\n \"controlledStatus\": \"Controlled\",\n \"checkStatus\": \"Completed\",\n \"companyDefinedRule\": false,\n \"nativeLink\": \"https://eur-lex.europa.eu/legal-content/EN/TXT/PDF/?uri=CELEX:32005R0111&from=EN\",\n \"link\": \"http://eur-lex.europa.eu/legal-content/EN/TXT/?qid=1430479010032&uri=CELEX:32005R0111\",\n \"legislationName\": \"European Union Regulation (EC) No 111/2005 on drug precursors (UK implementation - The Controlled Drugs (Drug Precursors)(Community External Trade) Regulations 2008)\",\n \"idJurisdiction\": 2,\n \"jurisdictionName\": \"United Kingdom\",\n \"substanceLegislationName\": \"Acetone\",\n \"codeName\": [\n \"UK EU Drug Precursor Category 3\"\n ]\n },\n {\n \"sysControlCodeDocument\": [\n \"https://staging.scitegrity.com/client/#docs/systemControlCode/2798\"\n ],\n \"idSysControlledCode\": [\n 408\n ],\n \"corporateId\": \"SCITEGRITY-1\",\n \"fastlookupIdSource\": \"SCITEGRITY_DB_1\",\n \"idLeg2Sub\": 47217,\n \"resultComments\": \"Exact match.\",\n \"controlledStatus\": \"Controlled\",\n \"checkStatus\": \"Completed\",\n \"companyDefinedRule\": false,\n \"nativeLink\": \"https://www.legislation.gov.uk/ukpga/1972/66\",\n \"link\": \"https://www-legislation-gov-uk.translate.goog/ukpga/1972/66?_x_tr_sl=auto&_x_tr_tl=en&_x_tr_hl=en-GB\",\n \"legislationName\": \"Poisons Act 1972\",\n \"idJurisdiction\": 2,\n \"jurisdictionName\": \"United Kingdom\",\n \"substanceLegislationName\": \"Acetone\",\n \"codeName\": [\n \"UK Reportable Explosive Precursors\"\n ]\n },\n {\n \"sysControlCodeDocument\": [\n \"https://staging.scitegrity.com/client/#docs/systemControlCode/2884\"\n ],\n \"idSysControlledCode\": [\n 43\n ],\n \"corporateId\": \"SCITEGRITY-1\",\n \"fastlookupIdSource\": \"SCITEGRITY_DB_1\",\n \"idLeg2Sub\": 35747,\n \"resultComments\": \"Exact match.\",\n \"controlledStatus\": \"Controlled\",\n \"checkStatus\": \"Completed\",\n \"companyDefinedRule\": false,\n \"nativeLink\": \"https://www.ecfr.gov/current/title-21/chapter-II\",\n \"link\": \"https://www-ecfr-gov.translate.goog/current/title-21/chapter-II?_x_tr_sl=auto&_x_tr_tl=en&_x_tr_hl=en-GB&_x_tr_pto=nui\",\n \"legislationName\": \"Controlled Substances Act - Regulations 21 CFR, Part 1300-1399\",\n \"idJurisdiction\": 3,\n \"jurisdictionName\": \"United States of America\",\n \"substanceLegislationName\": \"Acetone\",\n \"codeName\": [\n \"US CSA List 2 Regulated Chemical\"\n ]\n },\n {\n \"sysControlCodeDocument\": [\n \"https://staging.scitegrity.com/client/#docs/systemControlCode/3677\"\n ],\n \"idSysControlledCode\": [\n 134\n ],\n \"corporateId\": \"SCITEGRITY-1\",\n \"fastlookupIdSource\": \"SCITEGRITY_DB_1\",\n \"idLeg2Sub\": 14055,\n \"resultComments\": \"Exact match.\",\n \"controlledStatus\": \"Controlled\",\n \"checkStatus\": \"Completed\",\n \"companyDefinedRule\": false,\n \"nativeLink\": \"https://eur-lex.europa.eu/legal-content/FR/TXT/PDF/?uri=CELEX:32004R0273&from=EN\",\n \"link\": \"https://eur-lex.europa.eu/legal-content/EN/TXT/?uri=CELEX:32004R0273\",\n \"legislationName\": \"France - Regulation (EC) No 273/2004 on drug precursors\",\n \"idJurisdiction\": 4,\n \"jurisdictionName\": \"France\",\n \"substanceLegislationName\": \"Acétone\",\n \"codeName\": [\n \"French EU Drug Precursor Category 3\"\n ]\n },\n {\n \"sysControlCodeDocument\": [\n \"https://staging.scitegrity.com/client/#docs/systemControlCode/3677\"\n ],\n \"idSysControlledCode\": [\n 134\n ],\n \"corporateId\": \"SCITEGRITY-1\",\n \"fastlookupIdSource\": \"SCITEGRITY_DB_1\",\n \"idLeg2Sub\": 14056,\n \"resultComments\": \"Exact match.\",\n \"controlledStatus\": \"Controlled\",\n \"checkStatus\": \"Completed\",\n \"companyDefinedRule\": false,\n \"nativeLink\": \"https://eur-lex.europa.eu/legal-content/FR/TXT/PDF/?uri=CELEX:32005R0111&from=EN\",\n \"link\": \"https://eur-lex.europa.eu/legal-content/EN/TXT/?qid=1430479010032&uri=CELEX:32005R0111\",\n \"legislationName\": \"France - Regulation (EC) No 111/2005 on drug precursors\",\n \"idJurisdiction\": 4,\n \"jurisdictionName\": \"France\",\n \"substanceLegislationName\": \"Acétone\",\n \"codeName\": [\n \"French EU Drug Precursor Category 3\"\n ]\n },\n {\n \"sysControlCodeDocument\": [\n \"https://staging.scitegrity.com/client/#docs/systemControlCode/3683\"\n ],\n \"idSysControlledCode\": [\n 112\n ],\n \"corporateId\": \"SCITEGRITY-1\",\n \"fastlookupIdSource\": \"SCITEGRITY_DB_1\",\n \"idLeg2Sub\": 4559,\n \"resultComments\": \"Exact match.\",\n \"controlledStatus\": \"Controlled\",\n \"checkStatus\": \"Completed\",\n \"companyDefinedRule\": false,\n \"nativeLink\": \"https://eur-lex.europa.eu/legal-content/EN/TXT/PDF/?uri=CELEX:32004R0273&from=EN\",\n \"link\": \"https://eur-lex.europa.eu/legal-content/EN/TXT/?uri=CELEX:32004R0273\",\n \"legislationName\": \"Ireland - Regulation (EC) No 273/2004 on drug precursors\",\n \"idJurisdiction\": 5,\n \"jurisdictionName\": \"Ireland\",\n \"substanceLegislationName\": \"Acetone\",\n \"codeName\": [\n \"Irish EU Drug Precursor Category 3\"\n ]\n },\n {\n \"sysControlCodeDocument\": [\n \"https://staging.scitegrity.com/client/#docs/systemControlCode/3683\"\n ],\n \"idSysControlledCode\": [\n 112\n ],\n \"corporateId\": \"SCITEGRITY-1\",\n \"fastlookupIdSource\": \"SCITEGRITY_DB_1\",\n \"idLeg2Sub\": 13997,\n \"resultComments\": \"Exact match.\",\n \"controlledStatus\": \"Controlled\",\n \"checkStatus\": \"Completed\",\n \"companyDefinedRule\": false,\n \"nativeLink\": \"https://eur-lex.europa.eu/legal-content/EN/TXT/PDF/?uri=CELEX:32005R0111&from=EN\",\n \"link\": \"https://eur-lex.europa.eu/legal-content/EN/TXT/?qid=1430479010032&uri=CELEX:32005R0111\",\n \"legislationName\": \"Ireland - Regulation (EC) No 111/2005 on drug precursors\",\n \"idJurisdiction\": 5,\n \"jurisdictionName\": \"Ireland\",\n \"substanceLegislationName\": \"Acetone\",\n \"codeName\": [\n \"Irish EU Drug Precursor Category 3\"\n ]\n },\n {\n \"sysControlCodeDocument\": [\n \"https://staging.scitegrity.com/client/#docs/systemControlCode/3647\"\n ],\n \"idSysControlledCode\": [\n 129\n ],\n \"corporateId\": \"SCITEGRITY-1\",\n \"fastlookupIdSource\": \"SCITEGRITY_DB_1\",\n \"idLeg2Sub\": 13917,\n \"resultComments\": \"Exact match.\",\n \"controlledStatus\": \"Controlled\",\n \"checkStatus\": \"Completed\",\n \"companyDefinedRule\": false,\n \"nativeLink\": \"https://eur-lex.europa.eu/legal-content/FR/TXT/PDF/?uri=CELEX:32004R0273&from=EN\",\n \"link\": \"https://eur-lex.europa.eu/legal-content/EN/TXT/?uri=CELEX:32004R0273\",\n \"legislationName\": \"Belgium - Regulation (EC) No 273/2004 on drug precursors\",\n \"idJurisdiction\": 6,\n \"jurisdictionName\": \"Belgium\",\n \"substanceLegislationName\": \"Acétone\",\n \"codeName\": [\n \"Belgium EU Drug Precursor Category 3\"\n ]\n },\n {\n \"sysControlCodeDocument\": [\n \"https://staging.scitegrity.com/client/#docs/systemControlCode/3647\"\n ],\n \"idSysControlledCode\": [\n 129\n ],\n \"corporateId\": \"SCITEGRITY-1\",\n \"fastlookupIdSource\": \"SCITEGRITY_DB_1\",\n \"idLeg2Sub\": 13918,\n \"resultComments\": \"Exact match.\",\n \"controlledStatus\": \"Controlled\",\n \"checkStatus\": \"Completed\",\n \"companyDefinedRule\": false,\n \"nativeLink\": \"https://eur-lex.europa.eu/legal-content/FR/TXT/PDF/?uri=CELEX:32005R0111&from=EN\",\n \"link\": \"http://eur-lex.europa.eu/legal-content/EN/TXT/?qid=1430479010032&uri=CELEX:32005R0111\",\n \"legislationName\": \"Belgium - Regulation (EC) No 111/2005 on drug precursors\",\n \"idJurisdiction\": 6,\n \"jurisdictionName\": \"Belgium\",\n \"substanceLegislationName\": \"Acétone\",\n \"codeName\": [\n \"Belgium EU Drug Precursor Category 3\"\n ]\n },\n {\n \"sysControlCodeDocument\": [\n \"https://staging.scitegrity.com/client/#docs/systemControlCode/3659\"\n ],\n \"idSysControlledCode\": [\n 149\n ],\n \"corporateId\": \"SCITEGRITY-1\",\n \"fastlookupIdSource\": \"SCITEGRITY_DB_1\",\n \"idLeg2Sub\": 13972,\n \"resultComments\": \"Exact match.\",\n \"controlledStatus\": \"Controlled\",\n \"checkStatus\": \"Completed\",\n \"companyDefinedRule\": false,\n \"nativeLink\": \"https://eur-lex.europa.eu/legal-content/DA/TXT/PDF/?uri=CELEX:32005R0111&from=EN\",\n \"link\": \"https://eur-lex.europa.eu/legal-content/EN/TXT/?qid=1430479010032&uri=CELEX:32005R0111\",\n \"legislationName\": \"Denmark - Regulation (EC) No 111/2005 on drug precursors\",\n \"idJurisdiction\": 7,\n \"jurisdictionName\": \"Denmark\",\n \"substanceLegislationName\": \"Acetone\",\n \"codeName\": [\n \"Danish EU Drug Precursor Category 3\"\n ]\n },\n {\n \"sysControlCodeDocument\": [\n \"https://staging.scitegrity.com/client/#docs/systemControlCode/3659\"\n ],\n \"idSysControlledCode\": [\n 149\n ],\n \"corporateId\": \"SCITEGRITY-1\",\n \"fastlookupIdSource\": \"SCITEGRITY_DB_1\",\n \"idLeg2Sub\": 11623,\n \"resultComments\": \"Exact match.\",\n \"controlledStatus\": \"Controlled\",\n \"checkStatus\": \"Completed\",\n \"companyDefinedRule\": false,\n \"nativeLink\": \"https://eur-lex.europa.eu/legal-content/DA/TXT/PDF/?uri=CELEX:32004R0273&from=EN\",\n \"link\": \"https://eur-lex.europa.eu/legal-content/EN/TXT/?uri=CELEX:32004R0273\",\n \"legislationName\": \"Denmark - Regulation (EC) No 273/2004 on drug precursors\",\n \"idJurisdiction\": 7,\n \"jurisdictionName\": \"Denmark\",\n \"substanceLegislationName\": \"Acetone\",\n \"codeName\": [\n \"Danish EU Drug Precursor Category 3\"\n ]\n },\n {\n \"sysControlCodeDocument\": [\n \"https://staging.scitegrity.com/client/#docs/systemControlCode/3653\"\n ],\n \"idSysControlledCode\": [\n 160\n ],\n \"corporateId\": \"SCITEGRITY-1\",\n \"fastlookupIdSource\": \"SCITEGRITY_DB_1\",\n \"idLeg2Sub\": 4614,\n \"resultComments\": \"Exact match.\",\n \"controlledStatus\": \"Controlled\",\n \"checkStatus\": \"Completed\",\n \"companyDefinedRule\": false,\n \"nativeLink\": \"https://eur-lex.europa.eu/legal-content/DE/TXT/PDF/?uri=CELEX:32004R0273&from=EN\",\n \"link\": \"https://eur-lex.europa.eu/legal-content/EN/TXT/?uri=CELEX:32004R0273\",\n \"legislationName\": \"Germany - Regulation (EC) No 273/2004 on drug precursors\",\n \"idJurisdiction\": 8,\n \"jurisdictionName\": \"Germany\",\n \"substanceLegislationName\": \"Aceton\",\n \"codeName\": [\n \"German EU Drug Precursor Category 3\"\n ]\n },\n {\n \"sysControlCodeDocument\": [\n \"https://staging.scitegrity.com/client/#docs/systemControlCode/3653\"\n ],\n \"idSysControlledCode\": [\n 160\n ],\n \"corporateId\": \"SCITEGRITY-1\",\n \"fastlookupIdSource\": \"SCITEGRITY_DB_1\",\n \"idLeg2Sub\": 13947,\n \"resultComments\": \"Exact match.\",\n \"controlledStatus\": \"Controlled\",\n \"checkStatus\": \"Completed\",\n \"companyDefinedRule\": false,\n \"nativeLink\": \"https://eur-lex.europa.eu/legal-content/DE/TXT/PDF/?uri=CELEX:32005R0111&from=EN\",\n \"link\": \"https://eur-lex.europa.eu/legal-content/EN/TXT/?qid=1430479010032&uri=CELEX:32005R0111\",\n \"legislationName\": \"Germany - Regulation (EC) No 111/2005 on drug precursors\",\n \"idJurisdiction\": 8,\n \"jurisdictionName\": \"Germany\",\n \"substanceLegislationName\": \"Aceton\",\n \"codeName\": [\n \"German EU Drug Precursor Category 3\"\n ]\n },\n {\n \"sysControlCodeDocument\": [\n \"https://staging.scitegrity.com/client/#docs/systemControlCode/3689\"\n ],\n \"idSysControlledCode\": [\n 139\n ],\n \"corporateId\": \"SCITEGRITY-1\",\n \"fastlookupIdSource\": \"SCITEGRITY_DB_1\",\n \"idLeg2Sub\": 4666,\n \"resultComments\": \"Exact match.\",\n \"controlledStatus\": \"Controlled\",\n \"checkStatus\": \"Completed\",\n \"companyDefinedRule\": false,\n \"nativeLink\": \"https://eur-lex.europa.eu/legal-content/IT/TXT/PDF/?uri=CELEX:32004R0273&from=EN\",\n \"link\": \"https://eur-lex.europa.eu/legal-content/EN/TXT/?uri=CELEX:32004R0273\",\n \"legislationName\": \"Italy - Regulation (EC) No 273/2004 on drug precursors\",\n \"idJurisdiction\": 9,\n \"jurisdictionName\": \"Italy\",\n \"substanceLegislationName\": \"Acetone\",\n \"codeName\": [\n \"Italian EU Drug Precursor Category 3\"\n ]\n },\n {\n \"sysControlCodeDocument\": [\n \"https://staging.scitegrity.com/client/#docs/systemControlCode/3689\"\n ],\n \"idSysControlledCode\": [\n 139\n ],\n \"corporateId\": \"SCITEGRITY-1\",\n \"fastlookupIdSource\": \"SCITEGRITY_DB_1\",\n \"idLeg2Sub\": 14115,\n \"resultComments\": \"Exact match.\",\n \"controlledStatus\": \"Controlled\",\n \"checkStatus\": \"Completed\",\n \"companyDefinedRule\": false,\n \"nativeLink\": \"https://eur-lex.europa.eu/legal-content/IT/TXT/PDF/?uri=CELEX:32005R0111&from=EN\",\n \"link\": \"https://eur-lex.europa.eu/legal-content/EN/TXT/?qid=1430479010032&uri=CELEX:32005R0111\",\n \"legislationName\": \"Italy - Regulation (EC) No 111/2005 on drug precursors\",\n \"idJurisdiction\": 9,\n \"jurisdictionName\": \"Italy\",\n \"substanceLegislationName\": \"Acetone\",\n \"codeName\": [\n \"Italian EU Drug Precursor Category 3\"\n ]\n },\n {\n \"sysControlCodeDocument\": [\n \"https://staging.scitegrity.com/client/#docs/systemControlCode/3695\"\n ],\n \"idSysControlledCode\": [\n 154\n ],\n \"corporateId\": \"SCITEGRITY-1\",\n \"fastlookupIdSource\": \"SCITEGRITY_DB_1\",\n \"idLeg2Sub\": 4692,\n \"resultComments\": \"Exact match.\",\n \"controlledStatus\": \"Controlled\",\n \"checkStatus\": \"Completed\",\n \"companyDefinedRule\": false,\n \"nativeLink\": \"https://eur-lex.europa.eu/legal-content/NL/TXT/PDF/?uri=CELEX:32004R0273&from=EN\",\n \"link\": \"https://eur-lex.europa.eu/legal-content/EN/ALL/?uri=CELEX%3A32004R0273\",\n \"legislationName\": \"Netherlands - Regulation (EC) No 273/2004 on drug precursors\",\n \"idJurisdiction\": 10,\n \"jurisdictionName\": \"Netherlands\",\n \"substanceLegislationName\": \"Aceton\",\n \"codeName\": [\n \"Netherlands EU Drug Precursor Category 3\"\n ]\n },\n {\n \"sysControlCodeDocument\": [\n \"https://staging.scitegrity.com/client/#docs/systemControlCode/3695\"\n ],\n \"idSysControlledCode\": [\n 154\n ],\n \"corporateId\": \"SCITEGRITY-1\",\n \"fastlookupIdSource\": \"SCITEGRITY_DB_1\",\n \"idLeg2Sub\": 14088,\n \"resultComments\": \"Exact match.\",\n \"controlledStatus\": \"Controlled\",\n \"checkStatus\": \"Completed\",\n \"companyDefinedRule\": false,\n \"nativeLink\": \"https://eur-lex.europa.eu/legal-content/NL/TXT/PDF/?uri=CELEX:32005R0111&from=EN\",\n \"link\": \"https://eur-lex.europa.eu/legal-content/EN/TXT/?qid=1430479010032&uri=CELEX:32005R0111\",\n \"legislationName\": \"Netherlands - Regulation (EC) No 111/2005 on drug precursors\",\n \"idJurisdiction\": 10,\n \"jurisdictionName\": \"Netherlands\",\n \"substanceLegislationName\": \"Aceton\",\n \"codeName\": [\n \"Netherlands EU Drug Precursor Category 3\"\n ]\n },\n {\n \"sysControlCodeDocument\": [\n \"https://staging.scitegrity.com/client/#docs/systemControlCode/3665\"\n ],\n \"idSysControlledCode\": [\n 144\n ],\n \"corporateId\": \"SCITEGRITY-1\",\n \"fastlookupIdSource\": \"SCITEGRITY_DB_1\",\n \"idLeg2Sub\": 4718,\n \"resultComments\": \"Exact match.\",\n \"controlledStatus\": \"Controlled\",\n \"checkStatus\": \"Completed\",\n \"companyDefinedRule\": false,\n \"nativeLink\": \"https://eur-lex.europa.eu/legal-content/ES/TXT/PDF/?uri=CELEX:32004R0273&from=EN\",\n \"link\": \"https://eur-lex.europa.eu/legal-content/EN/TXT/?uri=CELEX:32004R0273\",\n \"legislationName\": \"Spain - Regulation (EC) No 273/2004 on drug precursors\",\n \"idJurisdiction\": 11,\n \"jurisdictionName\": \"Spain\",\n \"substanceLegislationName\": \"Acetona\",\n \"codeName\": [\n \"Spanish EU Drug Precursor Category 3\"\n ]\n },\n {\n \"sysControlCodeDocument\": [\n \"https://staging.scitegrity.com/client/#docs/systemControlCode/3665\"\n ],\n \"idSysControlledCode\": [\n 144\n ],\n \"corporateId\": \"SCITEGRITY-1\",\n \"fastlookupIdSource\": \"SCITEGRITY_DB_1\",\n \"idLeg2Sub\": 14140,\n \"resultComments\": \"Exact match.\",\n \"controlledStatus\": \"Controlled\",\n \"checkStatus\": \"Completed\",\n \"companyDefinedRule\": false,\n \"nativeLink\": \"https://eur-lex.europa.eu/legal-content/ES/TXT/PDF/?uri=CELEX:32005R0111&from=EN\",\n \"link\": \"https://eur-lex.europa.eu/legal-content/EN/TXT/?qid=1430479010032&uri=CELEX:32005R0111\",\n \"legislationName\": \"Spain - Regulation (EC) No 111/2005 on drug precursors\",\n \"idJurisdiction\": 11,\n \"jurisdictionName\": \"Spain\",\n \"substanceLegislationName\": \"Acetona\",\n \"codeName\": [\n \"Spanish EU Drug Precursor Category 3\"\n ]\n },\n {\n \"sysControlCodeDocument\": [\n \"https://staging.scitegrity.com/client/#docs/systemControlCode/3707\"\n ],\n \"idSysControlledCode\": [\n 165\n ],\n \"corporateId\": \"SCITEGRITY-1\",\n \"fastlookupIdSource\": \"SCITEGRITY_DB_1\",\n \"idLeg2Sub\": 4745,\n \"resultComments\": \"Exact match.\",\n \"controlledStatus\": \"Controlled\",\n \"checkStatus\": \"Completed\",\n \"companyDefinedRule\": false,\n \"nativeLink\": \"https://eur-lex.europa.eu/legal-content/SV/TXT/PDF/?uri=CELEX:32004R0273&from=EN\",\n \"link\": \"https://eur-lex.europa.eu/legal-content/EN/TXT/?uri=CELEX:32004R0273\",\n \"legislationName\": \"Sweden - Regulation (EC) No 273/2004 on drug precursors\",\n \"idJurisdiction\": 12,\n \"jurisdictionName\": \"Sweden\",\n \"substanceLegislationName\": \"Aceton\",\n \"codeName\": [\n \"Swedish EU Drug Precursor Category 3\"\n ]\n },\n {\n \"corporateId\": \"SCITEGRITY-1\",\n \"fastlookupIdSource\": \"SCITEGRITY_DB_1\",\n \"idLeg2Sub\": 60522,\n \"resultComments\": \"Exact match.\",\n \"controlledStatus\": \"Controlled\",\n \"checkStatus\": \"Completed\",\n \"companyDefinedRule\": false,\n \"nativeLink\": \"https://laboratorium.bnn.go.id/asset/permenkes/PMK%20No.%2029%20Th%202023%20ttg%20Perubahan%20Penggolongan%20Prekursor-signed.pdf\",\n \"link\": \"\",\n \"legislationName\": \"Changes in the classification of precursros\",\n \"idJurisdiction\": 37,\n \"jurisdictionName\": \"Indonesia\",\n \"substanceLegislationName\": \"Acetone\",\n \"codeName\": [\n \"Indonesian Table 2 Precursors\"\n ]\n },\n {\n \"corporateId\": \"SCITEGRITY-1\",\n \"fastlookupIdSource\": \"SCITEGRITY_DB_1\",\n \"idLeg2Sub\": 58672,\n \"resultComments\": \"Exact match.\",\n \"controlledStatus\": \"Controlled\",\n \"checkStatus\": \"Completed\",\n \"companyDefinedRule\": false,\n \"nativeLink\": \"https://laws.boe.gov.sa/BoeLaws/Laws/LawDetails/221b3286-a3c6-4ea4-97c7-a9a700f18273/1\",\n \"link\": \"https://laws-boe-gov-sa.translate.goog/BoeLaws/Laws/LawDetails/221b3286-a3c6-4ea4-97c7-a9a700f18273/1?_x_tr_sl=auto&_x_tr_tl=en&_x_tr_hl=en-US&_x_tr_pto=wapp\",\n \"legislationName\": \"Drugs and Narcotics Control Law\",\n \"idJurisdiction\": 35,\n \"jurisdictionName\": \"Saudi Arabia\",\n \"substanceLegislationName\": \"Acetone\",\n \"codeName\": [\n \"Saudi Category B Precursors\"\n ]\n },\n {\n \"sysControlCodeDocument\": [\n \"https://staging.scitegrity.com/client/#docs/systemControlCode/3707\"\n ],\n \"idSysControlledCode\": [\n 165\n ],\n \"corporateId\": \"SCITEGRITY-1\",\n \"fastlookupIdSource\": \"SCITEGRITY_DB_1\",\n \"idLeg2Sub\": 13849,\n \"resultComments\": \"Exact match.\",\n \"controlledStatus\": \"Controlled\",\n \"checkStatus\": \"Completed\",\n \"companyDefinedRule\": false,\n \"nativeLink\": \"https://eur-lex.europa.eu/legal-content/SV/TXT/PDF/?uri=CELEX:32005R0111&from=EN\",\n \"link\": \"https://eur-lex.europa.eu/legal-content/EN/TXT/?qid=1430479010032&uri=CELEX:32005R0111\",\n \"legislationName\": \"Sweden - Regulation (EC) No 111/2005 on drug precursors\",\n \"idJurisdiction\": 12,\n \"jurisdictionName\": \"Sweden\",\n \"substanceLegislationName\": \"Aceton\",\n \"codeName\": [\n \"Swedish EU Drug Precursor Category 3\"\n ]\n },\n {\n \"sysControlCodeDocument\": [\n \"https://staging.scitegrity.com/client/#docs/systemControlCode/3229\"\n ],\n \"idSysControlledCode\": [\n 49\n ],\n \"corporateId\": \"SCITEGRITY-1\",\n \"fastlookupIdSource\": \"SCITEGRITY_DB_1\",\n \"idLeg2Sub\": 27296,\n \"resultComments\": \"Exact match.\",\n \"controlledStatus\": \"Controlled\",\n \"checkStatus\": \"Completed\",\n \"companyDefinedRule\": false,\n \"nativeLink\": \"http://www.admin.ch/opc/de/classified-compilation/20101220/index.html\",\n \"link\": \"\",\n \"legislationName\": \"Regulation of EDI over the lists of narcotics, psychotropic substances, precursors and auxiliary chemicals\",\n \"idJurisdiction\": 13,\n \"jurisdictionName\": \"Switzerland\",\n \"substanceLegislationName\": \"Aceton\",\n \"codeName\": [\n \"Swiss Directory G\"\n ]\n },\n {\n \"sysControlCodeDocument\": [\n \"https://staging.scitegrity.com/client/#docs/systemControlCode/2843\"\n ],\n \"idSysControlledCode\": [\n 168\n ],\n \"corporateId\": \"SCITEGRITY-1\",\n \"fastlookupIdSource\": \"SCITEGRITY_DB_1\",\n \"idLeg2Sub\": 6858,\n \"resultComments\": \"Exact match.\",\n \"controlledStatus\": \"Controlled\",\n \"checkStatus\": \"Completed\",\n \"companyDefinedRule\": false,\n \"nativeLink\": \"http://laws-lois.justice.gc.ca/eng/acts/C-38.8/\",\n \"link\": \"https://laws--lois-justice-gc-ca.translate.goog/eng/acts/C-38.8/?_x_tr_sl=auto&_x_tr_tl=en&_x_tr_hl=en-GB&_x_tr_pto=nui\",\n \"legislationName\": \"Controlled Drugs and Substances Act (S.C. 1996, c. 19)\",\n \"idJurisdiction\": 14,\n \"jurisdictionName\": \"Canada\",\n \"substanceLegislationName\": \"Acetone\",\n \"codeName\": [\n \"Canadian Schedule VI pt2\"\n ]\n },\n {\n \"sysControlCodeDocument\": [\n \"https://staging.scitegrity.com/client/#docs/systemControlCode/3201\"\n ],\n \"idSysControlledCode\": [\n 170\n ],\n \"corporateId\": \"SCITEGRITY-1\",\n \"fastlookupIdSource\": \"SCITEGRITY_DB_1\",\n \"idLeg2Sub\": 25010,\n \"resultComments\": \"Exact match.\",\n \"controlledStatus\": \"Controlled\",\n \"checkStatus\": \"Completed\",\n \"companyDefinedRule\": false,\n \"nativeLink\": \"http://www.incb.org/incb/en/precursors/Red_Forms/red-list.html\",\n \"link\": \"http://www.incb.org/incb/en/precursors/Red_Forms/red-list.html\",\n \"legislationName\": \"International Narcotics Control Board (INCB) Red List (Precursors and chemicals frequently used in the illicit manufacture of narcotic drugs and psychotropic substances under International Control)\",\n \"idJurisdiction\": 15,\n \"jurisdictionName\": \"UN (INCB)\",\n \"substanceLegislationName\": \"Acetone\",\n \"codeName\": [\n \"UN Precursor Table II\"\n ]\n },\n {\n \"sysControlCodeDocument\": [\n \"https://staging.scitegrity.com/client/#docs/systemControlCode/3861\"\n ],\n \"idSysControlledCode\": [\n 196\n ],\n \"corporateId\": \"SCITEGRITY-1\",\n \"fastlookupIdSource\": \"SCITEGRITY_DB_1\",\n \"idLeg2Sub\": 23182,\n \"resultComments\": \"Exact match.\",\n \"controlledStatus\": \"Controlled\",\n \"checkStatus\": \"Completed\",\n \"companyDefinedRule\": false,\n \"nativeLink\": \"https://staging.scitegrity.com/client/#docs/legislation/298\",\n \"legislationName\": \"Consolidated precursor listing for China\",\n \"idJurisdiction\": 19,\n \"jurisdictionName\": \"China\",\n \"substanceLegislationName\": \"丙酮\",\n \"codeName\": [\n \"China Precursors - Category 3\"\n ]\n },\n {\n \"sysControlCodeDocument\": [\n \"https://staging.scitegrity.com/client/#docs/systemControlCode/3485\"\n ],\n \"idSysControlledCode\": [\n 410\n ],\n \"corporateId\": \"SCITEGRITY-1\",\n \"fastlookupIdSource\": \"SCITEGRITY_DB_1\",\n \"idLeg2Sub\": 47238,\n \"resultComments\": \"Exact match.\",\n \"controlledStatus\": \"Controlled\",\n \"checkStatus\": \"Completed\",\n \"companyDefinedRule\": false,\n \"nativeLink\": \"https://eur-lex.europa.eu/legal-content/EN/TXT/PDF/?uri=CELEX:32019R1148&from=EN\",\n \"link\": \"https://eur-lex.europa.eu/legal-content/EN/TXT/?uri=celex%3A32019R1148\",\n \"legislationName\": \"REGULATION (EU) 2019/1148 OF THE EUROPEAN PARLIAMENT on the marketing and use of explosives precursors\",\n \"idJurisdiction\": 21,\n \"jurisdictionName\": \"European Union\",\n \"substanceLegislationName\": \"Acetone\",\n \"codeName\": [\n \"EU Annex II Reportable Explosives Precursors\"\n ]\n },\n {\n \"sysControlCodeDocument\": [\n \"https://staging.scitegrity.com/client/#docs/systemControlCode/3701\"\n ],\n \"idSysControlledCode\": [\n 357\n ],\n \"corporateId\": \"SCITEGRITY-1\",\n \"fastlookupIdSource\": \"SCITEGRITY_DB_1\",\n \"idLeg2Sub\": 33996,\n \"resultComments\": \"Exact match.\",\n \"controlledStatus\": \"Controlled\",\n \"checkStatus\": \"Completed\",\n \"companyDefinedRule\": false,\n \"nativeLink\": \"https://eur-lex.europa.eu/legal-content/PL/TXT/PDF/?uri=CELEX:32004R0273&from=EN\",\n \"link\": \"https://eur-lex.europa.eu/legal-content/EN/TXT/?uri=CELEX:32004R0273\",\n \"legislationName\": \"Poland - Regulation (EC) No 273/2004 on drug precursors\",\n \"idJurisdiction\": 28,\n \"jurisdictionName\": \"Poland\",\n \"substanceLegislationName\": \"Aceton\",\n \"codeName\": [\n \"Polish EU Drug Precursor Category 3\"\n ]\n },\n {\n \"sysControlCodeDocument\": [\n \"https://staging.scitegrity.com/client/#docs/systemControlCode/3701\"\n ],\n \"idSysControlledCode\": [\n 357\n ],\n \"corporateId\": \"SCITEGRITY-1\",\n \"fastlookupIdSource\": \"SCITEGRITY_DB_1\",\n \"idLeg2Sub\": 34043,\n \"resultComments\": \"Exact match.\",\n \"controlledStatus\": \"Controlled\",\n \"checkStatus\": \"Completed\",\n \"companyDefinedRule\": false,\n \"nativeLink\": \"https://eur-lex.europa.eu/legal-content/PL/TXT/PDF/?uri=CELEX:32005R0111&from=EN\",\n \"link\": \"https://eur-lex.europa.eu/legal-content/EN/TXT/?qid=1430479010032&uri=CELEX:32005R0111\",\n \"legislationName\": \"Poland - Regulation (EC) No 111/2005 on drug precursors\",\n \"idJurisdiction\": 28,\n \"jurisdictionName\": \"Poland\",\n \"substanceLegislationName\": \"Aceton\",\n \"codeName\": [\n \"Polish EU Drug Precursor Category 3\"\n ]\n },\n {\n \"sysControlCodeDocument\": [\n \"https://staging.scitegrity.com/client/#docs/systemControlCode/3641\"\n ],\n \"idSysControlledCode\": [\n 267\n ],\n \"corporateId\": \"SCITEGRITY-1\",\n \"fastlookupIdSource\": \"SCITEGRITY_DB_1\",\n \"idLeg2Sub\": 15995,\n \"resultComments\": \"Exact match.\",\n \"controlledStatus\": \"Controlled\",\n \"checkStatus\": \"Completed\",\n \"companyDefinedRule\": false,\n \"nativeLink\": \"https://eur-lex.europa.eu/legal-content/DE/TXT/PDF/?uri=CELEX:32004R0273&from=EN\",\n \"link\": \"https://eur-lex.europa.eu/legal-content/EN/TXT/?uri=CELEX:32004R0273\",\n \"legislationName\": \"Austria - Regulation (EC) No 273/2004 on drug precursors\",\n \"idJurisdiction\": 23,\n \"jurisdictionName\": \"Austria\",\n \"substanceLegislationName\": \"Aceton\",\n \"codeName\": [\n \"Austria EU Drug Precursor Category 3\"\n ]\n },\n {\n \"sysControlCodeDocument\": [\n \"https://staging.scitegrity.com/client/#docs/systemControlCode/3641\"\n ],\n \"idSysControlledCode\": [\n 267\n ],\n \"corporateId\": \"SCITEGRITY-1\",\n \"fastlookupIdSource\": \"SCITEGRITY_DB_1\",\n \"idLeg2Sub\": 15996,\n \"resultComments\": \"Exact match.\",\n \"controlledStatus\": \"Controlled\",\n \"checkStatus\": \"Completed\",\n \"companyDefinedRule\": false,\n \"nativeLink\": \"http://eur-lex.europa.eu/LexUriServ/LexUriServ.do?uri=OJ:L:2005:022:0001:0010:de:PDF\",\n \"link\": \"http://eur-lex.europa.eu/legal-content/EN/TXT/?qid=1430479010032&uri=CELEX:32005R0111\",\n \"legislationName\": \"Austria - Regulation (EC) No 111/2005 on drug precursors\",\n \"idJurisdiction\": 23,\n \"jurisdictionName\": \"Austria\",\n \"substanceLegislationName\": \"Aceton\",\n \"codeName\": [\n \"Austria EU Drug Precursor Category 3\"\n ]\n },\n {\n \"sysControlCodeDocument\": [\n \"https://staging.scitegrity.com/client/#docs/systemControlCode/3720\"\n ],\n \"idSysControlledCode\": [\n 278\n ],\n \"corporateId\": \"SCITEGRITY-1\",\n \"fastlookupIdSource\": \"SCITEGRITY_DB_1\",\n \"idLeg2Sub\": 24734,\n \"resultComments\": \"Exact match.\",\n \"controlledStatus\": \"Controlled\",\n \"checkStatus\": \"Completed\",\n \"companyDefinedRule\": false,\n \"nativeLink\": \"https://elaws.e-gov.go.jp/document?lawid=328AC0000000014\",\n \"link\": \"https://elaws-e--gov-go-jp.translate.goog/document?lawid=328AC0000000014&_x_tr_sl=ja&_x_tr_tl=en&_x_tr_hl=en-US&_x_tr_pto=wapp\",\n \"legislationName\": \"Narcotics and Psychotropics Control Law\",\n \"idJurisdiction\": 24,\n \"jurisdictionName\": \"Japan\",\n \"substanceLegislationName\": \"アセトン\",\n \"codeName\": [\n \"Japanese Table IV Drug Raw Materials\"\n ]\n },\n {\n \"sysControlCodeDocument\": [\n \"https://staging.scitegrity.com/client/#docs/systemControlCode/1822\"\n ],\n \"idSysControlledCode\": [\n 319\n ],\n \"corporateId\": \"SCITEGRITY-1\",\n \"fastlookupIdSource\": \"SCITEGRITY_DB_1\",\n \"idLeg2Sub\": 29715,\n \"resultComments\": \"Exact match.\",\n \"controlledStatus\": \"Controlled\",\n \"checkStatus\": \"Completed\",\n \"companyDefinedRule\": false,\n \"nativeLink\": \"https://sso.agc.gov.sg/Act/MDA1973\",\n \"link\": \"https://translate.google.co.uk/translate?hl=en&sl=en&tl=en&u=https%3A%2F%2Fsso.agc.gov.sg%2FSL%2FMDA1973-RG1%3F\",\n \"legislationName\": \"Misuse of Drugs Act\",\n \"idJurisdiction\": 25,\n \"jurisdictionName\": \"Singapore\",\n \"substanceLegislationName\": \"Acetone\",\n \"codeName\": [\n \"Singapore Precursors Part II\"\n ]\n },\n {\n \"sysControlCodeDocument\": [\n \"https://staging.scitegrity.com/client/#docs/systemControlCode/3222\"\n ],\n \"idSysControlledCode\": [\n 327\n ],\n \"corporateId\": \"SCITEGRITY-1\",\n \"fastlookupIdSource\": \"SCITEGRITY_DB_1\",\n \"idLeg2Sub\": 31529,\n \"resultComments\": \"Exact match.\",\n \"controlledStatus\": \"Controlled\",\n \"checkStatus\": \"Completed\",\n \"companyDefinedRule\": false,\n \"nativeLink\": \"http://www.diputados.gob.mx/LeyesBiblio/pdf_mov/Ley_Federal_para_el_Control-Precursores_Quimicos_Productos-Maquinas-Capsulas_Tabletas-Comprimidos.pdf\",\n \"link\": \"\",\n \"legislationName\": \"Federal Law for the Control of Chemical Precursors, Essential Chemical Products and Machines to Prepare Capsules, Tablets and/or Pills (Consolidated Version)\",\n \"idJurisdiction\": 26,\n \"jurisdictionName\": \"Mexico\",\n \"substanceLegislationName\": \"Acetona\",\n \"codeName\": [\n \"Mexican Chemical Precursors List II\"\n ]\n },\n {\n \"sysControlCodeDocument\": [\n \"https://staging.scitegrity.com/client/#docs/systemControlCode/2707\"\n ],\n \"idSysControlledCode\": [\n 339\n ],\n \"corporateId\": \"SCITEGRITY-1\",\n \"fastlookupIdSource\": \"SCITEGRITY_DB_1\",\n \"idLeg2Sub\": 32967,\n \"resultComments\": \"Exact match.\",\n \"controlledStatus\": \"Controlled\",\n \"checkStatus\": \"Completed\",\n \"companyDefinedRule\": false,\n \"nativeLink\": \"https://www.gov.br/anvisa/pt-br/assuntos/medicamentos/controlados/lista-substancias\",\n \"link\": \"https://translate.google.com/translate?sl=pt&tl=en&u=https://www.gov.br/anvisa/pt-br/assuntos/medicamentos/controlados/lista-substancias\",\n \"legislationName\": \"Ordinance SVS/MS No 344/98\",\n \"idJurisdiction\": 27,\n \"jurisdictionName\": \"Brazil\",\n \"substanceLegislationName\": \"Acetona\",\n \"codeName\": [\n \"Brazilian List D2\"\n ]\n },\n {\n \"sysControlCodeDocument\": [\n \"https://staging.scitegrity.com/client/#docs/systemControlCode/3671\"\n ],\n \"idSysControlledCode\": [\n 384\n ],\n \"corporateId\": \"SCITEGRITY-1\",\n \"fastlookupIdSource\": \"SCITEGRITY_DB_1\",\n \"idLeg2Sub\": 38052,\n \"resultComments\": \"Exact match.\",\n \"controlledStatus\": \"Controlled\",\n \"checkStatus\": \"Completed\",\n \"companyDefinedRule\": false,\n \"nativeLink\": \"https://eur-lex.europa.eu/legal-content/FI/TXT/PDF/?uri=CELEX:32005R0111&from=EN\",\n \"link\": \"https://eur-lex.europa.eu/legal-content/EN/TXT/?qid=1430479010032&uri=CELEX:32005R0111\",\n \"legislationName\": \"Finland - Regulation (EC) No 111/2005 on drug precursors\",\n \"idJurisdiction\": 29,\n \"jurisdictionName\": \"Finland\",\n \"substanceLegislationName\": \"Asetoni\",\n \"codeName\": [\n \"Finnish EU Drug Precursor Category 3\"\n ]\n },\n {\n \"sysControlCodeDocument\": [\n \"https://staging.scitegrity.com/client/#docs/systemControlCode/3671\"\n ],\n \"idSysControlledCode\": [\n 384\n ],\n \"corporateId\": \"SCITEGRITY-1\",\n \"fastlookupIdSource\": \"SCITEGRITY_DB_1\",\n \"idLeg2Sub\": 38051,\n \"resultComments\": \"Exact match.\",\n \"controlledStatus\": \"Controlled\",\n \"checkStatus\": \"Completed\",\n \"companyDefinedRule\": false,\n \"nativeLink\": \"https://eur-lex.europa.eu/legal-content/FI/TXT/PDF/?uri=CELEX:32004R0273&from=EN\",\n \"link\": \"https://eur-lex.europa.eu/legal-content/EN/TXT/?uri=CELEX:32004R0273\",\n \"legislationName\": \"Finland - Regulation (EC) No 273/2004 on drug precursors\",\n \"idJurisdiction\": 29,\n \"jurisdictionName\": \"Finland\",\n \"substanceLegislationName\": \"Asetoni\",\n \"codeName\": [\n \"Finnish EU Drug Precursor Category 3\"\n ]\n },\n {\n \"sysControlCodeDocument\": [\n \"https://staging.scitegrity.com/client/#docs/systemControlCode/3237\"\n ],\n \"idSysControlledCode\": [\n 379\n ],\n \"corporateId\": \"SCITEGRITY-1\",\n \"fastlookupIdSource\": \"SCITEGRITY_DB_1\",\n \"idLeg2Sub\": 38580,\n \"resultComments\": \"Exact match.\",\n \"controlledStatus\": \"Controlled\",\n \"checkStatus\": \"Completed\",\n \"companyDefinedRule\": false,\n \"nativeLink\": \"https://law.moj.gov.tw/LawClass/LawAll.aspx?pcode=J0030042\",\n \"link\": \"https://law.moj.gov.tw/ENG/LawClass/LawAll.aspx?pcode=J0030042\",\n \"legislationName\": \"Categories and Regulations Governing Inspection and Declaration of Industrial Precursor Chemicals\",\n \"idJurisdiction\": 30,\n \"jurisdictionName\": \"Taiwan\",\n \"substanceLegislationName\": \"丙酮 \",\n \"codeName\": [\n \"Table 2 - Category B\"\n ]\n },\n {\n \"sysControlCodeDocument\": [\n \"https://staging.scitegrity.com/client/#docs/systemControlCode/3714\"\n ],\n \"idSysControlledCode\": [\n 425\n ],\n \"corporateId\": \"SCITEGRITY-1\",\n \"fastlookupIdSource\": \"SCITEGRITY_DB_1\",\n \"idLeg2Sub\": 50157,\n \"resultComments\": \"Exact match.\",\n \"controlledStatus\": \"Controlled\",\n \"checkStatus\": \"Completed\",\n \"companyDefinedRule\": false,\n \"nativeLink\": \"https://eur-lex.europa.eu/legal-content/SL/TXT/PDF/?uri=CELEX:32004R0273&from=EN\",\n \"link\": \"https://eur-lex.europa.eu/legal-content/EN/TXT/?uri=CELEX:32004R0273\",\n \"legislationName\": \"Slovakia - Regulation (EC) No 273/2004 on drug precursors\",\n \"idJurisdiction\": 32,\n \"jurisdictionName\": \"Slovakia\",\n \"substanceLegislationName\": \"Aceton\",\n \"codeName\": [\n \"Slovakian EU Drug Precursor Category 3\"\n ]\n },\n {\n \"sysControlCodeDocument\": [\n \"https://staging.scitegrity.com/client/#docs/systemControlCode/3714\"\n ],\n \"idSysControlledCode\": [\n 425\n ],\n \"corporateId\": \"SCITEGRITY-1\",\n \"fastlookupIdSource\": \"SCITEGRITY_DB_1\",\n \"idLeg2Sub\": 50158,\n \"resultComments\": \"Exact match.\",\n \"controlledStatus\": \"Controlled\",\n \"checkStatus\": \"Completed\",\n \"companyDefinedRule\": false,\n \"nativeLink\": \"https://eur-lex.europa.eu/legal-content/SL/TXT/PDF/?uri=CELEX:32005R0111&from=EN\",\n \"link\": \"https://eur-lex.europa.eu/legal-content/EN/TXT/?qid=1430479010032&uri=CELEX:32005R0111\",\n \"legislationName\": \"Slovakia - Regulation (EC) No 111/2005 on drug precursors\",\n \"idJurisdiction\": 32,\n \"jurisdictionName\": \"Slovakia\",\n \"substanceLegislationName\": \"Aceton\",\n \"codeName\": [\n \"Slovakian EU Drug Precursor Category 3\"\n ]\n },\n {\n \"sysControlCodeDocument\": [\n \"https://staging.scitegrity.com/client/#docs/systemControlCode/4039\"\n ],\n \"idSysControlledCode\": [\n 501\n ],\n \"corporateId\": \"SCITEGRITY-1\",\n \"fastlookupIdSource\": \"SCITEGRITY_DB_1\",\n \"idLeg2Sub\": 60006,\n \"resultComments\": \"Exact match.\",\n \"controlledStatus\": \"Controlled\",\n \"checkStatus\": \"Completed\",\n \"companyDefinedRule\": false,\n \"nativeLink\": \"https://argentina.gob.ar/sites/default/files/anexo_ii_del_decreto_593-2019_ley_26045.pdf\",\n \"link\": \"\",\n \"legislationName\": \" National Registry of Chemical Precursors (RENPRE)\",\n \"idJurisdiction\": 36,\n \"jurisdictionName\": \"Argentina\",\n \"substanceLegislationName\": \"Acetona\",\n \"codeName\": [\n \"Precursor - List I\"\n ]\n },\n {\n \"sysControlCodeDocument\": [\n \"https://staging.scitegrity.com/client/#docs/systemControlCode/3080\"\n ],\n \"idSysControlledCode\": [\n 91\n ],\n \"corporateId\": \"SCITEGRITY-2\",\n \"fastlookupIdSource\": \"SCITEGRITY_DB_1\",\n \"idLeg2Sub\": 52617,\n \"resultComments\": \"Exact match.\",\n \"controlledStatus\": \"Controlled\",\n \"checkStatus\": \"Completed\",\n \"companyDefinedRule\": false,\n \"nativeLink\": \"https://www.retsinformation.dk/eli/lta/2021/2446\",\n \"link\": \"https://www-retsinformation-dk.translate.goog/eli/lta/2021/2446?_x_tr_sl=auto&_x_tr_tl=en&_x_tr_hl=en-GB\",\n \"legislationName\": \"Executive Order amending the Executive Order on narcotics, BEK no 2446 af 12/12/2021\",\n \"idJurisdiction\": 7,\n \"jurisdictionName\": \"Denmark\",\n \"substanceLegislationName\": \"MDMA\",\n \"codeName\": [\n \"Danish List B\"\n ]\n },\n {\n \"sysControlCodeDocument\": [\n \"https://staging.scitegrity.com/client/#docs/systemControlCode/3845\"\n ],\n \"idSysControlledCode\": [\n 300\n ],\n \"corporateId\": \"SCITEGRITY-2\",\n \"fastlookupIdSource\": \"SCITEGRITY_DB_1\",\n \"idLeg2Sub\": 25765,\n \"resultComments\": \"Exact match.\",\n \"controlledStatus\": \"Controlled\",\n \"checkStatus\": \"Completed\",\n \"companyDefinedRule\": false,\n \"nativeLink\": \"https://www.fagg-afmps.be/sites/default/files/content/INSP/NARC/kb-ar-20170906.pdf\",\n \"link\": \"https://translate.google.co.uk/translate?hl=en&sl=auto&tl=en&u=http%3A%2F%2Fwww.ejustice.just.fgov.be%2Fcgi_loi%2Fchange_lg.pl%3Flanguage%3Dfr%26la%3DF%26cn%3D2017090603%26table_name%3Dloi&sandbox=1\",\n \"legislationName\": \"6 September 2017 - Royal Decree regulating narcotic, psychotropic and soporific substances\",\n \"idJurisdiction\": 6,\n \"jurisdictionName\": \"Belgium\",\n \"substanceLegislationName\": \"MDMA\",\n \"codeName\": [\n \"Belgium Annex IIA\"\n ]\n },\n {\n \"sysControlCodeDocument\": [\n \"https://staging.scitegrity.com/client/#docs/systemControlCode/3202\"\n ],\n \"idSysControlledCode\": [\n 101\n ],\n \"corporateId\": \"SCITEGRITY-2\",\n \"fastlookupIdSource\": \"SCITEGRITY_DB_1\",\n \"idLeg2Sub\": 2640,\n \"resultComments\": \"Exact match.\",\n \"controlledStatus\": \"Controlled\",\n \"checkStatus\": \"Completed\",\n \"companyDefinedRule\": false,\n \"nativeLink\": \"http://www.gesetze-im-internet.de/btmg_1981/BJNR106810981.html\",\n \"link\": \"https://translate.google.com/translate?hl=en&sl=de&tl=en&u=http%3A%2F%2Fwww.gesetze-im-internet.de%2Fbtmg_1981%2FBJNR106810981.html\",\n \"legislationName\": \"Narcotics Act (BtMG)\",\n \"idJurisdiction\": 8,\n \"jurisdictionName\": \"Germany\",\n \"substanceLegislationName\": \"Methylendioxymetamfetamin\",\n \"codeName\": [\n \"German Schedule 1\"\n ]\n },\n {\n \"sysControlCodeDocument\": [\n \"https://staging.scitegrity.com/client/#docs/systemControlCode/525\"\n ],\n \"idSysControlledCode\": [\n 69\n ],\n \"corporateId\": \"SCITEGRITY-2\",\n \"fastlookupIdSource\": \"SCITEGRITY_DB_1\",\n \"idLeg2Sub\": 10677,\n \"resultComments\": \"Exact match.\",\n \"controlledStatus\": \"Controlled\",\n \"checkStatus\": \"Completed\",\n \"companyDefinedRule\": false,\n \"nativeLink\": \"http://www.salute.gov.it/portale/temi/p2_6.jsp?lingua=italiano&id=3729&area=sostanzeStupefacenti&menu=vuoto\",\n \"link\": \"https://www-salute-gov-it.translate.goog/portale/temi/p2_6.jsp?lingua=italiano&id=3729&area=sostanzeStupefacenti&menu=vuoto&_x_tr_sl=auto&_x_tr_tl=en&_x_tr_hl=en-GB&_x_tr_pto=nui\",\n \"legislationName\": \"Presidential Decree 9 October 1990, n. 309 - Consolidated Law on Discipline of narcotic drugs and psychotropic substances, prevention, treatment and rehabilitation of drug addiction\",\n \"idJurisdiction\": 9,\n \"jurisdictionName\": \"Italy\",\n \"substanceLegislationName\": \"MDMA\",\n \"codeName\": [\n \"Italian Table I\"\n ]\n },\n {\n \"sysControlCodeDocument\": [\n \"https://staging.scitegrity.com/client/#docs/systemControlCode/2785\"\n ],\n \"idSysControlledCode\": [\n 95\n ],\n \"corporateId\": \"SCITEGRITY-2\",\n \"fastlookupIdSource\": \"SCITEGRITY_DB_1\",\n \"idLeg2Sub\": 24932,\n \"resultComments\": \"Exact match.\",\n \"controlledStatus\": \"Controlled\",\n \"checkStatus\": \"Completed\",\n \"companyDefinedRule\": false,\n \"nativeLink\": \"http://wetten.overheid.nl/BWBR0001941/\",\n \"link\": \"https://translate.google.com/translate?sl=nl&tl=en&js=y&prev=_t&hl=en&ie=UTF-8&u=http%3A%2F%2Fwetten.overheid.nl%2FBWBR0001941%2F&edit-text=\",\n \"legislationName\": \"The Opium Act (Opiumwet)\",\n \"idJurisdiction\": 10,\n \"jurisdictionName\": \"Netherlands\",\n \"substanceLegislationName\": \"3,4-Methyleendioxymethamfetamine\",\n \"codeName\": [\n \"Netherlands List 1\"\n ]\n },\n {\n \"sysControlCodeDocument\": [\n \"https://staging.scitegrity.com/client/#docs/systemControlCode/3952\"\n ],\n \"idSysControlledCode\": [\n 83\n ],\n \"corporateId\": \"SCITEGRITY-2\",\n \"fastlookupIdSource\": \"SCITEGRITY_DB_1\",\n \"idLeg2Sub\": 35518,\n \"resultComments\": \"Exact match.\",\n \"controlledStatus\": \"Controlled\",\n \"checkStatus\": \"Completed\",\n \"companyDefinedRule\": false,\n \"nativeLink\": \"https://www.boe.es/buscar/doc.php?id=BOE-A-1986-14543\",\n \"link\": \"https://www-boe-es.translate.goog/buscar/doc.php?id=BOE-A-1986-14543&_x_tr_sl=auto&_x_tr_tl=en&_x_tr_hl=en-GB&_x_tr_pto=nui\",\n \"legislationName\": \"BOE-A-1986-14543- of the Royal Decree 2829/1977 of 6 October\",\n \"idJurisdiction\": 11,\n \"jurisdictionName\": \"Spain\",\n \"substanceLegislationName\": \"MDMA\",\n \"codeName\": [\n \"Spain UN Psychotropics List I\"\n ]\n },\n {\n \"sysControlCodeDocument\": [\n \"https://staging.scitegrity.com/client/#docs/systemControlCode/3364\"\n ],\n \"idSysControlledCode\": [\n 85\n ],\n \"corporateId\": \"SCITEGRITY-2\",\n \"fastlookupIdSource\": \"SCITEGRITY_DB_1\",\n \"idLeg2Sub\": 55351,\n \"resultComments\": \"Exact match.\",\n \"controlledStatus\": \"Controlled\",\n \"checkStatus\": \"Completed\",\n \"companyDefinedRule\": false,\n \"nativeLink\": \"https://www.lakemedelsverket.se/sv/lagar-och-regler/foreskrifter/2011-10-konsoliderad\",\n \"link\": \"https://www-lakemedelsverket-se.translate.goog/sv/lagar-och-regler/foreskrifter/2011-10-konsoliderad?_x_tr_sl=sv&_x_tr_tl=en&_x_tr_hl=en-US&_x_tr_pto=wapp\",\n \"legislationName\": \"The Swedish Medicines Agency's regulations (LVFS 2011:10) on the list of drugs - Consolidated regulation\",\n \"idJurisdiction\": 12,\n \"jurisdictionName\": \"Sweden\",\n \"substanceLegislationName\": \"MDMA\",\n \"codeName\": [\n \"Swedish List I\"\n ]\n },\n {\n \"sysControlCodeDocument\": [\n \"https://staging.scitegrity.com/client/#docs/systemControlCode/3159\"\n ],\n \"idSysControlledCode\": [\n 106\n ],\n \"corporateId\": \"SCITEGRITY-2\",\n \"fastlookupIdSource\": \"SCITEGRITY_DB_1\",\n \"idLeg2Sub\": 16451,\n \"resultComments\": \"Exact match.\",\n \"controlledStatus\": \"Controlled\",\n \"checkStatus\": \"Completed\",\n \"companyDefinedRule\": false,\n \"nativeLink\": \"http://www.legifrance.gouv.fr/affichTexte.do?cidTexte=JORFTEXT000000533085&fastPos=131&fastReqId=2041338000&categorieLien=cid&oldAction=rechTexte\",\n \"link\": \"https://www-legifrance-gouv-fr.translate.goog/loda/id/JORFTEXT000000533085/?_x_tr_sl=auto&_x_tr_tl=en&_x_tr_hl=en-GB&_x_tr_pto=nui\",\n \"legislationName\": \"List of substances classified as narcotics in France ('Decree of 22 February 1990 establishing the list substances classified as narcotics')\",\n \"idJurisdiction\": 4,\n \"jurisdictionName\": \"France\",\n \"substanceLegislationName\": \"MDMA\",\n \"codeName\": [\n \"French Narcotics Annex III\"\n ]\n },\n {\n \"sysControlCodeDocument\": [\n \"https://staging.scitegrity.com/client/#docs/systemControlCode/2877\"\n ],\n \"idSysControlledCode\": [\n 21\n ],\n \"controlCodeDocument\": [\n \"https://staging.scitegrity.com/client/#docs/customerSystemControlCode/244\"\n ],\n \"corporateId\": \"SCITEGRITY-2\",\n \"fastlookupIdSource\": \"SCITEGRITY_DB_1\",\n \"idLeg2Sub\": 27843,\n \"resultComments\": \"Exact match.\",\n \"controlledStatus\": \"Controlled\",\n \"checkStatus\": \"Completed\",\n \"companyDefinedRule\": false,\n \"nativeLink\": \"https://www.ecfr.gov/current/title-21/chapter-II\",\n \"link\": \"https://www-ecfr-gov.translate.goog/current/title-21/chapter-II?_x_tr_sl=auto&_x_tr_tl=en&_x_tr_hl=en-GB&_x_tr_pto=nui\",\n \"legislationName\": \"Controlled Substances Act - Regulations 21 CFR, Part 1300-1399\",\n \"idJurisdiction\": 3,\n \"jurisdictionName\": \"United States of America\",\n \"substanceLegislationName\": \"3,4-Methylenedioxymethamphetamine\",\n \"codeName\": [\n \"US CSA Schedule I\"\n ]\n },\n {\n \"corporateId\": \"SCITEGRITY-2\",\n \"fastlookupIdSource\": \"SCITEGRITY_DB_1\",\n \"idLeg2Sub\": 59091,\n \"resultComments\": \"Exact match.\",\n \"controlledStatus\": \"Controlled\",\n \"checkStatus\": \"Completed\",\n \"companyDefinedRule\": false,\n \"nativeLink\": \"https://laws.boe.gov.sa/BoeLaws/Laws/LawDetails/221b3286-a3c6-4ea4-97c7-a9a700f18273/1\",\n \"link\": \"https://laws-boe-gov-sa.translate.goog/BoeLaws/Laws/LawDetails/221b3286-a3c6-4ea4-97c7-a9a700f18273/1?_x_tr_sl=auto&_x_tr_tl=en&_x_tr_hl=en-US&_x_tr_pto=wapp\",\n \"legislationName\": \"Drugs and Narcotics Control Law\",\n \"idJurisdiction\": 35,\n \"jurisdictionName\": \"Saudi Arabia\",\n \"substanceLegislationName\": \"ام دي ام إي\",\n \"codeName\": [\n \"Saudi Category (A) of the Second Schedule\"\n ]\n },\n {\n \"corporateId\": \"SCITEGRITY-2\",\n \"fastlookupIdSource\": \"SCITEGRITY_DB_1\",\n \"idLeg2Sub\": 59660,\n \"resultComments\": \"Exact match.\",\n \"controlledStatus\": \"Controlled\",\n \"checkStatus\": \"Completed\",\n \"companyDefinedRule\": false,\n \"nativeLink\": \"http://servicios.infoleg.gob.ar/infolegInternet/anexos/325000-329999/326675/norma.htm\",\n \"link\": \"https://servicios-infoleg-gob-ar.translate.goog/infolegInternet/anexos/325000-329999/326675/norma.htm?_x_tr_sch=http&_x_tr_sl=es&_x_tr_tl=en&_x_tr_hl=en-US&_x_tr_pto=wapp\",\n \"legislationName\": \"Decree 560/2019 - Narcotic Drugs\",\n \"idJurisdiction\": 36,\n \"jurisdictionName\": \"Argentina\",\n \"substanceLegislationName\": \"MDMA\",\n \"codeName\": [\n \"Annex 1\"\n ]\n },\n {\n \"corporateId\": \"SCITEGRITY-2\",\n \"fastlookupIdSource\": \"SCITEGRITY_DB_1\",\n \"idLeg2Sub\": 59380,\n \"resultComments\": \"Exact match.\",\n \"controlledStatus\": \"Controlled\",\n \"checkStatus\": \"Completed\",\n \"companyDefinedRule\": false,\n \"nativeLink\": \"https://www.argentina.gob.ar/anmat/regulados/controlespecial/listados\",\n \"link\": \"\",\n \"legislationName\": \"ANMET Drugs and Psychotropics listings\",\n \"idJurisdiction\": 36,\n \"jurisdictionName\": \"Argentina\",\n \"substanceLegislationName\": \"MDMA\",\n \"codeName\": [\n \"List 1 - Psychotropics\"\n ]\n },\n {\n \"corporateId\": \"SCITEGRITY-2\",\n \"fastlookupIdSource\": \"SCITEGRITY_DB_1\",\n \"idLeg2Sub\": 60201,\n \"resultComments\": \"Exact match.\",\n \"controlledStatus\": \"Controlled\",\n \"checkStatus\": \"Completed\",\n \"companyDefinedRule\": false,\n \"nativeLink\": \"https://laboratorium.bnn.go.id/asset/permenkes/PMK%20No.%2030%20Th%202023%20ttg%20Perubahan%20Penggolongan%20Narkotika-signed.pdf\",\n \"link\": \"\",\n \"legislationName\": \"Changes in the classification of Narcotics (consolidated)\",\n \"idJurisdiction\": 37,\n \"jurisdictionName\": \"Indonesia\",\n \"substanceLegislationName\": \"MDMA\",\n \"codeName\": [\n \"Indonesian List 1 Narcotics\"\n ]\n },\n {\n \"sysControlCodeDocument\": [\n \"https://staging.scitegrity.com/client/#docs/systemControlCode/2737\",\n \"https://staging.scitegrity.com/client/#docs/systemControlCode/2742\"\n ],\n \"idSysControlledCode\": [\n 23,\n 28\n ],\n \"controlCodeDocument\": [\n \"\",\n \"\"\n ],\n \"corporateId\": \"SCITEGRITY-2\",\n \"fastlookupIdSource\": \"SCITEGRITY_DB_1\",\n \"idLeg2Sub\": 55917,\n \"resultComments\": \"Generic structure match. (The input structure has hit a system Markush rule, see legislation for details)\",\n \"controlledStatus\": \"Controlled\",\n \"checkStatus\": \"Completed\",\n \"companyDefinedRule\": false,\n \"nativeLink\": \"https://www.legislation.gov.uk/ukpga/1971/38/contents\",\n \"link\": \"https://www-legislation-gov-uk.translate.goog/ukpga/1971/38/contents?_x_tr_sl=sv&_x_tr_tl=en&_x_tr_hl=en-US&_x_tr_pto=wapp\",\n \"legislationName\": \"The Misuse of Drugs Act 1971 official consolidation\",\n \"idJurisdiction\": 2,\n \"jurisdictionName\": \"United Kingdom\",\n \"codeName\": [\n \"UK Class A\",\n \"UK Schedule 1\"\n ],\n \"sysMarkushDocument\": \"https://staging.scitegrity.com/client/#docs/systemMarkush/65\"\n },\n {\n \"sysControlCodeDocument\": [\n \"https://staging.scitegrity.com/client/#docs/systemControlCode/1417\"\n ],\n \"idSysControlledCode\": [\n 97\n ],\n \"corporateId\": \"SCITEGRITY-2\",\n \"fastlookupIdSource\": \"SCITEGRITY_DB_1\",\n \"idLeg2Sub\": 27367,\n \"resultComments\": \"Generic structure match. (The input structure has hit a system Markush rule, see legislation for details)\",\n \"controlledStatus\": \"Controlled\",\n \"checkStatus\": \"Completed\",\n \"companyDefinedRule\": false,\n \"nativeLink\": \"http://www.thepsi.ie/Libraries/Legislation/MDA_Regulations_2017_SI_173.sflb.ashx\",\n \"link\": \"https://translate.google.co.uk/translate?hl=en&sl=en&tl=en&u=http%3A%2F%2Fwww.thepsi.ie%2FLibraries%2FLegislation%2FMDA_Regulations_2017_SI_173.sflb.ashx\",\n \"legislationName\": \"Misuse of Drugs Regulations 2017\",\n \"idJurisdiction\": 5,\n \"jurisdictionName\": \"Ireland\",\n \"codeName\": [\n \"Irish Schedule 1\"\n ],\n \"sysMarkushDocument\": \"https://staging.scitegrity.com/client/#docs/systemMarkush/65\"\n },\n {\n \"sysControlCodeDocument\": [\n \"https://staging.scitegrity.com/client/#docs/systemControlCode/2710\"\n ],\n \"idSysControlledCode\": [\n 342\n ],\n \"corporateId\": \"SCITEGRITY-2\",\n \"fastlookupIdSource\": \"SCITEGRITY_DB_1\",\n \"idLeg2Sub\": 32171,\n \"resultComments\": \"Exact match.\",\n \"controlledStatus\": \"Controlled\",\n \"checkStatus\": \"Completed\",\n \"companyDefinedRule\": false,\n \"nativeLink\": \"https://www.gov.br/anvisa/pt-br/assuntos/medicamentos/controlados/lista-substancias\",\n \"link\": \"https://translate.google.com/translate?sl=pt&tl=en&u=https://www.gov.br/anvisa/pt-br/assuntos/medicamentos/controlados/lista-substancias\",\n \"legislationName\": \"Ordinance SVS/MS No 344/98\",\n \"idJurisdiction\": 27,\n \"jurisdictionName\": \"Brazil\",\n \"substanceLegislationName\": \"MDMA\",\n \"codeName\": [\n \"Brazilian List F2\"\n ]\n },\n {\n \"sysControlCodeDocument\": [\n \"https://staging.scitegrity.com/client/#docs/systemControlCode/3215\"\n ],\n \"idSysControlledCode\": [\n 321\n ],\n \"corporateId\": \"SCITEGRITY-2\",\n \"fastlookupIdSource\": \"SCITEGRITY_DB_1\",\n \"idLeg2Sub\": 39907,\n \"resultComments\": \"Exact match.\",\n \"controlledStatus\": \"Controlled\",\n \"checkStatus\": \"Completed\",\n \"companyDefinedRule\": false,\n \"nativeLink\": \"http://www.diputados.gob.mx/LeyesBiblio/pdf_mov/Ley_General_de_Salud.pdf\",\n \"link\": \"\",\n \"legislationName\": \"General Law of Health (consolidated version)\",\n \"idJurisdiction\": 26,\n \"jurisdictionName\": \"Mexico\",\n \"substanceLegislationName\": \"MDMA\",\n \"codeName\": [\n \"Mexican Psychotropics Group 1\"\n ]\n },\n {\n \"sysControlCodeDocument\": [\n \"https://staging.scitegrity.com/client/#docs/systemControlCode/3941\"\n ],\n \"idSysControlledCode\": [\n 366\n ],\n \"corporateId\": \"SCITEGRITY-2\",\n \"fastlookupIdSource\": \"SCITEGRITY_DB_1\",\n \"idLeg2Sub\": 43769,\n \"resultComments\": \"Exact match.\",\n \"controlledStatus\": \"Controlled\",\n \"checkStatus\": \"Completed\",\n \"companyDefinedRule\": false,\n \"nativeLink\": \"https://www.finlex.fi/fi/laki/ajantasa/2008/20080543#a27.6.2018-517\",\n \"link\": \"https://www-finlex-fi.translate.goog/fi/laki/ajantasa/2008/20080543?_x_tr_sl=auto&_x_tr_tl=en&_x_tr_hl=en-GB&_x_tr_pto=nui#a27.6.2018-517\",\n \"legislationName\": \"Government Decree on Substances, Preparations and Plants considered as Drugs\",\n \"idJurisdiction\": 29,\n \"jurisdictionName\": \"Finland\",\n \"substanceLegislationName\": \"Metyleenidioksimetamfetamiini\",\n \"codeName\": [\n \"Annex 2 List I\"\n ]\n },\n {\n \"sysControlCodeDocument\": [\n \"https://staging.scitegrity.com/client/#docs/systemControlCode/3231\"\n ],\n \"idSysControlledCode\": [\n 374\n ],\n \"corporateId\": \"SCITEGRITY-2\",\n \"fastlookupIdSource\": \"SCITEGRITY_DB_1\",\n \"idLeg2Sub\": 38450,\n \"resultComments\": \"Exact match.\",\n \"controlledStatus\": \"Controlled\",\n \"checkStatus\": \"Completed\",\n \"companyDefinedRule\": false,\n \"nativeLink\": \"https://law.moj.gov.tw/LawClass/LawAll.aspx?pcode=L0030010\",\n \"link\": \"https://translate.google.com/translate?sl=zh-CN&tl=en&u=https%3A%2F%2Flaw.moj.gov.tw%2FLawClass%2FLawAll.aspx%3Fpcode%3DL0030010\",\n \"legislationName\": \"Controlled Drugs Act\",\n \"idJurisdiction\": 30,\n \"jurisdictionName\": \"Taiwan\",\n \"substanceLegislationName\": \"3,4-亞甲基雙氧甲基安非他命\",\n \"codeName\": [\n \"Schedule 2 Controlled Drugs\"\n ]\n },\n {\n \"sysControlCodeDocument\": [\n \"https://staging.scitegrity.com/client/#docs/systemControlCode/1815\",\n \"https://staging.scitegrity.com/client/#docs/systemControlCode/1818\",\n \"https://staging.scitegrity.com/client/#docs/systemControlCode/1816\"\n ],\n \"idSysControlledCode\": [\n 312,\n 316,\n 313\n ],\n \"corporateId\": \"SCITEGRITY-2\",\n \"fastlookupIdSource\": \"SCITEGRITY_DB_1\",\n \"idLeg2Sub\": 29941,\n \"resultComments\": \"Exact match.\",\n \"controlledStatus\": \"Controlled\",\n \"checkStatus\": \"Completed\",\n \"companyDefinedRule\": false,\n \"nativeLink\": \"https://sso.agc.gov.sg/Act/MDA1973\",\n \"link\": \"https://translate.google.co.uk/translate?hl=en&sl=en&tl=en&u=https%3A%2F%2Fsso.agc.gov.sg%2FSL%2FMDA1973-RG1%3F\",\n \"legislationName\": \"Misuse of Drugs Act\",\n \"idJurisdiction\": 25,\n \"jurisdictionName\": \"Singapore\",\n \"substanceLegislationName\": \"N,α-Dimethyl-3,4-(methylenedioxy)phenethylamine\",\n \"codeName\": [\n \"Singapore Class A\",\n \"Singapore Regulations Fourth Schedule\",\n \"Singapore Specified Drug\"\n ]\n },\n {\n \"sysControlCodeDocument\": [\n \"https://staging.scitegrity.com/client/#docs/systemControlCode/3726\"\n ],\n \"idSysControlledCode\": [\n 284\n ],\n \"corporateId\": \"SCITEGRITY-2\",\n \"fastlookupIdSource\": \"SCITEGRITY_DB_1\",\n \"idLeg2Sub\": 24495,\n \"resultComments\": \"Exact match.\",\n \"controlledStatus\": \"Controlled\",\n \"checkStatus\": \"Completed\",\n \"companyDefinedRule\": false,\n \"nativeLink\": \"https://elaws.e-gov.go.jp/document?lawid=328AC0000000014\",\n \"link\": \"https://elaws-e--gov-go-jp.translate.goog/document?lawid=328AC0000000014&_x_tr_sl=ja&_x_tr_tl=en&_x_tr_hl=en-US&_x_tr_pto=wapp\",\n \"legislationName\": \"Narcotics and Psychotropics Control Law\",\n \"idJurisdiction\": 24,\n \"jurisdictionName\": \"Japan\",\n \"substanceLegislationName\": \"３，４－メチレンジオキシメタンフェタミン\",\n \"codeName\": [\n \"Japanese Table I Narcotics Similar\"\n ]\n },\n {\n \"sysControlCodeDocument\": [\n \"https://staging.scitegrity.com/client/#docs/systemControlCode/2048\"\n ],\n \"idSysControlledCode\": [\n 261\n ],\n \"corporateId\": \"SCITEGRITY-2\",\n \"fastlookupIdSource\": \"SCITEGRITY_DB_1\",\n \"idLeg2Sub\": 15854,\n \"resultComments\": \"Exact match.\",\n \"controlledStatus\": \"Controlled\",\n \"checkStatus\": \"Completed\",\n \"companyDefinedRule\": false,\n \"nativeLink\": \"https://www.ris.bka.gv.at/GeltendeFassung.wxe?Abfrage=Bundesnormen&Gesetzesnummer=10011053\",\n \"link\": \"https://www-ris-bka-gv-at.translate.goog/GeltendeFassung.wxe?Abfrage=Bundesnormen&Gesetzesnummer=10011053&_x_tr_sl=auto&_x_tr_tl=en&_x_tr_hl=en-GB&_x_tr_pto=nui\",\n \"legislationName\": \"Ordinance of the Federal Minister of Labor, Health and Social Affairs on the traffic and handling of narcotics (Suchtgiftverordnung - SV) No. 374/1997\",\n \"idJurisdiction\": 23,\n \"jurisdictionName\": \"Austria\",\n \"substanceLegislationName\": \"MDMA\",\n \"codeName\": [\n \"Austrian Narcotics Annex V.1\"\n ]\n },\n {\n \"sysControlCodeDocument\": [\n \"https://staging.scitegrity.com/client/#docs/systemControlCode/3108\"\n ],\n \"idSysControlledCode\": [\n 349\n ],\n \"corporateId\": \"SCITEGRITY-2\",\n \"fastlookupIdSource\": \"SCITEGRITY_DB_1\",\n \"idLeg2Sub\": 53794,\n \"resultComments\": \"Exact match.\",\n \"controlledStatus\": \"Controlled\",\n \"checkStatus\": \"Completed\",\n \"companyDefinedRule\": false,\n \"nativeLink\": \"https://isap.sejm.gov.pl/isap.nsf/DocDetails.xsp?id=WDU20220001665\",\n \"link\": \"https://isap-sejm-gov-pl.translate.goog/isap.nsf/DocDetails.xsp?id=WDU20220001665&_x_tr_sl=pl&_x_tr_tl=en&_x_tr_hl=en-US&_x_tr_pto=wapp\",\n \"legislationName\": \"Journal of Laws 2022 item 1665, Announcement of the Minister of Health of 27 June 2022 on the publication of the uniform text of the Regulation of the Minister of Health on the list of psychotropic substances, narcotic drugs and new psychoactive substances\",\n \"idJurisdiction\": 28,\n \"jurisdictionName\": \"Poland\",\n \"substanceLegislationName\": \"MDMA\",\n \"codeName\": [\n \"Polish Psychotropic Substances I-P\"\n ]\n },\n {\n \"sysControlCodeDocument\": [\n \"https://staging.scitegrity.com/client/#docs/systemControlCode/2944\"\n ],\n \"idSysControlledCode\": [\n 415\n ],\n \"corporateId\": \"SCITEGRITY-2\",\n \"fastlookupIdSource\": \"SCITEGRITY_DB_1\",\n \"idLeg2Sub\": 49764,\n \"resultComments\": \"Exact match.\",\n \"controlledStatus\": \"Controlled\",\n \"checkStatus\": \"Completed\",\n \"companyDefinedRule\": false,\n \"nativeLink\": \"https://www.slov-lex.sk/pravne-predpisy/SK/ZZ/1998/139/\",\n \"link\": \"https://www-slov--lex-sk.translate.goog/pravne-predpisy/SK/ZZ/1998/139/?_x_tr_sl=auto&_x_tr_tl=en&_x_tr_hl=en-US&_x_tr_pto=wapp\",\n \"legislationName\": \"Narcotic substances, psychotropic substances and preparations Act\",\n \"idJurisdiction\": 32,\n \"jurisdictionName\": \"Slovakia\",\n \"substanceLegislationName\": \"3,4-Metyléndioxymetamfetamín\",\n \"codeName\": [\n \"Slovakian Grp I Psychotropic\"\n ]\n },\n {\n \"sysControlCodeDocument\": [\n \"https://staging.scitegrity.com/client/#docs/systemControlCode/2482\"\n ],\n \"idSysControlledCode\": [\n 393\n ],\n \"corporateId\": \"SCITEGRITY-2\",\n \"fastlookupIdSource\": \"SCITEGRITY_DB_1\",\n \"idLeg2Sub\": 45673,\n \"resultComments\": \"Exact match.\",\n \"controlledStatus\": \"Controlled\",\n \"checkStatus\": \"Completed\",\n \"companyDefinedRule\": false,\n \"nativeLink\": \"https://www.wada-ama.org/en/resources/world-anti-doping-program/prohibited-list\",\n \"link\": \"https://www.wada-ama.org/sites/default/files/2022-09/2023list_en_final_9_september_2022.pdf\",\n \"legislationName\": \"The World Anti-Doping Code International Standard Prohibited List\",\n \"idJurisdiction\": 31,\n \"jurisdictionName\": \"World Anti-Doping Agency\",\n \"substanceLegislationName\": \"Methylenedioxymethamphetamine\",\n \"codeName\": [\n \"WADA S6 Stimulants\"\n ]\n },\n {\n \"sysControlCodeDocument\": [\n \"https://staging.scitegrity.com/client/#docs/systemControlCode/3344\"\n ],\n \"idSysControlledCode\": [\n 182\n ],\n \"corporateId\": \"SCITEGRITY-2\",\n \"fastlookupIdSource\": \"SCITEGRITY_DB_1\",\n \"idLeg2Sub\": 35075,\n \"resultComments\": \"Exact match.\",\n \"controlledStatus\": \"Controlled\",\n \"checkStatus\": \"Completed\",\n \"companyDefinedRule\": false,\n \"nativeLink\": \"https://staging.scitegrity.com/client/#docs/legislation/321\",\n \"legislationName\": \"List of Psychotropic Substances, The Narcotic Drugs and Psychotropic Substances Act, 1985\",\n \"idJurisdiction\": 17,\n \"jurisdictionName\": \"India\",\n \"substanceLegislationName\": \"MDMA\",\n \"codeName\": [\n \"Indian NDPS Act - Psychotropic\"\n ]\n },\n {\n \"sysControlCodeDocument\": [\n \"https://staging.scitegrity.com/client/#docs/systemControlCode/3862\"\n ],\n \"idSysControlledCode\": [\n 191\n ],\n \"corporateId\": \"SCITEGRITY-2\",\n \"fastlookupIdSource\": \"SCITEGRITY_DB_1\",\n \"idLeg2Sub\": 58389,\n \"resultComments\": \"Exact match.\",\n \"controlledStatus\": \"Controlled\",\n \"checkStatus\": \"Completed\",\n \"companyDefinedRule\": false,\n \"nativeLink\": \"https://www.nmpa.gov.cn/directory/web/nmpa/xxgk/fgwj/gzwj/gzwjyp/20131111120001419.html\",\n \"link\": \"https://staging.scitegrity.com/client/#docs/legislation/296\",\n \"legislationName\": \"Lists of Anaesthetic and Psychotropic Drugs (2013) \",\n \"idJurisdiction\": 19,\n \"jurisdictionName\": \"China\",\n \"substanceLegislationName\": \"二亚甲基双氧安非他明\",\n \"codeName\": [\n \"China Psychotropic Drugs - Category 1\"\n ]\n },\n {\n \"sysControlCodeDocument\": [\n \"https://staging.scitegrity.com/client/#docs/systemControlCode/3195\"\n ],\n \"idSysControlledCode\": [\n 6\n ],\n \"corporateId\": \"SCITEGRITY-2\",\n \"fastlookupIdSource\": \"SCITEGRITY_DB_1\",\n \"idLeg2Sub\": 23534,\n \"resultComments\": \"Exact match.\",\n \"controlledStatus\": \"Controlled\",\n \"checkStatus\": \"Completed\",\n \"companyDefinedRule\": false,\n \"nativeLink\": \"http://www.incb.org/incb/en/psychotropics/green-list.html\",\n \"link\": \"http://www.incb.org/incb/en/psychotropics/green-list.html\",\n \"legislationName\": \"International Narcotics Control Board (INCB) Green List (Psychotropic Substances under International Control)\",\n \"idJurisdiction\": 15,\n \"jurisdictionName\": \"UN (INCB)\",\n \"substanceLegislationName\": \"PM 011\",\n \"codeName\": [\n \"UN Psychotropics Schedule I\"\n ]\n },\n {\n \"sysControlCodeDocument\": [\n \"https://staging.scitegrity.com/client/#docs/systemControlCode/2837\"\n ],\n \"idSysControlledCode\": [\n 63\n ],\n \"corporateId\": \"SCITEGRITY-2\",\n \"fastlookupIdSource\": \"SCITEGRITY_DB_1\",\n \"idLeg2Sub\": 32526,\n \"resultComments\": \"Exact match.\",\n \"controlledStatus\": \"Controlled\",\n \"checkStatus\": \"Completed\",\n \"companyDefinedRule\": false,\n \"nativeLink\": \"http://laws-lois.justice.gc.ca/eng/acts/C-38.8/\",\n \"link\": \"https://laws--lois-justice-gc-ca.translate.goog/eng/acts/C-38.8/?_x_tr_sl=auto&_x_tr_tl=en&_x_tr_hl=en-GB&_x_tr_pto=nui\",\n \"legislationName\": \"Controlled Drugs and Substances Act (S.C. 1996, c. 19)\",\n \"idJurisdiction\": 14,\n \"jurisdictionName\": \"Canada\",\n \"substanceLegislationName\": \"N-Methyl-3,4-methylenedioxy-amphetamine\",\n \"codeName\": [\n \"Canadian Schedule I\"\n ]\n },\n {\n \"sysControlCodeDocument\": [\n \"https://staging.scitegrity.com/client/#docs/systemControlCode/3226\"\n ],\n \"idSysControlledCode\": [\n 37\n ],\n \"corporateId\": \"SCITEGRITY-2\",\n \"fastlookupIdSource\": \"SCITEGRITY_DB_1\",\n \"idLeg2Sub\": 17539,\n \"resultComments\": \"Exact match.\",\n \"controlledStatus\": \"Controlled\",\n \"checkStatus\": \"Completed\",\n \"companyDefinedRule\": false,\n \"nativeLink\": \"http://www.admin.ch/opc/de/classified-compilation/20101220/index.html\",\n \"link\": \"\",\n \"legislationName\": \"Regulation of EDI over the lists of narcotics, psychotropic substances, precursors and auxiliary chemicals\",\n \"idJurisdiction\": 13,\n \"jurisdictionName\": \"Switzerland\",\n \"substanceLegislationName\": \"3,4-Methylendioxymethamphetamin\",\n \"codeName\": [\n \"Swiss Directory D\"\n ]\n },\n {\n \"corporateId\": \"SCITEGRITY-3\",\n \"fastlookupIdSource\": \"SCITEGRITY_DB_1\",\n \"idLeg2Sub\": null,\n \"resultComments\": null,\n \"controlledStatus\": \"No\",\n \"checkStatus\": \"Completed\"\n },\n {\n \"corporateId\": \"SCITEGRITY-4\",\n \"fastlookupIdSource\": \"SCITEGRITY_DB_1\",\n \"idLeg2Sub\": null,\n \"resultComments\": null,\n \"controlledStatus\": \"No\",\n \"checkStatus\": \"Completed\"\n }\n ]\n },\n \"searchQuery\": \"\"\n}"}],"_postman_id":"8a217ff1-b3ab-4d51-b647-2a287bac30f0"}],"id":"531fbece-7a1f-4b0d-8f27-20413d448aa5","description":"

Endpoints to start fastlookup refresh jobs and get job results.

\n","_postman_id":"531fbece-7a1f-4b0d-8f27-20413d448aa5"},{"name":"/overrides","item":[{"name":"/id/update/run","event":[{"listen":"test","script":{"id":"e997415c-a429-46b5-90f2-0b95bdc62471","exec":["// parse response and set gatewayJobId as environment variable\r","var response = pm.response.json();\r","pm.environment.set(\"jobId\", response.gatewayJobId);"],"type":"text/javascript","packages":{}}}],"id":"38ad0540-4840-4365-bee7-4bf5112b693c","protocolProfileBehavior":{"disableBodyPruning":true},"request":{"method":"POST","header":[{"key":"x-access-token","value":"{{token}}","description":"

This header needs to have the authenication token obtained from the /authenticate API to allow requests to be sent to this endpoint

\n","type":"text"}],"body":{"mode":"raw","raw":"{\r\n \"overrides\": [\r\n {\"corporateId\": \"SCIT-0001\", \"comment\": \"Scitegrity considers this compound to be controlled\"},\r\n {\"corporateId\": \"SCIT-0002\", \"comment\": \"Scitegrity considers this compound to be controlled\"}\r\n ],\r\n \"idJurisdiction\": [2, 3],\r\n \"overrideType\": \"controlled\"\r\n}","options":{"raw":{"language":"json"}}},"url":"https://{{host}}:{{port}}/overrides/id/update/run","description":"

Starts a job to add the specified overrides into CS2 and then updates the cached CS2 result data (fastlookup).

This is a polling job which will return a job id. The status of this job can be polled using the /job/status endpoint.

Body parameters

overrides: object array
This is an array of objects. Each object should have a corporateId key specifiying the compound IDs to override and a comment key which contains comment to state why the override has been applied. This comment will be returned to users in the CS2 user interface and webservices.

idJurisdiction: integer array
An array of the jurisdictions in which to apply the controlled status overrides.

overrideType: string
Specify the new controlled status to override these restrictions to. This parameter can take the following values:

controlled
\n
possiblyControlled
\n
notControlled
\n

\n","urlObject":{"protocol":"https","port":"{{port}}","path":["overrides","id","update","run"],"host":["{{host}}"],"query":[],"variable":[]}},"response":[{"id":"5a67af8b-68f2-4395-a698-5b73387400ff","name":"/id/update/run","originalRequest":{"method":"POST","header":[{"key":"x-access-token","value":"{{token}}","description":"This header needs to have the authenication token obtained from the /owner/authenticate API to allow requests to be sent to this endpoint","type":"text"}],"body":{"mode":"raw","raw":"{\r\n \"overrides\": [\r\n {\"corporateId\": \"MFCD00055368\", \"comment\": \"testing overrides\"},\r\n {\"corporateId\": \"badCpdId\", \"comment\": \"testing overrides\"}\r\n ],\r\n \"idJurisdiction\": [2, 3],\r\n \"overrideType\": \"possiblyControlled\"\r\n}","options":{"raw":{"language":"json"}}},"url":"https://{{host}}:{{port}}/overrides/id/update/run"},"status":"Created","code":201,"_postman_previewlanguage":"json","header":[{"key":"X-Powered-By","value":"Express","enabled":true},{"key":"X-Frame-Options","value":"SAMEORIGIN","enabled":true},{"key":"Content-Type","value":"application/json; charset=utf-8","enabled":true},{"key":"Content-Length","value":"59","enabled":true},{"key":"ETag","value":"W/\"3b-CVPuh/OLPMe6yW/vCX86YEcv0MA\"","enabled":true},{"key":"Date","value":"Wed, 27 Apr 2022 10:20:13 GMT","enabled":true},{"key":"Connection","value":"keep-alive","enabled":true},{"key":"Keep-Alive","value":"timeout=5","enabled":true}],"cookie":[],"responseTime":null,"body":"{\n \"gatewayJobId\": \"GWJ-a020dfb0-c613-11ec-81b0-db7d0fe48722\"\n}"}],"_postman_id":"38ad0540-4840-4365-bee7-4bf5112b693c"},{"name":"/id/update/result","event":[{"listen":"test","script":{"id":"5b2ebc2d-f1eb-4f36-b342-2639dba7dcaf","exec":[""],"type":"text/javascript","packages":{}}}],"id":"68e88356-7c65-4462-9ddd-3193e41d003b","protocolProfileBehavior":{"disableBodyPruning":true},"request":{"method":"POST","header":[{"key":"x-access-token","value":"{{token}}","description":"

This header needs to have the authenication token obtained from the /authenticate API to allow requests to be sent to this endpoint

\n","type":"text"}],"body":{"mode":"raw","raw":"{\n\t\"gatewayJobId\": \"{{jobId}}\"\n}\n","options":{"raw":{"language":"json"}}},"url":"https://{{host}}:{{port}}/overrides/id/update/result","description":"

Retrieve the results of an overrides update job. If any overrides could not be added these will be returned in a failedIds array (see example response).

\n","urlObject":{"protocol":"https","port":"{{port}}","path":["overrides","id","update","result"],"host":["{{host}}"],"query":[],"variable":[]}},"response":[{"id":"b49d8cd3-c79f-4a47-95b6-8cc3b2ce8278","name":"/id/update/result","originalRequest":{"method":"POST","header":[{"key":"Content-Type","name":"Content-Type","value":"application/json","type":"text"},{"key":"x-access-token","value":"{{token}}","description":"This header needs to have the authenication token obtained from the /owner/authenticate API to allow requests to be sent to this endpoint","type":"text"}],"body":{"mode":"raw","raw":"{\n\t\"gatewayJobId\": \"GWJ-a020dfb0-c613-11ec-81b0-db7d0fe48722\"\n}\n"},"url":"https://{{host}}:{{port}}/job/search/result"},"status":"OK","code":200,"_postman_previewlanguage":"json","header":[{"key":"X-Powered-By","value":"Express","enabled":true},{"key":"X-Frame-Options","value":"SAMEORIGIN","enabled":true},{"key":"Content-Type","value":"application/json; charset=utf-8","enabled":true},{"key":"Content-Length","value":"129","enabled":true},{"key":"ETag","value":"W/\"81-UWrKaKe2ma7+VzDG87MKsnFsB2E\"","enabled":true},{"key":"Date","value":"Wed, 27 Apr 2022 10:20:43 GMT","enabled":true},{"key":"Connection","value":"keep-alive","enabled":true},{"key":"Keep-Alive","value":"timeout=5","enabled":true}],"cookie":[],"responseTime":null,"body":"{\n \"jobStatus\": \"complete\",\n \"jobResult\": {\n \"message\": \"Overrides have been created and applied to fastlookup\",\n \"failedIds\": [\n \"badCpdId\"\n ]\n }\n}"}],"_postman_id":"68e88356-7c65-4462-9ddd-3193e41d003b"},{"name":"/id/remove","event":[{"listen":"test","script":{"id":"0a420b95-8fef-4400-952e-f210a1952ef1","exec":[""],"type":"text/javascript","packages":{}}}],"id":"789e5bb8-9f4c-42fc-ab68-2412150cb1f8","protocolProfileBehavior":{"disableBodyPruning":true},"request":{"method":"POST","header":[{"key":"x-access-token","value":"{{token}}","description":"

This header needs to have the authenication token obtained from the /authenticate API to allow requests to be sent to this endpoint

\n","type":"text"}],"body":{"mode":"raw","raw":"{\r\n \"corporateId\": [\"SCIT-0001\"],\r\n \"idJurisdiction\": [2]\r\n}","options":{"raw":{"language":"json"}}},"url":"https://{{host}}:{{port}}/overrides/id/remove","description":"

Remove overrides for specified corporate IDs in the specified jurisdictions.

Body parameters

corporateId: string array
This is an array of of compound IDs for which to remove overrides

idJurisdiction: integer array
An array of the jurisdictions in which to remove the controlled status overrides.

\n","urlObject":{"protocol":"https","port":"{{port}}","path":["overrides","id","remove"],"host":["{{host}}"],"query":[],"variable":[]}},"response":[],"_postman_id":"789e5bb8-9f4c-42fc-ab68-2412150cb1f8"}],"id":"5fab1972-7215-4814-9772-661eea479f0b","description":"

Endpoints to programmatically add and remove controlled status overrides on compounds.

\n","_postman_id":"5fab1972-7215-4814-9772-661eea479f0b"},{"name":"/customrestrictions","item":[{"name":"/id/substancelist/substances/list","event":[{"listen":"test","script":{"id":"397a334c-ee13-45d5-983d-3be2c3cd8a19","exec":[""],"type":"text/javascript","packages":{}}}],"id":"db56ed7e-1b75-4399-a9e6-8517192cd75f","protocolProfileBehavior":{"disableBodyPruning":true},"request":{"method":"GET","header":[{"key":"x-access-token","value":"{{token}}","description":"

This header needs to have the authentication token obtained from the /authenticate API to allow requests to be sent to this endpoint

\n"}],"url":"https://{{host}}:{{port}}/customrestrictions/id/substancelist/substances/list/:listId","description":"

This endpoint can be used to get a list of the compound IDs currently in the specified list.

\n","urlObject":{"protocol":"https","port":"{{port}}","path":["customrestrictions","id","substancelist","substances","list",":listId"],"host":["{{host}}"],"query":[],"variable":[{"description":{"content":"

ID of the list to show substances in

\n","type":"text/plain"},"type":"any","value":"1","key":"listId"}]}},"response":[],"_postman_id":"db56ed7e-1b75-4399-a9e6-8517192cd75f"},{"name":"/id/substancelist/populate/run","event":[{"listen":"test","script":{"id":"550b985e-0644-4d5a-b632-ed660e003207","exec":["// parse response and set gatewayJobId as environment variable\r","var response = pm.response.json();\r","pm.environment.set(\"jobId\", response.gatewayJobId);"],"type":"text/javascript","packages":{}}}],"id":"893e1726-87b6-44e1-9965-40c5dd10fe24","protocolProfileBehavior":{"disableBodyPruning":true},"request":{"method":"POST","header":[{"key":"x-access-token","value":"{{token}}","description":"

This header needs to have the authentication token obtained from the /authenticate API to allow requests to be sent to this endpoint

\n"}],"body":{"mode":"raw","raw":"{\r\n \"listId\": 17,\r\n \"substances\": [\r\n {\"corporateId\": \"SCIT-1000\", \"comment\": \"substance list comment\"},\r\n {\"corporateId\": \"SCIT-1001\", \"comment\": \"substance list comment\"}\r\n ],\r\n \"populationOption\": \"add\"\r\n}","options":{"raw":{"language":"json"}}},"url":"https://{{host}}:{{port}}/customrestrictions/id/substancelist/populate/run","description":"

Starts a job to add the specified compound IDs to the specified CS2 substance list. The job will apply these changes to the cached CS2 data in the fastlookup.

This is a polling job which will return a job id. The status of this job can be polled using the /job/status endpoint.

Body parameters

listId: integer
The numerical indentifier for the substance list to populate.

substances: object array
This parameter takes an array of JSON objects. Each object should have a corporateId key specifiying the compound IDs to add to the specified list and a comment key which contains comment to state why the compound has been added to this list. This comment will be returned to users in the CS2 user interface and webservices.

populationOption: string
Specify the new controlled status to override these restrictions to. This parameter can take the following values:

add - add the provided compounds ID to the list keeping all existing IDs in the list. If a provided compound ID is already in the list it will not be added to avoid duplicates
\n
clearThenAdd -remove all current IDs from the list then adds in those provided in the request.
\n
remove - remove the provided compounds ID from the specified list.
\n

\n","urlObject":{"protocol":"https","port":"{{port}}","path":["customrestrictions","id","substancelist","populate","run"],"host":["{{host}}"],"query":[],"variable":[]}},"response":[],"_postman_id":"893e1726-87b6-44e1-9965-40c5dd10fe24"},{"name":"/id/substancelist/populate/result","event":[{"listen":"test","script":{"id":"25728fcb-66e4-4e7c-93cd-0ed3a1e591a1","exec":[""],"type":"text/javascript","packages":{}}}],"id":"38807b44-793a-44e3-9bd8-da32d39a5f1e","protocolProfileBehavior":{"disableBodyPruning":true},"request":{"method":"POST","header":[{"key":"x-access-token","value":"{{token}}","description":"

This header needs to have the authentication token obtained from the /authenticate API to allow requests to be sent to this endpoint

\n"}],"body":{"mode":"raw","raw":"{\r\n \"gatewayJobId\": \"{{jobId}}\"\r\n}","options":{"raw":{"language":"json"}}},"url":"https://{{host}}:{{port}}/customrestrictions/id/substancelist/populate/result","description":"

Retrieve the results of an list population job using the job ID returned by the /customrestrictions/id/substancelist/populate/run endpoint.

\n","urlObject":{"protocol":"https","port":"{{port}}","path":["customrestrictions","id","substancelist","populate","result"],"host":["{{host}}"],"query":[],"variable":[]}},"response":[],"_postman_id":"38807b44-793a-44e3-9bd8-da32d39a5f1e"}],"id":"4689f93f-c366-4652-858a-23a80affa1b8","description":"

Endpoints to programmatically add compound IDs to customer created restrictions

\n","_postman_id":"4689f93f-c366-4652-858a-23a80affa1b8"},{"name":"search using URL","item":[{"name":"/auth/search/string","id":"466365b3-f04a-4e8e-b3aa-af4afa182859","protocolProfileBehavior":{"disableBodyPruning":true},"request":{"method":"GET","header":[],"url":"https://{{host}}:{{port}}/auth/search/string?searchTerm=mdma&idJurisdiction=2&idJurisdiction=3","description":"

Run a CS2 search from a URL with a chemical name/ID, this will then direct you to the CS2 UI to display results. Provide the chemical name/compound ID and jurisdictions you wish to search.

\n","urlObject":{"protocol":"https","port":"{{port}}","path":["auth","search","string"],"host":["{{host}}"],"query":[{"description":{"content":"

Chemical name to search for

\n","type":"text/plain"},"key":"searchTerm","value":"mdma"},{"description":{"content":"

This parameter is optional. If not provided CS2 will search against all jurisdictions you license within CS2. If provided this should the integer id of the jurisdiction for the search to consider. If multiple jurisdictions required add them as additional parameters.

\n","type":"text/plain"},"key":"idJurisdiction","value":"2"},{"description":{"content":"

see above

\n","type":"text/plain"},"key":"idJurisdiction","value":"3"}],"variable":[]}},"response":[{"id":"2c95acdc-d2f0-41f7-bb8d-7e7f4a3b0e88","name":"/controlcodes/list","originalRequest":{"method":"GET","header":[{"key":"x-access-token","value":"{{token}}","description":"This header needs to have the authenication token obtained from the /owner/authenticate API to allow requests to be sent to this endpoint","type":"text"}],"body":{"mode":"raw","raw":"","options":{"raw":{"language":"json"}}},"url":{"raw":"https://{{host}}:{{port}}/controlcodes/list?system=true&customer=true","protocol":"https","host":["{{host}}"],"port":"{{port}}","path":["controlcodes","list"],"query":[{"key":"system","value":"true","description":"Optional. If not provided this defaults to true. This toggles whether to return system control codes."},{"key":"customer","value":"true","description":"Optional. If not provided this defaults to true. This toggles whether to return customer control codes."}]}},"status":"OK","code":200,"_postman_previewlanguage":"json","header":[{"key":"Date","value":"Tue, 29 Jun 2021 09:32:19 GMT","enabled":true},{"key":"Content-Type","value":"application/json; charset=utf-8","enabled":true},{"key":"Content-Length","value":"78727","enabled":true},{"key":"Connection","value":"keep-alive","enabled":true},{"key":"Set-Cookie","value":"AWSALBTG=/zq57vRvdNU1RDOVYcFBm+Gz2V48s21koMuiQM+3C4XvTbpCVbE3z/NDFp5J+QwCAReirbcavvmK7SvNw43ene470w0kepkLiS5jYN+mZzeCO7+k4f/wi/+rV/Qp08Fhuog6rBSlO8heaB1OziNnveOgb8pw30j6vbiMxgAGSe2vUS+nABQ=; Expires=Tue, 06 Jul 2021 09:32:19 GMT; Path=/","enabled":true},{"key":"Set-Cookie","value":"AWSALBTGCORS=/zq57vRvdNU1RDOVYcFBm+Gz2V48s21koMuiQM+3C4XvTbpCVbE3z/NDFp5J+QwCAReirbcavvmK7SvNw43ene470w0kepkLiS5jYN+mZzeCO7+k4f/wi/+rV/Qp08Fhuog6rBSlO8heaB1OziNnveOgb8pw30j6vbiMxgAGSe2vUS+nABQ=; Expires=Tue, 06 Jul 2021 09:32:19 GMT; Path=/; SameSite=None; Secure","enabled":true},{"key":"X-Powered-By","value":"Express","enabled":true},{"key":"X-Frame-Options","value":"SAMEORIGIN","enabled":true},{"key":"ETag","value":"W/\"13387-yMsxifOenhh1GqH68lOMkrbrcdo\"","enabled":true}],"cookie":[],"responseTime":null,"body":"[\n {\n \"idSysControlledCode\": 97,\n \"codeName\": \"Irish Schedule 1\",\n \"idJurisdiction\": 5,\n \"jurisdictionName\": \"Ireland\",\n \"description\": \"Drugs subject to very strict controls and have little or no use in medicine or industry\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 98,\n \"codeName\": \"Irish Schedule 2\",\n \"idJurisdiction\": 5,\n \"jurisdictionName\": \"Ireland\",\n \"description\": \"Drugs used for scientific purposes which have a high likelihood of their being abused\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 99,\n \"codeName\": \"Irish Schedule 3\",\n \"idJurisdiction\": 5,\n \"jurisdictionName\": \"Ireland\",\n \"description\": \"Controlled medicinal products with a high likelihood of abuse\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 100,\n \"codeName\": \"Irish Schedule 4 pt 1\",\n \"idJurisdiction\": 5,\n \"jurisdictionName\": \"Ireland\",\n \"description\": \"Controlled medicinal products\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 108,\n \"codeName\": \"Irish Schedule 5\",\n \"idJurisdiction\": 5,\n \"jurisdictionName\": \"Ireland\",\n \"description\": \"Controlled drugs exempted from the prohibition on importation and exportation \",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 109,\n \"codeName\": \"Irish Schedule 8 pt1\",\n \"idJurisdiction\": 5,\n \"jurisdictionName\": \"Ireland\",\n \"description\": \"Can be prescribed for pain relief by a nurse in hospital\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 110,\n \"codeName\": \"Irish EU Drug Precursor Category 1\",\n \"idJurisdiction\": 5,\n \"jurisdictionName\": \"Ireland\",\n \"description\": \"EU Drug Precursor Category 1\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 111,\n \"codeName\": \"Irish EU Drug Precursor Category 2A\",\n \"idJurisdiction\": 5,\n \"jurisdictionName\": \"Ireland\",\n \"description\": \"EU Drug Precursor Category 2A\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 112,\n \"codeName\": \"Irish EU Drug Precursor Category 3\",\n \"idJurisdiction\": 5,\n \"jurisdictionName\": \"Ireland\",\n \"description\": \"EU Drug Precursor Category 3\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 113,\n \"codeName\": \"Irish EU Drug Precursor Category 4\",\n \"idJurisdiction\": 5,\n \"jurisdictionName\": \"Ireland\",\n \"description\": \"EU Drug Precursor Category 4\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 114,\n \"codeName\": \"Irish Schedule 4 pt 2\",\n \"idJurisdiction\": 5,\n \"jurisdictionName\": \"Ireland\",\n \"description\": \"Controlled medicinal products\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 175,\n \"codeName\": \"Canadian Schedule VII\",\n \"idJurisdiction\": 14,\n \"jurisdictionName\": \"Canada\",\n \"description\": \"Canadian Schedule VII\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 1176,\n \"codeName\": \"Canadian Schedule VIII\",\n \"idJurisdiction\": 14,\n \"jurisdictionName\": \"Canada\",\n \"description\": \"Canadian Schedule VIII\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 115,\n \"codeName\": \"Irish Schedule 8 pt2\",\n \"idJurisdiction\": 5,\n \"jurisdictionName\": \"Ireland\",\n \"description\": \"Can be prescribed for pain relief by a nurse in hospital\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 116,\n \"codeName\": \"Irish Schedule 8 pt3\",\n \"idJurisdiction\": 5,\n \"jurisdictionName\": \"Ireland\",\n \"description\": \"Can be prescribed for pain relief by a nurse in hospital\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 117,\n \"codeName\": \"Irish Schedule 8 pt4\",\n \"idJurisdiction\": 5,\n \"jurisdictionName\": \"Ireland\",\n \"description\": \"Can be prescribed for pain relief by a nurse in hospital\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 118,\n \"codeName\": \"Irish no schedule given\",\n \"idJurisdiction\": 5,\n \"jurisdictionName\": \"Ireland\",\n \"description\": \"Some substances are controlled in the general text of the legislation but not listed in a named schedule\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 23,\n \"codeName\": \"UK Schedule 1\",\n \"idJurisdiction\": 2,\n \"jurisdictionName\": \"United Kingdom\",\n \"description\": \"Schedule 1 drugs are thought to have no therapeutic value and cannot be lawfully possessed or prescribed. A Home Office license is required for research and significant regulations govern record keeping and storage.\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 24,\n \"codeName\": \"UK Schedule 2\",\n \"idJurisdiction\": 2,\n \"jurisdictionName\": \"United Kingdom\",\n \"description\": \"Schedule 2 drugs can be prescribed and therefore legally possessed and supplied by pharmacists and doctors (possesion or supply is otherwise illegal) and include drugs such as Heroin. Significant regulations govern record keeping and storage requirements for research use. \",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 25,\n \"codeName\": \"UK Schedule 3\",\n \"idJurisdiction\": 2,\n \"jurisdictionName\": \"United Kingdom\",\n \"description\": \"Schedule 3 drugs can be prescribed and therefore legally possessed and supplied by pharmacists and doctors (possession or supply is otherwise illegal). They have less onerous record keeping and storage regulations.\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 26,\n \"codeName\": \"UK Schedule 4\",\n \"idJurisdiction\": 2,\n \"jurisdictionName\": \"United Kingdom\",\n \"description\": \"Schedule 4 contain drugs such as steroids and benzodiazepines. Depending on the substance import / export licenses maybe required as well as a home office permit for scientific use.\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 27,\n \"codeName\": \"UK Schedule 5\",\n \"idJurisdiction\": 2,\n \"jurisdictionName\": \"United Kingdom\",\n \"description\": \"Schedule 5 drugs are sold over the counter and can be legally possessed without a prescription and imported / exported.\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 28,\n \"codeName\": \"UK Class A\",\n \"idJurisdiction\": 2,\n \"jurisdictionName\": \"United Kingdom\",\n \"description\": \"UK Class A\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 29,\n \"codeName\": \"UK Class B\",\n \"idJurisdiction\": 2,\n \"jurisdictionName\": \"United Kingdom\",\n \"description\": \"UK Class B\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 30,\n \"codeName\": \"UK Class C\",\n \"idJurisdiction\": 2,\n \"jurisdictionName\": \"United Kingdom\",\n \"description\": \"UK Class C\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 1,\n \"codeName\": \"UK Temporary Class Drug\",\n \"idJurisdiction\": 2,\n \"jurisdictionName\": \"United Kingdom\",\n \"description\": \"UK TEMPORARY CONTROL\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 2,\n \"codeName\": \"UNKNOWN\",\n \"idJurisdiction\": 2,\n \"jurisdictionName\": \"United Kingdom\",\n \"description\": \"UNKNOWN\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 3,\n \"codeName\": \"UK Schedule 3 Part 2\",\n \"idJurisdiction\": 2,\n \"jurisdictionName\": \"United Kingdom\",\n \"description\": \"Not used\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 4,\n \"codeName\": \"UK Schedule 4 Part 1\",\n \"idJurisdiction\": 2,\n \"jurisdictionName\": \"United Kingdom\",\n \"description\": \"UK Schedule 4 Part 1\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 5,\n \"codeName\": \"UK Schedule 4 Part 2\",\n \"idJurisdiction\": 2,\n \"jurisdictionName\": \"United Kingdom\",\n \"description\": \"UK Schedule 4 Part 2\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 41,\n \"codeName\": \"Test-partA\",\n \"idJurisdiction\": 16,\n \"jurisdictionName\": \"Used for testing\",\n \"description\": \"Test-partA\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 6,\n \"codeName\": \"UN Psychotropics Schedule I \",\n \"idJurisdiction\": 15,\n \"jurisdictionName\": \"UN (INCB)\",\n \"description\": \"UN Psychotropics Schedule I\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 7,\n \"codeName\": \"UN Psychotropics Schedule II\",\n \"idJurisdiction\": 15,\n \"jurisdictionName\": \"UN (INCB)\",\n \"description\": \"UN Psychotropics Schedule II\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 8,\n \"codeName\": \"UN Psychotropics Schedule III\",\n \"idJurisdiction\": 15,\n \"jurisdictionName\": \"UN (INCB)\",\n \"description\": \"UN Psychotropics Schedule III\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 9,\n \"codeName\": \"UN Psychotropics Schedule IV\",\n \"idJurisdiction\": 15,\n \"jurisdictionName\": \"UN (INCB)\",\n \"description\": \"UN Psychotropics Schedule IV\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 21,\n \"codeName\": \"US CSA Schedule I\",\n \"idJurisdiction\": 3,\n \"jurisdictionName\": \"United States of America\",\n \"description\": \"Schedule I drugs, substances, or chemicals are defined as drugs with no currently accepted medical use and a high potential for abuse. Schedule I drugs are the most dangerous drugs of all the drug schedules with potentially severe psychological or physical dependence. Significant controls need to be in place \",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 22,\n \"codeName\": \"US CSA Schedule II\",\n \"idJurisdiction\": 3,\n \"jurisdictionName\": \"United States of America\",\n \"description\": \"Schedule II drugs, substances, or chemicals are defined as drugs with a high potential for abuse, less abuse potential than Schedule I drugs, with use potentially leading to severe psychological or physical dependence. These drugs are also considered dangerous. Significant controls need to be in place\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 31,\n \"codeName\": \"US CSA Schedule III\",\n \"idJurisdiction\": 3,\n \"jurisdictionName\": \"United States of America\",\n \"description\": \"Schedule III drugs, substances, or chemicals are defined as drugs with a moderate to low potential for physical and psychological dependence. Schedule III drugs abuse potential is less than Schedule I and Schedule II drugs but more than Schedule IV. Significant controls generally need to be in place\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 32,\n \"codeName\": \"US CSA Schedule IV\",\n \"idJurisdiction\": 3,\n \"jurisdictionName\": \"United States of America\",\n \"description\": \"Schedule IV drugs, substances, or chemicals are defined as drugs with a low potential for abuse and low risk of dependence. \",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 33,\n \"codeName\": \"US CSA Schedule V\",\n \"idJurisdiction\": 3,\n \"jurisdictionName\": \"United States of America\",\n \"description\": \"Schedule V drugs, substances, or chemicals are defined as drugs with lower potential for abuse than Schedule IV and consist of preparations containing limited quantities of certain narcotics. Schedule V drugs are generally used for antidiarrheal, antitussive, and analgesic purposes.\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 40,\n \"codeName\": \"US CSA Schedule I (temporary)\",\n \"idJurisdiction\": 3,\n \"jurisdictionName\": \"United States of America\",\n \"description\": \"Schedule I drugs, substances, or chemicals are defined as drugs with no currently accepted medical use and a high potential for abuse. Schedule I drugs are the most dangerous drugs of all the drug schedules with potentially severe psychological or physical dependence. Significant controls need to be in place \",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 42,\n \"codeName\": \"US CSA List 1 Regulated Chemical\",\n \"idJurisdiction\": 3,\n \"jurisdictionName\": \"United States of America\",\n \"description\": \"US List 1 Regulated Chemical\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 43,\n \"codeName\": \"US CSA List 2 Regulated Chemical\",\n \"idJurisdiction\": 3,\n \"jurisdictionName\": \"United States of America\",\n \"description\": \"US List 2 Regulated Chemical\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 44,\n \"codeName\": \"UK EU Drug Precursor Category 1\",\n \"idJurisdiction\": 2,\n \"jurisdictionName\": \"United Kingdom\",\n \"description\": \"UK EU Drug Precursor Category 1\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 45,\n \"codeName\": \"UK EU Drug Precursor Category 2B\",\n \"idJurisdiction\": 2,\n \"jurisdictionName\": \"United Kingdom\",\n \"description\": \"UK EU Drug Precursor Category 2B\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 46,\n \"codeName\": \"UK EU Drug Precursor Category 3\",\n \"idJurisdiction\": 2,\n \"jurisdictionName\": \"United Kingdom\",\n \"description\": \"UK EU Drug Precursor Category 3\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 78,\n \"codeName\": \"Spain UN Narcotics List I\",\n \"idJurisdiction\": 11,\n \"jurisdictionName\": \"Spain\",\n \"description\": \"Spain UN Narcotics List I\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 75,\n \"codeName\": \"Spain UN Narcotics List II\",\n \"idJurisdiction\": 11,\n \"jurisdictionName\": \"Spain\",\n \"description\": \"Spain UN Narcotics List II\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 76,\n \"codeName\": \"Spain UN Narcotics List III\",\n \"idJurisdiction\": 11,\n \"jurisdictionName\": \"Spain\",\n \"description\": \"Spain UN Narcotics List III\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 77,\n \"codeName\": \"Spain UN Narcotics List IV\",\n \"idJurisdiction\": 11,\n \"jurisdictionName\": \"Spain\",\n \"description\": \"Spain UN Narcotics List IV\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 79,\n \"codeName\": \"US ARCOS List\",\n \"idJurisdiction\": 3,\n \"jurisdictionName\": \"United States of America\",\n \"description\": \"Substances, which may not be listed in legislation but within US ARCOS system as likely requiring import/export licences and should be considered as controlled\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 80,\n \"codeName\": \"Spain UN Psychotropics List II\",\n \"idJurisdiction\": 11,\n \"jurisdictionName\": \"Spain\",\n \"description\": \"Spain UN Psychotropics List II\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 81,\n \"codeName\": \"Spain UN Psychotropics List III\",\n \"idJurisdiction\": 11,\n \"jurisdictionName\": \"Spain\",\n \"description\": \"Spain UN Psychotropics List III\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 82,\n \"codeName\": \"Spain UN Psychotropics List IV\",\n \"idJurisdiction\": 11,\n \"jurisdictionName\": \"Spain\",\n \"description\": \"Spain UN Psychotropics List IV\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 83,\n \"codeName\": \"Spain UN Psychotropics List I\",\n \"idJurisdiction\": 11,\n \"jurisdictionName\": \"Spain\",\n \"description\": \"Spain UN Psychotropics List I\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 84,\n \"codeName\": \"Spain Psychotropics Annex 2\",\n \"idJurisdiction\": 11,\n \"jurisdictionName\": \"Spain\",\n \"description\": \"Spain Annex substances controlled in addition to UN lists\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 85,\n \"codeName\": \"Swedish List I\",\n \"idJurisdiction\": 12,\n \"jurisdictionName\": \"Sweden\",\n \"description\": \"substances , plant material and fungi that normally do not have medical use\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 86,\n \"codeName\": \"Swedish List II\",\n \"idJurisdiction\": 12,\n \"jurisdictionName\": \"Sweden\",\n \"description\": \"substances , plant material and fungi with medical use\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 87,\n \"codeName\": \"Swedish List III\",\n \"idJurisdiction\": 12,\n \"jurisdictionName\": \"Sweden\",\n \"description\": \"substances , plant material and fungi with medical use\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 88,\n \"codeName\": \"Swedish List IV\",\n \"idJurisdiction\": 12,\n \"jurisdictionName\": \"Sweden\",\n \"description\": \"substances , plant material and fungi with medical use\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 89,\n \"codeName\": \"Swedish List V\",\n \"idJurisdiction\": 12,\n \"jurisdictionName\": \"Sweden\",\n \"description\": \"Swedish List 5\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 90,\n \"codeName\": \"Danish List A\",\n \"idJurisdiction\": 7,\n \"jurisdictionName\": \"Denmark\",\n \"description\": \"Danish List A\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 91,\n \"codeName\": \"Danish List B\",\n \"idJurisdiction\": 7,\n \"jurisdictionName\": \"Denmark\",\n \"description\": \"Danish List B\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 92,\n \"codeName\": \"Danish List C\",\n \"idJurisdiction\": 7,\n \"jurisdictionName\": \"Denmark\",\n \"description\": \"Danish List C\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 93,\n \"codeName\": \"Danish List D\",\n \"idJurisdiction\": 7,\n \"jurisdictionName\": \"Denmark\",\n \"description\": \"Danish List D\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 94,\n \"codeName\": \"Danish List E\",\n \"idJurisdiction\": 7,\n \"jurisdictionName\": \"Denmark\",\n \"description\": \"Danish List E\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 34,\n \"codeName\": \"Swiss Directory A\",\n \"idJurisdiction\": 13,\n \"jurisdictionName\": \"Switzerland\",\n \"description\": \"controlled substances that are subject to all of the control measures; \",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 35,\n \"codeName\": \"Swiss Directory B\",\n \"idJurisdiction\": 13,\n \"jurisdictionName\": \"Switzerland\",\n \"description\": \"controlled substances that are partially exempt from the control measures; \",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 36,\n \"codeName\": \"Swiss Directory C\",\n \"idJurisdiction\": 13,\n \"jurisdictionName\": \"Switzerland\",\n \"description\": \"controlled substances that may be contained in preparations in reduced concentrations and are partially exempt from the control measures; \",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 37,\n \"codeName\": \"Swiss Directory D\",\n \"idJurisdiction\": 13,\n \"jurisdictionName\": \"Switzerland\",\n \"description\": \"illegal controlled substances\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 47,\n \"codeName\": \"Swiss Directory E\",\n \"idJurisdiction\": 13,\n \"jurisdictionName\": \"Switzerland\",\n \"description\": \"Raw Materials and Products with Suspected Similar Narcotics Effect\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 48,\n \"codeName\": \"Swiss Directory F\",\n \"idJurisdiction\": 13,\n \"jurisdictionName\": \"Switzerland\",\n \"description\": \"Precursors\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 49,\n \"codeName\": \"Swiss Directory G\",\n \"idJurisdiction\": 13,\n \"jurisdictionName\": \"Switzerland\",\n \"description\": \"Auxiliary Chemicals\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 50,\n \"codeName\": \"Belgium 1930-art1 (stup)\",\n \"idJurisdiction\": 6,\n \"jurisdictionName\": \"Belgium\",\n \"description\": \"Belgium 1930-art1 (stup)\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 51,\n \"codeName\": \"Belgium 1930-art1bis (stup)\",\n \"idJurisdiction\": 6,\n \"jurisdictionName\": \"Belgium\",\n \"description\": \"Belgium 1930-art1bis (stup)\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 52,\n \"codeName\": \"Belgium 1998-art2 (as-stup)\",\n \"idJurisdiction\": 6,\n \"jurisdictionName\": \"Belgium\",\n \"description\": \"Belgium 1998-art2 (as-stup)\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 53,\n \"codeName\": \"Belgium 1998-art25 (psy)\",\n \"idJurisdiction\": 6,\n \"jurisdictionName\": \"Belgium\",\n \"description\": \"Belgium 1998-art25 (psy)\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 54,\n \"codeName\": \"Belgium 1998-art38 (psy)\",\n \"idJurisdiction\": 6,\n \"jurisdictionName\": \"Belgium\",\n \"description\": \"Belgium 1998-art38 (psy)\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 64,\n \"codeName\": \"Canadian Schedule II\",\n \"idJurisdiction\": 14,\n \"jurisdictionName\": \"Canada\",\n \"description\": \"Canadian Schedule II\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 65,\n \"codeName\": \"Canadian Schedule III\",\n \"idJurisdiction\": 14,\n \"jurisdictionName\": \"Canada\",\n \"description\": \"Canadian Schedule III\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 66,\n \"codeName\": \"Canadian Schedule IV\",\n \"idJurisdiction\": 14,\n \"jurisdictionName\": \"Canada\",\n \"description\": \"Canadian Schedule IV\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 67,\n \"codeName\": \"Canadian Schedule V\",\n \"idJurisdiction\": 14,\n \"jurisdictionName\": \"Canada\",\n \"description\": \"Canadian Schedule V\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 59,\n \"codeName\": \"French Psychotropics Part 1 UN Schedule III\",\n \"idJurisdiction\": 4,\n \"jurisdictionName\": \"France\",\n \"description\": \"This has the contents of Schedule III of the List of Psychotropic Substances under International Control in accordance with the United Nations Convention on Psychotropic Substances of 1971\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 60,\n \"codeName\": \"French Psychotropics Part 1 UN Schedule IV\",\n \"idJurisdiction\": 4,\n \"jurisdictionName\": \"France\",\n \"description\": \"This has the contents of Schedule IV of the List of Psychotropic Substances under International Control in accordance with the United Nations Convention on Psychotropic Substances of 1971\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 61,\n \"codeName\": \"French Psychotropics Part 2\",\n \"idJurisdiction\": 4,\n \"jurisdictionName\": \"France\",\n \"description\": \"Certain preparations of psychotropics.\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 62,\n \"codeName\": \"French Psychotropics Part 3\",\n \"idJurisdiction\": 4,\n \"jurisdictionName\": \"France\",\n \"description\": \"Psychotropics not covered by the List of Psychotropic Substances under International Control in accordance with the United Nations Convention on Psychotropic Substances of 1971.\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 101,\n \"codeName\": \"German Schedule 1\",\n \"idJurisdiction\": 8,\n \"jurisdictionName\": \"Germany\",\n \"description\": \"German Schedule 1\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 102,\n \"codeName\": \"German Schedule 2\",\n \"idJurisdiction\": 8,\n \"jurisdictionName\": \"Germany\",\n \"description\": \"German Schedule 2\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 103,\n \"codeName\": \"German Schedule 3\",\n \"idJurisdiction\": 8,\n \"jurisdictionName\": \"Germany\",\n \"description\": \"German Schedule 3 - not controlled\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 104,\n \"codeName\": \"French Narcotics Annex I\",\n \"idJurisdiction\": 4,\n \"jurisdictionName\": \"France\",\n \"description\": \"Narcotics Annex I: narcotic substances such as heroin, cocaine, cannabis, methadone, opium, etc. Corresponds to Schedule I of the list of narcotic drugs under international control in accordance with the UN Single Convention on Narcotic Drugs 1961.\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 106,\n \"codeName\": \"French Narcotics Annex III\",\n \"idJurisdiction\": 4,\n \"jurisdictionName\": \"France\",\n \"description\": \"Narcotic Annex III: psychotropic substances such as: amphetamines, ecstasy (MDMA), LSD, etc. Corresponds to Schedule I the list of psychotropic drugs under international control in accordance with the UN Convention on Psychotropic Substances of 1971\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 105,\n \"codeName\": \"French Narcotics Annex II\",\n \"idJurisdiction\": 4,\n \"jurisdictionName\": \"France\",\n \"description\": \"Narcotics Annex II: substances like codeine, propiram, etc. Corresponds to Schedule II of the list of narcotics drugs under international control in accordance with the UN Single Convention on Narcotic Drugs, 1961\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 107,\n \"codeName\": \"French Narcotics Annex IV\",\n \"idJurisdiction\": 4,\n \"jurisdictionName\": \"France\",\n \"description\": \"Narcotics Annex IV: substances not controlled at the international level.\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 63,\n \"codeName\": \"Canadian Schedule I\",\n \"idJurisdiction\": 14,\n \"jurisdictionName\": \"Canada\",\n \"description\": \"Canadian Schedule I\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 68,\n \"codeName\": \"Canadian Schedule VI pt1\",\n \"idJurisdiction\": 14,\n \"jurisdictionName\": \"Canada\",\n \"description\": \"Canadian Schedule VI pt1\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 69,\n \"codeName\": \"Italian Table I\",\n \"idJurisdiction\": 9,\n \"jurisdictionName\": \"Italy\",\n \"description\": \"Italian table 1\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 70,\n \"codeName\": \"Italian Table V(a)\",\n \"idJurisdiction\": 9,\n \"jurisdictionName\": \"Italy\",\n \"description\": \"Italian table V(a)\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 71,\n \"codeName\": \"Italian Table V(b)\",\n \"idJurisdiction\": 9,\n \"jurisdictionName\": \"Italy\",\n \"description\": \"Italian table V(b)\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 72,\n \"codeName\": \"Italian Table V(c)\",\n \"idJurisdiction\": 9,\n \"jurisdictionName\": \"Italy\",\n \"description\": \"Italian table V(c)\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 73,\n \"codeName\": \"Italian Table V(d)\",\n \"idJurisdiction\": 9,\n \"jurisdictionName\": \"Italy\",\n \"description\": \"Italian table V(d)\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 74,\n \"codeName\": \"Italian Table V(e)\",\n \"idJurisdiction\": 9,\n \"jurisdictionName\": \"Italy\",\n \"description\": \"Italian table V(e)\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 157,\n \"codeName\": \"German EU Drug Precursor Category 1\",\n \"idJurisdiction\": 8,\n \"jurisdictionName\": \"Germany\",\n \"description\": \"EU Drug Precursor Category 1\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 158,\n \"codeName\": \"German EU Drug Precursor Category 2A\",\n \"idJurisdiction\": 8,\n \"jurisdictionName\": \"Germany\",\n \"description\": \"EU Drug Precursor Category 2A\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 159,\n \"codeName\": \"German EU Drug Precursor Category 2B\",\n \"idJurisdiction\": 8,\n \"jurisdictionName\": \"Germany\",\n \"description\": \"EU Drug Precursor Category 2B\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 160,\n \"codeName\": \"German EU Drug Precursor Category 3\",\n \"idJurisdiction\": 8,\n \"jurisdictionName\": \"Germany\",\n \"description\": \"EU Drug Precursor Category 3\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 161,\n \"codeName\": \"German EU Drug Precursor Category 4\",\n \"idJurisdiction\": 8,\n \"jurisdictionName\": \"Germany\",\n \"description\": \"EU Drug Precursor Category 4\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 162,\n \"codeName\": \"Swedish EU Drug Precursor Category 1\",\n \"idJurisdiction\": 12,\n \"jurisdictionName\": \"Sweden\",\n \"description\": \"EU Drug Precursor Category 1\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 163,\n \"codeName\": \"Swedish EU Drug Precursor Category 2A\",\n \"idJurisdiction\": 12,\n \"jurisdictionName\": \"Sweden\",\n \"description\": \"EU Drug Precursor Category 2A\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 164,\n \"codeName\": \"Swedish EU Drug Precursor Category 2B\",\n \"idJurisdiction\": 12,\n \"jurisdictionName\": \"Sweden\",\n \"description\": \"EU Drug Precursor Category 2B\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 165,\n \"codeName\": \"Swedish EU Drug Precursor Category 3\",\n \"idJurisdiction\": 12,\n \"jurisdictionName\": \"Sweden\",\n \"description\": \"EU Drug Precursor Category 3\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 166,\n \"codeName\": \"Swedish EU Drug Precursor Category 4\",\n \"idJurisdiction\": 12,\n \"jurisdictionName\": \"Sweden\",\n \"description\": \"EU Drug Precursor Category 4\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 168,\n \"codeName\": \"Canadian Schedule VI pt2\",\n \"idJurisdiction\": 14,\n \"jurisdictionName\": \"Canada\",\n \"description\": \"Canadian Schedule VI pt2\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 95,\n \"codeName\": \"Netherlands List 1\",\n \"idJurisdiction\": 10,\n \"jurisdictionName\": \"Netherlands\",\n \"description\": \"Netherlands List 1\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 96,\n \"codeName\": \"Netherlands List 2\",\n \"idJurisdiction\": 10,\n \"jurisdictionName\": \"Netherlands\",\n \"description\": \"Netherlands List 2\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 119,\n \"codeName\": \"UK EU Drug Precursor Category 2A\",\n \"idJurisdiction\": 2,\n \"jurisdictionName\": \"United Kingdom\",\n \"description\": \"UK EU Drug Precursor Category 2A\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 120,\n \"codeName\": \"UK EU Drug Precursor Category 4\",\n \"idJurisdiction\": 2,\n \"jurisdictionName\": \"United Kingdom\",\n \"description\": \"UK EU Drug Precursor Category 4\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 171,\n \"codeName\": \"Italian Table II\",\n \"idJurisdiction\": 9,\n \"jurisdictionName\": \"Italy\",\n \"description\": \"Italian Table II\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 172,\n \"codeName\": \"Italian Table III\",\n \"idJurisdiction\": 9,\n \"jurisdictionName\": \"Italy\",\n \"description\": \"Italian Table III\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 173,\n \"codeName\": \"Italian Table IV\",\n \"idJurisdiction\": 9,\n \"jurisdictionName\": \"Italy\",\n \"description\": \"Italian Table IV\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 174,\n \"codeName\": \"Italian Annex 3a\",\n \"idJurisdiction\": 9,\n \"jurisdictionName\": \"Italy\",\n \"description\": \"Italian Annex 3a\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 126,\n \"codeName\": \"Belgium EU Drug Precursor Category 1\",\n \"idJurisdiction\": 6,\n \"jurisdictionName\": \"Belgium\",\n \"description\": \"EU Drug Precursor Category 1\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 127,\n \"codeName\": \"Belgium EU Drug Precursor Category 2A\",\n \"idJurisdiction\": 6,\n \"jurisdictionName\": \"Belgium\",\n \"description\": \"EU Drug Precursor Category 2A\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 128,\n \"codeName\": \"Belgium EU Drug Precursor Category 2B\",\n \"idJurisdiction\": 6,\n \"jurisdictionName\": \"Belgium\",\n \"description\": \"EU Drug Precursor Category 2B\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 129,\n \"codeName\": \"Belgium EU Drug Precursor Category 3\",\n \"idJurisdiction\": 6,\n \"jurisdictionName\": \"Belgium\",\n \"description\": \"EU Drug Precursor Category 3\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 130,\n \"codeName\": \"Belgium EU Drug Precursor Category 4\",\n \"idJurisdiction\": 6,\n \"jurisdictionName\": \"Belgium\",\n \"description\": \"EU Drug Precursor Category 4\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 131,\n \"codeName\": \"French EU Drug Precursor Category 1\",\n \"idJurisdiction\": 4,\n \"jurisdictionName\": \"France\",\n \"description\": \"EU Drug Precursor Category 1\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 132,\n \"codeName\": \"French EU Drug Precursor Category 2A\",\n \"idJurisdiction\": 4,\n \"jurisdictionName\": \"France\",\n \"description\": \"EU Drug Precursor Category 2A\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 133,\n \"codeName\": \"French EU Drug Precursor Category 2B\",\n \"idJurisdiction\": 4,\n \"jurisdictionName\": \"France\",\n \"description\": \"EU Drug Precursor Category 2B\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 134,\n \"codeName\": \"French EU Drug Precursor Category 3\",\n \"idJurisdiction\": 4,\n \"jurisdictionName\": \"France\",\n \"description\": \"EU Drug Precursor Category 3\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 135,\n \"codeName\": \"French EU Drug Precursor Category 4\",\n \"idJurisdiction\": 4,\n \"jurisdictionName\": \"France\",\n \"description\": \"EU Drug Precursor Category 4\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 136,\n \"codeName\": \"Italian EU Drug Precursor Category 1\",\n \"idJurisdiction\": 9,\n \"jurisdictionName\": \"Italy\",\n \"description\": \"EU Drug Precursor Category 1\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 137,\n \"codeName\": \"Italian EU Drug Precursor Category 2A\",\n \"idJurisdiction\": 9,\n \"jurisdictionName\": \"Italy\",\n \"description\": \"EU Drug Precursor Category 2A\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 138,\n \"codeName\": \"Italian EU Drug Precursor Category 2B\",\n \"idJurisdiction\": 9,\n \"jurisdictionName\": \"Italy\",\n \"description\": \"EU Drug Precursor Category 2B\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 139,\n \"codeName\": \"Italian EU Drug Precursor Category 3\",\n \"idJurisdiction\": 9,\n \"jurisdictionName\": \"Italy\",\n \"description\": \"EU Drug Precursor Category 3\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 140,\n \"codeName\": \"Italian EU Drug Precursor Category 4\",\n \"idJurisdiction\": 9,\n \"jurisdictionName\": \"Italy\",\n \"description\": \"EU Drug Precursor Category 4\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 141,\n \"codeName\": \"Spanish EU Drug Precursor Category 1\",\n \"idJurisdiction\": 11,\n \"jurisdictionName\": \"Spain\",\n \"description\": \"EU Drug Precursor Category 1\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 142,\n \"codeName\": \"Spanish EU Drug Precursor Category 2A\",\n \"idJurisdiction\": 11,\n \"jurisdictionName\": \"Spain\",\n \"description\": \"EU Drug Precursor Category 2A\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 143,\n \"codeName\": \"Spanish EU Drug Precursor Category 2B\",\n \"idJurisdiction\": 11,\n \"jurisdictionName\": \"Spain\",\n \"description\": \"EU Drug Precursor Category 2B\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 144,\n \"codeName\": \"Spanish EU Drug Precursor Category 3\",\n \"idJurisdiction\": 11,\n \"jurisdictionName\": \"Spain\",\n \"description\": \"EU Drug Precursor Category 3\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 145,\n \"codeName\": \"Spanish EU Drug Precursor Category 4\",\n \"idJurisdiction\": 11,\n \"jurisdictionName\": \"Spain\",\n \"description\": \"EU Drug Precursor Category 4\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 146,\n \"codeName\": \"Danish EU Drug Precursor Category 1\",\n \"idJurisdiction\": 7,\n \"jurisdictionName\": \"Denmark\",\n \"description\": \"EU Drug Precursor Category 1\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 147,\n \"codeName\": \"Danish EU Drug Precursor Category 2A\",\n \"idJurisdiction\": 7,\n \"jurisdictionName\": \"Denmark\",\n \"description\": \"EU Drug Precursor Category 2A\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 148,\n \"codeName\": \"Danish EU Drug Precursor Category 2B\",\n \"idJurisdiction\": 7,\n \"jurisdictionName\": \"Denmark\",\n \"description\": \"EU Drug Precursor Category 2B\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 149,\n \"codeName\": \"Danish EU Drug Precursor Category 3\",\n \"idJurisdiction\": 7,\n \"jurisdictionName\": \"Denmark\",\n \"description\": \"EU Drug Precursor Category 3\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 150,\n \"codeName\": \"Danish EU Drug Precursor Category 4\",\n \"idJurisdiction\": 7,\n \"jurisdictionName\": \"Denmark\",\n \"description\": \"EU Drug Precursor Category 4\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 151,\n \"codeName\": \"Netherlands EU Drug Precursor Category 1\",\n \"idJurisdiction\": 10,\n \"jurisdictionName\": \"Netherlands\",\n \"description\": \"EU Drug Precursor Category 1\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 152,\n \"codeName\": \"Netherlands EU Drug Precursor Category 2A\",\n \"idJurisdiction\": 10,\n \"jurisdictionName\": \"Netherlands\",\n \"description\": \"EU Drug Precursor Category 2A\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 153,\n \"codeName\": \"Netherlands EU Drug Precursor Category 2B\",\n \"idJurisdiction\": 10,\n \"jurisdictionName\": \"Netherlands\",\n \"description\": \"EU Drug Precursor Category 2B\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 154,\n \"codeName\": \"Netherlands EU Drug Precursor Category 3\",\n \"idJurisdiction\": 10,\n \"jurisdictionName\": \"Netherlands\",\n \"description\": \"EU Drug Precursor Category 3\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 155,\n \"codeName\": \"Netherlands EU Drug Precursor Category 4\",\n \"idJurisdiction\": 10,\n \"jurisdictionName\": \"Netherlands\",\n \"description\": \"EU Drug Precursor Category 4\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 156,\n \"codeName\": \"Irish EU Drug Precursor Category 2B\",\n \"idJurisdiction\": 5,\n \"jurisdictionName\": \"Ireland\",\n \"description\": \"EU Drug Precursor Category 2B\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 169,\n \"codeName\": \"UN Precursor Table I\",\n \"idJurisdiction\": 15,\n \"jurisdictionName\": \"UN (INCB)\",\n \"description\": \"UN Precursor Table I\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 170,\n \"codeName\": \"UN Precursor Table II\",\n \"idJurisdiction\": 15,\n \"jurisdictionName\": \"UN (INCB)\",\n \"description\": \"UN Precursor Table II\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 176,\n \"codeName\": \"Swedish Hazardous Goods\",\n \"idJurisdiction\": 12,\n \"jurisdictionName\": \"Sweden\",\n \"description\": \"Swedish Hazardous Goods\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 123,\n \"codeName\": \"UN Narcotics Schedule I\",\n \"idJurisdiction\": 15,\n \"jurisdictionName\": \"UN (INCB)\",\n \"description\": \"UN Narcotics Schedule I\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 124,\n \"codeName\": \"UN Narcotics Schedule II\",\n \"idJurisdiction\": 15,\n \"jurisdictionName\": \"UN (INCB)\",\n \"description\": \"UN Narcotics Schedule II\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 125,\n \"codeName\": \"UN Narcotics Schedule III\",\n \"idJurisdiction\": 15,\n \"jurisdictionName\": \"UN (INCB)\",\n \"description\": \"UN Narcotics Schedule III\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 177,\n \"codeName\": \"UN Narcotics Schedule IV\",\n \"idJurisdiction\": 15,\n \"jurisdictionName\": \"UN (INCB)\",\n \"description\": \"UN Narcotics Schedule IV\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 178,\n \"codeName\": \"Indian Schedule A Precursor\",\n \"idJurisdiction\": 17,\n \"jurisdictionName\": \"India\",\n \"description\": \"Indian Schedule A Precursor\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 179,\n \"codeName\": \"Indian Schedule B Precursor\",\n \"idJurisdiction\": 17,\n \"jurisdictionName\": \"India\",\n \"description\": \"Indian Schedule B Precursor\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 180,\n \"codeName\": \"Indian Schedule C Precursor\",\n \"idJurisdiction\": 17,\n \"jurisdictionName\": \"India\",\n \"description\": \"Indian Schedule C Precursor\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 185,\n \"codeName\": \"CWC Schedule 1 A\",\n \"idJurisdiction\": 18,\n \"jurisdictionName\": \"Chemical Weapons Convention\",\n \"description\": \"Chemical Weapons Convention Schedule 1 A - Toxic chemicals\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 186,\n \"codeName\": \"CWC Schedule 1 B\",\n \"idJurisdiction\": 18,\n \"jurisdictionName\": \"Chemical Weapons Convention\",\n \"description\": \"Chemical Weapons Convention Schedule 1 B - Precursors\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 187,\n \"codeName\": \"CWC Schedule 2 A\",\n \"idJurisdiction\": 18,\n \"jurisdictionName\": \"Chemical Weapons Convention\",\n \"description\": \"Chemical Weapons Convention Schedule 2 A - Toxic chemicals\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 188,\n \"codeName\": \"CWC Schedule 2 B\",\n \"idJurisdiction\": 18,\n \"jurisdictionName\": \"Chemical Weapons Convention\",\n \"description\": \"Chemical Weapons Convention Schedule 2 B - Precursors\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 189,\n \"codeName\": \"CWC Schedule 3 A\",\n \"idJurisdiction\": 18,\n \"jurisdictionName\": \"Chemical Weapons Convention\",\n \"description\": \"Chemical Weapons Convention Schedule 3 A - Toxic chemicals\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 190,\n \"codeName\": \"CWC Schedule 3 B\",\n \"idJurisdiction\": 18,\n \"jurisdictionName\": \"Chemical Weapons Convention\",\n \"description\": \"Chemical Weapons Convention Schedule 3 B - Precursors\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 218,\n \"codeName\": \"UK EU Drug Precursor Category 2\",\n \"idJurisdiction\": 2,\n \"jurisdictionName\": \"United Kingdom\",\n \"description\": \"UK EU Drug Precursor Category 2\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 219,\n \"codeName\": \"US CCL RS\",\n \"idJurisdiction\": 3,\n \"jurisdictionName\": \"United States of America\",\n \"description\": \"CCL Regional Stability control code\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 182,\n \"codeName\": \"Indian NDPS Act – Psychotropic \",\n \"idJurisdiction\": 17,\n \"jurisdictionName\": \"India\",\n \"description\": \"Indian NDPS Act – Psychotropic \",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 183,\n \"codeName\": \"Indian NDPS Act – Narcotic \",\n \"idJurisdiction\": 17,\n \"jurisdictionName\": \"India\",\n \"description\": \"Indian NDPS Act – Narcotic \",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 184,\n \"codeName\": \"Indian NDPs Act – Manufactured Narcotic Drug \",\n \"idJurisdiction\": 17,\n \"jurisdictionName\": \"India\",\n \"description\": \"Indian NDPs Act – Manufactured Narcotic Drug \",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 191,\n \"codeName\": \"China Psychotropic Drugs - Category 1\",\n \"idJurisdiction\": 19,\n \"jurisdictionName\": \"China\",\n \"description\": \"精神药品品种目录第一类\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 192,\n \"codeName\": \"China Psychotropic Drugs - Category 2 \",\n \"idJurisdiction\": 19,\n \"jurisdictionName\": \"China\",\n \"description\": \"精神药品品种目录第二类\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 193,\n \"codeName\": \"China Anesthetic Drugs\",\n \"idJurisdiction\": 19,\n \"jurisdictionName\": \"China\",\n \"description\": \"麻醉药品品种目录\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 194,\n \"codeName\": \"China Precursors - Category 1\",\n \"idJurisdiction\": 19,\n \"jurisdictionName\": \"China\",\n \"description\": \"易制毒化学品的分类和品种目录第一类\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 195,\n \"codeName\": \"China Precursors - Category 2\",\n \"idJurisdiction\": 19,\n \"jurisdictionName\": \"China\",\n \"description\": \"易制毒化学品的分类和品种目录第二类\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 196,\n \"codeName\": \"China Precursors - Category 3\",\n \"idJurisdiction\": 19,\n \"jurisdictionName\": \"China\",\n \"description\": \"易制毒化学品的分类和品种目录第一类\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 197,\n \"codeName\": \"US CCL CB1\",\n \"idJurisdiction\": 3,\n \"jurisdictionName\": \"United States of America\",\n \"description\": \"CCL Chemical and Biological Weapons control code\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 198,\n \"codeName\": \"US CCL CB2\",\n \"idJurisdiction\": 3,\n \"jurisdictionName\": \"United States of America\",\n \"description\": \"CCL Chemical and Biological Weapons control code\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 199,\n \"codeName\": \"US CCL CB3\",\n \"idJurisdiction\": 3,\n \"jurisdictionName\": \"United States of America\",\n \"description\": \"CCL Chemical and Biological Weapons control code\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 200,\n \"codeName\": \"US CCL NP1\",\n \"idJurisdiction\": 3,\n \"jurisdictionName\": \"United States of America\",\n \"description\": \"CCL Nuclear non proliferation control code\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 201,\n \"codeName\": \"US CCL NP2\",\n \"idJurisdiction\": 3,\n \"jurisdictionName\": \"United States of America\",\n \"description\": \"CCL Nuclear non proliferation control code\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 202,\n \"codeName\": \"US CCL NS1\",\n \"idJurisdiction\": 3,\n \"jurisdictionName\": \"United States of America\",\n \"description\": \"CCL National Security control code\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 203,\n \"codeName\": \"US CCL NS2\",\n \"idJurisdiction\": 3,\n \"jurisdictionName\": \"United States of America\",\n \"description\": \"CCL National Security control code\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 204,\n \"codeName\": \"US CCL MT1\",\n \"idJurisdiction\": 3,\n \"jurisdictionName\": \"United States of America\",\n \"description\": \"CCL Missile Technology control code\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 205,\n \"codeName\": \"US CCL RS1\",\n \"idJurisdiction\": 3,\n \"jurisdictionName\": \"United States of America\",\n \"description\": \"CCL Regional Security control code\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 206,\n \"codeName\": \"US CCL RS2\",\n \"idJurisdiction\": 3,\n \"jurisdictionName\": \"United States of America\",\n \"description\": \"CCL Regional Security control code\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 207,\n \"codeName\": \"US CCL FC1\",\n \"idJurisdiction\": 3,\n \"jurisdictionName\": \"United States of America\",\n \"description\": \"CCL Firearms Convension control code\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 208,\n \"codeName\": \"US CCL CC1\",\n \"idJurisdiction\": 3,\n \"jurisdictionName\": \"United States of America\",\n \"description\": \"CCL Crime control code\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 209,\n \"codeName\": \"US CCL CC2\",\n \"idJurisdiction\": 3,\n \"jurisdictionName\": \"United States of America\",\n \"description\": \"CCL Crime control code\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 210,\n \"codeName\": \"US CCL CC3\",\n \"idJurisdiction\": 3,\n \"jurisdictionName\": \"United States of America\",\n \"description\": \"CCL Crime control code\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 211,\n \"codeName\": \"US CCL AT1\",\n \"idJurisdiction\": 3,\n \"jurisdictionName\": \"United States of America\",\n \"description\": \"CCL Anti Terrorism control code\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 212,\n \"codeName\": \"US CCL AT2\",\n \"idJurisdiction\": 3,\n \"jurisdictionName\": \"United States of America\",\n \"description\": \"CCL Anti Terrorism control code\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 213,\n \"codeName\": \"US ITAR PT 121 Category V\",\n \"idJurisdiction\": 3,\n \"jurisdictionName\": \"United States of America\",\n \"description\": \"EXPLOSIVES AND ENERGETIC MATERIALS, PROPELLANTS, INCENDIARY AGENTS AND THEIR CONSTITUENTS\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 214,\n \"codeName\": \"US ITAR PT 121 Category XIV\",\n \"idJurisdiction\": 3,\n \"jurisdictionName\": \"United States of America\",\n \"description\": \"TOXICOLOGICAL AGENTS, INCLUDING CHEMICAL AGENTS, BIOLOGICAL AGENTS, AND ASSOCIATED EQUIPMENT\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 215,\n \"codeName\": \"US CCL UN\",\n \"idJurisdiction\": 3,\n \"jurisdictionName\": \"United States of America\",\n \"description\": \"CCL United Nations Embargo control code\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 216,\n \"codeName\": \"US CCL CW\",\n \"idJurisdiction\": 3,\n \"jurisdictionName\": \"United States of America\",\n \"description\": \"CCL Chemical Weapons Convention control code\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 217,\n \"codeName\": \"US CCL AT\",\n \"idJurisdiction\": 3,\n \"jurisdictionName\": \"United States of America\",\n \"description\": \"CCL Anti Terrorism control code\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 227,\n \"codeName\": \"Australia Group CW Precursor\",\n \"idJurisdiction\": 20,\n \"jurisdictionName\": \"Australia Group\",\n \"description\": \"Australia Group Chemical Weapons Precursor\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 228,\n \"codeName\": \"EU Military List ML 7\",\n \"idJurisdiction\": 21,\n \"jurisdictionName\": \"European Union\",\n \"description\": \"European Union Military List ML 7\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 229,\n \"codeName\": \"EU Military List ML 8\",\n \"idJurisdiction\": 21,\n \"jurisdictionName\": \"European Union\",\n \"description\": \"European Union Military List ML 8\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 230,\n \"codeName\": \"Montreal Ozone Annex A, Group I\",\n \"idJurisdiction\": 22,\n \"jurisdictionName\": \"Montreal Ozone Protocol\",\n \"description\": \"Montreal Protocol on Substances that deplete the Ozone Layer Annex A, Group I control code\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 231,\n \"codeName\": \"Montreal Ozone Annex A, Group II\",\n \"idJurisdiction\": 22,\n \"jurisdictionName\": \"Montreal Ozone Protocol\",\n \"description\": \"Montreal Protocol on Substances that deplete the Ozone Layer Annex A, Group II control code\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 233,\n \"codeName\": \"Montreal Ozone Annex B, Group II\",\n \"idJurisdiction\": 22,\n \"jurisdictionName\": \"Montreal Ozone Protocol\",\n \"description\": \"Montreal Protocol on Substances that deplete the Ozone Layer Annex B, Group II control code\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 232,\n \"codeName\": \"Montreal Ozone Annex B, Group I\",\n \"idJurisdiction\": 22,\n \"jurisdictionName\": \"Montreal Ozone Protocol\",\n \"description\": \"Montreal Protocol on Substances that deplete the Ozone Layer Annex B, Group I control code\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 235,\n \"codeName\": \"Montreal Ozone Annex C, Group I\",\n \"idJurisdiction\": 22,\n \"jurisdictionName\": \"Montreal Ozone Protocol\",\n \"description\": \"Montreal Protocol on Substances that deplete the Ozone Layer Annex C, Group I control code\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 236,\n \"codeName\": \"Montreal Ozone Annex C, Group II\",\n \"idJurisdiction\": 22,\n \"jurisdictionName\": \"Montreal Ozone Protocol\",\n \"description\": \"Montreal Protocol on Substances that deplete the Ozone Layer Annex C, Group II control code\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 234,\n \"codeName\": \"Montreal Ozone Annex B, Group III\",\n \"idJurisdiction\": 22,\n \"jurisdictionName\": \"Montreal Ozone Protocol\",\n \"description\": \"Montreal Protocol on Substances that deplete the Ozone Layer Annex B, Group III control code\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 238,\n \"codeName\": \"Montreal Ozone Annex E, Group I\",\n \"idJurisdiction\": 22,\n \"jurisdictionName\": \"Montreal Ozone Protocol\",\n \"description\": \"Montreal Protocol on Substances that deplete the Ozone Layer Annex E, Group I control code\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 237,\n \"codeName\": \"Montreal Ozone Annex C, Group III\",\n \"idJurisdiction\": 22,\n \"jurisdictionName\": \"Montreal Ozone Protocol\",\n \"description\": \"Montreal Protocol on Substances that deplete the Ozone Layer Annex C, Group III control code\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 246,\n \"codeName\": \"French EU Drug Precursor Category 2\",\n \"idJurisdiction\": 4,\n \"jurisdictionName\": \"France\",\n \"description\": \"EU Drug Precursor Category 2\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 264,\n \"codeName\": \"Austria EU Drug Precursor Category 1\",\n \"idJurisdiction\": 23,\n \"jurisdictionName\": \"Austria\",\n \"description\": \"EU Drug Precursor Category 1\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 265,\n \"codeName\": \"Austria EU Drug Precursor Category 2\",\n \"idJurisdiction\": 23,\n \"jurisdictionName\": \"Austria\",\n \"description\": \"EU Drug Precursor Category 2\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 266,\n \"codeName\": \"Austria EU Drug Precursor Category 2A\",\n \"idJurisdiction\": 23,\n \"jurisdictionName\": \"Austria\",\n \"description\": \"EU Drug Precursor Category 2A\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 267,\n \"codeName\": \"Austria EU Drug Precursor Category 3\",\n \"idJurisdiction\": 23,\n \"jurisdictionName\": \"Austria\",\n \"description\": \"EU Drug Precursor Category 3\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 268,\n \"codeName\": \"Austria EU Drug Precursor Category 4\",\n \"idJurisdiction\": 23,\n \"jurisdictionName\": \"Austria\",\n \"description\": \"EU Drug Precursor Category 4\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 269,\n \"codeName\": \"Austria EU Drug Precursor Category 2B\",\n \"idJurisdiction\": 23,\n \"jurisdictionName\": \"Austria\",\n \"description\": \"Austria EU Drug Precursor Category 2B\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 271,\n \"codeName\": \"EU Human Rights List Annex III\",\n \"idJurisdiction\": 21,\n \"jurisdictionName\": \"European Union\",\n \"description\": \"EU Human Rights List Annex III\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 239,\n \"codeName\": \"Swedish Toxic Group A\",\n \"idJurisdiction\": 12,\n \"jurisdictionName\": \"Sweden\",\n \"description\": \"Swedish Toxic Group A\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 240,\n \"codeName\": \"Swedish Toxic Group B\",\n \"idJurisdiction\": 12,\n \"jurisdictionName\": \"Sweden\",\n \"description\": \"Swedish Toxic Group B\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 241,\n \"codeName\": \"Swedish EU Drug Precursor Category 2\",\n \"idJurisdiction\": 12,\n \"jurisdictionName\": \"Sweden\",\n \"description\": \"Swedish EU Drug Precursor Category 2\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 242,\n \"codeName\": \"Belgium EU Drug Precursor Category 2\",\n \"idJurisdiction\": 6,\n \"jurisdictionName\": \"Belgium\",\n \"description\": \"Belgium EU Drug Precursor Category 2\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 243,\n \"codeName\": \"German EU Drug Precursor Category 2\",\n \"idJurisdiction\": 8,\n \"jurisdictionName\": \"Germany\",\n \"description\": \"German EU Drug Precursor Category 2\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 244,\n \"codeName\": \"Danish EU Drug Precursor Category 2\",\n \"idJurisdiction\": 7,\n \"jurisdictionName\": \"Denmark\",\n \"description\": \"Danish EU Drug Precursor Category 2\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 245,\n \"codeName\": \"Irish EU Drug Precursor Category 2\",\n \"idJurisdiction\": 5,\n \"jurisdictionName\": \"Ireland\",\n \"description\": \"Irish EU Drug Precursor Category 2\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 247,\n \"codeName\": \"Netherlands EU Drug Precursor Category 2\",\n \"idJurisdiction\": 10,\n \"jurisdictionName\": \"Netherlands\",\n \"description\": \"Netherlands EU Drug Precursor Category 2\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 248,\n \"codeName\": \"Italian EU Drug Precursor Category 2\",\n \"idJurisdiction\": 9,\n \"jurisdictionName\": \"Italy\",\n \"description\": \"Italian EU Drug Precursor Category 2\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 249,\n \"codeName\": \"Spanish EU Drug Precursor Category 2\",\n \"idJurisdiction\": 11,\n \"jurisdictionName\": \"Spain\",\n \"description\": \"Spanish EU Drug Precursor Category 2\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 250,\n \"codeName\": \"Indian NDPS Rules Schedule I (I Narcotics)\",\n \"idJurisdiction\": 17,\n \"jurisdictionName\": \"India\",\n \"description\": \"Indian NDPS Rules Schedule I (I Narcotics)\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 251,\n \"codeName\": \"Indian NDPS Rules Schedule I (II Psychotrps)\",\n \"idJurisdiction\": 17,\n \"jurisdictionName\": \"India\",\n \"description\": \"Indian NDPS Rules Schedule I (II Psychotrps)\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 252,\n \"codeName\": \"Indian NDPS Rules Schedule II\",\n \"idJurisdiction\": 17,\n \"jurisdictionName\": \"India\",\n \"description\": \"Indian NDPS Rules Schedule II\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 253,\n \"codeName\": \"Indian NDPS Rules Schedule III (Psychotrps)\",\n \"idJurisdiction\": 17,\n \"jurisdictionName\": \"India\",\n \"description\": \"Indian NDPS Rules Schedule III (Psychotrps)\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 254,\n \"codeName\": \"EU Dual Use Items - Category 1C (Materials)\",\n \"idJurisdiction\": 21,\n \"jurisdictionName\": \"European Union\",\n \"description\": \"EU Dual Use Items - Category 1C (Materials)\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 255,\n \"codeName\": \"Austrian Narcotics Annex I.1\",\n \"idJurisdiction\": 23,\n \"jurisdictionName\": \"Austria\",\n \"description\": \"Austrian Narcotics Annex I.1\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 256,\n \"codeName\": \"Austrian Narcotics Annex I.2\",\n \"idJurisdiction\": 23,\n \"jurisdictionName\": \"Austria\",\n \"description\": \"Austrian Narcotics Annex I.2\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 257,\n \"codeName\": \"Austrian Narcotics Annex II\",\n \"idJurisdiction\": 23,\n \"jurisdictionName\": \"Austria\",\n \"description\": \"Austrian Narcotics Annex II\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 258,\n \"codeName\": \"Austrian Narcotics Annex III\",\n \"idJurisdiction\": 23,\n \"jurisdictionName\": \"Austria\",\n \"description\": \"Austrian Narcotics Annex III\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 259,\n \"codeName\": \"Austrian Narcotics Annex IV.1\",\n \"idJurisdiction\": 23,\n \"jurisdictionName\": \"Austria\",\n \"description\": \"Austrian Narcotics Annex IV.1\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 260,\n \"codeName\": \"Austrian Narcotics Annex IV.2\",\n \"idJurisdiction\": 23,\n \"jurisdictionName\": \"Austria\",\n \"description\": \"Austrian Narcotics Annex IV.2\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 261,\n \"codeName\": \"Austrian Narcotics Annex V.1\",\n \"idJurisdiction\": 23,\n \"jurisdictionName\": \"Austria\",\n \"description\": \"Austrian Narcotics Annex V.1\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 262,\n \"codeName\": \"Austrian Narcotics Annex V.2\",\n \"idJurisdiction\": 23,\n \"jurisdictionName\": \"Austria\",\n \"description\": \"Austrian Narcotics Annex V.2\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 263,\n \"codeName\": \"Austrian Psychotropics\",\n \"idJurisdiction\": 23,\n \"jurisdictionName\": \"Austria\",\n \"description\": \"Austrian Psychotropics\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 270,\n \"codeName\": \"UK Dual Use List Materials,Micro-orgs,Toxins\",\n \"idJurisdiction\": 2,\n \"jurisdictionName\": \"United Kingdom\",\n \"description\": \"UK Dual Use List Materials, Micro-organisms and toxins\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 272,\n \"codeName\": \"UK Human Rights – Prohibited Medical Prods\",\n \"idJurisdiction\": 2,\n \"jurisdictionName\": \"United Kingdom\",\n \"description\": \"UK Security and Human Rights - Prohibited Medicinal Products\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 273,\n \"codeName\": \"UK Controlled Radioactive Sources\",\n \"idJurisdiction\": 2,\n \"jurisdictionName\": \"United Kingdom\",\n \"description\": \"UK Radioactive Sources List\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 274,\n \"codeName\": \"China Non-medical Narcotics and Psychotropics\",\n \"idJurisdiction\": 19,\n \"jurisdictionName\": \"China\",\n \"description\": \"非药用类麻醉药品和精神药品管制品种增补目录\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 275,\n \"codeName\": \"Japanese Table I Narcotics\",\n \"idJurisdiction\": 24,\n \"jurisdictionName\": \"Japan\",\n \"description\": \"Narcotics and Psychotropics Control Law - Article 2 Table I Narcotics 第2条表I麻薬 - 麻薬及び向精神薬取締法 \",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 276,\n \"codeName\": \"Japanese Table II Narcotics Plants\",\n \"idJurisdiction\": 24,\n \"jurisdictionName\": \"Japan\",\n \"description\": \"Narcotics and Psychotropics Control Law - Article 2 Table II Narcotics Plants 第2条表II麻薬プラント - 麻薬及び向精神薬取締法 \",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 277,\n \"codeName\": \"Japanese Table III Psychotropics\",\n \"idJurisdiction\": 24,\n \"jurisdictionName\": \"Japan\",\n \"description\": \"Narcotics and Psychotropics Control Law - Article 2 Table III Psychotropics 第2条表III 向精神薬 - 麻薬及び向精神薬取締法 \",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 278,\n \"codeName\": \"Japanese Table IV Drug Raw Materials\",\n \"idJurisdiction\": 24,\n \"jurisdictionName\": \"Japan\",\n \"description\": \"Narcotics and Psychotropics Control Law - Table IV Precursors (Raw Materials) 麻薬原料\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 279,\n \"codeName\": \"Japanese Designated Substance\",\n \"idJurisdiction\": 24,\n \"jurisdictionName\": \"Japan\",\n \"description\": \"Designated substances according to the Pharmaceutical and Medical Device Act. 医薬品、医療機器等の品質、有効性及び安全性の確保等に関する法律指定薬物\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 280,\n \"codeName\": \"Japanese Poisonous Substances\",\n \"idJurisdiction\": 24,\n \"jurisdictionName\": \"Japan\",\n \"description\": \"Poisonous according to the Poisonous and Deleterious Substances Control Law 毒物 - 毒物及び劇物取締法\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 281,\n \"codeName\": \"Japanese Deleterious Substances\",\n \"idJurisdiction\": 24,\n \"jurisdictionName\": \"Japan\",\n \"description\": \"Deleterious Substances according to the Poisonous and Deleterious Substances Control Law 劇物 - 毒物及び劇物取締法\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 282,\n \"codeName\": \"Japanese Specific Poisonous Substances\",\n \"idJurisdiction\": 24,\n \"jurisdictionName\": \"Japan\",\n \"description\": \"Specific Poisonous Substances according to the Poisonous and Deleterious Substances Control Law 特定毒物 - 毒物及び劇物取締法\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 283,\n \"codeName\": \"Japanese Stimulants Raw Materials\",\n \"idJurisdiction\": 24,\n \"jurisdictionName\": \"Japan\",\n \"description\": \"\\rStimulants Raw Material 覚せい剤取締法 \\r\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 284,\n \"codeName\": \"Japanese Table I Narcotics Similar\",\n \"idJurisdiction\": 24,\n \"jurisdictionName\": \"Japan\",\n \"description\": \"Narcotics and Psychotropics Control Law - Article 2 Table I Narcotics 第1条表I麻薬 - 麻薬及び向精神薬取締法 \",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 285,\n \"codeName\": \"Japanese Table III Psychotropics Similar\",\n \"idJurisdiction\": 24,\n \"jurisdictionName\": \"Japan\",\n \"description\": \"Narcotics and Psychotropics Control Law Article 3, Division 1. 麻薬、麻薬原料植物、向精神薬及び麻薬向精神薬原料を指定する政令（第3条関係）第1種\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 286,\n \"codeName\": \"Japanese Article 3 Division 2 Psychotropics\",\n \"idJurisdiction\": 24,\n \"jurisdictionName\": \"Japan\",\n \"description\": \"Not used\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 287,\n \"codeName\": \"Japanese Article 3 Division 3 Psychotropics\",\n \"idJurisdiction\": 24,\n \"jurisdictionName\": \"Japan\",\n \"description\": \"Not used\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 288,\n \"codeName\": \"Japanese Opium Law\",\n \"idJurisdiction\": 24,\n \"jurisdictionName\": \"Japan\",\n \"description\": \"Japanese Opium Law (あへん法)\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 289,\n \"codeName\": \"Japanese Cannabis Control Law\",\n \"idJurisdiction\": 24,\n \"jurisdictionName\": \"Japan\",\n \"description\": \"Japanese Cannabis Control Law (大麻取締法)\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 290,\n \"codeName\": \"Japanese Stimulants Law\",\n \"idJurisdiction\": 24,\n \"jurisdictionName\": \"Japan\",\n \"description\": \"Japanese Stimulants Law 覚せい剤取締法 \\n\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 291,\n \"codeName\": \"US CWC Precursors\",\n \"idJurisdiction\": 3,\n \"jurisdictionName\": \"United States of America\",\n \"description\": \"This is a CS2 generated control code to enable CS2 to flag CWC and Australia Group precursors enacted in US CCL and ITAR legislation as precursors\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 292,\n \"codeName\": \"EU CWC Precursors\",\n \"idJurisdiction\": 21,\n \"jurisdictionName\": \"European Union\",\n \"description\": \"This is a CS2 generated control code to enable CS2 to flag CWC and Australia Group precursors enacted in the EU Military List and EU Dual Use legislation as precursors.\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 293,\n \"codeName\": \"UK 3rd Generation Cannabinoid\",\n \"idJurisdiction\": 2,\n \"jurisdictionName\": \"United Kingdom\",\n \"description\": \"This a CS2 generated control code to enable CS2 to specifically flag 3rd generation cannabinoids, allowing them to be filtered by donwstream systems for special handling\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 294,\n \"codeName\": \"Spanish National Level Narcotic\",\n \"idJurisdiction\": 11,\n \"jurisdictionName\": \"Spain\",\n \"description\": \"These are considered controlled narcotics and are not on the UN Yellow List\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 295,\n \"codeName\": \"Montreal Ozone Annex F, Group I\",\n \"idJurisdiction\": 22,\n \"jurisdictionName\": \"Montreal Ozone Protocol\",\n \"description\": \"Montreal Protocol on Substances that deplete the Ozone Layer Annex F, Group I control code\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 296,\n \"codeName\": \"Montreal Ozone Annex F, Group II\",\n \"idJurisdiction\": 22,\n \"jurisdictionName\": \"Montreal Ozone Protocol\",\n \"description\": \"Montreal Protocol on Substances that deplete the Ozone Layer Annex F, Group II control code\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 297,\n \"codeName\": \"Irish Schedule 8 pt5\",\n \"idJurisdiction\": 5,\n \"jurisdictionName\": \"Ireland\",\n \"description\": \"Drugs for use in mental health or intellectual disbaility\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 298,\n \"codeName\": \"Belgium Annex IA\",\n \"idJurisdiction\": 6,\n \"jurisdictionName\": \"Belgium\",\n \"description\": \"Belgium Annex IA\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 299,\n \"codeName\": \"Belgium Annex IB\",\n \"idJurisdiction\": 6,\n \"jurisdictionName\": \"Belgium\",\n \"description\": \"Belgium Annex IB\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 300,\n \"codeName\": \"Belgium Annex IIA\",\n \"idJurisdiction\": 6,\n \"jurisdictionName\": \"Belgium\",\n \"description\": \"Belgium Annex IIA\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 301,\n \"codeName\": \"Belgium Annex IIB\",\n \"idJurisdiction\": 6,\n \"jurisdictionName\": \"Belgium\",\n \"description\": \"Belgium Annex IIB\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 302,\n \"codeName\": \"Belgium Annex IIC\",\n \"idJurisdiction\": 6,\n \"jurisdictionName\": \"Belgium\",\n \"description\": \"Belgium Annex IIC\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 303,\n \"codeName\": \"Belgium Annex III\",\n \"idJurisdiction\": 6,\n \"jurisdictionName\": \"Belgium\",\n \"description\": \"Belgium Annex III\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 304,\n \"codeName\": \"Belgium Annex IVB\",\n \"idJurisdiction\": 6,\n \"jurisdictionName\": \"Belgium\",\n \"description\": \"Belgium Annex IVB\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 305,\n \"codeName\": \"Belgium Annex IVA\",\n \"idJurisdiction\": 6,\n \"jurisdictionName\": \"Belgium\",\n \"description\": \"Belgium Annex IVA\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 306,\n \"codeName\": \"Belgium Annex IC\",\n \"idJurisdiction\": 6,\n \"jurisdictionName\": \"Belgium\",\n \"description\": \"Belgium Annex IC\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 307,\n \"codeName\": \"Belgium Annex V\",\n \"idJurisdiction\": 6,\n \"jurisdictionName\": \"Belgium\",\n \"description\": \"Belgium Annex V\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 308,\n \"codeName\": \"EU Controlled Psychoactive Substance\",\n \"idJurisdiction\": 21,\n \"jurisdictionName\": \"European Union\",\n \"description\": \"EU Controlled Psychoactive Substance\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 309,\n \"codeName\": \"Singapore Regulations First Schedule\",\n \"idJurisdiction\": 25,\n \"jurisdictionName\": \"Singapore\",\n \"description\": \"Singapore Regulations First Schedule\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 310,\n \"codeName\": \"Singapore Regulations Second Schedule\",\n \"idJurisdiction\": 25,\n \"jurisdictionName\": \"Singapore\",\n \"description\": \"Singapore Regulations Second Schedule\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 311,\n \"codeName\": \"Singapore Regulations Third Schedule\",\n \"idJurisdiction\": 25,\n \"jurisdictionName\": \"Singapore\",\n \"description\": \"Singapore Regulations Third Schedule\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 312,\n \"codeName\": \"Singapore Regulations Fourth Schedule\",\n \"idJurisdiction\": 25,\n \"jurisdictionName\": \"Singapore\",\n \"description\": \"Singapore Regulations Fourth Schedule\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 313,\n \"codeName\": \"Singapore Class A\",\n \"idJurisdiction\": 25,\n \"jurisdictionName\": \"Singapore\",\n \"description\": \"Singapore Class A\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 314,\n \"codeName\": \"Singapore Class B\",\n \"idJurisdiction\": 25,\n \"jurisdictionName\": \"Singapore\",\n \"description\": \"Singapore Class B\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 316,\n \"codeName\": \"Singapore Specified Drug\",\n \"idJurisdiction\": 25,\n \"jurisdictionName\": \"Singapore\",\n \"description\": \"Singapore Specified Drug\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 315,\n \"codeName\": \"Singapore Class C\",\n \"idJurisdiction\": 25,\n \"jurisdictionName\": \"Singapore\",\n \"description\": \"Singapore Class C\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 317,\n \"codeName\": \"Singapore Temporarily Listed Drugs\",\n \"idJurisdiction\": 25,\n \"jurisdictionName\": \"Singapore\",\n \"description\": \"Singapore Temporarily Listed Drugs\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 318,\n \"codeName\": \"Singapore Precursors Part I\",\n \"idJurisdiction\": 25,\n \"jurisdictionName\": \"Singapore\",\n \"description\": \"Singapore Substances useful for Manufacturing Controlled Drugs Part 1\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 319,\n \"codeName\": \"Singapore Precursors Part II\",\n \"idJurisdiction\": 25,\n \"jurisdictionName\": \"Singapore\",\n \"description\": \"Singapore Substances useful for Manufacturing Controlled Drugs Part II\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 320,\n \"codeName\": \"Mexican Narcotics\",\n \"idJurisdiction\": 26,\n \"jurisdictionName\": \"Mexico\",\n \"description\": \"Mexican Narcotic Substances\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 321,\n \"codeName\": \"Mexican Psychotropics Group 1\",\n \"idJurisdiction\": 26,\n \"jurisdictionName\": \"Mexico\",\n \"description\": \"Mexican Psychotropic Substances Group 1\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 322,\n \"codeName\": \"Mexican Psychotropics Group 2\",\n \"idJurisdiction\": 26,\n \"jurisdictionName\": \"Mexico\",\n \"description\": \"Mexican Psychotropic Substances Group 2\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 323,\n \"codeName\": \"Mexican Psychotropics Group 3\",\n \"idJurisdiction\": 26,\n \"jurisdictionName\": \"Mexico\",\n \"description\": \"Mexican Psychotropic Substances Group 3\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 324,\n \"codeName\": \"Mexican Psychotropics Group 4\",\n \"idJurisdiction\": 26,\n \"jurisdictionName\": \"Mexico\",\n \"description\": \"Mexican Psychotropic Substances Group 4\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 325,\n \"codeName\": \"Mexican Psychotropics Group 5\",\n \"idJurisdiction\": 26,\n \"jurisdictionName\": \"Mexico\",\n \"description\": \"Mexican Psychotropic Substances Group 5\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 326,\n \"codeName\": \"Mexican Chemical Precursors List I\",\n \"idJurisdiction\": 26,\n \"jurisdictionName\": \"Mexico\",\n \"description\": \"Mexican Chemical Precursors List I (Chemical Precursors)\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 327,\n \"codeName\": \"Mexican Chemical Precursors List II\",\n \"idJurisdiction\": 26,\n \"jurisdictionName\": \"Mexico\",\n \"description\": \"Mexican Chemical Precursors List II (Essential Chemicals)\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 328,\n \"codeName\": \"Singapore Psychotropic Substance\",\n \"idJurisdiction\": 25,\n \"jurisdictionName\": \"Singapore\",\n \"description\": \"Singapore Psychotropic Substance\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 329,\n \"codeName\": \"Brazilian List A1\",\n \"idJurisdiction\": 27,\n \"jurisdictionName\": \"Brazil\",\n \"description\": \"Brazilian List A1 (Narcotic Substances subject to Revenue Notification A)\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 330,\n \"codeName\": \"Brazilian List A2\",\n \"idJurisdiction\": 27,\n \"jurisdictionName\": \"Brazil\",\n \"description\": \"Brazilian List A2 (Narcotic Substances permitted for use in special concentrations and subject to Revenue Notification A)\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 331,\n \"codeName\": \"Brazilian List A3\",\n \"idJurisdiction\": 27,\n \"jurisdictionName\": \"Brazil\",\n \"description\": \"Brazilian List A3 (Psychotropic Substances subject to Revenue Notification A)\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 332,\n \"codeName\": \"Brazilian List B1\",\n \"idJurisdiction\": 27,\n \"jurisdictionName\": \"Brazil\",\n \"description\": \"Brazilian List B1 (Psychotropic Substances subject to Revenue Notification B)\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 333,\n \"codeName\": \"Brazilian List B2\",\n \"idJurisdiction\": 27,\n \"jurisdictionName\": \"Brazil\",\n \"description\": \"Brazilian List B2 (Anorectic Psychotropic Substances subject to Revenue Notification B)\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 334,\n \"codeName\": \"Brazilian List C1\",\n \"idJurisdiction\": 27,\n \"jurisdictionName\": \"Brazil\",\n \"description\": \"Brazilian List C1 (Other Substances under special control and subject to two-way Special Control Revenue)\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 335,\n \"codeName\": \"Brazilian List C2\",\n \"idJurisdiction\": 27,\n \"jurisdictionName\": \"Brazil\",\n \"description\": \"Brazilian List C2 (Retinoic Substances which are subject to Special Revenue Notification)\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 336,\n \"codeName\": \"Brazilian List C3\",\n \"idJurisdiction\": 27,\n \"jurisdictionName\": \"Brazil\",\n \"description\": \"Brazilian List C3 (Immunosuppressant Substances which are subject to Special Revenue Notification)\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 380,\n \"codeName\": \"Finnish EU Drug Precursor Category 1\",\n \"idJurisdiction\": 29,\n \"jurisdictionName\": \"Finland\",\n \"description\": \"EU Drug Precursor Category 1\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 381,\n \"codeName\": \"Finnish EU Drug Precursor Category 2\",\n \"idJurisdiction\": 29,\n \"jurisdictionName\": \"Finland\",\n \"description\": \"EU Drug Precursor Category 2\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 382,\n \"codeName\": \"Finnish EU Drug Precursor Category 2A\",\n \"idJurisdiction\": 29,\n \"jurisdictionName\": \"Finland\",\n \"description\": \"EU Drug Precursor Category 2A\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 383,\n \"codeName\": \"Finnish EU Drug Precursor Category 2B\",\n \"idJurisdiction\": 29,\n \"jurisdictionName\": \"Finland\",\n \"description\": \"EU Drug Precursor Category 2B\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 384,\n \"codeName\": \"Finnish EU Drug Precursor Category 3\",\n \"idJurisdiction\": 29,\n \"jurisdictionName\": \"Finland\",\n \"description\": \"EU Drug Precursor Category 3\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 385,\n \"codeName\": \"Finnish EU Drug Precursor Category 4\",\n \"idJurisdiction\": 29,\n \"jurisdictionName\": \"Finland\",\n \"description\": \"EU Drug Precursor Category 4\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 353,\n \"codeName\": \"Polish EU Drug Precursor Category 1\",\n \"idJurisdiction\": 28,\n \"jurisdictionName\": \"Poland\",\n \"description\": \"Polish EU Drug Precursor Category 1\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 354,\n \"codeName\": \"Polish EU Drug Precursor Category 2\",\n \"idJurisdiction\": 28,\n \"jurisdictionName\": \"Poland\",\n \"description\": \"Polish EU Drug Precursor Category 2\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 355,\n \"codeName\": \"Polish EU Drug Precursor Category 2A\",\n \"idJurisdiction\": 28,\n \"jurisdictionName\": \"Poland\",\n \"description\": \"Polish EU Drug Precursor Category 2A\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 356,\n \"codeName\": \"Polish EU Drug Precursor Category 2B\",\n \"idJurisdiction\": 28,\n \"jurisdictionName\": \"Poland\",\n \"description\": \"Polish EU Drug Precursor Category 2B\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 357,\n \"codeName\": \"Polish EU Drug Precursor Category 3 \",\n \"idJurisdiction\": 28,\n \"jurisdictionName\": \"Poland\",\n \"description\": \"Polish EU Drug Precursor Category 3\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 358,\n \"codeName\": \"Polish EU Drug Precursor Category 4\",\n \"idJurisdiction\": 28,\n \"jurisdictionName\": \"Poland\",\n \"description\": \"Polish EU Drug Precursor Category 4\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 337,\n \"codeName\": \"Brazilian List C5\",\n \"idJurisdiction\": 27,\n \"jurisdictionName\": \"Brazil\",\n \"description\": \"Brazilian List C5 (Anabolic Substances which are subject to two-way Special Control Revenue)\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 338,\n \"codeName\": \"Brazilian List D1\",\n \"idJurisdiction\": 27,\n \"jurisdictionName\": \"Brazil\",\n \"description\": \"Brazilian List D1 (Precursor Substances for narcotics and/or psychotropics, which are subject to Non-Retention Medical Revenue)\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 339,\n \"codeName\": \"Brazilian List D2\",\n \"idJurisdiction\": 27,\n \"jurisdictionName\": \"Brazil\",\n \"description\": \"Brazilian List D2 (Chemical Inputs in manufacturing and synthesis of narcotics and/or psychotropic substances which are subject to the control of the Ministry of Justice)\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 340,\n \"codeName\": \"Brazilian List E\",\n \"idJurisdiction\": 27,\n \"jurisdictionName\": \"Brazil\",\n \"description\": \"Brazilian List E (Proscribed plants from which narcotics and/or psychotropics originate)\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 341,\n \"codeName\": \"Brazilian List F1\",\n \"idJurisdiction\": 27,\n \"jurisdictionName\": \"Brazil\",\n \"description\": \"Brazilian List F1 (List F is reserved for substances which are prohibited in Brazil. List F1 is for narcotic substances)\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 342,\n \"codeName\": \"Brazilian List F2\",\n \"idJurisdiction\": 27,\n \"jurisdictionName\": \"Brazil\",\n \"description\": \"Brazilian List F2 (List F is reserved for substances which are prohibited in Brazil. List F2a is for psychotropic substances. List F2b and F2c contain the cannabinoid and cathinone Markush definitions, respectively.)\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 343,\n \"codeName\": \"Brazilian List F3\",\n \"idJurisdiction\": 27,\n \"jurisdictionName\": \"Brazil\",\n \"description\": \"Brazilian List F3 (List F is reserved for substances which are prohibited in Brazil. List F3 is reserved for precursor substances)\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 344,\n \"codeName\": \"Brazilian List F4\",\n \"idJurisdiction\": 27,\n \"jurisdictionName\": \"Brazil\",\n \"description\": \"Brazilian List F4 (List F is reserved for substances which are prohibited in Brazil. List F4 is reserved for other substances)\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 361,\n \"codeName\": \"NOT-IN-USE-REUSE THIS IDSYS_CONTROLLEDCODE\",\n \"idJurisdiction\": 19,\n \"jurisdictionName\": \"China\",\n \"description\": \"NOT-IN-USE-REUSE THIS IDSYS_CONTROLLEDCODE - edit all fields including IDJurisdiction\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 362,\n \"codeName\": \"Annex 1 List I\",\n \"idJurisdiction\": 29,\n \"jurisdictionName\": \"Finland\",\n \"description\": \"List of the 1961 Convention on Drugs I (Vuoden 1961 huumausaineyleissopimuksen lista I)\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 363,\n \"codeName\": \"Annex 1 List II\",\n \"idJurisdiction\": 29,\n \"jurisdictionName\": \"Finland\",\n \"description\": \"List of the 1961 Convention on Drugs II (Vuoden 1961 huumausaineyleissopimuksen lista II)\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 364,\n \"codeName\": \"Annex 1 List III\",\n \"idJurisdiction\": 29,\n \"jurisdictionName\": \"Finland\",\n \"description\": \"List of the 1961 Convention on Drugs III (Vuoden 1961 huumausaineyleissopimuksen lista III)\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 365,\n \"codeName\": \"Annex 1 List IV\",\n \"idJurisdiction\": 29,\n \"jurisdictionName\": \"Finland\",\n \"description\": \"List of the 1961 Convention on Drugs IV (Vuoden 1961 huumausaineyleissopimuksen lista IV)\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 366,\n \"codeName\": \"Annex 2 List I\",\n \"idJurisdiction\": 29,\n \"jurisdictionName\": \"Finland\",\n \"description\": \"List of the 1971 Convention on Psychotropic Substances I (Psykotrooppisia aineita koskevan yleissopimuksen lista I)\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 367,\n \"codeName\": \"Annex 2 List II\",\n \"idJurisdiction\": 29,\n \"jurisdictionName\": \"Finland\",\n \"description\": \"List of the 1971 Convention on Psychotropic Substances II (Psykotrooppisia aineita koskevan yleissopimuksen lista II)\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 368,\n \"codeName\": \"Annex 2 List III\",\n \"idJurisdiction\": 29,\n \"jurisdictionName\": \"Finland\",\n \"description\": \"List of the 1971 Convention on Psychotropic Substances III (Psykotrooppisia aineita koskevan yleissopimuksen lista III)\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 369,\n \"codeName\": \"Annex 2 List IV\",\n \"idJurisdiction\": 29,\n \"jurisdictionName\": \"Finland\",\n \"description\": \"List of the 1971 Convention on Psychotropic Substances IV (Psykotrooppisia aineita koskevan yleissopimuksen lista IV)\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 370,\n \"codeName\": \"Annex 3\",\n \"idJurisdiction\": 29,\n \"jurisdictionName\": \"Finland\",\n \"description\": \"Substances subject to surveillance under Council Decisions adopted under Joint Action 97/396 / JHA on new synthetic drugs or Decision 2005/387 / JHA on the exchange, risk assessment and control of new psychoactive substances:\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 371,\n \"codeName\": \"Annex 4\",\n \"idJurisdiction\": 29,\n \"jurisdictionName\": \"Finland\",\n \"description\": \"Annex 4 substances\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 372,\n \"codeName\": \"Psychoactive Substances Appendix\",\n \"idJurisdiction\": 29,\n \"jurisdictionName\": \"Finland\",\n \"description\": \"Substances list under Government Decree on Psychoactive Substances as Banned from the Consumer Market\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 360,\n \"codeName\": \"Polish New Psychotropic Substances\",\n \"idJurisdiction\": 28,\n \"jurisdictionName\": \"Poland\",\n \"description\": \"Polish New Psychotropic Substances (Nowych substancji psychoaktywnych)\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 373,\n \"codeName\": \"Schedule 1 Controlled Drugs \",\n \"idJurisdiction\": 30,\n \"jurisdictionName\": \"Taiwan\",\n \"description\": \"Schedule 1 Controlled Drugs 第一級管制藥品\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 374,\n \"codeName\": \"Schedule 2 Controlled Drugs \",\n \"idJurisdiction\": 30,\n \"jurisdictionName\": \"Taiwan\",\n \"description\": \"Schedule 2 Controlled Drugs 第二級管制藥品\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 375,\n \"codeName\": \"Schedule 3 Controlled Drugs \",\n \"idJurisdiction\": 30,\n \"jurisdictionName\": \"Taiwan\",\n \"description\": \"Schedule 3 Controlled Drugs 第三級管制藥品\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 376,\n \"codeName\": \"Schedule 4 Controlled Drugs \",\n \"idJurisdiction\": 30,\n \"jurisdictionName\": \"Taiwan\",\n \"description\": \"Schedule 4 Controlled Drugs 第四級管制藥品\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 377,\n \"codeName\": \"Schedule 4 Controlled Drug Materials\",\n \"idJurisdiction\": 30,\n \"jurisdictionName\": \"Taiwan\",\n \"description\": \"Schedule 4 Controlled Drug Materials 第四級管制藥品原料藥\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 378,\n \"codeName\": \"Table I – Category A\",\n \"idJurisdiction\": 30,\n \"jurisdictionName\": \"Taiwan\",\n \"description\": \"Table I – Category A 一、甲類\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 379,\n \"codeName\": \"Table 2 – Category B\",\n \"idJurisdiction\": 30,\n \"jurisdictionName\": \"Taiwan\",\n \"description\": \"Table 2 – Category B 二、乙類\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 359,\n \"codeName\": \"EU Human Rights List Annex IV\",\n \"idJurisdiction\": 21,\n \"jurisdictionName\": \"European Union\",\n \"description\": \"EU Human Rights List Annex IV\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 345,\n \"codeName\": \"Polish Narcotic drugs I-N\",\n \"idJurisdiction\": 28,\n \"jurisdictionName\": \"Poland\",\n \"description\": \"Polish Narcotic drugs Group 1 (Środki odurzające grupy I-N)\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 346,\n \"codeName\": \"Polish Narcotic drugs II-N\",\n \"idJurisdiction\": 28,\n \"jurisdictionName\": \"Poland\",\n \"description\": \"Polish Narcotic drugs Group 2 (Środki odurzające grupy II-N)\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 347,\n \"codeName\": \"Polish Narcotic drugs III-N\",\n \"idJurisdiction\": 28,\n \"jurisdictionName\": \"Poland\",\n \"description\": \"Polish Narcotic drugs Group 3 (Środki odurzające grupy III-N)\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 348,\n \"codeName\": \"Polish Narcotic drugs IV-N\",\n \"idJurisdiction\": 28,\n \"jurisdictionName\": \"Poland\",\n \"description\": \"Polish Narcotic drugs Group 4 (Środki odurzające grupy IV-N)\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 349,\n \"codeName\": \"Polish Psychotropic Substances I-P\",\n \"idJurisdiction\": 28,\n \"jurisdictionName\": \"Poland\",\n \"description\": \"Polish Psychotropic Substances group 1 (Substancje psychotropowe grupy I-P)\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 350,\n \"codeName\": \"Polish Psychotropic Substances II-P\",\n \"idJurisdiction\": 28,\n \"jurisdictionName\": \"Poland\",\n \"description\": \"Polish Psychotropic Substances group 2 (Substancje psychotropowe grupy II-P)\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 351,\n \"codeName\": \"Polish Psychotropic Substances III-P\",\n \"idJurisdiction\": 28,\n \"jurisdictionName\": \"Poland\",\n \"description\": \"Polish Psychotropic Substances group 3 (Substancje psychotropowe grupy III-P)\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 352,\n \"codeName\": \"Polish Psychotropic Substances IV-P\",\n \"idJurisdiction\": 28,\n \"jurisdictionName\": \"Poland\",\n \"description\": \"Polish Psychotropic Substances group 4 (Substancje psychotropowe grupy IV-P)\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 386,\n \"codeName\": \"UK 3rd Generation Cannabinoid 2019\",\n \"idJurisdiction\": 2,\n \"jurisdictionName\": \"United Kingdom\",\n \"description\": \"This a CS2 generated control code to enable CS2 to specifically flag 3rd generation cannabinoids as defined by the 2019 amendment, allowing them to be filtered by downstream systems for special handling\",\n \"idControlledCode\": null\n },\n {\n \"idControlledCode\": 141,\n \"codeName\": \"TestCC\",\n \"idJurisdiction\": 2,\n \"jurisdictionName\": \"United Kingdom\",\n \"description\": \"This is a test\",\n \"idSysControlledCode\": null\n },\n {\n \"idControlledCode\": 61,\n \"codeName\": \"Sci UK Test\",\n \"idJurisdiction\": 2,\n \"jurisdictionName\": \"United Kingdom\",\n \"description\": \"Sci test control code for the UK\",\n \"idSysControlledCode\": null\n },\n {\n \"idControlledCode\": 201,\n \"codeName\": \"FR_testCustomerCC\",\n \"idJurisdiction\": 4,\n \"jurisdictionName\": \"France\",\n \"description\": \"testing\",\n \"idSysControlledCode\": null\n },\n {\n \"idControlledCode\": 181,\n \"codeName\": \"UserDefinedCC2\",\n \"idJurisdiction\": 10000,\n \"jurisdictionName\": \"UserDefined\",\n \"description\": \"newUSerDefinedCC_forTestiing multiple customer controls codes per sub2jur \",\n \"idSysControlledCode\": null\n },\n {\n \"idControlledCode\": 121,\n \"codeName\": \"Userdefined Control Code\",\n \"idJurisdiction\": 10000,\n \"jurisdictionName\": \"UserDefined\",\n \"description\": \"this is a test\",\n \"idSysControlledCode\": null\n },\n {\n \"idControlledCode\": 161,\n \"codeName\": \"Adam Test CC 2\",\n \"idJurisdiction\": 10001,\n \"jurisdictionName\": \"Adam Test\",\n \"description\": \"Test control code 2\",\n \"idSysControlledCode\": null\n },\n {\n \"idControlledCode\": 101,\n \"codeName\": \"Adam Test CC\",\n \"idJurisdiction\": 10001,\n \"jurisdictionName\": \"Adam Test\",\n \"description\": \"This is a test control code\",\n \"idSysControlledCode\": null\n }\n]"}],"_postman_id":"466365b3-f04a-4e8e-b3aa-af4afa182859"},{"name":"/auth/search/inchi","id":"4cfa606a-d195-470d-8975-800bcdae9afb","protocolProfileBehavior":{"disableBodyPruning":true},"request":{"method":"GET","header":[],"url":"https://{{host}}:{{port}}/auth/search/inchi?searchTerm=InChI=1S/C11H15NO2/c1-8(12-2)5-9-3-4-10-11(6-9)14-7-13-10/h3-4,6,8,12H,5,7H2,1-2H3&idJurisdiction=2&idJurisdiction=3","description":"

Run a CS2 search from a URL with a InChI string, this will then direct you to the CS2 UI to display results. Provide the InChI string for the compound and jurisdictions you wish to search.

\n","urlObject":{"protocol":"https","port":"{{port}}","path":["auth","search","inchi"],"host":["{{host}}"],"query":[{"description":{"content":"

InChI string for substance

\n","type":"text/plain"},"key":"searchTerm","value":"InChI=1S/C11H15NO2/c1-8(12-2)5-9-3-4-10-11(6-9)14-7-13-10/h3-4,6,8,12H,5,7H2,1-2H3"},{"description":{"content":"

\n","type":"text/plain"},"key":"idJurisdiction","value":"2"},{"description":{"content":"

see above

\n","type":"text/plain"},"key":"idJurisdiction","value":"3"}],"variable":[]}},"response":[{"id":"cd0a1b93-850c-426e-b0ca-a65f2d715d70","name":"/controlcodes/list","originalRequest":{"method":"GET","header":[{"key":"x-access-token","value":"{{token}}","description":"This header needs to have the authenication token obtained from the /owner/authenticate API to allow requests to be sent to this endpoint","type":"text"}],"body":{"mode":"raw","raw":"","options":{"raw":{"language":"json"}}},"url":{"raw":"https://{{host}}:{{port}}/controlcodes/list?system=true&customer=true","protocol":"https","host":["{{host}}"],"port":"{{port}}","path":["controlcodes","list"],"query":[{"key":"system","value":"true","description":"Optional. If not provided this defaults to true. This toggles whether to return system control codes."},{"key":"customer","value":"true","description":"Optional. If not provided this defaults to true. This toggles whether to return customer control codes."}]}},"status":"OK","code":200,"_postman_previewlanguage":"json","header":[{"key":"Date","value":"Tue, 29 Jun 2021 09:32:19 GMT","enabled":true},{"key":"Content-Type","value":"application/json; charset=utf-8","enabled":true},{"key":"Content-Length","value":"78727","enabled":true},{"key":"Connection","value":"keep-alive","enabled":true},{"key":"Set-Cookie","value":"AWSALBTG=/zq57vRvdNU1RDOVYcFBm+Gz2V48s21koMuiQM+3C4XvTbpCVbE3z/NDFp5J+QwCAReirbcavvmK7SvNw43ene470w0kepkLiS5jYN+mZzeCO7+k4f/wi/+rV/Qp08Fhuog6rBSlO8heaB1OziNnveOgb8pw30j6vbiMxgAGSe2vUS+nABQ=; Expires=Tue, 06 Jul 2021 09:32:19 GMT; Path=/","enabled":true},{"key":"Set-Cookie","value":"AWSALBTGCORS=/zq57vRvdNU1RDOVYcFBm+Gz2V48s21koMuiQM+3C4XvTbpCVbE3z/NDFp5J+QwCAReirbcavvmK7SvNw43ene470w0kepkLiS5jYN+mZzeCO7+k4f/wi/+rV/Qp08Fhuog6rBSlO8heaB1OziNnveOgb8pw30j6vbiMxgAGSe2vUS+nABQ=; Expires=Tue, 06 Jul 2021 09:32:19 GMT; Path=/; SameSite=None; Secure","enabled":true},{"key":"X-Powered-By","value":"Express","enabled":true},{"key":"X-Frame-Options","value":"SAMEORIGIN","enabled":true},{"key":"ETag","value":"W/\"13387-yMsxifOenhh1GqH68lOMkrbrcdo\"","enabled":true}],"cookie":[],"responseTime":null,"body":"[\n {\n \"idSysControlledCode\": 97,\n \"codeName\": \"Irish Schedule 1\",\n \"idJurisdiction\": 5,\n \"jurisdictionName\": \"Ireland\",\n \"description\": \"Drugs subject to very strict controls and have little or no use in medicine or industry\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 98,\n \"codeName\": \"Irish Schedule 2\",\n \"idJurisdiction\": 5,\n \"jurisdictionName\": \"Ireland\",\n \"description\": \"Drugs used for scientific purposes which have a high likelihood of their being abused\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 99,\n \"codeName\": \"Irish Schedule 3\",\n \"idJurisdiction\": 5,\n \"jurisdictionName\": \"Ireland\",\n \"description\": \"Controlled medicinal products with a high likelihood of abuse\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 100,\n \"codeName\": \"Irish Schedule 4 pt 1\",\n \"idJurisdiction\": 5,\n \"jurisdictionName\": \"Ireland\",\n \"description\": \"Controlled medicinal products\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 108,\n \"codeName\": \"Irish Schedule 5\",\n \"idJurisdiction\": 5,\n \"jurisdictionName\": \"Ireland\",\n \"description\": \"Controlled drugs exempted from the prohibition on importation and exportation \",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 109,\n \"codeName\": \"Irish Schedule 8 pt1\",\n \"idJurisdiction\": 5,\n \"jurisdictionName\": \"Ireland\",\n \"description\": \"Can be prescribed for pain relief by a nurse in hospital\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 110,\n \"codeName\": \"Irish EU Drug Precursor Category 1\",\n \"idJurisdiction\": 5,\n \"jurisdictionName\": \"Ireland\",\n \"description\": \"EU Drug Precursor Category 1\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 111,\n \"codeName\": \"Irish EU Drug Precursor Category 2A\",\n \"idJurisdiction\": 5,\n \"jurisdictionName\": \"Ireland\",\n \"description\": \"EU Drug Precursor Category 2A\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 112,\n \"codeName\": \"Irish EU Drug Precursor Category 3\",\n \"idJurisdiction\": 5,\n \"jurisdictionName\": \"Ireland\",\n \"description\": \"EU Drug Precursor Category 3\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 113,\n \"codeName\": \"Irish EU Drug Precursor Category 4\",\n \"idJurisdiction\": 5,\n \"jurisdictionName\": \"Ireland\",\n \"description\": \"EU Drug Precursor Category 4\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 114,\n \"codeName\": \"Irish Schedule 4 pt 2\",\n \"idJurisdiction\": 5,\n \"jurisdictionName\": \"Ireland\",\n \"description\": \"Controlled medicinal products\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 175,\n \"codeName\": \"Canadian Schedule VII\",\n \"idJurisdiction\": 14,\n \"jurisdictionName\": \"Canada\",\n \"description\": \"Canadian Schedule VII\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 1176,\n \"codeName\": \"Canadian Schedule VIII\",\n \"idJurisdiction\": 14,\n \"jurisdictionName\": \"Canada\",\n \"description\": \"Canadian Schedule VIII\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 115,\n \"codeName\": \"Irish Schedule 8 pt2\",\n \"idJurisdiction\": 5,\n \"jurisdictionName\": \"Ireland\",\n \"description\": \"Can be prescribed for pain relief by a nurse in hospital\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 116,\n \"codeName\": \"Irish Schedule 8 pt3\",\n \"idJurisdiction\": 5,\n \"jurisdictionName\": \"Ireland\",\n \"description\": \"Can be prescribed for pain relief by a nurse in hospital\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 117,\n \"codeName\": \"Irish Schedule 8 pt4\",\n \"idJurisdiction\": 5,\n \"jurisdictionName\": \"Ireland\",\n \"description\": \"Can be prescribed for pain relief by a nurse in hospital\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 118,\n \"codeName\": \"Irish no schedule given\",\n \"idJurisdiction\": 5,\n \"jurisdictionName\": \"Ireland\",\n \"description\": \"Some substances are controlled in the general text of the legislation but not listed in a named schedule\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 23,\n \"codeName\": \"UK Schedule 1\",\n \"idJurisdiction\": 2,\n \"jurisdictionName\": \"United Kingdom\",\n \"description\": \"Schedule 1 drugs are thought to have no therapeutic value and cannot be lawfully possessed or prescribed. A Home Office license is required for research and significant regulations govern record keeping and storage.\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 24,\n \"codeName\": \"UK Schedule 2\",\n \"idJurisdiction\": 2,\n \"jurisdictionName\": \"United Kingdom\",\n \"description\": \"Schedule 2 drugs can be prescribed and therefore legally possessed and supplied by pharmacists and doctors (possesion or supply is otherwise illegal) and include drugs such as Heroin. Significant regulations govern record keeping and storage requirements for research use. \",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 25,\n \"codeName\": \"UK Schedule 3\",\n \"idJurisdiction\": 2,\n \"jurisdictionName\": \"United Kingdom\",\n \"description\": \"Schedule 3 drugs can be prescribed and therefore legally possessed and supplied by pharmacists and doctors (possession or supply is otherwise illegal). They have less onerous record keeping and storage regulations.\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 26,\n \"codeName\": \"UK Schedule 4\",\n \"idJurisdiction\": 2,\n \"jurisdictionName\": \"United Kingdom\",\n \"description\": \"Schedule 4 contain drugs such as steroids and benzodiazepines. Depending on the substance import / export licenses maybe required as well as a home office permit for scientific use.\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 27,\n \"codeName\": \"UK Schedule 5\",\n \"idJurisdiction\": 2,\n \"jurisdictionName\": \"United Kingdom\",\n \"description\": \"Schedule 5 drugs are sold over the counter and can be legally possessed without a prescription and imported / exported.\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 28,\n \"codeName\": \"UK Class A\",\n \"idJurisdiction\": 2,\n \"jurisdictionName\": \"United Kingdom\",\n \"description\": \"UK Class A\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 29,\n \"codeName\": \"UK Class B\",\n \"idJurisdiction\": 2,\n \"jurisdictionName\": \"United Kingdom\",\n \"description\": \"UK Class B\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 30,\n \"codeName\": \"UK Class C\",\n \"idJurisdiction\": 2,\n \"jurisdictionName\": \"United Kingdom\",\n \"description\": \"UK Class C\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 1,\n \"codeName\": \"UK Temporary Class Drug\",\n \"idJurisdiction\": 2,\n \"jurisdictionName\": \"United Kingdom\",\n \"description\": \"UK TEMPORARY CONTROL\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 2,\n \"codeName\": \"UNKNOWN\",\n \"idJurisdiction\": 2,\n \"jurisdictionName\": \"United Kingdom\",\n \"description\": \"UNKNOWN\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 3,\n \"codeName\": \"UK Schedule 3 Part 2\",\n \"idJurisdiction\": 2,\n \"jurisdictionName\": \"United Kingdom\",\n \"description\": \"Not used\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 4,\n \"codeName\": \"UK Schedule 4 Part 1\",\n \"idJurisdiction\": 2,\n \"jurisdictionName\": \"United Kingdom\",\n \"description\": \"UK Schedule 4 Part 1\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 5,\n \"codeName\": \"UK Schedule 4 Part 2\",\n \"idJurisdiction\": 2,\n \"jurisdictionName\": \"United Kingdom\",\n \"description\": \"UK Schedule 4 Part 2\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 41,\n \"codeName\": \"Test-partA\",\n \"idJurisdiction\": 16,\n \"jurisdictionName\": \"Used for testing\",\n \"description\": \"Test-partA\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 6,\n \"codeName\": \"UN Psychotropics Schedule I \",\n \"idJurisdiction\": 15,\n \"jurisdictionName\": \"UN (INCB)\",\n \"description\": \"UN Psychotropics Schedule I\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 7,\n \"codeName\": \"UN Psychotropics Schedule II\",\n \"idJurisdiction\": 15,\n \"jurisdictionName\": \"UN (INCB)\",\n \"description\": \"UN Psychotropics Schedule II\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 8,\n \"codeName\": \"UN Psychotropics Schedule III\",\n \"idJurisdiction\": 15,\n \"jurisdictionName\": \"UN (INCB)\",\n \"description\": \"UN Psychotropics Schedule III\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 9,\n \"codeName\": \"UN Psychotropics Schedule IV\",\n \"idJurisdiction\": 15,\n \"jurisdictionName\": \"UN (INCB)\",\n \"description\": \"UN Psychotropics Schedule IV\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 21,\n \"codeName\": \"US CSA Schedule I\",\n \"idJurisdiction\": 3,\n \"jurisdictionName\": \"United States of America\",\n \"description\": \"Schedule I drugs, substances, or chemicals are defined as drugs with no currently accepted medical use and a high potential for abuse. Schedule I drugs are the most dangerous drugs of all the drug schedules with potentially severe psychological or physical dependence. Significant controls need to be in place \",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 22,\n \"codeName\": \"US CSA Schedule II\",\n \"idJurisdiction\": 3,\n \"jurisdictionName\": \"United States of America\",\n \"description\": \"Schedule II drugs, substances, or chemicals are defined as drugs with a high potential for abuse, less abuse potential than Schedule I drugs, with use potentially leading to severe psychological or physical dependence. These drugs are also considered dangerous. Significant controls need to be in place\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 31,\n \"codeName\": \"US CSA Schedule III\",\n \"idJurisdiction\": 3,\n \"jurisdictionName\": \"United States of America\",\n \"description\": \"Schedule III drugs, substances, or chemicals are defined as drugs with a moderate to low potential for physical and psychological dependence. Schedule III drugs abuse potential is less than Schedule I and Schedule II drugs but more than Schedule IV. Significant controls generally need to be in place\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 32,\n \"codeName\": \"US CSA Schedule IV\",\n \"idJurisdiction\": 3,\n \"jurisdictionName\": \"United States of America\",\n \"description\": \"Schedule IV drugs, substances, or chemicals are defined as drugs with a low potential for abuse and low risk of dependence. \",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 33,\n \"codeName\": \"US CSA Schedule V\",\n \"idJurisdiction\": 3,\n \"jurisdictionName\": \"United States of America\",\n \"description\": \"Schedule V drugs, substances, or chemicals are defined as drugs with lower potential for abuse than Schedule IV and consist of preparations containing limited quantities of certain narcotics. Schedule V drugs are generally used for antidiarrheal, antitussive, and analgesic purposes.\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 40,\n \"codeName\": \"US CSA Schedule I (temporary)\",\n \"idJurisdiction\": 3,\n \"jurisdictionName\": \"United States of America\",\n \"description\": \"Schedule I drugs, substances, or chemicals are defined as drugs with no currently accepted medical use and a high potential for abuse. Schedule I drugs are the most dangerous drugs of all the drug schedules with potentially severe psychological or physical dependence. Significant controls need to be in place \",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 42,\n \"codeName\": \"US CSA List 1 Regulated Chemical\",\n \"idJurisdiction\": 3,\n \"jurisdictionName\": \"United States of America\",\n \"description\": \"US List 1 Regulated Chemical\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 43,\n \"codeName\": \"US CSA List 2 Regulated Chemical\",\n \"idJurisdiction\": 3,\n \"jurisdictionName\": \"United States of America\",\n \"description\": \"US List 2 Regulated Chemical\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 44,\n \"codeName\": \"UK EU Drug Precursor Category 1\",\n \"idJurisdiction\": 2,\n \"jurisdictionName\": \"United Kingdom\",\n \"description\": \"UK EU Drug Precursor Category 1\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 45,\n \"codeName\": \"UK EU Drug Precursor Category 2B\",\n \"idJurisdiction\": 2,\n \"jurisdictionName\": \"United Kingdom\",\n \"description\": \"UK EU Drug Precursor Category 2B\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 46,\n \"codeName\": \"UK EU Drug Precursor Category 3\",\n \"idJurisdiction\": 2,\n \"jurisdictionName\": \"United Kingdom\",\n \"description\": \"UK EU Drug Precursor Category 3\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 78,\n \"codeName\": \"Spain UN Narcotics List I\",\n \"idJurisdiction\": 11,\n \"jurisdictionName\": \"Spain\",\n \"description\": \"Spain UN Narcotics List I\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 75,\n \"codeName\": \"Spain UN Narcotics List II\",\n \"idJurisdiction\": 11,\n \"jurisdictionName\": \"Spain\",\n \"description\": \"Spain UN Narcotics List II\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 76,\n \"codeName\": \"Spain UN Narcotics List III\",\n \"idJurisdiction\": 11,\n \"jurisdictionName\": \"Spain\",\n \"description\": \"Spain UN Narcotics List III\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 77,\n \"codeName\": \"Spain UN Narcotics List IV\",\n \"idJurisdiction\": 11,\n \"jurisdictionName\": \"Spain\",\n \"description\": \"Spain UN Narcotics List IV\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 79,\n \"codeName\": \"US ARCOS List\",\n \"idJurisdiction\": 3,\n \"jurisdictionName\": \"United States of America\",\n \"description\": \"Substances, which may not be listed in legislation but within US ARCOS system as likely requiring import/export licences and should be considered as controlled\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 80,\n \"codeName\": \"Spain UN Psychotropics List II\",\n \"idJurisdiction\": 11,\n \"jurisdictionName\": \"Spain\",\n \"description\": \"Spain UN Psychotropics List II\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 81,\n \"codeName\": \"Spain UN Psychotropics List III\",\n \"idJurisdiction\": 11,\n \"jurisdictionName\": \"Spain\",\n \"description\": \"Spain UN Psychotropics List III\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 82,\n \"codeName\": \"Spain UN Psychotropics List IV\",\n \"idJurisdiction\": 11,\n \"jurisdictionName\": \"Spain\",\n \"description\": \"Spain UN Psychotropics List IV\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 83,\n \"codeName\": \"Spain UN Psychotropics List I\",\n \"idJurisdiction\": 11,\n \"jurisdictionName\": \"Spain\",\n \"description\": \"Spain UN Psychotropics List I\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 84,\n \"codeName\": \"Spain Psychotropics Annex 2\",\n \"idJurisdiction\": 11,\n \"jurisdictionName\": \"Spain\",\n \"description\": \"Spain Annex substances controlled in addition to UN lists\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 85,\n \"codeName\": \"Swedish List I\",\n \"idJurisdiction\": 12,\n \"jurisdictionName\": \"Sweden\",\n \"description\": \"substances , plant material and fungi that normally do not have medical use\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 86,\n \"codeName\": \"Swedish List II\",\n \"idJurisdiction\": 12,\n \"jurisdictionName\": \"Sweden\",\n \"description\": \"substances , plant material and fungi with medical use\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 87,\n \"codeName\": \"Swedish List III\",\n \"idJurisdiction\": 12,\n \"jurisdictionName\": \"Sweden\",\n \"description\": \"substances , plant material and fungi with medical use\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 88,\n \"codeName\": \"Swedish List IV\",\n \"idJurisdiction\": 12,\n \"jurisdictionName\": \"Sweden\",\n \"description\": \"substances , plant material and fungi with medical use\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 89,\n \"codeName\": \"Swedish List V\",\n \"idJurisdiction\": 12,\n \"jurisdictionName\": \"Sweden\",\n \"description\": \"Swedish List 5\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 90,\n \"codeName\": \"Danish List A\",\n \"idJurisdiction\": 7,\n \"jurisdictionName\": \"Denmark\",\n \"description\": \"Danish List A\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 91,\n \"codeName\": \"Danish List B\",\n \"idJurisdiction\": 7,\n \"jurisdictionName\": \"Denmark\",\n \"description\": \"Danish List B\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 92,\n \"codeName\": \"Danish List C\",\n \"idJurisdiction\": 7,\n \"jurisdictionName\": \"Denmark\",\n \"description\": \"Danish List C\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 93,\n \"codeName\": \"Danish List D\",\n \"idJurisdiction\": 7,\n \"jurisdictionName\": \"Denmark\",\n \"description\": \"Danish List D\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 94,\n \"codeName\": \"Danish List E\",\n \"idJurisdiction\": 7,\n \"jurisdictionName\": \"Denmark\",\n \"description\": \"Danish List E\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 34,\n \"codeName\": \"Swiss Directory A\",\n \"idJurisdiction\": 13,\n \"jurisdictionName\": \"Switzerland\",\n \"description\": \"controlled substances that are subject to all of the control measures; \",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 35,\n \"codeName\": \"Swiss Directory B\",\n \"idJurisdiction\": 13,\n \"jurisdictionName\": \"Switzerland\",\n \"description\": \"controlled substances that are partially exempt from the control measures; \",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 36,\n \"codeName\": \"Swiss Directory C\",\n \"idJurisdiction\": 13,\n \"jurisdictionName\": \"Switzerland\",\n \"description\": \"controlled substances that may be contained in preparations in reduced concentrations and are partially exempt from the control measures; \",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 37,\n \"codeName\": \"Swiss Directory D\",\n \"idJurisdiction\": 13,\n \"jurisdictionName\": \"Switzerland\",\n \"description\": \"illegal controlled substances\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 47,\n \"codeName\": \"Swiss Directory E\",\n \"idJurisdiction\": 13,\n \"jurisdictionName\": \"Switzerland\",\n \"description\": \"Raw Materials and Products with Suspected Similar Narcotics Effect\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 48,\n \"codeName\": \"Swiss Directory F\",\n \"idJurisdiction\": 13,\n \"jurisdictionName\": \"Switzerland\",\n \"description\": \"Precursors\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 49,\n \"codeName\": \"Swiss Directory G\",\n \"idJurisdiction\": 13,\n \"jurisdictionName\": \"Switzerland\",\n \"description\": \"Auxiliary Chemicals\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 50,\n \"codeName\": \"Belgium 1930-art1 (stup)\",\n \"idJurisdiction\": 6,\n \"jurisdictionName\": \"Belgium\",\n \"description\": \"Belgium 1930-art1 (stup)\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 51,\n \"codeName\": \"Belgium 1930-art1bis (stup)\",\n \"idJurisdiction\": 6,\n \"jurisdictionName\": \"Belgium\",\n \"description\": \"Belgium 1930-art1bis (stup)\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 52,\n \"codeName\": \"Belgium 1998-art2 (as-stup)\",\n \"idJurisdiction\": 6,\n \"jurisdictionName\": \"Belgium\",\n \"description\": \"Belgium 1998-art2 (as-stup)\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 53,\n \"codeName\": \"Belgium 1998-art25 (psy)\",\n \"idJurisdiction\": 6,\n \"jurisdictionName\": \"Belgium\",\n \"description\": \"Belgium 1998-art25 (psy)\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 54,\n \"codeName\": \"Belgium 1998-art38 (psy)\",\n \"idJurisdiction\": 6,\n \"jurisdictionName\": \"Belgium\",\n \"description\": \"Belgium 1998-art38 (psy)\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 64,\n \"codeName\": \"Canadian Schedule II\",\n \"idJurisdiction\": 14,\n \"jurisdictionName\": \"Canada\",\n \"description\": \"Canadian Schedule II\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 65,\n \"codeName\": \"Canadian Schedule III\",\n \"idJurisdiction\": 14,\n \"jurisdictionName\": \"Canada\",\n \"description\": \"Canadian Schedule III\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 66,\n \"codeName\": \"Canadian Schedule IV\",\n \"idJurisdiction\": 14,\n \"jurisdictionName\": \"Canada\",\n \"description\": \"Canadian Schedule IV\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 67,\n \"codeName\": \"Canadian Schedule V\",\n \"idJurisdiction\": 14,\n \"jurisdictionName\": \"Canada\",\n \"description\": \"Canadian Schedule V\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 59,\n \"codeName\": \"French Psychotropics Part 1 UN Schedule III\",\n \"idJurisdiction\": 4,\n \"jurisdictionName\": \"France\",\n \"description\": \"This has the contents of Schedule III of the List of Psychotropic Substances under International Control in accordance with the United Nations Convention on Psychotropic Substances of 1971\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 60,\n \"codeName\": \"French Psychotropics Part 1 UN Schedule IV\",\n \"idJurisdiction\": 4,\n \"jurisdictionName\": \"France\",\n \"description\": \"This has the contents of Schedule IV of the List of Psychotropic Substances under International Control in accordance with the United Nations Convention on Psychotropic Substances of 1971\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 61,\n \"codeName\": \"French Psychotropics Part 2\",\n \"idJurisdiction\": 4,\n \"jurisdictionName\": \"France\",\n \"description\": \"Certain preparations of psychotropics.\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 62,\n \"codeName\": \"French Psychotropics Part 3\",\n \"idJurisdiction\": 4,\n \"jurisdictionName\": \"France\",\n \"description\": \"Psychotropics not covered by the List of Psychotropic Substances under International Control in accordance with the United Nations Convention on Psychotropic Substances of 1971.\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 101,\n \"codeName\": \"German Schedule 1\",\n \"idJurisdiction\": 8,\n \"jurisdictionName\": \"Germany\",\n \"description\": \"German Schedule 1\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 102,\n \"codeName\": \"German Schedule 2\",\n \"idJurisdiction\": 8,\n \"jurisdictionName\": \"Germany\",\n \"description\": \"German Schedule 2\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 103,\n \"codeName\": \"German Schedule 3\",\n \"idJurisdiction\": 8,\n \"jurisdictionName\": \"Germany\",\n \"description\": \"German Schedule 3 - not controlled\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 104,\n \"codeName\": \"French Narcotics Annex I\",\n \"idJurisdiction\": 4,\n \"jurisdictionName\": \"France\",\n \"description\": \"Narcotics Annex I: narcotic substances such as heroin, cocaine, cannabis, methadone, opium, etc. Corresponds to Schedule I of the list of narcotic drugs under international control in accordance with the UN Single Convention on Narcotic Drugs 1961.\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 106,\n \"codeName\": \"French Narcotics Annex III\",\n \"idJurisdiction\": 4,\n \"jurisdictionName\": \"France\",\n \"description\": \"Narcotic Annex III: psychotropic substances such as: amphetamines, ecstasy (MDMA), LSD, etc. Corresponds to Schedule I the list of psychotropic drugs under international control in accordance with the UN Convention on Psychotropic Substances of 1971\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 105,\n \"codeName\": \"French Narcotics Annex II\",\n \"idJurisdiction\": 4,\n \"jurisdictionName\": \"France\",\n \"description\": \"Narcotics Annex II: substances like codeine, propiram, etc. Corresponds to Schedule II of the list of narcotics drugs under international control in accordance with the UN Single Convention on Narcotic Drugs, 1961\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 107,\n \"codeName\": \"French Narcotics Annex IV\",\n \"idJurisdiction\": 4,\n \"jurisdictionName\": \"France\",\n \"description\": \"Narcotics Annex IV: substances not controlled at the international level.\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 63,\n \"codeName\": \"Canadian Schedule I\",\n \"idJurisdiction\": 14,\n \"jurisdictionName\": \"Canada\",\n \"description\": \"Canadian Schedule I\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 68,\n \"codeName\": \"Canadian Schedule VI pt1\",\n \"idJurisdiction\": 14,\n \"jurisdictionName\": \"Canada\",\n \"description\": \"Canadian Schedule VI pt1\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 69,\n \"codeName\": \"Italian Table I\",\n \"idJurisdiction\": 9,\n \"jurisdictionName\": \"Italy\",\n \"description\": \"Italian table 1\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 70,\n \"codeName\": \"Italian Table V(a)\",\n \"idJurisdiction\": 9,\n \"jurisdictionName\": \"Italy\",\n \"description\": \"Italian table V(a)\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 71,\n \"codeName\": \"Italian Table V(b)\",\n \"idJurisdiction\": 9,\n \"jurisdictionName\": \"Italy\",\n \"description\": \"Italian table V(b)\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 72,\n \"codeName\": \"Italian Table V(c)\",\n \"idJurisdiction\": 9,\n \"jurisdictionName\": \"Italy\",\n \"description\": \"Italian table V(c)\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 73,\n \"codeName\": \"Italian Table V(d)\",\n \"idJurisdiction\": 9,\n \"jurisdictionName\": \"Italy\",\n \"description\": \"Italian table V(d)\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 74,\n \"codeName\": \"Italian Table V(e)\",\n \"idJurisdiction\": 9,\n \"jurisdictionName\": \"Italy\",\n \"description\": \"Italian table V(e)\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 157,\n \"codeName\": \"German EU Drug Precursor Category 1\",\n \"idJurisdiction\": 8,\n \"jurisdictionName\": \"Germany\",\n \"description\": \"EU Drug Precursor Category 1\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 158,\n \"codeName\": \"German EU Drug Precursor Category 2A\",\n \"idJurisdiction\": 8,\n \"jurisdictionName\": \"Germany\",\n \"description\": \"EU Drug Precursor Category 2A\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 159,\n \"codeName\": \"German EU Drug Precursor Category 2B\",\n \"idJurisdiction\": 8,\n \"jurisdictionName\": \"Germany\",\n \"description\": \"EU Drug Precursor Category 2B\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 160,\n \"codeName\": \"German EU Drug Precursor Category 3\",\n \"idJurisdiction\": 8,\n \"jurisdictionName\": \"Germany\",\n \"description\": \"EU Drug Precursor Category 3\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 161,\n \"codeName\": \"German EU Drug Precursor Category 4\",\n \"idJurisdiction\": 8,\n \"jurisdictionName\": \"Germany\",\n \"description\": \"EU Drug Precursor Category 4\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 162,\n \"codeName\": \"Swedish EU Drug Precursor Category 1\",\n \"idJurisdiction\": 12,\n \"jurisdictionName\": \"Sweden\",\n \"description\": \"EU Drug Precursor Category 1\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 163,\n \"codeName\": \"Swedish EU Drug Precursor Category 2A\",\n \"idJurisdiction\": 12,\n \"jurisdictionName\": \"Sweden\",\n \"description\": \"EU Drug Precursor Category 2A\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 164,\n \"codeName\": \"Swedish EU Drug Precursor Category 2B\",\n \"idJurisdiction\": 12,\n \"jurisdictionName\": \"Sweden\",\n \"description\": \"EU Drug Precursor Category 2B\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 165,\n \"codeName\": \"Swedish EU Drug Precursor Category 3\",\n \"idJurisdiction\": 12,\n \"jurisdictionName\": \"Sweden\",\n \"description\": \"EU Drug Precursor Category 3\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 166,\n \"codeName\": \"Swedish EU Drug Precursor Category 4\",\n \"idJurisdiction\": 12,\n \"jurisdictionName\": \"Sweden\",\n \"description\": \"EU Drug Precursor Category 4\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 168,\n \"codeName\": \"Canadian Schedule VI pt2\",\n \"idJurisdiction\": 14,\n \"jurisdictionName\": \"Canada\",\n \"description\": \"Canadian Schedule VI pt2\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 95,\n \"codeName\": \"Netherlands List 1\",\n \"idJurisdiction\": 10,\n \"jurisdictionName\": \"Netherlands\",\n \"description\": \"Netherlands List 1\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 96,\n \"codeName\": \"Netherlands List 2\",\n \"idJurisdiction\": 10,\n \"jurisdictionName\": \"Netherlands\",\n \"description\": \"Netherlands List 2\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 119,\n \"codeName\": \"UK EU Drug Precursor Category 2A\",\n \"idJurisdiction\": 2,\n \"jurisdictionName\": \"United Kingdom\",\n \"description\": \"UK EU Drug Precursor Category 2A\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 120,\n \"codeName\": \"UK EU Drug Precursor Category 4\",\n \"idJurisdiction\": 2,\n \"jurisdictionName\": \"United Kingdom\",\n \"description\": \"UK EU Drug Precursor Category 4\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 171,\n \"codeName\": \"Italian Table II\",\n \"idJurisdiction\": 9,\n \"jurisdictionName\": \"Italy\",\n \"description\": \"Italian Table II\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 172,\n \"codeName\": \"Italian Table III\",\n \"idJurisdiction\": 9,\n \"jurisdictionName\": \"Italy\",\n \"description\": \"Italian Table III\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 173,\n \"codeName\": \"Italian Table IV\",\n \"idJurisdiction\": 9,\n \"jurisdictionName\": \"Italy\",\n \"description\": \"Italian Table IV\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 174,\n \"codeName\": \"Italian Annex 3a\",\n \"idJurisdiction\": 9,\n \"jurisdictionName\": \"Italy\",\n \"description\": \"Italian Annex 3a\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 126,\n \"codeName\": \"Belgium EU Drug Precursor Category 1\",\n \"idJurisdiction\": 6,\n \"jurisdictionName\": \"Belgium\",\n \"description\": \"EU Drug Precursor Category 1\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 127,\n \"codeName\": \"Belgium EU Drug Precursor Category 2A\",\n \"idJurisdiction\": 6,\n \"jurisdictionName\": \"Belgium\",\n \"description\": \"EU Drug Precursor Category 2A\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 128,\n \"codeName\": \"Belgium EU Drug Precursor Category 2B\",\n \"idJurisdiction\": 6,\n \"jurisdictionName\": \"Belgium\",\n \"description\": \"EU Drug Precursor Category 2B\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 129,\n \"codeName\": \"Belgium EU Drug Precursor Category 3\",\n \"idJurisdiction\": 6,\n \"jurisdictionName\": \"Belgium\",\n \"description\": \"EU Drug Precursor Category 3\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 130,\n \"codeName\": \"Belgium EU Drug Precursor Category 4\",\n \"idJurisdiction\": 6,\n \"jurisdictionName\": \"Belgium\",\n \"description\": \"EU Drug Precursor Category 4\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 131,\n \"codeName\": \"French EU Drug Precursor Category 1\",\n \"idJurisdiction\": 4,\n \"jurisdictionName\": \"France\",\n \"description\": \"EU Drug Precursor Category 1\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 132,\n \"codeName\": \"French EU Drug Precursor Category 2A\",\n \"idJurisdiction\": 4,\n \"jurisdictionName\": \"France\",\n \"description\": \"EU Drug Precursor Category 2A\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 133,\n \"codeName\": \"French EU Drug Precursor Category 2B\",\n \"idJurisdiction\": 4,\n \"jurisdictionName\": \"France\",\n \"description\": \"EU Drug Precursor Category 2B\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 134,\n \"codeName\": \"French EU Drug Precursor Category 3\",\n \"idJurisdiction\": 4,\n \"jurisdictionName\": \"France\",\n \"description\": \"EU Drug Precursor Category 3\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 135,\n \"codeName\": \"French EU Drug Precursor Category 4\",\n \"idJurisdiction\": 4,\n \"jurisdictionName\": \"France\",\n \"description\": \"EU Drug Precursor Category 4\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 136,\n \"codeName\": \"Italian EU Drug Precursor Category 1\",\n \"idJurisdiction\": 9,\n \"jurisdictionName\": \"Italy\",\n \"description\": \"EU Drug Precursor Category 1\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 137,\n \"codeName\": \"Italian EU Drug Precursor Category 2A\",\n \"idJurisdiction\": 9,\n \"jurisdictionName\": \"Italy\",\n \"description\": \"EU Drug Precursor Category 2A\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 138,\n \"codeName\": \"Italian EU Drug Precursor Category 2B\",\n \"idJurisdiction\": 9,\n \"jurisdictionName\": \"Italy\",\n \"description\": \"EU Drug Precursor Category 2B\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 139,\n \"codeName\": \"Italian EU Drug Precursor Category 3\",\n \"idJurisdiction\": 9,\n \"jurisdictionName\": \"Italy\",\n \"description\": \"EU Drug Precursor Category 3\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 140,\n \"codeName\": \"Italian EU Drug Precursor Category 4\",\n \"idJurisdiction\": 9,\n \"jurisdictionName\": \"Italy\",\n \"description\": \"EU Drug Precursor Category 4\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 141,\n \"codeName\": \"Spanish EU Drug Precursor Category 1\",\n \"idJurisdiction\": 11,\n \"jurisdictionName\": \"Spain\",\n \"description\": \"EU Drug Precursor Category 1\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 142,\n \"codeName\": \"Spanish EU Drug Precursor Category 2A\",\n \"idJurisdiction\": 11,\n \"jurisdictionName\": \"Spain\",\n \"description\": \"EU Drug Precursor Category 2A\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 143,\n \"codeName\": \"Spanish EU Drug Precursor Category 2B\",\n \"idJurisdiction\": 11,\n \"jurisdictionName\": \"Spain\",\n \"description\": \"EU Drug Precursor Category 2B\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 144,\n \"codeName\": \"Spanish EU Drug Precursor Category 3\",\n \"idJurisdiction\": 11,\n \"jurisdictionName\": \"Spain\",\n \"description\": \"EU Drug Precursor Category 3\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 145,\n \"codeName\": \"Spanish EU Drug Precursor Category 4\",\n \"idJurisdiction\": 11,\n \"jurisdictionName\": \"Spain\",\n \"description\": \"EU Drug Precursor Category 4\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 146,\n \"codeName\": \"Danish EU Drug Precursor Category 1\",\n \"idJurisdiction\": 7,\n \"jurisdictionName\": \"Denmark\",\n \"description\": \"EU Drug Precursor Category 1\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 147,\n \"codeName\": \"Danish EU Drug Precursor Category 2A\",\n \"idJurisdiction\": 7,\n \"jurisdictionName\": \"Denmark\",\n \"description\": \"EU Drug Precursor Category 2A\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 148,\n \"codeName\": \"Danish EU Drug Precursor Category 2B\",\n \"idJurisdiction\": 7,\n \"jurisdictionName\": \"Denmark\",\n \"description\": \"EU Drug Precursor Category 2B\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 149,\n \"codeName\": \"Danish EU Drug Precursor Category 3\",\n \"idJurisdiction\": 7,\n \"jurisdictionName\": \"Denmark\",\n \"description\": \"EU Drug Precursor Category 3\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 150,\n \"codeName\": \"Danish EU Drug Precursor Category 4\",\n \"idJurisdiction\": 7,\n \"jurisdictionName\": \"Denmark\",\n \"description\": \"EU Drug Precursor Category 4\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 151,\n \"codeName\": \"Netherlands EU Drug Precursor Category 1\",\n \"idJurisdiction\": 10,\n \"jurisdictionName\": \"Netherlands\",\n \"description\": \"EU Drug Precursor Category 1\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 152,\n \"codeName\": \"Netherlands EU Drug Precursor Category 2A\",\n \"idJurisdiction\": 10,\n \"jurisdictionName\": \"Netherlands\",\n \"description\": \"EU Drug Precursor Category 2A\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 153,\n \"codeName\": \"Netherlands EU Drug Precursor Category 2B\",\n \"idJurisdiction\": 10,\n \"jurisdictionName\": \"Netherlands\",\n \"description\": \"EU Drug Precursor Category 2B\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 154,\n \"codeName\": \"Netherlands EU Drug Precursor Category 3\",\n \"idJurisdiction\": 10,\n \"jurisdictionName\": \"Netherlands\",\n \"description\": \"EU Drug Precursor Category 3\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 155,\n \"codeName\": \"Netherlands EU Drug Precursor Category 4\",\n \"idJurisdiction\": 10,\n \"jurisdictionName\": \"Netherlands\",\n \"description\": \"EU Drug Precursor Category 4\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 156,\n \"codeName\": \"Irish EU Drug Precursor Category 2B\",\n \"idJurisdiction\": 5,\n \"jurisdictionName\": \"Ireland\",\n \"description\": \"EU Drug Precursor Category 2B\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 169,\n \"codeName\": \"UN Precursor Table I\",\n \"idJurisdiction\": 15,\n \"jurisdictionName\": \"UN (INCB)\",\n \"description\": \"UN Precursor Table I\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 170,\n \"codeName\": \"UN Precursor Table II\",\n \"idJurisdiction\": 15,\n \"jurisdictionName\": \"UN (INCB)\",\n \"description\": \"UN Precursor Table II\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 176,\n \"codeName\": \"Swedish Hazardous Goods\",\n \"idJurisdiction\": 12,\n \"jurisdictionName\": \"Sweden\",\n \"description\": \"Swedish Hazardous Goods\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 123,\n \"codeName\": \"UN Narcotics Schedule I\",\n \"idJurisdiction\": 15,\n \"jurisdictionName\": \"UN (INCB)\",\n \"description\": \"UN Narcotics Schedule I\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 124,\n \"codeName\": \"UN Narcotics Schedule II\",\n \"idJurisdiction\": 15,\n \"jurisdictionName\": \"UN (INCB)\",\n \"description\": \"UN Narcotics Schedule II\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 125,\n \"codeName\": \"UN Narcotics Schedule III\",\n \"idJurisdiction\": 15,\n \"jurisdictionName\": \"UN (INCB)\",\n \"description\": \"UN Narcotics Schedule III\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 177,\n \"codeName\": \"UN Narcotics Schedule IV\",\n \"idJurisdiction\": 15,\n \"jurisdictionName\": \"UN (INCB)\",\n \"description\": \"UN Narcotics Schedule IV\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 178,\n \"codeName\": \"Indian Schedule A Precursor\",\n \"idJurisdiction\": 17,\n \"jurisdictionName\": \"India\",\n \"description\": \"Indian Schedule A Precursor\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 179,\n \"codeName\": \"Indian Schedule B Precursor\",\n \"idJurisdiction\": 17,\n \"jurisdictionName\": \"India\",\n \"description\": \"Indian Schedule B Precursor\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 180,\n \"codeName\": \"Indian Schedule C Precursor\",\n \"idJurisdiction\": 17,\n \"jurisdictionName\": \"India\",\n \"description\": \"Indian Schedule C Precursor\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 185,\n \"codeName\": \"CWC Schedule 1 A\",\n \"idJurisdiction\": 18,\n \"jurisdictionName\": \"Chemical Weapons Convention\",\n \"description\": \"Chemical Weapons Convention Schedule 1 A - Toxic chemicals\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 186,\n \"codeName\": \"CWC Schedule 1 B\",\n \"idJurisdiction\": 18,\n \"jurisdictionName\": \"Chemical Weapons Convention\",\n \"description\": \"Chemical Weapons Convention Schedule 1 B - Precursors\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 187,\n \"codeName\": \"CWC Schedule 2 A\",\n \"idJurisdiction\": 18,\n \"jurisdictionName\": \"Chemical Weapons Convention\",\n \"description\": \"Chemical Weapons Convention Schedule 2 A - Toxic chemicals\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 188,\n \"codeName\": \"CWC Schedule 2 B\",\n \"idJurisdiction\": 18,\n \"jurisdictionName\": \"Chemical Weapons Convention\",\n \"description\": \"Chemical Weapons Convention Schedule 2 B - Precursors\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 189,\n \"codeName\": \"CWC Schedule 3 A\",\n \"idJurisdiction\": 18,\n \"jurisdictionName\": \"Chemical Weapons Convention\",\n \"description\": \"Chemical Weapons Convention Schedule 3 A - Toxic chemicals\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 190,\n \"codeName\": \"CWC Schedule 3 B\",\n \"idJurisdiction\": 18,\n \"jurisdictionName\": \"Chemical Weapons Convention\",\n \"description\": \"Chemical Weapons Convention Schedule 3 B - Precursors\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 218,\n \"codeName\": \"UK EU Drug Precursor Category 2\",\n \"idJurisdiction\": 2,\n \"jurisdictionName\": \"United Kingdom\",\n \"description\": \"UK EU Drug Precursor Category 2\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 219,\n \"codeName\": \"US CCL RS\",\n \"idJurisdiction\": 3,\n \"jurisdictionName\": \"United States of America\",\n \"description\": \"CCL Regional Stability control code\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 182,\n \"codeName\": \"Indian NDPS Act – Psychotropic \",\n \"idJurisdiction\": 17,\n \"jurisdictionName\": \"India\",\n \"description\": \"Indian NDPS Act – Psychotropic \",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 183,\n \"codeName\": \"Indian NDPS Act – Narcotic \",\n \"idJurisdiction\": 17,\n \"jurisdictionName\": \"India\",\n \"description\": \"Indian NDPS Act – Narcotic \",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 184,\n \"codeName\": \"Indian NDPs Act – Manufactured Narcotic Drug \",\n \"idJurisdiction\": 17,\n \"jurisdictionName\": \"India\",\n \"description\": \"Indian NDPs Act – Manufactured Narcotic Drug \",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 191,\n \"codeName\": \"China Psychotropic Drugs - Category 1\",\n \"idJurisdiction\": 19,\n \"jurisdictionName\": \"China\",\n \"description\": \"精神药品品种目录第一类\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 192,\n \"codeName\": \"China Psychotropic Drugs - Category 2 \",\n \"idJurisdiction\": 19,\n \"jurisdictionName\": \"China\",\n \"description\": \"精神药品品种目录第二类\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 193,\n \"codeName\": \"China Anesthetic Drugs\",\n \"idJurisdiction\": 19,\n \"jurisdictionName\": \"China\",\n \"description\": \"麻醉药品品种目录\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 194,\n \"codeName\": \"China Precursors - Category 1\",\n \"idJurisdiction\": 19,\n \"jurisdictionName\": \"China\",\n \"description\": \"易制毒化学品的分类和品种目录第一类\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 195,\n \"codeName\": \"China Precursors - Category 2\",\n \"idJurisdiction\": 19,\n \"jurisdictionName\": \"China\",\n \"description\": \"易制毒化学品的分类和品种目录第二类\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 196,\n \"codeName\": \"China Precursors - Category 3\",\n \"idJurisdiction\": 19,\n \"jurisdictionName\": \"China\",\n \"description\": \"易制毒化学品的分类和品种目录第一类\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 197,\n \"codeName\": \"US CCL CB1\",\n \"idJurisdiction\": 3,\n \"jurisdictionName\": \"United States of America\",\n \"description\": \"CCL Chemical and Biological Weapons control code\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 198,\n \"codeName\": \"US CCL CB2\",\n \"idJurisdiction\": 3,\n \"jurisdictionName\": \"United States of America\",\n \"description\": \"CCL Chemical and Biological Weapons control code\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 199,\n \"codeName\": \"US CCL CB3\",\n \"idJurisdiction\": 3,\n \"jurisdictionName\": \"United States of America\",\n \"description\": \"CCL Chemical and Biological Weapons control code\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 200,\n \"codeName\": \"US CCL NP1\",\n \"idJurisdiction\": 3,\n \"jurisdictionName\": \"United States of America\",\n \"description\": \"CCL Nuclear non proliferation control code\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 201,\n \"codeName\": \"US CCL NP2\",\n \"idJurisdiction\": 3,\n \"jurisdictionName\": \"United States of America\",\n \"description\": \"CCL Nuclear non proliferation control code\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 202,\n \"codeName\": \"US CCL NS1\",\n \"idJurisdiction\": 3,\n \"jurisdictionName\": \"United States of America\",\n \"description\": \"CCL National Security control code\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 203,\n \"codeName\": \"US CCL NS2\",\n \"idJurisdiction\": 3,\n \"jurisdictionName\": \"United States of America\",\n \"description\": \"CCL National Security control code\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 204,\n \"codeName\": \"US CCL MT1\",\n \"idJurisdiction\": 3,\n \"jurisdictionName\": \"United States of America\",\n \"description\": \"CCL Missile Technology control code\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 205,\n \"codeName\": \"US CCL RS1\",\n \"idJurisdiction\": 3,\n \"jurisdictionName\": \"United States of America\",\n \"description\": \"CCL Regional Security control code\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 206,\n \"codeName\": \"US CCL RS2\",\n \"idJurisdiction\": 3,\n \"jurisdictionName\": \"United States of America\",\n \"description\": \"CCL Regional Security control code\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 207,\n \"codeName\": \"US CCL FC1\",\n \"idJurisdiction\": 3,\n \"jurisdictionName\": \"United States of America\",\n \"description\": \"CCL Firearms Convension control code\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 208,\n \"codeName\": \"US CCL CC1\",\n \"idJurisdiction\": 3,\n \"jurisdictionName\": \"United States of America\",\n \"description\": \"CCL Crime control code\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 209,\n \"codeName\": \"US CCL CC2\",\n \"idJurisdiction\": 3,\n \"jurisdictionName\": \"United States of America\",\n \"description\": \"CCL Crime control code\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 210,\n \"codeName\": \"US CCL CC3\",\n \"idJurisdiction\": 3,\n \"jurisdictionName\": \"United States of America\",\n \"description\": \"CCL Crime control code\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 211,\n \"codeName\": \"US CCL AT1\",\n \"idJurisdiction\": 3,\n \"jurisdictionName\": \"United States of America\",\n \"description\": \"CCL Anti Terrorism control code\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 212,\n \"codeName\": \"US CCL AT2\",\n \"idJurisdiction\": 3,\n \"jurisdictionName\": \"United States of America\",\n \"description\": \"CCL Anti Terrorism control code\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 213,\n \"codeName\": \"US ITAR PT 121 Category V\",\n \"idJurisdiction\": 3,\n \"jurisdictionName\": \"United States of America\",\n \"description\": \"EXPLOSIVES AND ENERGETIC MATERIALS, PROPELLANTS, INCENDIARY AGENTS AND THEIR CONSTITUENTS\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 214,\n \"codeName\": \"US ITAR PT 121 Category XIV\",\n \"idJurisdiction\": 3,\n \"jurisdictionName\": \"United States of America\",\n \"description\": \"TOXICOLOGICAL AGENTS, INCLUDING CHEMICAL AGENTS, BIOLOGICAL AGENTS, AND ASSOCIATED EQUIPMENT\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 215,\n \"codeName\": \"US CCL UN\",\n \"idJurisdiction\": 3,\n \"jurisdictionName\": \"United States of America\",\n \"description\": \"CCL United Nations Embargo control code\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 216,\n \"codeName\": \"US CCL CW\",\n \"idJurisdiction\": 3,\n \"jurisdictionName\": \"United States of America\",\n \"description\": \"CCL Chemical Weapons Convention control code\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 217,\n \"codeName\": \"US CCL AT\",\n \"idJurisdiction\": 3,\n \"jurisdictionName\": \"United States of America\",\n \"description\": \"CCL Anti Terrorism control code\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 227,\n \"codeName\": \"Australia Group CW Precursor\",\n \"idJurisdiction\": 20,\n \"jurisdictionName\": \"Australia Group\",\n \"description\": \"Australia Group Chemical Weapons Precursor\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 228,\n \"codeName\": \"EU Military List ML 7\",\n \"idJurisdiction\": 21,\n \"jurisdictionName\": \"European Union\",\n \"description\": \"European Union Military List ML 7\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 229,\n \"codeName\": \"EU Military List ML 8\",\n \"idJurisdiction\": 21,\n \"jurisdictionName\": \"European Union\",\n \"description\": \"European Union Military List ML 8\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 230,\n \"codeName\": \"Montreal Ozone Annex A, Group I\",\n \"idJurisdiction\": 22,\n \"jurisdictionName\": \"Montreal Ozone Protocol\",\n \"description\": \"Montreal Protocol on Substances that deplete the Ozone Layer Annex A, Group I control code\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 231,\n \"codeName\": \"Montreal Ozone Annex A, Group II\",\n \"idJurisdiction\": 22,\n \"jurisdictionName\": \"Montreal Ozone Protocol\",\n \"description\": \"Montreal Protocol on Substances that deplete the Ozone Layer Annex A, Group II control code\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 233,\n \"codeName\": \"Montreal Ozone Annex B, Group II\",\n \"idJurisdiction\": 22,\n \"jurisdictionName\": \"Montreal Ozone Protocol\",\n \"description\": \"Montreal Protocol on Substances that deplete the Ozone Layer Annex B, Group II control code\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 232,\n \"codeName\": \"Montreal Ozone Annex B, Group I\",\n \"idJurisdiction\": 22,\n \"jurisdictionName\": \"Montreal Ozone Protocol\",\n \"description\": \"Montreal Protocol on Substances that deplete the Ozone Layer Annex B, Group I control code\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 235,\n \"codeName\": \"Montreal Ozone Annex C, Group I\",\n \"idJurisdiction\": 22,\n \"jurisdictionName\": \"Montreal Ozone Protocol\",\n \"description\": \"Montreal Protocol on Substances that deplete the Ozone Layer Annex C, Group I control code\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 236,\n \"codeName\": \"Montreal Ozone Annex C, Group II\",\n \"idJurisdiction\": 22,\n \"jurisdictionName\": \"Montreal Ozone Protocol\",\n \"description\": \"Montreal Protocol on Substances that deplete the Ozone Layer Annex C, Group II control code\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 234,\n \"codeName\": \"Montreal Ozone Annex B, Group III\",\n \"idJurisdiction\": 22,\n \"jurisdictionName\": \"Montreal Ozone Protocol\",\n \"description\": \"Montreal Protocol on Substances that deplete the Ozone Layer Annex B, Group III control code\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 238,\n \"codeName\": \"Montreal Ozone Annex E, Group I\",\n \"idJurisdiction\": 22,\n \"jurisdictionName\": \"Montreal Ozone Protocol\",\n \"description\": \"Montreal Protocol on Substances that deplete the Ozone Layer Annex E, Group I control code\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 237,\n \"codeName\": \"Montreal Ozone Annex C, Group III\",\n \"idJurisdiction\": 22,\n \"jurisdictionName\": \"Montreal Ozone Protocol\",\n \"description\": \"Montreal Protocol on Substances that deplete the Ozone Layer Annex C, Group III control code\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 246,\n \"codeName\": \"French EU Drug Precursor Category 2\",\n \"idJurisdiction\": 4,\n \"jurisdictionName\": \"France\",\n \"description\": \"EU Drug Precursor Category 2\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 264,\n \"codeName\": \"Austria EU Drug Precursor Category 1\",\n \"idJurisdiction\": 23,\n \"jurisdictionName\": \"Austria\",\n \"description\": \"EU Drug Precursor Category 1\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 265,\n \"codeName\": \"Austria EU Drug Precursor Category 2\",\n \"idJurisdiction\": 23,\n \"jurisdictionName\": \"Austria\",\n \"description\": \"EU Drug Precursor Category 2\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 266,\n \"codeName\": \"Austria EU Drug Precursor Category 2A\",\n \"idJurisdiction\": 23,\n \"jurisdictionName\": \"Austria\",\n \"description\": \"EU Drug Precursor Category 2A\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 267,\n \"codeName\": \"Austria EU Drug Precursor Category 3\",\n \"idJurisdiction\": 23,\n \"jurisdictionName\": \"Austria\",\n \"description\": \"EU Drug Precursor Category 3\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 268,\n \"codeName\": \"Austria EU Drug Precursor Category 4\",\n \"idJurisdiction\": 23,\n \"jurisdictionName\": \"Austria\",\n \"description\": \"EU Drug Precursor Category 4\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 269,\n \"codeName\": \"Austria EU Drug Precursor Category 2B\",\n \"idJurisdiction\": 23,\n \"jurisdictionName\": \"Austria\",\n \"description\": \"Austria EU Drug Precursor Category 2B\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 271,\n \"codeName\": \"EU Human Rights List Annex III\",\n \"idJurisdiction\": 21,\n \"jurisdictionName\": \"European Union\",\n \"description\": \"EU Human Rights List Annex III\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 239,\n \"codeName\": \"Swedish Toxic Group A\",\n \"idJurisdiction\": 12,\n \"jurisdictionName\": \"Sweden\",\n \"description\": \"Swedish Toxic Group A\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 240,\n \"codeName\": \"Swedish Toxic Group B\",\n \"idJurisdiction\": 12,\n \"jurisdictionName\": \"Sweden\",\n \"description\": \"Swedish Toxic Group B\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 241,\n \"codeName\": \"Swedish EU Drug Precursor Category 2\",\n \"idJurisdiction\": 12,\n \"jurisdictionName\": \"Sweden\",\n \"description\": \"Swedish EU Drug Precursor Category 2\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 242,\n \"codeName\": \"Belgium EU Drug Precursor Category 2\",\n \"idJurisdiction\": 6,\n \"jurisdictionName\": \"Belgium\",\n \"description\": \"Belgium EU Drug Precursor Category 2\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 243,\n \"codeName\": \"German EU Drug Precursor Category 2\",\n \"idJurisdiction\": 8,\n \"jurisdictionName\": \"Germany\",\n \"description\": \"German EU Drug Precursor Category 2\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 244,\n \"codeName\": \"Danish EU Drug Precursor Category 2\",\n \"idJurisdiction\": 7,\n \"jurisdictionName\": \"Denmark\",\n \"description\": \"Danish EU Drug Precursor Category 2\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 245,\n \"codeName\": \"Irish EU Drug Precursor Category 2\",\n \"idJurisdiction\": 5,\n \"jurisdictionName\": \"Ireland\",\n \"description\": \"Irish EU Drug Precursor Category 2\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 247,\n \"codeName\": \"Netherlands EU Drug Precursor Category 2\",\n \"idJurisdiction\": 10,\n \"jurisdictionName\": \"Netherlands\",\n \"description\": \"Netherlands EU Drug Precursor Category 2\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 248,\n \"codeName\": \"Italian EU Drug Precursor Category 2\",\n \"idJurisdiction\": 9,\n \"jurisdictionName\": \"Italy\",\n \"description\": \"Italian EU Drug Precursor Category 2\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 249,\n \"codeName\": \"Spanish EU Drug Precursor Category 2\",\n \"idJurisdiction\": 11,\n \"jurisdictionName\": \"Spain\",\n \"description\": \"Spanish EU Drug Precursor Category 2\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 250,\n \"codeName\": \"Indian NDPS Rules Schedule I (I Narcotics)\",\n \"idJurisdiction\": 17,\n \"jurisdictionName\": \"India\",\n \"description\": \"Indian NDPS Rules Schedule I (I Narcotics)\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 251,\n \"codeName\": \"Indian NDPS Rules Schedule I (II Psychotrps)\",\n \"idJurisdiction\": 17,\n \"jurisdictionName\": \"India\",\n \"description\": \"Indian NDPS Rules Schedule I (II Psychotrps)\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 252,\n \"codeName\": \"Indian NDPS Rules Schedule II\",\n \"idJurisdiction\": 17,\n \"jurisdictionName\": \"India\",\n \"description\": \"Indian NDPS Rules Schedule II\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 253,\n \"codeName\": \"Indian NDPS Rules Schedule III (Psychotrps)\",\n \"idJurisdiction\": 17,\n \"jurisdictionName\": \"India\",\n \"description\": \"Indian NDPS Rules Schedule III (Psychotrps)\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 254,\n \"codeName\": \"EU Dual Use Items - Category 1C (Materials)\",\n \"idJurisdiction\": 21,\n \"jurisdictionName\": \"European Union\",\n \"description\": \"EU Dual Use Items - Category 1C (Materials)\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 255,\n \"codeName\": \"Austrian Narcotics Annex I.1\",\n \"idJurisdiction\": 23,\n \"jurisdictionName\": \"Austria\",\n \"description\": \"Austrian Narcotics Annex I.1\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 256,\n \"codeName\": \"Austrian Narcotics Annex I.2\",\n \"idJurisdiction\": 23,\n \"jurisdictionName\": \"Austria\",\n \"description\": \"Austrian Narcotics Annex I.2\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 257,\n \"codeName\": \"Austrian Narcotics Annex II\",\n \"idJurisdiction\": 23,\n \"jurisdictionName\": \"Austria\",\n \"description\": \"Austrian Narcotics Annex II\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 258,\n \"codeName\": \"Austrian Narcotics Annex III\",\n \"idJurisdiction\": 23,\n \"jurisdictionName\": \"Austria\",\n \"description\": \"Austrian Narcotics Annex III\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 259,\n \"codeName\": \"Austrian Narcotics Annex IV.1\",\n \"idJurisdiction\": 23,\n \"jurisdictionName\": \"Austria\",\n \"description\": \"Austrian Narcotics Annex IV.1\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 260,\n \"codeName\": \"Austrian Narcotics Annex IV.2\",\n \"idJurisdiction\": 23,\n \"jurisdictionName\": \"Austria\",\n \"description\": \"Austrian Narcotics Annex IV.2\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 261,\n \"codeName\": \"Austrian Narcotics Annex V.1\",\n \"idJurisdiction\": 23,\n \"jurisdictionName\": \"Austria\",\n \"description\": \"Austrian Narcotics Annex V.1\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 262,\n \"codeName\": \"Austrian Narcotics Annex V.2\",\n \"idJurisdiction\": 23,\n \"jurisdictionName\": \"Austria\",\n \"description\": \"Austrian Narcotics Annex V.2\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 263,\n \"codeName\": \"Austrian Psychotropics\",\n \"idJurisdiction\": 23,\n \"jurisdictionName\": \"Austria\",\n \"description\": \"Austrian Psychotropics\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 270,\n \"codeName\": \"UK Dual Use List Materials,Micro-orgs,Toxins\",\n \"idJurisdiction\": 2,\n \"jurisdictionName\": \"United Kingdom\",\n \"description\": \"UK Dual Use List Materials, Micro-organisms and toxins\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 272,\n \"codeName\": \"UK Human Rights – Prohibited Medical Prods\",\n \"idJurisdiction\": 2,\n \"jurisdictionName\": \"United Kingdom\",\n \"description\": \"UK Security and Human Rights - Prohibited Medicinal Products\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 273,\n \"codeName\": \"UK Controlled Radioactive Sources\",\n \"idJurisdiction\": 2,\n \"jurisdictionName\": \"United Kingdom\",\n \"description\": \"UK Radioactive Sources List\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 274,\n \"codeName\": \"China Non-medical Narcotics and Psychotropics\",\n \"idJurisdiction\": 19,\n \"jurisdictionName\": \"China\",\n \"description\": \"非药用类麻醉药品和精神药品管制品种增补目录\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 275,\n \"codeName\": \"Japanese Table I Narcotics\",\n \"idJurisdiction\": 24,\n \"jurisdictionName\": \"Japan\",\n \"description\": \"Narcotics and Psychotropics Control Law - Article 2 Table I Narcotics 第2条表I麻薬 - 麻薬及び向精神薬取締法 \",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 276,\n \"codeName\": \"Japanese Table II Narcotics Plants\",\n \"idJurisdiction\": 24,\n \"jurisdictionName\": \"Japan\",\n \"description\": \"Narcotics and Psychotropics Control Law - Article 2 Table II Narcotics Plants 第2条表II麻薬プラント - 麻薬及び向精神薬取締法 \",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 277,\n \"codeName\": \"Japanese Table III Psychotropics\",\n \"idJurisdiction\": 24,\n \"jurisdictionName\": \"Japan\",\n \"description\": \"Narcotics and Psychotropics Control Law - Article 2 Table III Psychotropics 第2条表III 向精神薬 - 麻薬及び向精神薬取締法 \",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 278,\n \"codeName\": \"Japanese Table IV Drug Raw Materials\",\n \"idJurisdiction\": 24,\n \"jurisdictionName\": \"Japan\",\n \"description\": \"Narcotics and Psychotropics Control Law - Table IV Precursors (Raw Materials) 麻薬原料\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 279,\n \"codeName\": \"Japanese Designated Substance\",\n \"idJurisdiction\": 24,\n \"jurisdictionName\": \"Japan\",\n \"description\": \"Designated substances according to the Pharmaceutical and Medical Device Act. 医薬品、医療機器等の品質、有効性及び安全性の確保等に関する法律指定薬物\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 280,\n \"codeName\": \"Japanese Poisonous Substances\",\n \"idJurisdiction\": 24,\n \"jurisdictionName\": \"Japan\",\n \"description\": \"Poisonous according to the Poisonous and Deleterious Substances Control Law 毒物 - 毒物及び劇物取締法\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 281,\n \"codeName\": \"Japanese Deleterious Substances\",\n \"idJurisdiction\": 24,\n \"jurisdictionName\": \"Japan\",\n \"description\": \"Deleterious Substances according to the Poisonous and Deleterious Substances Control Law 劇物 - 毒物及び劇物取締法\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 282,\n \"codeName\": \"Japanese Specific Poisonous Substances\",\n \"idJurisdiction\": 24,\n \"jurisdictionName\": \"Japan\",\n \"description\": \"Specific Poisonous Substances according to the Poisonous and Deleterious Substances Control Law 特定毒物 - 毒物及び劇物取締法\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 283,\n \"codeName\": \"Japanese Stimulants Raw Materials\",\n \"idJurisdiction\": 24,\n \"jurisdictionName\": \"Japan\",\n \"description\": \"\\rStimulants Raw Material 覚せい剤取締法 \\r\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 284,\n \"codeName\": \"Japanese Table I Narcotics Similar\",\n \"idJurisdiction\": 24,\n \"jurisdictionName\": \"Japan\",\n \"description\": \"Narcotics and Psychotropics Control Law - Article 2 Table I Narcotics 第1条表I麻薬 - 麻薬及び向精神薬取締法 \",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 285,\n \"codeName\": \"Japanese Table III Psychotropics Similar\",\n \"idJurisdiction\": 24,\n \"jurisdictionName\": \"Japan\",\n \"description\": \"Narcotics and Psychotropics Control Law Article 3, Division 1. 麻薬、麻薬原料植物、向精神薬及び麻薬向精神薬原料を指定する政令（第3条関係）第1種\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 286,\n \"codeName\": \"Japanese Article 3 Division 2 Psychotropics\",\n \"idJurisdiction\": 24,\n \"jurisdictionName\": \"Japan\",\n \"description\": \"Not used\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 287,\n \"codeName\": \"Japanese Article 3 Division 3 Psychotropics\",\n \"idJurisdiction\": 24,\n \"jurisdictionName\": \"Japan\",\n \"description\": \"Not used\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 288,\n \"codeName\": \"Japanese Opium Law\",\n \"idJurisdiction\": 24,\n \"jurisdictionName\": \"Japan\",\n \"description\": \"Japanese Opium Law (あへん法)\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 289,\n \"codeName\": \"Japanese Cannabis Control Law\",\n \"idJurisdiction\": 24,\n \"jurisdictionName\": \"Japan\",\n \"description\": \"Japanese Cannabis Control Law (大麻取締法)\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 290,\n \"codeName\": \"Japanese Stimulants Law\",\n \"idJurisdiction\": 24,\n \"jurisdictionName\": \"Japan\",\n \"description\": \"Japanese Stimulants Law 覚せい剤取締法 \\n\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 291,\n \"codeName\": \"US CWC Precursors\",\n \"idJurisdiction\": 3,\n \"jurisdictionName\": \"United States of America\",\n \"description\": \"This is a CS2 generated control code to enable CS2 to flag CWC and Australia Group precursors enacted in US CCL and ITAR legislation as precursors\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 292,\n \"codeName\": \"EU CWC Precursors\",\n \"idJurisdiction\": 21,\n \"jurisdictionName\": \"European Union\",\n \"description\": \"This is a CS2 generated control code to enable CS2 to flag CWC and Australia Group precursors enacted in the EU Military List and EU Dual Use legislation as precursors.\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 293,\n \"codeName\": \"UK 3rd Generation Cannabinoid\",\n \"idJurisdiction\": 2,\n \"jurisdictionName\": \"United Kingdom\",\n \"description\": \"This a CS2 generated control code to enable CS2 to specifically flag 3rd generation cannabinoids, allowing them to be filtered by donwstream systems for special handling\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 294,\n \"codeName\": \"Spanish National Level Narcotic\",\n \"idJurisdiction\": 11,\n \"jurisdictionName\": \"Spain\",\n \"description\": \"These are considered controlled narcotics and are not on the UN Yellow List\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 295,\n \"codeName\": \"Montreal Ozone Annex F, Group I\",\n \"idJurisdiction\": 22,\n \"jurisdictionName\": \"Montreal Ozone Protocol\",\n \"description\": \"Montreal Protocol on Substances that deplete the Ozone Layer Annex F, Group I control code\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 296,\n \"codeName\": \"Montreal Ozone Annex F, Group II\",\n \"idJurisdiction\": 22,\n \"jurisdictionName\": \"Montreal Ozone Protocol\",\n \"description\": \"Montreal Protocol on Substances that deplete the Ozone Layer Annex F, Group II control code\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 297,\n \"codeName\": \"Irish Schedule 8 pt5\",\n \"idJurisdiction\": 5,\n \"jurisdictionName\": \"Ireland\",\n \"description\": \"Drugs for use in mental health or intellectual disbaility\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 298,\n \"codeName\": \"Belgium Annex IA\",\n \"idJurisdiction\": 6,\n \"jurisdictionName\": \"Belgium\",\n \"description\": \"Belgium Annex IA\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 299,\n \"codeName\": \"Belgium Annex IB\",\n \"idJurisdiction\": 6,\n \"jurisdictionName\": \"Belgium\",\n \"description\": \"Belgium Annex IB\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 300,\n \"codeName\": \"Belgium Annex IIA\",\n \"idJurisdiction\": 6,\n \"jurisdictionName\": \"Belgium\",\n \"description\": \"Belgium Annex IIA\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 301,\n \"codeName\": \"Belgium Annex IIB\",\n \"idJurisdiction\": 6,\n \"jurisdictionName\": \"Belgium\",\n \"description\": \"Belgium Annex IIB\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 302,\n \"codeName\": \"Belgium Annex IIC\",\n \"idJurisdiction\": 6,\n \"jurisdictionName\": \"Belgium\",\n \"description\": \"Belgium Annex IIC\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 303,\n \"codeName\": \"Belgium Annex III\",\n \"idJurisdiction\": 6,\n \"jurisdictionName\": \"Belgium\",\n \"description\": \"Belgium Annex III\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 304,\n \"codeName\": \"Belgium Annex IVB\",\n \"idJurisdiction\": 6,\n \"jurisdictionName\": \"Belgium\",\n \"description\": \"Belgium Annex IVB\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 305,\n \"codeName\": \"Belgium Annex IVA\",\n \"idJurisdiction\": 6,\n \"jurisdictionName\": \"Belgium\",\n \"description\": \"Belgium Annex IVA\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 306,\n \"codeName\": \"Belgium Annex IC\",\n \"idJurisdiction\": 6,\n \"jurisdictionName\": \"Belgium\",\n \"description\": \"Belgium Annex IC\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 307,\n \"codeName\": \"Belgium Annex V\",\n \"idJurisdiction\": 6,\n \"jurisdictionName\": \"Belgium\",\n \"description\": \"Belgium Annex V\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 308,\n \"codeName\": \"EU Controlled Psychoactive Substance\",\n \"idJurisdiction\": 21,\n \"jurisdictionName\": \"European Union\",\n \"description\": \"EU Controlled Psychoactive Substance\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 309,\n \"codeName\": \"Singapore Regulations First Schedule\",\n \"idJurisdiction\": 25,\n \"jurisdictionName\": \"Singapore\",\n \"description\": \"Singapore Regulations First Schedule\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 310,\n \"codeName\": \"Singapore Regulations Second Schedule\",\n \"idJurisdiction\": 25,\n \"jurisdictionName\": \"Singapore\",\n \"description\": \"Singapore Regulations Second Schedule\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 311,\n \"codeName\": \"Singapore Regulations Third Schedule\",\n \"idJurisdiction\": 25,\n \"jurisdictionName\": \"Singapore\",\n \"description\": \"Singapore Regulations Third Schedule\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 312,\n \"codeName\": \"Singapore Regulations Fourth Schedule\",\n \"idJurisdiction\": 25,\n \"jurisdictionName\": \"Singapore\",\n \"description\": \"Singapore Regulations Fourth Schedule\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 313,\n \"codeName\": \"Singapore Class A\",\n \"idJurisdiction\": 25,\n \"jurisdictionName\": \"Singapore\",\n \"description\": \"Singapore Class A\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 314,\n \"codeName\": \"Singapore Class B\",\n \"idJurisdiction\": 25,\n \"jurisdictionName\": \"Singapore\",\n \"description\": \"Singapore Class B\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 316,\n \"codeName\": \"Singapore Specified Drug\",\n \"idJurisdiction\": 25,\n \"jurisdictionName\": \"Singapore\",\n \"description\": \"Singapore Specified Drug\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 315,\n \"codeName\": \"Singapore Class C\",\n \"idJurisdiction\": 25,\n \"jurisdictionName\": \"Singapore\",\n \"description\": \"Singapore Class C\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 317,\n \"codeName\": \"Singapore Temporarily Listed Drugs\",\n \"idJurisdiction\": 25,\n \"jurisdictionName\": \"Singapore\",\n \"description\": \"Singapore Temporarily Listed Drugs\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 318,\n \"codeName\": \"Singapore Precursors Part I\",\n \"idJurisdiction\": 25,\n \"jurisdictionName\": \"Singapore\",\n \"description\": \"Singapore Substances useful for Manufacturing Controlled Drugs Part 1\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 319,\n \"codeName\": \"Singapore Precursors Part II\",\n \"idJurisdiction\": 25,\n \"jurisdictionName\": \"Singapore\",\n \"description\": \"Singapore Substances useful for Manufacturing Controlled Drugs Part II\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 320,\n \"codeName\": \"Mexican Narcotics\",\n \"idJurisdiction\": 26,\n \"jurisdictionName\": \"Mexico\",\n \"description\": \"Mexican Narcotic Substances\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 321,\n \"codeName\": \"Mexican Psychotropics Group 1\",\n \"idJurisdiction\": 26,\n \"jurisdictionName\": \"Mexico\",\n \"description\": \"Mexican Psychotropic Substances Group 1\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 322,\n \"codeName\": \"Mexican Psychotropics Group 2\",\n \"idJurisdiction\": 26,\n \"jurisdictionName\": \"Mexico\",\n \"description\": \"Mexican Psychotropic Substances Group 2\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 323,\n \"codeName\": \"Mexican Psychotropics Group 3\",\n \"idJurisdiction\": 26,\n \"jurisdictionName\": \"Mexico\",\n \"description\": \"Mexican Psychotropic Substances Group 3\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 324,\n \"codeName\": \"Mexican Psychotropics Group 4\",\n \"idJurisdiction\": 26,\n \"jurisdictionName\": \"Mexico\",\n \"description\": \"Mexican Psychotropic Substances Group 4\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 325,\n \"codeName\": \"Mexican Psychotropics Group 5\",\n \"idJurisdiction\": 26,\n \"jurisdictionName\": \"Mexico\",\n \"description\": \"Mexican Psychotropic Substances Group 5\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 326,\n \"codeName\": \"Mexican Chemical Precursors List I\",\n \"idJurisdiction\": 26,\n \"jurisdictionName\": \"Mexico\",\n \"description\": \"Mexican Chemical Precursors List I (Chemical Precursors)\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 327,\n \"codeName\": \"Mexican Chemical Precursors List II\",\n \"idJurisdiction\": 26,\n \"jurisdictionName\": \"Mexico\",\n \"description\": \"Mexican Chemical Precursors List II (Essential Chemicals)\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 328,\n \"codeName\": \"Singapore Psychotropic Substance\",\n \"idJurisdiction\": 25,\n \"jurisdictionName\": \"Singapore\",\n \"description\": \"Singapore Psychotropic Substance\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 329,\n \"codeName\": \"Brazilian List A1\",\n \"idJurisdiction\": 27,\n \"jurisdictionName\": \"Brazil\",\n \"description\": \"Brazilian List A1 (Narcotic Substances subject to Revenue Notification A)\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 330,\n \"codeName\": \"Brazilian List A2\",\n \"idJurisdiction\": 27,\n \"jurisdictionName\": \"Brazil\",\n \"description\": \"Brazilian List A2 (Narcotic Substances permitted for use in special concentrations and subject to Revenue Notification A)\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 331,\n \"codeName\": \"Brazilian List A3\",\n \"idJurisdiction\": 27,\n \"jurisdictionName\": \"Brazil\",\n \"description\": \"Brazilian List A3 (Psychotropic Substances subject to Revenue Notification A)\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 332,\n \"codeName\": \"Brazilian List B1\",\n \"idJurisdiction\": 27,\n \"jurisdictionName\": \"Brazil\",\n \"description\": \"Brazilian List B1 (Psychotropic Substances subject to Revenue Notification B)\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 333,\n \"codeName\": \"Brazilian List B2\",\n \"idJurisdiction\": 27,\n \"jurisdictionName\": \"Brazil\",\n \"description\": \"Brazilian List B2 (Anorectic Psychotropic Substances subject to Revenue Notification B)\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 334,\n \"codeName\": \"Brazilian List C1\",\n \"idJurisdiction\": 27,\n \"jurisdictionName\": \"Brazil\",\n \"description\": \"Brazilian List C1 (Other Substances under special control and subject to two-way Special Control Revenue)\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 335,\n \"codeName\": \"Brazilian List C2\",\n \"idJurisdiction\": 27,\n \"jurisdictionName\": \"Brazil\",\n \"description\": \"Brazilian List C2 (Retinoic Substances which are subject to Special Revenue Notification)\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 336,\n \"codeName\": \"Brazilian List C3\",\n \"idJurisdiction\": 27,\n \"jurisdictionName\": \"Brazil\",\n \"description\": \"Brazilian List C3 (Immunosuppressant Substances which are subject to Special Revenue Notification)\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 380,\n \"codeName\": \"Finnish EU Drug Precursor Category 1\",\n \"idJurisdiction\": 29,\n \"jurisdictionName\": \"Finland\",\n \"description\": \"EU Drug Precursor Category 1\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 381,\n \"codeName\": \"Finnish EU Drug Precursor Category 2\",\n \"idJurisdiction\": 29,\n \"jurisdictionName\": \"Finland\",\n \"description\": \"EU Drug Precursor Category 2\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 382,\n \"codeName\": \"Finnish EU Drug Precursor Category 2A\",\n \"idJurisdiction\": 29,\n \"jurisdictionName\": \"Finland\",\n \"description\": \"EU Drug Precursor Category 2A\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 383,\n \"codeName\": \"Finnish EU Drug Precursor Category 2B\",\n \"idJurisdiction\": 29,\n \"jurisdictionName\": \"Finland\",\n \"description\": \"EU Drug Precursor Category 2B\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 384,\n \"codeName\": \"Finnish EU Drug Precursor Category 3\",\n \"idJurisdiction\": 29,\n \"jurisdictionName\": \"Finland\",\n \"description\": \"EU Drug Precursor Category 3\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 385,\n \"codeName\": \"Finnish EU Drug Precursor Category 4\",\n \"idJurisdiction\": 29,\n \"jurisdictionName\": \"Finland\",\n \"description\": \"EU Drug Precursor Category 4\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 353,\n \"codeName\": \"Polish EU Drug Precursor Category 1\",\n \"idJurisdiction\": 28,\n \"jurisdictionName\": \"Poland\",\n \"description\": \"Polish EU Drug Precursor Category 1\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 354,\n \"codeName\": \"Polish EU Drug Precursor Category 2\",\n \"idJurisdiction\": 28,\n \"jurisdictionName\": \"Poland\",\n \"description\": \"Polish EU Drug Precursor Category 2\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 355,\n \"codeName\": \"Polish EU Drug Precursor Category 2A\",\n \"idJurisdiction\": 28,\n \"jurisdictionName\": \"Poland\",\n \"description\": \"Polish EU Drug Precursor Category 2A\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 356,\n \"codeName\": \"Polish EU Drug Precursor Category 2B\",\n \"idJurisdiction\": 28,\n \"jurisdictionName\": \"Poland\",\n \"description\": \"Polish EU Drug Precursor Category 2B\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 357,\n \"codeName\": \"Polish EU Drug Precursor Category 3 \",\n \"idJurisdiction\": 28,\n \"jurisdictionName\": \"Poland\",\n \"description\": \"Polish EU Drug Precursor Category 3\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 358,\n \"codeName\": \"Polish EU Drug Precursor Category 4\",\n \"idJurisdiction\": 28,\n \"jurisdictionName\": \"Poland\",\n \"description\": \"Polish EU Drug Precursor Category 4\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 337,\n \"codeName\": \"Brazilian List C5\",\n \"idJurisdiction\": 27,\n \"jurisdictionName\": \"Brazil\",\n \"description\": \"Brazilian List C5 (Anabolic Substances which are subject to two-way Special Control Revenue)\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 338,\n \"codeName\": \"Brazilian List D1\",\n \"idJurisdiction\": 27,\n \"jurisdictionName\": \"Brazil\",\n \"description\": \"Brazilian List D1 (Precursor Substances for narcotics and/or psychotropics, which are subject to Non-Retention Medical Revenue)\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 339,\n \"codeName\": \"Brazilian List D2\",\n \"idJurisdiction\": 27,\n \"jurisdictionName\": \"Brazil\",\n \"description\": \"Brazilian List D2 (Chemical Inputs in manufacturing and synthesis of narcotics and/or psychotropic substances which are subject to the control of the Ministry of Justice)\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 340,\n \"codeName\": \"Brazilian List E\",\n \"idJurisdiction\": 27,\n \"jurisdictionName\": \"Brazil\",\n \"description\": \"Brazilian List E (Proscribed plants from which narcotics and/or psychotropics originate)\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 341,\n \"codeName\": \"Brazilian List F1\",\n \"idJurisdiction\": 27,\n \"jurisdictionName\": \"Brazil\",\n \"description\": \"Brazilian List F1 (List F is reserved for substances which are prohibited in Brazil. List F1 is for narcotic substances)\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 342,\n \"codeName\": \"Brazilian List F2\",\n \"idJurisdiction\": 27,\n \"jurisdictionName\": \"Brazil\",\n \"description\": \"Brazilian List F2 (List F is reserved for substances which are prohibited in Brazil. List F2a is for psychotropic substances. List F2b and F2c contain the cannabinoid and cathinone Markush definitions, respectively.)\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 343,\n \"codeName\": \"Brazilian List F3\",\n \"idJurisdiction\": 27,\n \"jurisdictionName\": \"Brazil\",\n \"description\": \"Brazilian List F3 (List F is reserved for substances which are prohibited in Brazil. List F3 is reserved for precursor substances)\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 344,\n \"codeName\": \"Brazilian List F4\",\n \"idJurisdiction\": 27,\n \"jurisdictionName\": \"Brazil\",\n \"description\": \"Brazilian List F4 (List F is reserved for substances which are prohibited in Brazil. List F4 is reserved for other substances)\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 361,\n \"codeName\": \"NOT-IN-USE-REUSE THIS IDSYS_CONTROLLEDCODE\",\n \"idJurisdiction\": 19,\n \"jurisdictionName\": \"China\",\n \"description\": \"NOT-IN-USE-REUSE THIS IDSYS_CONTROLLEDCODE - edit all fields including IDJurisdiction\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 362,\n \"codeName\": \"Annex 1 List I\",\n \"idJurisdiction\": 29,\n \"jurisdictionName\": \"Finland\",\n \"description\": \"List of the 1961 Convention on Drugs I (Vuoden 1961 huumausaineyleissopimuksen lista I)\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 363,\n \"codeName\": \"Annex 1 List II\",\n \"idJurisdiction\": 29,\n \"jurisdictionName\": \"Finland\",\n \"description\": \"List of the 1961 Convention on Drugs II (Vuoden 1961 huumausaineyleissopimuksen lista II)\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 364,\n \"codeName\": \"Annex 1 List III\",\n \"idJurisdiction\": 29,\n \"jurisdictionName\": \"Finland\",\n \"description\": \"List of the 1961 Convention on Drugs III (Vuoden 1961 huumausaineyleissopimuksen lista III)\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 365,\n \"codeName\": \"Annex 1 List IV\",\n \"idJurisdiction\": 29,\n \"jurisdictionName\": \"Finland\",\n \"description\": \"List of the 1961 Convention on Drugs IV (Vuoden 1961 huumausaineyleissopimuksen lista IV)\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 366,\n \"codeName\": \"Annex 2 List I\",\n \"idJurisdiction\": 29,\n \"jurisdictionName\": \"Finland\",\n \"description\": \"List of the 1971 Convention on Psychotropic Substances I (Psykotrooppisia aineita koskevan yleissopimuksen lista I)\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 367,\n \"codeName\": \"Annex 2 List II\",\n \"idJurisdiction\": 29,\n \"jurisdictionName\": \"Finland\",\n \"description\": \"List of the 1971 Convention on Psychotropic Substances II (Psykotrooppisia aineita koskevan yleissopimuksen lista II)\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 368,\n \"codeName\": \"Annex 2 List III\",\n \"idJurisdiction\": 29,\n \"jurisdictionName\": \"Finland\",\n \"description\": \"List of the 1971 Convention on Psychotropic Substances III (Psykotrooppisia aineita koskevan yleissopimuksen lista III)\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 369,\n \"codeName\": \"Annex 2 List IV\",\n \"idJurisdiction\": 29,\n \"jurisdictionName\": \"Finland\",\n \"description\": \"List of the 1971 Convention on Psychotropic Substances IV (Psykotrooppisia aineita koskevan yleissopimuksen lista IV)\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 370,\n \"codeName\": \"Annex 3\",\n \"idJurisdiction\": 29,\n \"jurisdictionName\": \"Finland\",\n \"description\": \"Substances subject to surveillance under Council Decisions adopted under Joint Action 97/396 / JHA on new synthetic drugs or Decision 2005/387 / JHA on the exchange, risk assessment and control of new psychoactive substances:\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 371,\n \"codeName\": \"Annex 4\",\n \"idJurisdiction\": 29,\n \"jurisdictionName\": \"Finland\",\n \"description\": \"Annex 4 substances\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 372,\n \"codeName\": \"Psychoactive Substances Appendix\",\n \"idJurisdiction\": 29,\n \"jurisdictionName\": \"Finland\",\n \"description\": \"Substances list under Government Decree on Psychoactive Substances as Banned from the Consumer Market\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 360,\n \"codeName\": \"Polish New Psychotropic Substances\",\n \"idJurisdiction\": 28,\n \"jurisdictionName\": \"Poland\",\n \"description\": \"Polish New Psychotropic Substances (Nowych substancji psychoaktywnych)\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 373,\n \"codeName\": \"Schedule 1 Controlled Drugs \",\n \"idJurisdiction\": 30,\n \"jurisdictionName\": \"Taiwan\",\n \"description\": \"Schedule 1 Controlled Drugs 第一級管制藥品\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 374,\n \"codeName\": \"Schedule 2 Controlled Drugs \",\n \"idJurisdiction\": 30,\n \"jurisdictionName\": \"Taiwan\",\n \"description\": \"Schedule 2 Controlled Drugs 第二級管制藥品\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 375,\n \"codeName\": \"Schedule 3 Controlled Drugs \",\n \"idJurisdiction\": 30,\n \"jurisdictionName\": \"Taiwan\",\n \"description\": \"Schedule 3 Controlled Drugs 第三級管制藥品\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 376,\n \"codeName\": \"Schedule 4 Controlled Drugs \",\n \"idJurisdiction\": 30,\n \"jurisdictionName\": \"Taiwan\",\n \"description\": \"Schedule 4 Controlled Drugs 第四級管制藥品\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 377,\n \"codeName\": \"Schedule 4 Controlled Drug Materials\",\n \"idJurisdiction\": 30,\n \"jurisdictionName\": \"Taiwan\",\n \"description\": \"Schedule 4 Controlled Drug Materials 第四級管制藥品原料藥\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 378,\n \"codeName\": \"Table I – Category A\",\n \"idJurisdiction\": 30,\n \"jurisdictionName\": \"Taiwan\",\n \"description\": \"Table I – Category A 一、甲類\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 379,\n \"codeName\": \"Table 2 – Category B\",\n \"idJurisdiction\": 30,\n \"jurisdictionName\": \"Taiwan\",\n \"description\": \"Table 2 – Category B 二、乙類\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 359,\n \"codeName\": \"EU Human Rights List Annex IV\",\n \"idJurisdiction\": 21,\n \"jurisdictionName\": \"European Union\",\n \"description\": \"EU Human Rights List Annex IV\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 345,\n \"codeName\": \"Polish Narcotic drugs I-N\",\n \"idJurisdiction\": 28,\n \"jurisdictionName\": \"Poland\",\n \"description\": \"Polish Narcotic drugs Group 1 (Środki odurzające grupy I-N)\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 346,\n \"codeName\": \"Polish Narcotic drugs II-N\",\n \"idJurisdiction\": 28,\n \"jurisdictionName\": \"Poland\",\n \"description\": \"Polish Narcotic drugs Group 2 (Środki odurzające grupy II-N)\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 347,\n \"codeName\": \"Polish Narcotic drugs III-N\",\n \"idJurisdiction\": 28,\n \"jurisdictionName\": \"Poland\",\n \"description\": \"Polish Narcotic drugs Group 3 (Środki odurzające grupy III-N)\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 348,\n \"codeName\": \"Polish Narcotic drugs IV-N\",\n \"idJurisdiction\": 28,\n \"jurisdictionName\": \"Poland\",\n \"description\": \"Polish Narcotic drugs Group 4 (Środki odurzające grupy IV-N)\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 349,\n \"codeName\": \"Polish Psychotropic Substances I-P\",\n \"idJurisdiction\": 28,\n \"jurisdictionName\": \"Poland\",\n \"description\": \"Polish Psychotropic Substances group 1 (Substancje psychotropowe grupy I-P)\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 350,\n \"codeName\": \"Polish Psychotropic Substances II-P\",\n \"idJurisdiction\": 28,\n \"jurisdictionName\": \"Poland\",\n \"description\": \"Polish Psychotropic Substances group 2 (Substancje psychotropowe grupy II-P)\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 351,\n \"codeName\": \"Polish Psychotropic Substances III-P\",\n \"idJurisdiction\": 28,\n \"jurisdictionName\": \"Poland\",\n \"description\": \"Polish Psychotropic Substances group 3 (Substancje psychotropowe grupy III-P)\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 352,\n \"codeName\": \"Polish Psychotropic Substances IV-P\",\n \"idJurisdiction\": 28,\n \"jurisdictionName\": \"Poland\",\n \"description\": \"Polish Psychotropic Substances group 4 (Substancje psychotropowe grupy IV-P)\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 386,\n \"codeName\": \"UK 3rd Generation Cannabinoid 2019\",\n \"idJurisdiction\": 2,\n \"jurisdictionName\": \"United Kingdom\",\n \"description\": \"This a CS2 generated control code to enable CS2 to specifically flag 3rd generation cannabinoids as defined by the 2019 amendment, allowing them to be filtered by downstream systems for special handling\",\n \"idControlledCode\": null\n },\n {\n \"idControlledCode\": 141,\n \"codeName\": \"TestCC\",\n \"idJurisdiction\": 2,\n \"jurisdictionName\": \"United Kingdom\",\n \"description\": \"This is a test\",\n \"idSysControlledCode\": null\n },\n {\n \"idControlledCode\": 61,\n \"codeName\": \"Sci UK Test\",\n \"idJurisdiction\": 2,\n \"jurisdictionName\": \"United Kingdom\",\n \"description\": \"Sci test control code for the UK\",\n \"idSysControlledCode\": null\n },\n {\n \"idControlledCode\": 201,\n \"codeName\": \"FR_testCustomerCC\",\n \"idJurisdiction\": 4,\n \"jurisdictionName\": \"France\",\n \"description\": \"testing\",\n \"idSysControlledCode\": null\n },\n {\n \"idControlledCode\": 181,\n \"codeName\": \"UserDefinedCC2\",\n \"idJurisdiction\": 10000,\n \"jurisdictionName\": \"UserDefined\",\n \"description\": \"newUSerDefinedCC_forTestiing multiple customer controls codes per sub2jur \",\n \"idSysControlledCode\": null\n },\n {\n \"idControlledCode\": 121,\n \"codeName\": \"Userdefined Control Code\",\n \"idJurisdiction\": 10000,\n \"jurisdictionName\": \"UserDefined\",\n \"description\": \"this is a test\",\n \"idSysControlledCode\": null\n },\n {\n \"idControlledCode\": 161,\n \"codeName\": \"Adam Test CC 2\",\n \"idJurisdiction\": 10001,\n \"jurisdictionName\": \"Adam Test\",\n \"description\": \"Test control code 2\",\n \"idSysControlledCode\": null\n },\n {\n \"idControlledCode\": 101,\n \"codeName\": \"Adam Test CC\",\n \"idJurisdiction\": 10001,\n \"jurisdictionName\": \"Adam Test\",\n \"description\": \"This is a test control code\",\n \"idSysControlledCode\": null\n }\n]"}],"_postman_id":"4cfa606a-d195-470d-8975-800bcdae9afb"},{"name":"/auth/search/smiles","id":"6265338c-e456-4d82-8744-defc8551d74b","protocolProfileBehavior":{"disableBodyPruning":true},"request":{"method":"GET","header":[],"url":"https://{{host}}:{{port}}/auth/search/smiles?searchTerm=CC(NC)CC1=CC=C(OCO2)C2=C1&idJurisdiction=2&idJurisdiction=3","description":"

Run a CS2 search from a URL with a SMILES string, this will then direct you to the CS2 UI to display results. Provide the SMILES string for the compound and jurisdictions you wish to search.

\n","urlObject":{"protocol":"https","port":"{{port}}","path":["auth","search","smiles"],"host":["{{host}}"],"query":[{"description":{"content":"

SMILES string for substance

\n","type":"text/plain"},"key":"searchTerm","value":"CC(NC)CC1=CC=C(OCO2)C2=C1"},{"description":{"content":"

\n","type":"text/plain"},"key":"idJurisdiction","value":"2"},{"description":{"content":"

see above

\n","type":"text/plain"},"key":"idJurisdiction","value":"3"}],"variable":[]}},"response":[{"id":"45fc3105-6ee6-4841-b35a-727e40b58c85","name":"/controlcodes/list","originalRequest":{"method":"GET","header":[{"key":"x-access-token","value":"{{token}}","description":"This header needs to have the authenication token obtained from the /owner/authenticate API to allow requests to be sent to this endpoint","type":"text"}],"body":{"mode":"raw","raw":"","options":{"raw":{"language":"json"}}},"url":{"raw":"https://{{host}}:{{port}}/controlcodes/list?system=true&customer=true","protocol":"https","host":["{{host}}"],"port":"{{port}}","path":["controlcodes","list"],"query":[{"key":"system","value":"true","description":"Optional. If not provided this defaults to true. This toggles whether to return system control codes."},{"key":"customer","value":"true","description":"Optional. If not provided this defaults to true. This toggles whether to return customer control codes."}]}},"status":"OK","code":200,"_postman_previewlanguage":"json","header":[{"key":"Date","value":"Tue, 29 Jun 2021 09:32:19 GMT","enabled":true},{"key":"Content-Type","value":"application/json; charset=utf-8","enabled":true},{"key":"Content-Length","value":"78727","enabled":true},{"key":"Connection","value":"keep-alive","enabled":true},{"key":"Set-Cookie","value":"AWSALBTG=/zq57vRvdNU1RDOVYcFBm+Gz2V48s21koMuiQM+3C4XvTbpCVbE3z/NDFp5J+QwCAReirbcavvmK7SvNw43ene470w0kepkLiS5jYN+mZzeCO7+k4f/wi/+rV/Qp08Fhuog6rBSlO8heaB1OziNnveOgb8pw30j6vbiMxgAGSe2vUS+nABQ=; Expires=Tue, 06 Jul 2021 09:32:19 GMT; Path=/","enabled":true},{"key":"Set-Cookie","value":"AWSALBTGCORS=/zq57vRvdNU1RDOVYcFBm+Gz2V48s21koMuiQM+3C4XvTbpCVbE3z/NDFp5J+QwCAReirbcavvmK7SvNw43ene470w0kepkLiS5jYN+mZzeCO7+k4f/wi/+rV/Qp08Fhuog6rBSlO8heaB1OziNnveOgb8pw30j6vbiMxgAGSe2vUS+nABQ=; Expires=Tue, 06 Jul 2021 09:32:19 GMT; Path=/; SameSite=None; Secure","enabled":true},{"key":"X-Powered-By","value":"Express","enabled":true},{"key":"X-Frame-Options","value":"SAMEORIGIN","enabled":true},{"key":"ETag","value":"W/\"13387-yMsxifOenhh1GqH68lOMkrbrcdo\"","enabled":true}],"cookie":[],"responseTime":null,"body":"[\n {\n \"idSysControlledCode\": 97,\n \"codeName\": \"Irish Schedule 1\",\n \"idJurisdiction\": 5,\n \"jurisdictionName\": \"Ireland\",\n \"description\": \"Drugs subject to very strict controls and have little or no use in medicine or industry\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 98,\n \"codeName\": \"Irish Schedule 2\",\n \"idJurisdiction\": 5,\n \"jurisdictionName\": \"Ireland\",\n \"description\": \"Drugs used for scientific purposes which have a high likelihood of their being abused\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 99,\n \"codeName\": \"Irish Schedule 3\",\n \"idJurisdiction\": 5,\n \"jurisdictionName\": \"Ireland\",\n \"description\": \"Controlled medicinal products with a high likelihood of abuse\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 100,\n \"codeName\": \"Irish Schedule 4 pt 1\",\n \"idJurisdiction\": 5,\n \"jurisdictionName\": \"Ireland\",\n \"description\": \"Controlled medicinal products\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 108,\n \"codeName\": \"Irish Schedule 5\",\n \"idJurisdiction\": 5,\n \"jurisdictionName\": \"Ireland\",\n \"description\": \"Controlled drugs exempted from the prohibition on importation and exportation \",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 109,\n \"codeName\": \"Irish Schedule 8 pt1\",\n \"idJurisdiction\": 5,\n \"jurisdictionName\": \"Ireland\",\n \"description\": \"Can be prescribed for pain relief by a nurse in hospital\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 110,\n \"codeName\": \"Irish EU Drug Precursor Category 1\",\n \"idJurisdiction\": 5,\n \"jurisdictionName\": \"Ireland\",\n \"description\": \"EU Drug Precursor Category 1\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 111,\n \"codeName\": \"Irish EU Drug Precursor Category 2A\",\n \"idJurisdiction\": 5,\n \"jurisdictionName\": \"Ireland\",\n \"description\": \"EU Drug Precursor Category 2A\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 112,\n \"codeName\": \"Irish EU Drug Precursor Category 3\",\n \"idJurisdiction\": 5,\n \"jurisdictionName\": \"Ireland\",\n \"description\": \"EU Drug Precursor Category 3\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 113,\n \"codeName\": \"Irish EU Drug Precursor Category 4\",\n \"idJurisdiction\": 5,\n \"jurisdictionName\": \"Ireland\",\n \"description\": \"EU Drug Precursor Category 4\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 114,\n \"codeName\": \"Irish Schedule 4 pt 2\",\n \"idJurisdiction\": 5,\n \"jurisdictionName\": \"Ireland\",\n \"description\": \"Controlled medicinal products\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 175,\n \"codeName\": \"Canadian Schedule VII\",\n \"idJurisdiction\": 14,\n \"jurisdictionName\": \"Canada\",\n \"description\": \"Canadian Schedule VII\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 1176,\n \"codeName\": \"Canadian Schedule VIII\",\n \"idJurisdiction\": 14,\n \"jurisdictionName\": \"Canada\",\n \"description\": \"Canadian Schedule VIII\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 115,\n \"codeName\": \"Irish Schedule 8 pt2\",\n \"idJurisdiction\": 5,\n \"jurisdictionName\": \"Ireland\",\n \"description\": \"Can be prescribed for pain relief by a nurse in hospital\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 116,\n \"codeName\": \"Irish Schedule 8 pt3\",\n \"idJurisdiction\": 5,\n \"jurisdictionName\": \"Ireland\",\n \"description\": \"Can be prescribed for pain relief by a nurse in hospital\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 117,\n \"codeName\": \"Irish Schedule 8 pt4\",\n \"idJurisdiction\": 5,\n \"jurisdictionName\": \"Ireland\",\n \"description\": \"Can be prescribed for pain relief by a nurse in hospital\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 118,\n \"codeName\": \"Irish no schedule given\",\n \"idJurisdiction\": 5,\n \"jurisdictionName\": \"Ireland\",\n \"description\": \"Some substances are controlled in the general text of the legislation but not listed in a named schedule\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 23,\n \"codeName\": \"UK Schedule 1\",\n \"idJurisdiction\": 2,\n \"jurisdictionName\": \"United Kingdom\",\n \"description\": \"Schedule 1 drugs are thought to have no therapeutic value and cannot be lawfully possessed or prescribed. A Home Office license is required for research and significant regulations govern record keeping and storage.\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 24,\n \"codeName\": \"UK Schedule 2\",\n \"idJurisdiction\": 2,\n \"jurisdictionName\": \"United Kingdom\",\n \"description\": \"Schedule 2 drugs can be prescribed and therefore legally possessed and supplied by pharmacists and doctors (possesion or supply is otherwise illegal) and include drugs such as Heroin. Significant regulations govern record keeping and storage requirements for research use. \",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 25,\n \"codeName\": \"UK Schedule 3\",\n \"idJurisdiction\": 2,\n \"jurisdictionName\": \"United Kingdom\",\n \"description\": \"Schedule 3 drugs can be prescribed and therefore legally possessed and supplied by pharmacists and doctors (possession or supply is otherwise illegal). They have less onerous record keeping and storage regulations.\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 26,\n \"codeName\": \"UK Schedule 4\",\n \"idJurisdiction\": 2,\n \"jurisdictionName\": \"United Kingdom\",\n \"description\": \"Schedule 4 contain drugs such as steroids and benzodiazepines. Depending on the substance import / export licenses maybe required as well as a home office permit for scientific use.\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 27,\n \"codeName\": \"UK Schedule 5\",\n \"idJurisdiction\": 2,\n \"jurisdictionName\": \"United Kingdom\",\n \"description\": \"Schedule 5 drugs are sold over the counter and can be legally possessed without a prescription and imported / exported.\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 28,\n \"codeName\": \"UK Class A\",\n \"idJurisdiction\": 2,\n \"jurisdictionName\": \"United Kingdom\",\n \"description\": \"UK Class A\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 29,\n \"codeName\": \"UK Class B\",\n \"idJurisdiction\": 2,\n \"jurisdictionName\": \"United Kingdom\",\n \"description\": \"UK Class B\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 30,\n \"codeName\": \"UK Class C\",\n \"idJurisdiction\": 2,\n \"jurisdictionName\": \"United Kingdom\",\n \"description\": \"UK Class C\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 1,\n \"codeName\": \"UK Temporary Class Drug\",\n \"idJurisdiction\": 2,\n \"jurisdictionName\": \"United Kingdom\",\n \"description\": \"UK TEMPORARY CONTROL\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 2,\n \"codeName\": \"UNKNOWN\",\n \"idJurisdiction\": 2,\n \"jurisdictionName\": \"United Kingdom\",\n \"description\": \"UNKNOWN\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 3,\n \"codeName\": \"UK Schedule 3 Part 2\",\n \"idJurisdiction\": 2,\n \"jurisdictionName\": \"United Kingdom\",\n \"description\": \"Not used\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 4,\n \"codeName\": \"UK Schedule 4 Part 1\",\n \"idJurisdiction\": 2,\n \"jurisdictionName\": \"United Kingdom\",\n \"description\": \"UK Schedule 4 Part 1\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 5,\n \"codeName\": \"UK Schedule 4 Part 2\",\n \"idJurisdiction\": 2,\n \"jurisdictionName\": \"United Kingdom\",\n \"description\": \"UK Schedule 4 Part 2\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 41,\n \"codeName\": \"Test-partA\",\n \"idJurisdiction\": 16,\n \"jurisdictionName\": \"Used for testing\",\n \"description\": \"Test-partA\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 6,\n \"codeName\": \"UN Psychotropics Schedule I \",\n \"idJurisdiction\": 15,\n \"jurisdictionName\": \"UN (INCB)\",\n \"description\": \"UN Psychotropics Schedule I\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 7,\n \"codeName\": \"UN Psychotropics Schedule II\",\n \"idJurisdiction\": 15,\n \"jurisdictionName\": \"UN (INCB)\",\n \"description\": \"UN Psychotropics Schedule II\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 8,\n \"codeName\": \"UN Psychotropics Schedule III\",\n \"idJurisdiction\": 15,\n \"jurisdictionName\": \"UN (INCB)\",\n \"description\": \"UN Psychotropics Schedule III\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 9,\n \"codeName\": \"UN Psychotropics Schedule IV\",\n \"idJurisdiction\": 15,\n \"jurisdictionName\": \"UN (INCB)\",\n \"description\": \"UN Psychotropics Schedule IV\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 21,\n \"codeName\": \"US CSA Schedule I\",\n \"idJurisdiction\": 3,\n \"jurisdictionName\": \"United States of America\",\n \"description\": \"Schedule I drugs, substances, or chemicals are defined as drugs with no currently accepted medical use and a high potential for abuse. Schedule I drugs are the most dangerous drugs of all the drug schedules with potentially severe psychological or physical dependence. Significant controls need to be in place \",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 22,\n \"codeName\": \"US CSA Schedule II\",\n \"idJurisdiction\": 3,\n \"jurisdictionName\": \"United States of America\",\n \"description\": \"Schedule II drugs, substances, or chemicals are defined as drugs with a high potential for abuse, less abuse potential than Schedule I drugs, with use potentially leading to severe psychological or physical dependence. These drugs are also considered dangerous. Significant controls need to be in place\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 31,\n \"codeName\": \"US CSA Schedule III\",\n \"idJurisdiction\": 3,\n \"jurisdictionName\": \"United States of America\",\n \"description\": \"Schedule III drugs, substances, or chemicals are defined as drugs with a moderate to low potential for physical and psychological dependence. Schedule III drugs abuse potential is less than Schedule I and Schedule II drugs but more than Schedule IV. Significant controls generally need to be in place\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 32,\n \"codeName\": \"US CSA Schedule IV\",\n \"idJurisdiction\": 3,\n \"jurisdictionName\": \"United States of America\",\n \"description\": \"Schedule IV drugs, substances, or chemicals are defined as drugs with a low potential for abuse and low risk of dependence. \",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 33,\n \"codeName\": \"US CSA Schedule V\",\n \"idJurisdiction\": 3,\n \"jurisdictionName\": \"United States of America\",\n \"description\": \"Schedule V drugs, substances, or chemicals are defined as drugs with lower potential for abuse than Schedule IV and consist of preparations containing limited quantities of certain narcotics. Schedule V drugs are generally used for antidiarrheal, antitussive, and analgesic purposes.\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 40,\n \"codeName\": \"US CSA Schedule I (temporary)\",\n \"idJurisdiction\": 3,\n \"jurisdictionName\": \"United States of America\",\n \"description\": \"Schedule I drugs, substances, or chemicals are defined as drugs with no currently accepted medical use and a high potential for abuse. Schedule I drugs are the most dangerous drugs of all the drug schedules with potentially severe psychological or physical dependence. Significant controls need to be in place \",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 42,\n \"codeName\": \"US CSA List 1 Regulated Chemical\",\n \"idJurisdiction\": 3,\n \"jurisdictionName\": \"United States of America\",\n \"description\": \"US List 1 Regulated Chemical\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 43,\n \"codeName\": \"US CSA List 2 Regulated Chemical\",\n \"idJurisdiction\": 3,\n \"jurisdictionName\": \"United States of America\",\n \"description\": \"US List 2 Regulated Chemical\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 44,\n \"codeName\": \"UK EU Drug Precursor Category 1\",\n \"idJurisdiction\": 2,\n \"jurisdictionName\": \"United Kingdom\",\n \"description\": \"UK EU Drug Precursor Category 1\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 45,\n \"codeName\": \"UK EU Drug Precursor Category 2B\",\n \"idJurisdiction\": 2,\n \"jurisdictionName\": \"United Kingdom\",\n \"description\": \"UK EU Drug Precursor Category 2B\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 46,\n \"codeName\": \"UK EU Drug Precursor Category 3\",\n \"idJurisdiction\": 2,\n \"jurisdictionName\": \"United Kingdom\",\n \"description\": \"UK EU Drug Precursor Category 3\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 78,\n \"codeName\": \"Spain UN Narcotics List I\",\n \"idJurisdiction\": 11,\n \"jurisdictionName\": \"Spain\",\n \"description\": \"Spain UN Narcotics List I\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 75,\n \"codeName\": \"Spain UN Narcotics List II\",\n \"idJurisdiction\": 11,\n \"jurisdictionName\": \"Spain\",\n \"description\": \"Spain UN Narcotics List II\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 76,\n \"codeName\": \"Spain UN Narcotics List III\",\n \"idJurisdiction\": 11,\n \"jurisdictionName\": \"Spain\",\n \"description\": \"Spain UN Narcotics List III\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 77,\n \"codeName\": \"Spain UN Narcotics List IV\",\n \"idJurisdiction\": 11,\n \"jurisdictionName\": \"Spain\",\n \"description\": \"Spain UN Narcotics List IV\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 79,\n \"codeName\": \"US ARCOS List\",\n \"idJurisdiction\": 3,\n \"jurisdictionName\": \"United States of America\",\n \"description\": \"Substances, which may not be listed in legislation but within US ARCOS system as likely requiring import/export licences and should be considered as controlled\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 80,\n \"codeName\": \"Spain UN Psychotropics List II\",\n \"idJurisdiction\": 11,\n \"jurisdictionName\": \"Spain\",\n \"description\": \"Spain UN Psychotropics List II\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 81,\n \"codeName\": \"Spain UN Psychotropics List III\",\n \"idJurisdiction\": 11,\n \"jurisdictionName\": \"Spain\",\n \"description\": \"Spain UN Psychotropics List III\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 82,\n \"codeName\": \"Spain UN Psychotropics List IV\",\n \"idJurisdiction\": 11,\n \"jurisdictionName\": \"Spain\",\n \"description\": \"Spain UN Psychotropics List IV\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 83,\n \"codeName\": \"Spain UN Psychotropics List I\",\n \"idJurisdiction\": 11,\n \"jurisdictionName\": \"Spain\",\n \"description\": \"Spain UN Psychotropics List I\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 84,\n \"codeName\": \"Spain Psychotropics Annex 2\",\n \"idJurisdiction\": 11,\n \"jurisdictionName\": \"Spain\",\n \"description\": \"Spain Annex substances controlled in addition to UN lists\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 85,\n \"codeName\": \"Swedish List I\",\n \"idJurisdiction\": 12,\n \"jurisdictionName\": \"Sweden\",\n \"description\": \"substances , plant material and fungi that normally do not have medical use\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 86,\n \"codeName\": \"Swedish List II\",\n \"idJurisdiction\": 12,\n \"jurisdictionName\": \"Sweden\",\n \"description\": \"substances , plant material and fungi with medical use\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 87,\n \"codeName\": \"Swedish List III\",\n \"idJurisdiction\": 12,\n \"jurisdictionName\": \"Sweden\",\n \"description\": \"substances , plant material and fungi with medical use\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 88,\n \"codeName\": \"Swedish List IV\",\n \"idJurisdiction\": 12,\n \"jurisdictionName\": \"Sweden\",\n \"description\": \"substances , plant material and fungi with medical use\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 89,\n \"codeName\": \"Swedish List V\",\n \"idJurisdiction\": 12,\n \"jurisdictionName\": \"Sweden\",\n \"description\": \"Swedish List 5\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 90,\n \"codeName\": \"Danish List A\",\n \"idJurisdiction\": 7,\n \"jurisdictionName\": \"Denmark\",\n \"description\": \"Danish List A\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 91,\n \"codeName\": \"Danish List B\",\n \"idJurisdiction\": 7,\n \"jurisdictionName\": \"Denmark\",\n \"description\": \"Danish List B\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 92,\n \"codeName\": \"Danish List C\",\n \"idJurisdiction\": 7,\n \"jurisdictionName\": \"Denmark\",\n \"description\": \"Danish List C\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 93,\n \"codeName\": \"Danish List D\",\n \"idJurisdiction\": 7,\n \"jurisdictionName\": \"Denmark\",\n \"description\": \"Danish List D\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 94,\n \"codeName\": \"Danish List E\",\n \"idJurisdiction\": 7,\n \"jurisdictionName\": \"Denmark\",\n \"description\": \"Danish List E\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 34,\n \"codeName\": \"Swiss Directory A\",\n \"idJurisdiction\": 13,\n \"jurisdictionName\": \"Switzerland\",\n \"description\": \"controlled substances that are subject to all of the control measures; \",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 35,\n \"codeName\": \"Swiss Directory B\",\n \"idJurisdiction\": 13,\n \"jurisdictionName\": \"Switzerland\",\n \"description\": \"controlled substances that are partially exempt from the control measures; \",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 36,\n \"codeName\": \"Swiss Directory C\",\n \"idJurisdiction\": 13,\n \"jurisdictionName\": \"Switzerland\",\n \"description\": \"controlled substances that may be contained in preparations in reduced concentrations and are partially exempt from the control measures; \",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 37,\n \"codeName\": \"Swiss Directory D\",\n \"idJurisdiction\": 13,\n \"jurisdictionName\": \"Switzerland\",\n \"description\": \"illegal controlled substances\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 47,\n \"codeName\": \"Swiss Directory E\",\n \"idJurisdiction\": 13,\n \"jurisdictionName\": \"Switzerland\",\n \"description\": \"Raw Materials and Products with Suspected Similar Narcotics Effect\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 48,\n \"codeName\": \"Swiss Directory F\",\n \"idJurisdiction\": 13,\n \"jurisdictionName\": \"Switzerland\",\n \"description\": \"Precursors\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 49,\n \"codeName\": \"Swiss Directory G\",\n \"idJurisdiction\": 13,\n \"jurisdictionName\": \"Switzerland\",\n \"description\": \"Auxiliary Chemicals\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 50,\n \"codeName\": \"Belgium 1930-art1 (stup)\",\n \"idJurisdiction\": 6,\n \"jurisdictionName\": \"Belgium\",\n \"description\": \"Belgium 1930-art1 (stup)\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 51,\n \"codeName\": \"Belgium 1930-art1bis (stup)\",\n \"idJurisdiction\": 6,\n \"jurisdictionName\": \"Belgium\",\n \"description\": \"Belgium 1930-art1bis (stup)\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 52,\n \"codeName\": \"Belgium 1998-art2 (as-stup)\",\n \"idJurisdiction\": 6,\n \"jurisdictionName\": \"Belgium\",\n \"description\": \"Belgium 1998-art2 (as-stup)\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 53,\n \"codeName\": \"Belgium 1998-art25 (psy)\",\n \"idJurisdiction\": 6,\n \"jurisdictionName\": \"Belgium\",\n \"description\": \"Belgium 1998-art25 (psy)\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 54,\n \"codeName\": \"Belgium 1998-art38 (psy)\",\n \"idJurisdiction\": 6,\n \"jurisdictionName\": \"Belgium\",\n \"description\": \"Belgium 1998-art38 (psy)\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 64,\n \"codeName\": \"Canadian Schedule II\",\n \"idJurisdiction\": 14,\n \"jurisdictionName\": \"Canada\",\n \"description\": \"Canadian Schedule II\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 65,\n \"codeName\": \"Canadian Schedule III\",\n \"idJurisdiction\": 14,\n \"jurisdictionName\": \"Canada\",\n \"description\": \"Canadian Schedule III\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 66,\n \"codeName\": \"Canadian Schedule IV\",\n \"idJurisdiction\": 14,\n \"jurisdictionName\": \"Canada\",\n \"description\": \"Canadian Schedule IV\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 67,\n \"codeName\": \"Canadian Schedule V\",\n \"idJurisdiction\": 14,\n \"jurisdictionName\": \"Canada\",\n \"description\": \"Canadian Schedule V\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 59,\n \"codeName\": \"French Psychotropics Part 1 UN Schedule III\",\n \"idJurisdiction\": 4,\n \"jurisdictionName\": \"France\",\n \"description\": \"This has the contents of Schedule III of the List of Psychotropic Substances under International Control in accordance with the United Nations Convention on Psychotropic Substances of 1971\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 60,\n \"codeName\": \"French Psychotropics Part 1 UN Schedule IV\",\n \"idJurisdiction\": 4,\n \"jurisdictionName\": \"France\",\n \"description\": \"This has the contents of Schedule IV of the List of Psychotropic Substances under International Control in accordance with the United Nations Convention on Psychotropic Substances of 1971\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 61,\n \"codeName\": \"French Psychotropics Part 2\",\n \"idJurisdiction\": 4,\n \"jurisdictionName\": \"France\",\n \"description\": \"Certain preparations of psychotropics.\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 62,\n \"codeName\": \"French Psychotropics Part 3\",\n \"idJurisdiction\": 4,\n \"jurisdictionName\": \"France\",\n \"description\": \"Psychotropics not covered by the List of Psychotropic Substances under International Control in accordance with the United Nations Convention on Psychotropic Substances of 1971.\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 101,\n \"codeName\": \"German Schedule 1\",\n \"idJurisdiction\": 8,\n \"jurisdictionName\": \"Germany\",\n \"description\": \"German Schedule 1\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 102,\n \"codeName\": \"German Schedule 2\",\n \"idJurisdiction\": 8,\n \"jurisdictionName\": \"Germany\",\n \"description\": \"German Schedule 2\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 103,\n \"codeName\": \"German Schedule 3\",\n \"idJurisdiction\": 8,\n \"jurisdictionName\": \"Germany\",\n \"description\": \"German Schedule 3 - not controlled\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 104,\n \"codeName\": \"French Narcotics Annex I\",\n \"idJurisdiction\": 4,\n \"jurisdictionName\": \"France\",\n \"description\": \"Narcotics Annex I: narcotic substances such as heroin, cocaine, cannabis, methadone, opium, etc. Corresponds to Schedule I of the list of narcotic drugs under international control in accordance with the UN Single Convention on Narcotic Drugs 1961.\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 106,\n \"codeName\": \"French Narcotics Annex III\",\n \"idJurisdiction\": 4,\n \"jurisdictionName\": \"France\",\n \"description\": \"Narcotic Annex III: psychotropic substances such as: amphetamines, ecstasy (MDMA), LSD, etc. Corresponds to Schedule I the list of psychotropic drugs under international control in accordance with the UN Convention on Psychotropic Substances of 1971\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 105,\n \"codeName\": \"French Narcotics Annex II\",\n \"idJurisdiction\": 4,\n \"jurisdictionName\": \"France\",\n \"description\": \"Narcotics Annex II: substances like codeine, propiram, etc. Corresponds to Schedule II of the list of narcotics drugs under international control in accordance with the UN Single Convention on Narcotic Drugs, 1961\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 107,\n \"codeName\": \"French Narcotics Annex IV\",\n \"idJurisdiction\": 4,\n \"jurisdictionName\": \"France\",\n \"description\": \"Narcotics Annex IV: substances not controlled at the international level.\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 63,\n \"codeName\": \"Canadian Schedule I\",\n \"idJurisdiction\": 14,\n \"jurisdictionName\": \"Canada\",\n \"description\": \"Canadian Schedule I\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 68,\n \"codeName\": \"Canadian Schedule VI pt1\",\n \"idJurisdiction\": 14,\n \"jurisdictionName\": \"Canada\",\n \"description\": \"Canadian Schedule VI pt1\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 69,\n \"codeName\": \"Italian Table I\",\n \"idJurisdiction\": 9,\n \"jurisdictionName\": \"Italy\",\n \"description\": \"Italian table 1\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 70,\n \"codeName\": \"Italian Table V(a)\",\n \"idJurisdiction\": 9,\n \"jurisdictionName\": \"Italy\",\n \"description\": \"Italian table V(a)\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 71,\n \"codeName\": \"Italian Table V(b)\",\n \"idJurisdiction\": 9,\n \"jurisdictionName\": \"Italy\",\n \"description\": \"Italian table V(b)\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 72,\n \"codeName\": \"Italian Table V(c)\",\n \"idJurisdiction\": 9,\n \"jurisdictionName\": \"Italy\",\n \"description\": \"Italian table V(c)\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 73,\n \"codeName\": \"Italian Table V(d)\",\n \"idJurisdiction\": 9,\n \"jurisdictionName\": \"Italy\",\n \"description\": \"Italian table V(d)\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 74,\n \"codeName\": \"Italian Table V(e)\",\n \"idJurisdiction\": 9,\n \"jurisdictionName\": \"Italy\",\n \"description\": \"Italian table V(e)\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 157,\n \"codeName\": \"German EU Drug Precursor Category 1\",\n \"idJurisdiction\": 8,\n \"jurisdictionName\": \"Germany\",\n \"description\": \"EU Drug Precursor Category 1\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 158,\n \"codeName\": \"German EU Drug Precursor Category 2A\",\n \"idJurisdiction\": 8,\n \"jurisdictionName\": \"Germany\",\n \"description\": \"EU Drug Precursor Category 2A\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 159,\n \"codeName\": \"German EU Drug Precursor Category 2B\",\n \"idJurisdiction\": 8,\n \"jurisdictionName\": \"Germany\",\n \"description\": \"EU Drug Precursor Category 2B\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 160,\n \"codeName\": \"German EU Drug Precursor Category 3\",\n \"idJurisdiction\": 8,\n \"jurisdictionName\": \"Germany\",\n \"description\": \"EU Drug Precursor Category 3\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 161,\n \"codeName\": \"German EU Drug Precursor Category 4\",\n \"idJurisdiction\": 8,\n \"jurisdictionName\": \"Germany\",\n \"description\": \"EU Drug Precursor Category 4\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 162,\n \"codeName\": \"Swedish EU Drug Precursor Category 1\",\n \"idJurisdiction\": 12,\n \"jurisdictionName\": \"Sweden\",\n \"description\": \"EU Drug Precursor Category 1\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 163,\n \"codeName\": \"Swedish EU Drug Precursor Category 2A\",\n \"idJurisdiction\": 12,\n \"jurisdictionName\": \"Sweden\",\n \"description\": \"EU Drug Precursor Category 2A\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 164,\n \"codeName\": \"Swedish EU Drug Precursor Category 2B\",\n \"idJurisdiction\": 12,\n \"jurisdictionName\": \"Sweden\",\n \"description\": \"EU Drug Precursor Category 2B\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 165,\n \"codeName\": \"Swedish EU Drug Precursor Category 3\",\n \"idJurisdiction\": 12,\n \"jurisdictionName\": \"Sweden\",\n \"description\": \"EU Drug Precursor Category 3\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 166,\n \"codeName\": \"Swedish EU Drug Precursor Category 4\",\n \"idJurisdiction\": 12,\n \"jurisdictionName\": \"Sweden\",\n \"description\": \"EU Drug Precursor Category 4\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 168,\n \"codeName\": \"Canadian Schedule VI pt2\",\n \"idJurisdiction\": 14,\n \"jurisdictionName\": \"Canada\",\n \"description\": \"Canadian Schedule VI pt2\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 95,\n \"codeName\": \"Netherlands List 1\",\n \"idJurisdiction\": 10,\n \"jurisdictionName\": \"Netherlands\",\n \"description\": \"Netherlands List 1\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 96,\n \"codeName\": \"Netherlands List 2\",\n \"idJurisdiction\": 10,\n \"jurisdictionName\": \"Netherlands\",\n \"description\": \"Netherlands List 2\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 119,\n \"codeName\": \"UK EU Drug Precursor Category 2A\",\n \"idJurisdiction\": 2,\n \"jurisdictionName\": \"United Kingdom\",\n \"description\": \"UK EU Drug Precursor Category 2A\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 120,\n \"codeName\": \"UK EU Drug Precursor Category 4\",\n \"idJurisdiction\": 2,\n \"jurisdictionName\": \"United Kingdom\",\n \"description\": \"UK EU Drug Precursor Category 4\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 171,\n \"codeName\": \"Italian Table II\",\n \"idJurisdiction\": 9,\n \"jurisdictionName\": \"Italy\",\n \"description\": \"Italian Table II\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 172,\n \"codeName\": \"Italian Table III\",\n \"idJurisdiction\": 9,\n \"jurisdictionName\": \"Italy\",\n \"description\": \"Italian Table III\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 173,\n \"codeName\": \"Italian Table IV\",\n \"idJurisdiction\": 9,\n \"jurisdictionName\": \"Italy\",\n \"description\": \"Italian Table IV\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 174,\n \"codeName\": \"Italian Annex 3a\",\n \"idJurisdiction\": 9,\n \"jurisdictionName\": \"Italy\",\n \"description\": \"Italian Annex 3a\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 126,\n \"codeName\": \"Belgium EU Drug Precursor Category 1\",\n \"idJurisdiction\": 6,\n \"jurisdictionName\": \"Belgium\",\n \"description\": \"EU Drug Precursor Category 1\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 127,\n \"codeName\": \"Belgium EU Drug Precursor Category 2A\",\n \"idJurisdiction\": 6,\n \"jurisdictionName\": \"Belgium\",\n \"description\": \"EU Drug Precursor Category 2A\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 128,\n \"codeName\": \"Belgium EU Drug Precursor Category 2B\",\n \"idJurisdiction\": 6,\n \"jurisdictionName\": \"Belgium\",\n \"description\": \"EU Drug Precursor Category 2B\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 129,\n \"codeName\": \"Belgium EU Drug Precursor Category 3\",\n \"idJurisdiction\": 6,\n \"jurisdictionName\": \"Belgium\",\n \"description\": \"EU Drug Precursor Category 3\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 130,\n \"codeName\": \"Belgium EU Drug Precursor Category 4\",\n \"idJurisdiction\": 6,\n \"jurisdictionName\": \"Belgium\",\n \"description\": \"EU Drug Precursor Category 4\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 131,\n \"codeName\": \"French EU Drug Precursor Category 1\",\n \"idJurisdiction\": 4,\n \"jurisdictionName\": \"France\",\n \"description\": \"EU Drug Precursor Category 1\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 132,\n \"codeName\": \"French EU Drug Precursor Category 2A\",\n \"idJurisdiction\": 4,\n \"jurisdictionName\": \"France\",\n \"description\": \"EU Drug Precursor Category 2A\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 133,\n \"codeName\": \"French EU Drug Precursor Category 2B\",\n \"idJurisdiction\": 4,\n \"jurisdictionName\": \"France\",\n \"description\": \"EU Drug Precursor Category 2B\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 134,\n \"codeName\": \"French EU Drug Precursor Category 3\",\n \"idJurisdiction\": 4,\n \"jurisdictionName\": \"France\",\n \"description\": \"EU Drug Precursor Category 3\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 135,\n \"codeName\": \"French EU Drug Precursor Category 4\",\n \"idJurisdiction\": 4,\n \"jurisdictionName\": \"France\",\n \"description\": \"EU Drug Precursor Category 4\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 136,\n \"codeName\": \"Italian EU Drug Precursor Category 1\",\n \"idJurisdiction\": 9,\n \"jurisdictionName\": \"Italy\",\n \"description\": \"EU Drug Precursor Category 1\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 137,\n \"codeName\": \"Italian EU Drug Precursor Category 2A\",\n \"idJurisdiction\": 9,\n \"jurisdictionName\": \"Italy\",\n \"description\": \"EU Drug Precursor Category 2A\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 138,\n \"codeName\": \"Italian EU Drug Precursor Category 2B\",\n \"idJurisdiction\": 9,\n \"jurisdictionName\": \"Italy\",\n \"description\": \"EU Drug Precursor Category 2B\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 139,\n \"codeName\": \"Italian EU Drug Precursor Category 3\",\n \"idJurisdiction\": 9,\n \"jurisdictionName\": \"Italy\",\n \"description\": \"EU Drug Precursor Category 3\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 140,\n \"codeName\": \"Italian EU Drug Precursor Category 4\",\n \"idJurisdiction\": 9,\n \"jurisdictionName\": \"Italy\",\n \"description\": \"EU Drug Precursor Category 4\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 141,\n \"codeName\": \"Spanish EU Drug Precursor Category 1\",\n \"idJurisdiction\": 11,\n \"jurisdictionName\": \"Spain\",\n \"description\": \"EU Drug Precursor Category 1\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 142,\n \"codeName\": \"Spanish EU Drug Precursor Category 2A\",\n \"idJurisdiction\": 11,\n \"jurisdictionName\": \"Spain\",\n \"description\": \"EU Drug Precursor Category 2A\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 143,\n \"codeName\": \"Spanish EU Drug Precursor Category 2B\",\n \"idJurisdiction\": 11,\n \"jurisdictionName\": \"Spain\",\n \"description\": \"EU Drug Precursor Category 2B\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 144,\n \"codeName\": \"Spanish EU Drug Precursor Category 3\",\n \"idJurisdiction\": 11,\n \"jurisdictionName\": \"Spain\",\n \"description\": \"EU Drug Precursor Category 3\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 145,\n \"codeName\": \"Spanish EU Drug Precursor Category 4\",\n \"idJurisdiction\": 11,\n \"jurisdictionName\": \"Spain\",\n \"description\": \"EU Drug Precursor Category 4\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 146,\n \"codeName\": \"Danish EU Drug Precursor Category 1\",\n \"idJurisdiction\": 7,\n \"jurisdictionName\": \"Denmark\",\n \"description\": \"EU Drug Precursor Category 1\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 147,\n \"codeName\": \"Danish EU Drug Precursor Category 2A\",\n \"idJurisdiction\": 7,\n \"jurisdictionName\": \"Denmark\",\n \"description\": \"EU Drug Precursor Category 2A\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 148,\n \"codeName\": \"Danish EU Drug Precursor Category 2B\",\n \"idJurisdiction\": 7,\n \"jurisdictionName\": \"Denmark\",\n \"description\": \"EU Drug Precursor Category 2B\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 149,\n \"codeName\": \"Danish EU Drug Precursor Category 3\",\n \"idJurisdiction\": 7,\n \"jurisdictionName\": \"Denmark\",\n \"description\": \"EU Drug Precursor Category 3\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 150,\n \"codeName\": \"Danish EU Drug Precursor Category 4\",\n \"idJurisdiction\": 7,\n \"jurisdictionName\": \"Denmark\",\n \"description\": \"EU Drug Precursor Category 4\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 151,\n \"codeName\": \"Netherlands EU Drug Precursor Category 1\",\n \"idJurisdiction\": 10,\n \"jurisdictionName\": \"Netherlands\",\n \"description\": \"EU Drug Precursor Category 1\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 152,\n \"codeName\": \"Netherlands EU Drug Precursor Category 2A\",\n \"idJurisdiction\": 10,\n \"jurisdictionName\": \"Netherlands\",\n \"description\": \"EU Drug Precursor Category 2A\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 153,\n \"codeName\": \"Netherlands EU Drug Precursor Category 2B\",\n \"idJurisdiction\": 10,\n \"jurisdictionName\": \"Netherlands\",\n \"description\": \"EU Drug Precursor Category 2B\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 154,\n \"codeName\": \"Netherlands EU Drug Precursor Category 3\",\n \"idJurisdiction\": 10,\n \"jurisdictionName\": \"Netherlands\",\n \"description\": \"EU Drug Precursor Category 3\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 155,\n \"codeName\": \"Netherlands EU Drug Precursor Category 4\",\n \"idJurisdiction\": 10,\n \"jurisdictionName\": \"Netherlands\",\n \"description\": \"EU Drug Precursor Category 4\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 156,\n \"codeName\": \"Irish EU Drug Precursor Category 2B\",\n \"idJurisdiction\": 5,\n \"jurisdictionName\": \"Ireland\",\n \"description\": \"EU Drug Precursor Category 2B\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 169,\n \"codeName\": \"UN Precursor Table I\",\n \"idJurisdiction\": 15,\n \"jurisdictionName\": \"UN (INCB)\",\n \"description\": \"UN Precursor Table I\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 170,\n \"codeName\": \"UN Precursor Table II\",\n \"idJurisdiction\": 15,\n \"jurisdictionName\": \"UN (INCB)\",\n \"description\": \"UN Precursor Table II\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 176,\n \"codeName\": \"Swedish Hazardous Goods\",\n \"idJurisdiction\": 12,\n \"jurisdictionName\": \"Sweden\",\n \"description\": \"Swedish Hazardous Goods\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 123,\n \"codeName\": \"UN Narcotics Schedule I\",\n \"idJurisdiction\": 15,\n \"jurisdictionName\": \"UN (INCB)\",\n \"description\": \"UN Narcotics Schedule I\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 124,\n \"codeName\": \"UN Narcotics Schedule II\",\n \"idJurisdiction\": 15,\n \"jurisdictionName\": \"UN (INCB)\",\n \"description\": \"UN Narcotics Schedule II\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 125,\n \"codeName\": \"UN Narcotics Schedule III\",\n \"idJurisdiction\": 15,\n \"jurisdictionName\": \"UN (INCB)\",\n \"description\": \"UN Narcotics Schedule III\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 177,\n \"codeName\": \"UN Narcotics Schedule IV\",\n \"idJurisdiction\": 15,\n \"jurisdictionName\": \"UN (INCB)\",\n \"description\": \"UN Narcotics Schedule IV\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 178,\n \"codeName\": \"Indian Schedule A Precursor\",\n \"idJurisdiction\": 17,\n \"jurisdictionName\": \"India\",\n \"description\": \"Indian Schedule A Precursor\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 179,\n \"codeName\": \"Indian Schedule B Precursor\",\n \"idJurisdiction\": 17,\n \"jurisdictionName\": \"India\",\n \"description\": \"Indian Schedule B Precursor\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 180,\n \"codeName\": \"Indian Schedule C Precursor\",\n \"idJurisdiction\": 17,\n \"jurisdictionName\": \"India\",\n \"description\": \"Indian Schedule C Precursor\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 185,\n \"codeName\": \"CWC Schedule 1 A\",\n \"idJurisdiction\": 18,\n \"jurisdictionName\": \"Chemical Weapons Convention\",\n \"description\": \"Chemical Weapons Convention Schedule 1 A - Toxic chemicals\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 186,\n \"codeName\": \"CWC Schedule 1 B\",\n \"idJurisdiction\": 18,\n \"jurisdictionName\": \"Chemical Weapons Convention\",\n \"description\": \"Chemical Weapons Convention Schedule 1 B - Precursors\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 187,\n \"codeName\": \"CWC Schedule 2 A\",\n \"idJurisdiction\": 18,\n \"jurisdictionName\": \"Chemical Weapons Convention\",\n \"description\": \"Chemical Weapons Convention Schedule 2 A - Toxic chemicals\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 188,\n \"codeName\": \"CWC Schedule 2 B\",\n \"idJurisdiction\": 18,\n \"jurisdictionName\": \"Chemical Weapons Convention\",\n \"description\": \"Chemical Weapons Convention Schedule 2 B - Precursors\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 189,\n \"codeName\": \"CWC Schedule 3 A\",\n \"idJurisdiction\": 18,\n \"jurisdictionName\": \"Chemical Weapons Convention\",\n \"description\": \"Chemical Weapons Convention Schedule 3 A - Toxic chemicals\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 190,\n \"codeName\": \"CWC Schedule 3 B\",\n \"idJurisdiction\": 18,\n \"jurisdictionName\": \"Chemical Weapons Convention\",\n \"description\": \"Chemical Weapons Convention Schedule 3 B - Precursors\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 218,\n \"codeName\": \"UK EU Drug Precursor Category 2\",\n \"idJurisdiction\": 2,\n \"jurisdictionName\": \"United Kingdom\",\n \"description\": \"UK EU Drug Precursor Category 2\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 219,\n \"codeName\": \"US CCL RS\",\n \"idJurisdiction\": 3,\n \"jurisdictionName\": \"United States of America\",\n \"description\": \"CCL Regional Stability control code\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 182,\n \"codeName\": \"Indian NDPS Act – Psychotropic \",\n \"idJurisdiction\": 17,\n \"jurisdictionName\": \"India\",\n \"description\": \"Indian NDPS Act – Psychotropic \",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 183,\n \"codeName\": \"Indian NDPS Act – Narcotic \",\n \"idJurisdiction\": 17,\n \"jurisdictionName\": \"India\",\n \"description\": \"Indian NDPS Act – Narcotic \",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 184,\n \"codeName\": \"Indian NDPs Act – Manufactured Narcotic Drug \",\n \"idJurisdiction\": 17,\n \"jurisdictionName\": \"India\",\n \"description\": \"Indian NDPs Act – Manufactured Narcotic Drug \",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 191,\n \"codeName\": \"China Psychotropic Drugs - Category 1\",\n \"idJurisdiction\": 19,\n \"jurisdictionName\": \"China\",\n \"description\": \"精神药品品种目录第一类\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 192,\n \"codeName\": \"China Psychotropic Drugs - Category 2 \",\n \"idJurisdiction\": 19,\n \"jurisdictionName\": \"China\",\n \"description\": \"精神药品品种目录第二类\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 193,\n \"codeName\": \"China Anesthetic Drugs\",\n \"idJurisdiction\": 19,\n \"jurisdictionName\": \"China\",\n \"description\": \"麻醉药品品种目录\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 194,\n \"codeName\": \"China Precursors - Category 1\",\n \"idJurisdiction\": 19,\n \"jurisdictionName\": \"China\",\n \"description\": \"易制毒化学品的分类和品种目录第一类\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 195,\n \"codeName\": \"China Precursors - Category 2\",\n \"idJurisdiction\": 19,\n \"jurisdictionName\": \"China\",\n \"description\": \"易制毒化学品的分类和品种目录第二类\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 196,\n \"codeName\": \"China Precursors - Category 3\",\n \"idJurisdiction\": 19,\n \"jurisdictionName\": \"China\",\n \"description\": \"易制毒化学品的分类和品种目录第一类\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 197,\n \"codeName\": \"US CCL CB1\",\n \"idJurisdiction\": 3,\n \"jurisdictionName\": \"United States of America\",\n \"description\": \"CCL Chemical and Biological Weapons control code\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 198,\n \"codeName\": \"US CCL CB2\",\n \"idJurisdiction\": 3,\n \"jurisdictionName\": \"United States of America\",\n \"description\": \"CCL Chemical and Biological Weapons control code\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 199,\n \"codeName\": \"US CCL CB3\",\n \"idJurisdiction\": 3,\n \"jurisdictionName\": \"United States of America\",\n \"description\": \"CCL Chemical and Biological Weapons control code\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 200,\n \"codeName\": \"US CCL NP1\",\n \"idJurisdiction\": 3,\n \"jurisdictionName\": \"United States of America\",\n \"description\": \"CCL Nuclear non proliferation control code\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 201,\n \"codeName\": \"US CCL NP2\",\n \"idJurisdiction\": 3,\n \"jurisdictionName\": \"United States of America\",\n \"description\": \"CCL Nuclear non proliferation control code\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 202,\n \"codeName\": \"US CCL NS1\",\n \"idJurisdiction\": 3,\n \"jurisdictionName\": \"United States of America\",\n \"description\": \"CCL National Security control code\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 203,\n \"codeName\": \"US CCL NS2\",\n \"idJurisdiction\": 3,\n \"jurisdictionName\": \"United States of America\",\n \"description\": \"CCL National Security control code\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 204,\n \"codeName\": \"US CCL MT1\",\n \"idJurisdiction\": 3,\n \"jurisdictionName\": \"United States of America\",\n \"description\": \"CCL Missile Technology control code\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 205,\n \"codeName\": \"US CCL RS1\",\n \"idJurisdiction\": 3,\n \"jurisdictionName\": \"United States of America\",\n \"description\": \"CCL Regional Security control code\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 206,\n \"codeName\": \"US CCL RS2\",\n \"idJurisdiction\": 3,\n \"jurisdictionName\": \"United States of America\",\n \"description\": \"CCL Regional Security control code\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 207,\n \"codeName\": \"US CCL FC1\",\n \"idJurisdiction\": 3,\n \"jurisdictionName\": \"United States of America\",\n \"description\": \"CCL Firearms Convension control code\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 208,\n \"codeName\": \"US CCL CC1\",\n \"idJurisdiction\": 3,\n \"jurisdictionName\": \"United States of America\",\n \"description\": \"CCL Crime control code\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 209,\n \"codeName\": \"US CCL CC2\",\n \"idJurisdiction\": 3,\n \"jurisdictionName\": \"United States of America\",\n \"description\": \"CCL Crime control code\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 210,\n \"codeName\": \"US CCL CC3\",\n \"idJurisdiction\": 3,\n \"jurisdictionName\": \"United States of America\",\n \"description\": \"CCL Crime control code\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 211,\n \"codeName\": \"US CCL AT1\",\n \"idJurisdiction\": 3,\n \"jurisdictionName\": \"United States of America\",\n \"description\": \"CCL Anti Terrorism control code\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 212,\n \"codeName\": \"US CCL AT2\",\n \"idJurisdiction\": 3,\n \"jurisdictionName\": \"United States of America\",\n \"description\": \"CCL Anti Terrorism control code\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 213,\n \"codeName\": \"US ITAR PT 121 Category V\",\n \"idJurisdiction\": 3,\n \"jurisdictionName\": \"United States of America\",\n \"description\": \"EXPLOSIVES AND ENERGETIC MATERIALS, PROPELLANTS, INCENDIARY AGENTS AND THEIR CONSTITUENTS\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 214,\n \"codeName\": \"US ITAR PT 121 Category XIV\",\n \"idJurisdiction\": 3,\n \"jurisdictionName\": \"United States of America\",\n \"description\": \"TOXICOLOGICAL AGENTS, INCLUDING CHEMICAL AGENTS, BIOLOGICAL AGENTS, AND ASSOCIATED EQUIPMENT\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 215,\n \"codeName\": \"US CCL UN\",\n \"idJurisdiction\": 3,\n \"jurisdictionName\": \"United States of America\",\n \"description\": \"CCL United Nations Embargo control code\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 216,\n \"codeName\": \"US CCL CW\",\n \"idJurisdiction\": 3,\n \"jurisdictionName\": \"United States of America\",\n \"description\": \"CCL Chemical Weapons Convention control code\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 217,\n \"codeName\": \"US CCL AT\",\n \"idJurisdiction\": 3,\n \"jurisdictionName\": \"United States of America\",\n \"description\": \"CCL Anti Terrorism control code\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 227,\n \"codeName\": \"Australia Group CW Precursor\",\n \"idJurisdiction\": 20,\n \"jurisdictionName\": \"Australia Group\",\n \"description\": \"Australia Group Chemical Weapons Precursor\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 228,\n \"codeName\": \"EU Military List ML 7\",\n \"idJurisdiction\": 21,\n \"jurisdictionName\": \"European Union\",\n \"description\": \"European Union Military List ML 7\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 229,\n \"codeName\": \"EU Military List ML 8\",\n \"idJurisdiction\": 21,\n \"jurisdictionName\": \"European Union\",\n \"description\": \"European Union Military List ML 8\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 230,\n \"codeName\": \"Montreal Ozone Annex A, Group I\",\n \"idJurisdiction\": 22,\n \"jurisdictionName\": \"Montreal Ozone Protocol\",\n \"description\": \"Montreal Protocol on Substances that deplete the Ozone Layer Annex A, Group I control code\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 231,\n \"codeName\": \"Montreal Ozone Annex A, Group II\",\n \"idJurisdiction\": 22,\n \"jurisdictionName\": \"Montreal Ozone Protocol\",\n \"description\": \"Montreal Protocol on Substances that deplete the Ozone Layer Annex A, Group II control code\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 233,\n \"codeName\": \"Montreal Ozone Annex B, Group II\",\n \"idJurisdiction\": 22,\n \"jurisdictionName\": \"Montreal Ozone Protocol\",\n \"description\": \"Montreal Protocol on Substances that deplete the Ozone Layer Annex B, Group II control code\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 232,\n \"codeName\": \"Montreal Ozone Annex B, Group I\",\n \"idJurisdiction\": 22,\n \"jurisdictionName\": \"Montreal Ozone Protocol\",\n \"description\": \"Montreal Protocol on Substances that deplete the Ozone Layer Annex B, Group I control code\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 235,\n \"codeName\": \"Montreal Ozone Annex C, Group I\",\n \"idJurisdiction\": 22,\n \"jurisdictionName\": \"Montreal Ozone Protocol\",\n \"description\": \"Montreal Protocol on Substances that deplete the Ozone Layer Annex C, Group I control code\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 236,\n \"codeName\": \"Montreal Ozone Annex C, Group II\",\n \"idJurisdiction\": 22,\n \"jurisdictionName\": \"Montreal Ozone Protocol\",\n \"description\": \"Montreal Protocol on Substances that deplete the Ozone Layer Annex C, Group II control code\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 234,\n \"codeName\": \"Montreal Ozone Annex B, Group III\",\n \"idJurisdiction\": 22,\n \"jurisdictionName\": \"Montreal Ozone Protocol\",\n \"description\": \"Montreal Protocol on Substances that deplete the Ozone Layer Annex B, Group III control code\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 238,\n \"codeName\": \"Montreal Ozone Annex E, Group I\",\n \"idJurisdiction\": 22,\n \"jurisdictionName\": \"Montreal Ozone Protocol\",\n \"description\": \"Montreal Protocol on Substances that deplete the Ozone Layer Annex E, Group I control code\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 237,\n \"codeName\": \"Montreal Ozone Annex C, Group III\",\n \"idJurisdiction\": 22,\n \"jurisdictionName\": \"Montreal Ozone Protocol\",\n \"description\": \"Montreal Protocol on Substances that deplete the Ozone Layer Annex C, Group III control code\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 246,\n \"codeName\": \"French EU Drug Precursor Category 2\",\n \"idJurisdiction\": 4,\n \"jurisdictionName\": \"France\",\n \"description\": \"EU Drug Precursor Category 2\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 264,\n \"codeName\": \"Austria EU Drug Precursor Category 1\",\n \"idJurisdiction\": 23,\n \"jurisdictionName\": \"Austria\",\n \"description\": \"EU Drug Precursor Category 1\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 265,\n \"codeName\": \"Austria EU Drug Precursor Category 2\",\n \"idJurisdiction\": 23,\n \"jurisdictionName\": \"Austria\",\n \"description\": \"EU Drug Precursor Category 2\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 266,\n \"codeName\": \"Austria EU Drug Precursor Category 2A\",\n \"idJurisdiction\": 23,\n \"jurisdictionName\": \"Austria\",\n \"description\": \"EU Drug Precursor Category 2A\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 267,\n \"codeName\": \"Austria EU Drug Precursor Category 3\",\n \"idJurisdiction\": 23,\n \"jurisdictionName\": \"Austria\",\n \"description\": \"EU Drug Precursor Category 3\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 268,\n \"codeName\": \"Austria EU Drug Precursor Category 4\",\n \"idJurisdiction\": 23,\n \"jurisdictionName\": \"Austria\",\n \"description\": \"EU Drug Precursor Category 4\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 269,\n \"codeName\": \"Austria EU Drug Precursor Category 2B\",\n \"idJurisdiction\": 23,\n \"jurisdictionName\": \"Austria\",\n \"description\": \"Austria EU Drug Precursor Category 2B\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 271,\n \"codeName\": \"EU Human Rights List Annex III\",\n \"idJurisdiction\": 21,\n \"jurisdictionName\": \"European Union\",\n \"description\": \"EU Human Rights List Annex III\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 239,\n \"codeName\": \"Swedish Toxic Group A\",\n \"idJurisdiction\": 12,\n \"jurisdictionName\": \"Sweden\",\n \"description\": \"Swedish Toxic Group A\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 240,\n \"codeName\": \"Swedish Toxic Group B\",\n \"idJurisdiction\": 12,\n \"jurisdictionName\": \"Sweden\",\n \"description\": \"Swedish Toxic Group B\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 241,\n \"codeName\": \"Swedish EU Drug Precursor Category 2\",\n \"idJurisdiction\": 12,\n \"jurisdictionName\": \"Sweden\",\n \"description\": \"Swedish EU Drug Precursor Category 2\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 242,\n \"codeName\": \"Belgium EU Drug Precursor Category 2\",\n \"idJurisdiction\": 6,\n \"jurisdictionName\": \"Belgium\",\n \"description\": \"Belgium EU Drug Precursor Category 2\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 243,\n \"codeName\": \"German EU Drug Precursor Category 2\",\n \"idJurisdiction\": 8,\n \"jurisdictionName\": \"Germany\",\n \"description\": \"German EU Drug Precursor Category 2\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 244,\n \"codeName\": \"Danish EU Drug Precursor Category 2\",\n \"idJurisdiction\": 7,\n \"jurisdictionName\": \"Denmark\",\n \"description\": \"Danish EU Drug Precursor Category 2\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 245,\n \"codeName\": \"Irish EU Drug Precursor Category 2\",\n \"idJurisdiction\": 5,\n \"jurisdictionName\": \"Ireland\",\n \"description\": \"Irish EU Drug Precursor Category 2\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 247,\n \"codeName\": \"Netherlands EU Drug Precursor Category 2\",\n \"idJurisdiction\": 10,\n \"jurisdictionName\": \"Netherlands\",\n \"description\": \"Netherlands EU Drug Precursor Category 2\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 248,\n \"codeName\": \"Italian EU Drug Precursor Category 2\",\n \"idJurisdiction\": 9,\n \"jurisdictionName\": \"Italy\",\n \"description\": \"Italian EU Drug Precursor Category 2\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 249,\n \"codeName\": \"Spanish EU Drug Precursor Category 2\",\n \"idJurisdiction\": 11,\n \"jurisdictionName\": \"Spain\",\n \"description\": \"Spanish EU Drug Precursor Category 2\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 250,\n \"codeName\": \"Indian NDPS Rules Schedule I (I Narcotics)\",\n \"idJurisdiction\": 17,\n \"jurisdictionName\": \"India\",\n \"description\": \"Indian NDPS Rules Schedule I (I Narcotics)\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 251,\n \"codeName\": \"Indian NDPS Rules Schedule I (II Psychotrps)\",\n \"idJurisdiction\": 17,\n \"jurisdictionName\": \"India\",\n \"description\": \"Indian NDPS Rules Schedule I (II Psychotrps)\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 252,\n \"codeName\": \"Indian NDPS Rules Schedule II\",\n \"idJurisdiction\": 17,\n \"jurisdictionName\": \"India\",\n \"description\": \"Indian NDPS Rules Schedule II\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 253,\n \"codeName\": \"Indian NDPS Rules Schedule III (Psychotrps)\",\n \"idJurisdiction\": 17,\n \"jurisdictionName\": \"India\",\n \"description\": \"Indian NDPS Rules Schedule III (Psychotrps)\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 254,\n \"codeName\": \"EU Dual Use Items - Category 1C (Materials)\",\n \"idJurisdiction\": 21,\n \"jurisdictionName\": \"European Union\",\n \"description\": \"EU Dual Use Items - Category 1C (Materials)\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 255,\n \"codeName\": \"Austrian Narcotics Annex I.1\",\n \"idJurisdiction\": 23,\n \"jurisdictionName\": \"Austria\",\n \"description\": \"Austrian Narcotics Annex I.1\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 256,\n \"codeName\": \"Austrian Narcotics Annex I.2\",\n \"idJurisdiction\": 23,\n \"jurisdictionName\": \"Austria\",\n \"description\": \"Austrian Narcotics Annex I.2\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 257,\n \"codeName\": \"Austrian Narcotics Annex II\",\n \"idJurisdiction\": 23,\n \"jurisdictionName\": \"Austria\",\n \"description\": \"Austrian Narcotics Annex II\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 258,\n \"codeName\": \"Austrian Narcotics Annex III\",\n \"idJurisdiction\": 23,\n \"jurisdictionName\": \"Austria\",\n \"description\": \"Austrian Narcotics Annex III\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 259,\n \"codeName\": \"Austrian Narcotics Annex IV.1\",\n \"idJurisdiction\": 23,\n \"jurisdictionName\": \"Austria\",\n \"description\": \"Austrian Narcotics Annex IV.1\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 260,\n \"codeName\": \"Austrian Narcotics Annex IV.2\",\n \"idJurisdiction\": 23,\n \"jurisdictionName\": \"Austria\",\n \"description\": \"Austrian Narcotics Annex IV.2\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 261,\n \"codeName\": \"Austrian Narcotics Annex V.1\",\n \"idJurisdiction\": 23,\n \"jurisdictionName\": \"Austria\",\n \"description\": \"Austrian Narcotics Annex V.1\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 262,\n \"codeName\": \"Austrian Narcotics Annex V.2\",\n \"idJurisdiction\": 23,\n \"jurisdictionName\": \"Austria\",\n \"description\": \"Austrian Narcotics Annex V.2\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 263,\n \"codeName\": \"Austrian Psychotropics\",\n \"idJurisdiction\": 23,\n \"jurisdictionName\": \"Austria\",\n \"description\": \"Austrian Psychotropics\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 270,\n \"codeName\": \"UK Dual Use List Materials,Micro-orgs,Toxins\",\n \"idJurisdiction\": 2,\n \"jurisdictionName\": \"United Kingdom\",\n \"description\": \"UK Dual Use List Materials, Micro-organisms and toxins\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 272,\n \"codeName\": \"UK Human Rights – Prohibited Medical Prods\",\n \"idJurisdiction\": 2,\n \"jurisdictionName\": \"United Kingdom\",\n \"description\": \"UK Security and Human Rights - Prohibited Medicinal Products\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 273,\n \"codeName\": \"UK Controlled Radioactive Sources\",\n \"idJurisdiction\": 2,\n \"jurisdictionName\": \"United Kingdom\",\n \"description\": \"UK Radioactive Sources List\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 274,\n \"codeName\": \"China Non-medical Narcotics and Psychotropics\",\n \"idJurisdiction\": 19,\n \"jurisdictionName\": \"China\",\n \"description\": \"非药用类麻醉药品和精神药品管制品种增补目录\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 275,\n \"codeName\": \"Japanese Table I Narcotics\",\n \"idJurisdiction\": 24,\n \"jurisdictionName\": \"Japan\",\n \"description\": \"Narcotics and Psychotropics Control Law - Article 2 Table I Narcotics 第2条表I麻薬 - 麻薬及び向精神薬取締法 \",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 276,\n \"codeName\": \"Japanese Table II Narcotics Plants\",\n \"idJurisdiction\": 24,\n \"jurisdictionName\": \"Japan\",\n \"description\": \"Narcotics and Psychotropics Control Law - Article 2 Table II Narcotics Plants 第2条表II麻薬プラント - 麻薬及び向精神薬取締法 \",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 277,\n \"codeName\": \"Japanese Table III Psychotropics\",\n \"idJurisdiction\": 24,\n \"jurisdictionName\": \"Japan\",\n \"description\": \"Narcotics and Psychotropics Control Law - Article 2 Table III Psychotropics 第2条表III 向精神薬 - 麻薬及び向精神薬取締法 \",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 278,\n \"codeName\": \"Japanese Table IV Drug Raw Materials\",\n \"idJurisdiction\": 24,\n \"jurisdictionName\": \"Japan\",\n \"description\": \"Narcotics and Psychotropics Control Law - Table IV Precursors (Raw Materials) 麻薬原料\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 279,\n \"codeName\": \"Japanese Designated Substance\",\n \"idJurisdiction\": 24,\n \"jurisdictionName\": \"Japan\",\n \"description\": \"Designated substances according to the Pharmaceutical and Medical Device Act. 医薬品、医療機器等の品質、有効性及び安全性の確保等に関する法律指定薬物\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 280,\n \"codeName\": \"Japanese Poisonous Substances\",\n \"idJurisdiction\": 24,\n \"jurisdictionName\": \"Japan\",\n \"description\": \"Poisonous according to the Poisonous and Deleterious Substances Control Law 毒物 - 毒物及び劇物取締法\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 281,\n \"codeName\": \"Japanese Deleterious Substances\",\n \"idJurisdiction\": 24,\n \"jurisdictionName\": \"Japan\",\n \"description\": \"Deleterious Substances according to the Poisonous and Deleterious Substances Control Law 劇物 - 毒物及び劇物取締法\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 282,\n \"codeName\": \"Japanese Specific Poisonous Substances\",\n \"idJurisdiction\": 24,\n \"jurisdictionName\": \"Japan\",\n \"description\": \"Specific Poisonous Substances according to the Poisonous and Deleterious Substances Control Law 特定毒物 - 毒物及び劇物取締法\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 283,\n \"codeName\": \"Japanese Stimulants Raw Materials\",\n \"idJurisdiction\": 24,\n \"jurisdictionName\": \"Japan\",\n \"description\": \"\\rStimulants Raw Material 覚せい剤取締法 \\r\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 284,\n \"codeName\": \"Japanese Table I Narcotics Similar\",\n \"idJurisdiction\": 24,\n \"jurisdictionName\": \"Japan\",\n \"description\": \"Narcotics and Psychotropics Control Law - Article 2 Table I Narcotics 第1条表I麻薬 - 麻薬及び向精神薬取締法 \",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 285,\n \"codeName\": \"Japanese Table III Psychotropics Similar\",\n \"idJurisdiction\": 24,\n \"jurisdictionName\": \"Japan\",\n \"description\": \"Narcotics and Psychotropics Control Law Article 3, Division 1. 麻薬、麻薬原料植物、向精神薬及び麻薬向精神薬原料を指定する政令（第3条関係）第1種\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 286,\n \"codeName\": \"Japanese Article 3 Division 2 Psychotropics\",\n \"idJurisdiction\": 24,\n \"jurisdictionName\": \"Japan\",\n \"description\": \"Not used\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 287,\n \"codeName\": \"Japanese Article 3 Division 3 Psychotropics\",\n \"idJurisdiction\": 24,\n \"jurisdictionName\": \"Japan\",\n \"description\": \"Not used\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 288,\n \"codeName\": \"Japanese Opium Law\",\n \"idJurisdiction\": 24,\n \"jurisdictionName\": \"Japan\",\n \"description\": \"Japanese Opium Law (あへん法)\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 289,\n \"codeName\": \"Japanese Cannabis Control Law\",\n \"idJurisdiction\": 24,\n \"jurisdictionName\": \"Japan\",\n \"description\": \"Japanese Cannabis Control Law (大麻取締法)\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 290,\n \"codeName\": \"Japanese Stimulants Law\",\n \"idJurisdiction\": 24,\n \"jurisdictionName\": \"Japan\",\n \"description\": \"Japanese Stimulants Law 覚せい剤取締法 \\n\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 291,\n \"codeName\": \"US CWC Precursors\",\n \"idJurisdiction\": 3,\n \"jurisdictionName\": \"United States of America\",\n \"description\": \"This is a CS2 generated control code to enable CS2 to flag CWC and Australia Group precursors enacted in US CCL and ITAR legislation as precursors\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 292,\n \"codeName\": \"EU CWC Precursors\",\n \"idJurisdiction\": 21,\n \"jurisdictionName\": \"European Union\",\n \"description\": \"This is a CS2 generated control code to enable CS2 to flag CWC and Australia Group precursors enacted in the EU Military List and EU Dual Use legislation as precursors.\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 293,\n \"codeName\": \"UK 3rd Generation Cannabinoid\",\n \"idJurisdiction\": 2,\n \"jurisdictionName\": \"United Kingdom\",\n \"description\": \"This a CS2 generated control code to enable CS2 to specifically flag 3rd generation cannabinoids, allowing them to be filtered by donwstream systems for special handling\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 294,\n \"codeName\": \"Spanish National Level Narcotic\",\n \"idJurisdiction\": 11,\n \"jurisdictionName\": \"Spain\",\n \"description\": \"These are considered controlled narcotics and are not on the UN Yellow List\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 295,\n \"codeName\": \"Montreal Ozone Annex F, Group I\",\n \"idJurisdiction\": 22,\n \"jurisdictionName\": \"Montreal Ozone Protocol\",\n \"description\": \"Montreal Protocol on Substances that deplete the Ozone Layer Annex F, Group I control code\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 296,\n \"codeName\": \"Montreal Ozone Annex F, Group II\",\n \"idJurisdiction\": 22,\n \"jurisdictionName\": \"Montreal Ozone Protocol\",\n \"description\": \"Montreal Protocol on Substances that deplete the Ozone Layer Annex F, Group II control code\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 297,\n \"codeName\": \"Irish Schedule 8 pt5\",\n \"idJurisdiction\": 5,\n \"jurisdictionName\": \"Ireland\",\n \"description\": \"Drugs for use in mental health or intellectual disbaility\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 298,\n \"codeName\": \"Belgium Annex IA\",\n \"idJurisdiction\": 6,\n \"jurisdictionName\": \"Belgium\",\n \"description\": \"Belgium Annex IA\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 299,\n \"codeName\": \"Belgium Annex IB\",\n \"idJurisdiction\": 6,\n \"jurisdictionName\": \"Belgium\",\n \"description\": \"Belgium Annex IB\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 300,\n \"codeName\": \"Belgium Annex IIA\",\n \"idJurisdiction\": 6,\n \"jurisdictionName\": \"Belgium\",\n \"description\": \"Belgium Annex IIA\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 301,\n \"codeName\": \"Belgium Annex IIB\",\n \"idJurisdiction\": 6,\n \"jurisdictionName\": \"Belgium\",\n \"description\": \"Belgium Annex IIB\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 302,\n \"codeName\": \"Belgium Annex IIC\",\n \"idJurisdiction\": 6,\n \"jurisdictionName\": \"Belgium\",\n \"description\": \"Belgium Annex IIC\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 303,\n \"codeName\": \"Belgium Annex III\",\n \"idJurisdiction\": 6,\n \"jurisdictionName\": \"Belgium\",\n \"description\": \"Belgium Annex III\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 304,\n \"codeName\": \"Belgium Annex IVB\",\n \"idJurisdiction\": 6,\n \"jurisdictionName\": \"Belgium\",\n \"description\": \"Belgium Annex IVB\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 305,\n \"codeName\": \"Belgium Annex IVA\",\n \"idJurisdiction\": 6,\n \"jurisdictionName\": \"Belgium\",\n \"description\": \"Belgium Annex IVA\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 306,\n \"codeName\": \"Belgium Annex IC\",\n \"idJurisdiction\": 6,\n \"jurisdictionName\": \"Belgium\",\n \"description\": \"Belgium Annex IC\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 307,\n \"codeName\": \"Belgium Annex V\",\n \"idJurisdiction\": 6,\n \"jurisdictionName\": \"Belgium\",\n \"description\": \"Belgium Annex V\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 308,\n \"codeName\": \"EU Controlled Psychoactive Substance\",\n \"idJurisdiction\": 21,\n \"jurisdictionName\": \"European Union\",\n \"description\": \"EU Controlled Psychoactive Substance\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 309,\n \"codeName\": \"Singapore Regulations First Schedule\",\n \"idJurisdiction\": 25,\n \"jurisdictionName\": \"Singapore\",\n \"description\": \"Singapore Regulations First Schedule\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 310,\n \"codeName\": \"Singapore Regulations Second Schedule\",\n \"idJurisdiction\": 25,\n \"jurisdictionName\": \"Singapore\",\n \"description\": \"Singapore Regulations Second Schedule\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 311,\n \"codeName\": \"Singapore Regulations Third Schedule\",\n \"idJurisdiction\": 25,\n \"jurisdictionName\": \"Singapore\",\n \"description\": \"Singapore Regulations Third Schedule\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 312,\n \"codeName\": \"Singapore Regulations Fourth Schedule\",\n \"idJurisdiction\": 25,\n \"jurisdictionName\": \"Singapore\",\n \"description\": \"Singapore Regulations Fourth Schedule\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 313,\n \"codeName\": \"Singapore Class A\",\n \"idJurisdiction\": 25,\n \"jurisdictionName\": \"Singapore\",\n \"description\": \"Singapore Class A\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 314,\n \"codeName\": \"Singapore Class B\",\n \"idJurisdiction\": 25,\n \"jurisdictionName\": \"Singapore\",\n \"description\": \"Singapore Class B\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 316,\n \"codeName\": \"Singapore Specified Drug\",\n \"idJurisdiction\": 25,\n \"jurisdictionName\": \"Singapore\",\n \"description\": \"Singapore Specified Drug\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 315,\n \"codeName\": \"Singapore Class C\",\n \"idJurisdiction\": 25,\n \"jurisdictionName\": \"Singapore\",\n \"description\": \"Singapore Class C\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 317,\n \"codeName\": \"Singapore Temporarily Listed Drugs\",\n \"idJurisdiction\": 25,\n \"jurisdictionName\": \"Singapore\",\n \"description\": \"Singapore Temporarily Listed Drugs\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 318,\n \"codeName\": \"Singapore Precursors Part I\",\n \"idJurisdiction\": 25,\n \"jurisdictionName\": \"Singapore\",\n \"description\": \"Singapore Substances useful for Manufacturing Controlled Drugs Part 1\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 319,\n \"codeName\": \"Singapore Precursors Part II\",\n \"idJurisdiction\": 25,\n \"jurisdictionName\": \"Singapore\",\n \"description\": \"Singapore Substances useful for Manufacturing Controlled Drugs Part II\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 320,\n \"codeName\": \"Mexican Narcotics\",\n \"idJurisdiction\": 26,\n \"jurisdictionName\": \"Mexico\",\n \"description\": \"Mexican Narcotic Substances\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 321,\n \"codeName\": \"Mexican Psychotropics Group 1\",\n \"idJurisdiction\": 26,\n \"jurisdictionName\": \"Mexico\",\n \"description\": \"Mexican Psychotropic Substances Group 1\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 322,\n \"codeName\": \"Mexican Psychotropics Group 2\",\n \"idJurisdiction\": 26,\n \"jurisdictionName\": \"Mexico\",\n \"description\": \"Mexican Psychotropic Substances Group 2\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 323,\n \"codeName\": \"Mexican Psychotropics Group 3\",\n \"idJurisdiction\": 26,\n \"jurisdictionName\": \"Mexico\",\n \"description\": \"Mexican Psychotropic Substances Group 3\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 324,\n \"codeName\": \"Mexican Psychotropics Group 4\",\n \"idJurisdiction\": 26,\n \"jurisdictionName\": \"Mexico\",\n \"description\": \"Mexican Psychotropic Substances Group 4\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 325,\n \"codeName\": \"Mexican Psychotropics Group 5\",\n \"idJurisdiction\": 26,\n \"jurisdictionName\": \"Mexico\",\n \"description\": \"Mexican Psychotropic Substances Group 5\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 326,\n \"codeName\": \"Mexican Chemical Precursors List I\",\n \"idJurisdiction\": 26,\n \"jurisdictionName\": \"Mexico\",\n \"description\": \"Mexican Chemical Precursors List I (Chemical Precursors)\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 327,\n \"codeName\": \"Mexican Chemical Precursors List II\",\n \"idJurisdiction\": 26,\n \"jurisdictionName\": \"Mexico\",\n \"description\": \"Mexican Chemical Precursors List II (Essential Chemicals)\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 328,\n \"codeName\": \"Singapore Psychotropic Substance\",\n \"idJurisdiction\": 25,\n \"jurisdictionName\": \"Singapore\",\n \"description\": \"Singapore Psychotropic Substance\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 329,\n \"codeName\": \"Brazilian List A1\",\n \"idJurisdiction\": 27,\n \"jurisdictionName\": \"Brazil\",\n \"description\": \"Brazilian List A1 (Narcotic Substances subject to Revenue Notification A)\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 330,\n \"codeName\": \"Brazilian List A2\",\n \"idJurisdiction\": 27,\n \"jurisdictionName\": \"Brazil\",\n \"description\": \"Brazilian List A2 (Narcotic Substances permitted for use in special concentrations and subject to Revenue Notification A)\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 331,\n \"codeName\": \"Brazilian List A3\",\n \"idJurisdiction\": 27,\n \"jurisdictionName\": \"Brazil\",\n \"description\": \"Brazilian List A3 (Psychotropic Substances subject to Revenue Notification A)\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 332,\n \"codeName\": \"Brazilian List B1\",\n \"idJurisdiction\": 27,\n \"jurisdictionName\": \"Brazil\",\n \"description\": \"Brazilian List B1 (Psychotropic Substances subject to Revenue Notification B)\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 333,\n \"codeName\": \"Brazilian List B2\",\n \"idJurisdiction\": 27,\n \"jurisdictionName\": \"Brazil\",\n \"description\": \"Brazilian List B2 (Anorectic Psychotropic Substances subject to Revenue Notification B)\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 334,\n \"codeName\": \"Brazilian List C1\",\n \"idJurisdiction\": 27,\n \"jurisdictionName\": \"Brazil\",\n \"description\": \"Brazilian List C1 (Other Substances under special control and subject to two-way Special Control Revenue)\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 335,\n \"codeName\": \"Brazilian List C2\",\n \"idJurisdiction\": 27,\n \"jurisdictionName\": \"Brazil\",\n \"description\": \"Brazilian List C2 (Retinoic Substances which are subject to Special Revenue Notification)\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 336,\n \"codeName\": \"Brazilian List C3\",\n \"idJurisdiction\": 27,\n \"jurisdictionName\": \"Brazil\",\n \"description\": \"Brazilian List C3 (Immunosuppressant Substances which are subject to Special Revenue Notification)\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 380,\n \"codeName\": \"Finnish EU Drug Precursor Category 1\",\n \"idJurisdiction\": 29,\n \"jurisdictionName\": \"Finland\",\n \"description\": \"EU Drug Precursor Category 1\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 381,\n \"codeName\": \"Finnish EU Drug Precursor Category 2\",\n \"idJurisdiction\": 29,\n \"jurisdictionName\": \"Finland\",\n \"description\": \"EU Drug Precursor Category 2\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 382,\n \"codeName\": \"Finnish EU Drug Precursor Category 2A\",\n \"idJurisdiction\": 29,\n \"jurisdictionName\": \"Finland\",\n \"description\": \"EU Drug Precursor Category 2A\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 383,\n \"codeName\": \"Finnish EU Drug Precursor Category 2B\",\n \"idJurisdiction\": 29,\n \"jurisdictionName\": \"Finland\",\n \"description\": \"EU Drug Precursor Category 2B\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 384,\n \"codeName\": \"Finnish EU Drug Precursor Category 3\",\n \"idJurisdiction\": 29,\n \"jurisdictionName\": \"Finland\",\n \"description\": \"EU Drug Precursor Category 3\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 385,\n \"codeName\": \"Finnish EU Drug Precursor Category 4\",\n \"idJurisdiction\": 29,\n \"jurisdictionName\": \"Finland\",\n \"description\": \"EU Drug Precursor Category 4\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 353,\n \"codeName\": \"Polish EU Drug Precursor Category 1\",\n \"idJurisdiction\": 28,\n \"jurisdictionName\": \"Poland\",\n \"description\": \"Polish EU Drug Precursor Category 1\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 354,\n \"codeName\": \"Polish EU Drug Precursor Category 2\",\n \"idJurisdiction\": 28,\n \"jurisdictionName\": \"Poland\",\n \"description\": \"Polish EU Drug Precursor Category 2\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 355,\n \"codeName\": \"Polish EU Drug Precursor Category 2A\",\n \"idJurisdiction\": 28,\n \"jurisdictionName\": \"Poland\",\n \"description\": \"Polish EU Drug Precursor Category 2A\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 356,\n \"codeName\": \"Polish EU Drug Precursor Category 2B\",\n \"idJurisdiction\": 28,\n \"jurisdictionName\": \"Poland\",\n \"description\": \"Polish EU Drug Precursor Category 2B\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 357,\n \"codeName\": \"Polish EU Drug Precursor Category 3 \",\n \"idJurisdiction\": 28,\n \"jurisdictionName\": \"Poland\",\n \"description\": \"Polish EU Drug Precursor Category 3\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 358,\n \"codeName\": \"Polish EU Drug Precursor Category 4\",\n \"idJurisdiction\": 28,\n \"jurisdictionName\": \"Poland\",\n \"description\": \"Polish EU Drug Precursor Category 4\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 337,\n \"codeName\": \"Brazilian List C5\",\n \"idJurisdiction\": 27,\n \"jurisdictionName\": \"Brazil\",\n \"description\": \"Brazilian List C5 (Anabolic Substances which are subject to two-way Special Control Revenue)\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 338,\n \"codeName\": \"Brazilian List D1\",\n \"idJurisdiction\": 27,\n \"jurisdictionName\": \"Brazil\",\n \"description\": \"Brazilian List D1 (Precursor Substances for narcotics and/or psychotropics, which are subject to Non-Retention Medical Revenue)\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 339,\n \"codeName\": \"Brazilian List D2\",\n \"idJurisdiction\": 27,\n \"jurisdictionName\": \"Brazil\",\n \"description\": \"Brazilian List D2 (Chemical Inputs in manufacturing and synthesis of narcotics and/or psychotropic substances which are subject to the control of the Ministry of Justice)\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 340,\n \"codeName\": \"Brazilian List E\",\n \"idJurisdiction\": 27,\n \"jurisdictionName\": \"Brazil\",\n \"description\": \"Brazilian List E (Proscribed plants from which narcotics and/or psychotropics originate)\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 341,\n \"codeName\": \"Brazilian List F1\",\n \"idJurisdiction\": 27,\n \"jurisdictionName\": \"Brazil\",\n \"description\": \"Brazilian List F1 (List F is reserved for substances which are prohibited in Brazil. List F1 is for narcotic substances)\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 342,\n \"codeName\": \"Brazilian List F2\",\n \"idJurisdiction\": 27,\n \"jurisdictionName\": \"Brazil\",\n \"description\": \"Brazilian List F2 (List F is reserved for substances which are prohibited in Brazil. List F2a is for psychotropic substances. List F2b and F2c contain the cannabinoid and cathinone Markush definitions, respectively.)\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 343,\n \"codeName\": \"Brazilian List F3\",\n \"idJurisdiction\": 27,\n \"jurisdictionName\": \"Brazil\",\n \"description\": \"Brazilian List F3 (List F is reserved for substances which are prohibited in Brazil. List F3 is reserved for precursor substances)\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 344,\n \"codeName\": \"Brazilian List F4\",\n \"idJurisdiction\": 27,\n \"jurisdictionName\": \"Brazil\",\n \"description\": \"Brazilian List F4 (List F is reserved for substances which are prohibited in Brazil. List F4 is reserved for other substances)\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 361,\n \"codeName\": \"NOT-IN-USE-REUSE THIS IDSYS_CONTROLLEDCODE\",\n \"idJurisdiction\": 19,\n \"jurisdictionName\": \"China\",\n \"description\": \"NOT-IN-USE-REUSE THIS IDSYS_CONTROLLEDCODE - edit all fields including IDJurisdiction\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 362,\n \"codeName\": \"Annex 1 List I\",\n \"idJurisdiction\": 29,\n \"jurisdictionName\": \"Finland\",\n \"description\": \"List of the 1961 Convention on Drugs I (Vuoden 1961 huumausaineyleissopimuksen lista I)\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 363,\n \"codeName\": \"Annex 1 List II\",\n \"idJurisdiction\": 29,\n \"jurisdictionName\": \"Finland\",\n \"description\": \"List of the 1961 Convention on Drugs II (Vuoden 1961 huumausaineyleissopimuksen lista II)\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 364,\n \"codeName\": \"Annex 1 List III\",\n \"idJurisdiction\": 29,\n \"jurisdictionName\": \"Finland\",\n \"description\": \"List of the 1961 Convention on Drugs III (Vuoden 1961 huumausaineyleissopimuksen lista III)\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 365,\n \"codeName\": \"Annex 1 List IV\",\n \"idJurisdiction\": 29,\n \"jurisdictionName\": \"Finland\",\n \"description\": \"List of the 1961 Convention on Drugs IV (Vuoden 1961 huumausaineyleissopimuksen lista IV)\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 366,\n \"codeName\": \"Annex 2 List I\",\n \"idJurisdiction\": 29,\n \"jurisdictionName\": \"Finland\",\n \"description\": \"List of the 1971 Convention on Psychotropic Substances I (Psykotrooppisia aineita koskevan yleissopimuksen lista I)\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 367,\n \"codeName\": \"Annex 2 List II\",\n \"idJurisdiction\": 29,\n \"jurisdictionName\": \"Finland\",\n \"description\": \"List of the 1971 Convention on Psychotropic Substances II (Psykotrooppisia aineita koskevan yleissopimuksen lista II)\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 368,\n \"codeName\": \"Annex 2 List III\",\n \"idJurisdiction\": 29,\n \"jurisdictionName\": \"Finland\",\n \"description\": \"List of the 1971 Convention on Psychotropic Substances III (Psykotrooppisia aineita koskevan yleissopimuksen lista III)\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 369,\n \"codeName\": \"Annex 2 List IV\",\n \"idJurisdiction\": 29,\n \"jurisdictionName\": \"Finland\",\n \"description\": \"List of the 1971 Convention on Psychotropic Substances IV (Psykotrooppisia aineita koskevan yleissopimuksen lista IV)\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 370,\n \"codeName\": \"Annex 3\",\n \"idJurisdiction\": 29,\n \"jurisdictionName\": \"Finland\",\n \"description\": \"Substances subject to surveillance under Council Decisions adopted under Joint Action 97/396 / JHA on new synthetic drugs or Decision 2005/387 / JHA on the exchange, risk assessment and control of new psychoactive substances:\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 371,\n \"codeName\": \"Annex 4\",\n \"idJurisdiction\": 29,\n \"jurisdictionName\": \"Finland\",\n \"description\": \"Annex 4 substances\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 372,\n \"codeName\": \"Psychoactive Substances Appendix\",\n \"idJurisdiction\": 29,\n \"jurisdictionName\": \"Finland\",\n \"description\": \"Substances list under Government Decree on Psychoactive Substances as Banned from the Consumer Market\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 360,\n \"codeName\": \"Polish New Psychotropic Substances\",\n \"idJurisdiction\": 28,\n \"jurisdictionName\": \"Poland\",\n \"description\": \"Polish New Psychotropic Substances (Nowych substancji psychoaktywnych)\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 373,\n \"codeName\": \"Schedule 1 Controlled Drugs \",\n \"idJurisdiction\": 30,\n \"jurisdictionName\": \"Taiwan\",\n \"description\": \"Schedule 1 Controlled Drugs 第一級管制藥品\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 374,\n \"codeName\": \"Schedule 2 Controlled Drugs \",\n \"idJurisdiction\": 30,\n \"jurisdictionName\": \"Taiwan\",\n \"description\": \"Schedule 2 Controlled Drugs 第二級管制藥品\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 375,\n \"codeName\": \"Schedule 3 Controlled Drugs \",\n \"idJurisdiction\": 30,\n \"jurisdictionName\": \"Taiwan\",\n \"description\": \"Schedule 3 Controlled Drugs 第三級管制藥品\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 376,\n \"codeName\": \"Schedule 4 Controlled Drugs \",\n \"idJurisdiction\": 30,\n \"jurisdictionName\": \"Taiwan\",\n \"description\": \"Schedule 4 Controlled Drugs 第四級管制藥品\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 377,\n \"codeName\": \"Schedule 4 Controlled Drug Materials\",\n \"idJurisdiction\": 30,\n \"jurisdictionName\": \"Taiwan\",\n \"description\": \"Schedule 4 Controlled Drug Materials 第四級管制藥品原料藥\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 378,\n \"codeName\": \"Table I – Category A\",\n \"idJurisdiction\": 30,\n \"jurisdictionName\": \"Taiwan\",\n \"description\": \"Table I – Category A 一、甲類\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 379,\n \"codeName\": \"Table 2 – Category B\",\n \"idJurisdiction\": 30,\n \"jurisdictionName\": \"Taiwan\",\n \"description\": \"Table 2 – Category B 二、乙類\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 359,\n \"codeName\": \"EU Human Rights List Annex IV\",\n \"idJurisdiction\": 21,\n \"jurisdictionName\": \"European Union\",\n \"description\": \"EU Human Rights List Annex IV\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 345,\n \"codeName\": \"Polish Narcotic drugs I-N\",\n \"idJurisdiction\": 28,\n \"jurisdictionName\": \"Poland\",\n \"description\": \"Polish Narcotic drugs Group 1 (Środki odurzające grupy I-N)\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 346,\n \"codeName\": \"Polish Narcotic drugs II-N\",\n \"idJurisdiction\": 28,\n \"jurisdictionName\": \"Poland\",\n \"description\": \"Polish Narcotic drugs Group 2 (Środki odurzające grupy II-N)\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 347,\n \"codeName\": \"Polish Narcotic drugs III-N\",\n \"idJurisdiction\": 28,\n \"jurisdictionName\": \"Poland\",\n \"description\": \"Polish Narcotic drugs Group 3 (Środki odurzające grupy III-N)\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 348,\n \"codeName\": \"Polish Narcotic drugs IV-N\",\n \"idJurisdiction\": 28,\n \"jurisdictionName\": \"Poland\",\n \"description\": \"Polish Narcotic drugs Group 4 (Środki odurzające grupy IV-N)\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 349,\n \"codeName\": \"Polish Psychotropic Substances I-P\",\n \"idJurisdiction\": 28,\n \"jurisdictionName\": \"Poland\",\n \"description\": \"Polish Psychotropic Substances group 1 (Substancje psychotropowe grupy I-P)\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 350,\n \"codeName\": \"Polish Psychotropic Substances II-P\",\n \"idJurisdiction\": 28,\n \"jurisdictionName\": \"Poland\",\n \"description\": \"Polish Psychotropic Substances group 2 (Substancje psychotropowe grupy II-P)\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 351,\n \"codeName\": \"Polish Psychotropic Substances III-P\",\n \"idJurisdiction\": 28,\n \"jurisdictionName\": \"Poland\",\n \"description\": \"Polish Psychotropic Substances group 3 (Substancje psychotropowe grupy III-P)\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 352,\n \"codeName\": \"Polish Psychotropic Substances IV-P\",\n \"idJurisdiction\": 28,\n \"jurisdictionName\": \"Poland\",\n \"description\": \"Polish Psychotropic Substances group 4 (Substancje psychotropowe grupy IV-P)\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 386,\n \"codeName\": \"UK 3rd Generation Cannabinoid 2019\",\n \"idJurisdiction\": 2,\n \"jurisdictionName\": \"United Kingdom\",\n \"description\": \"This a CS2 generated control code to enable CS2 to specifically flag 3rd generation cannabinoids as defined by the 2019 amendment, allowing them to be filtered by downstream systems for special handling\",\n \"idControlledCode\": null\n },\n {\n \"idControlledCode\": 141,\n \"codeName\": \"TestCC\",\n \"idJurisdiction\": 2,\n \"jurisdictionName\": \"United Kingdom\",\n \"description\": \"This is a test\",\n \"idSysControlledCode\": null\n },\n {\n \"idControlledCode\": 61,\n \"codeName\": \"Sci UK Test\",\n \"idJurisdiction\": 2,\n \"jurisdictionName\": \"United Kingdom\",\n \"description\": \"Sci test control code for the UK\",\n \"idSysControlledCode\": null\n },\n {\n \"idControlledCode\": 201,\n \"codeName\": \"FR_testCustomerCC\",\n \"idJurisdiction\": 4,\n \"jurisdictionName\": \"France\",\n \"description\": \"testing\",\n \"idSysControlledCode\": null\n },\n {\n \"idControlledCode\": 181,\n \"codeName\": \"UserDefinedCC2\",\n \"idJurisdiction\": 10000,\n \"jurisdictionName\": \"UserDefined\",\n \"description\": \"newUSerDefinedCC_forTestiing multiple customer controls codes per sub2jur \",\n \"idSysControlledCode\": null\n },\n {\n \"idControlledCode\": 121,\n \"codeName\": \"Userdefined Control Code\",\n \"idJurisdiction\": 10000,\n \"jurisdictionName\": \"UserDefined\",\n \"description\": \"this is a test\",\n \"idSysControlledCode\": null\n },\n {\n \"idControlledCode\": 161,\n \"codeName\": \"Adam Test CC 2\",\n \"idJurisdiction\": 10001,\n \"jurisdictionName\": \"Adam Test\",\n \"description\": \"Test control code 2\",\n \"idSysControlledCode\": null\n },\n {\n \"idControlledCode\": 101,\n \"codeName\": \"Adam Test CC\",\n \"idJurisdiction\": 10001,\n \"jurisdictionName\": \"Adam Test\",\n \"description\": \"This is a test control code\",\n \"idSysControlledCode\": null\n }\n]"}],"_postman_id":"6265338c-e456-4d82-8744-defc8551d74b"}],"id":"cc02a0c2-3610-4a4b-9fdf-6f2be318606e","description":"

These endpoints allow a CS2 to be executed in the browser, these URLs will start the job and direct the user to the UI to view the results.

\n","_postman_id":"cc02a0c2-3610-4a4b-9fdf-6f2be318606e"},{"name":"/jurisdictions","event":[{"listen":"test","script":{"id":"7ac08ae6-1d0a-44ab-8871-06c696ce7832","exec":[""],"type":"text/javascript","packages":{}}}],"id":"de4f174b-6a5a-4350-9af6-f802fdeb3869","protocolProfileBehavior":{"disableBodyPruning":true},"request":{"method":"GET","header":[{"key":"x-access-token","value":"{{token}}","description":"

This header needs to have the authenication token obtained from the /authenticate API to allow requests to be sent to this endpoint

\n","type":"text"}],"url":"https://{{host}}:{{port}}/jurisdictions","description":"

Get a list of jurisdictions in CS2

\n","urlObject":{"protocol":"https","port":"{{port}}","path":["jurisdictions"],"host":["{{host}}"],"query":[],"variable":[]}},"response":[{"id":"1007b640-2a65-4fb5-a32c-becc06667a7c","name":"/jurisdictions","originalRequest":{"method":"GET","header":[{"key":"x-access-token","value":"{{token}}","description":"This header needs to have the authenication token obtained from the /owner/authenticate API to allow requests to be sent to this endpoint","type":"text"}],"url":"https://{{host}}:{{port}}/jurisdictions"},"status":"OK","code":200,"_postman_previewlanguage":"json","header":[{"key":"Date","value":"Tue, 29 Jun 2021 09:31:39 GMT","enabled":true},{"key":"Content-Type","value":"application/json; charset=utf-8","enabled":true},{"key":"Content-Length","value":"11889","enabled":true},{"key":"Connection","value":"keep-alive","enabled":true},{"key":"Set-Cookie","value":"AWSALBTG=xCfwjhcMA+Sctqv6W1AHckPs2HU6/mEvD3Gw8LUH4XAhs+v1Kyktn5dL2ty5e8cqfDneIN4X4tU/UA34KjNiYfg/0wD5VxCGl+QrZT/trhgjllU9iyEUUvhKOuhdJ8d0sA1LTUJxSrFAggOePESCfCQpjCYkk7X9ATcC/IOIgSJk5J7oUWA=; Expires=Tue, 06 Jul 2021 09:31:39 GMT; Path=/","enabled":true},{"key":"Set-Cookie","value":"AWSALBTGCORS=xCfwjhcMA+Sctqv6W1AHckPs2HU6/mEvD3Gw8LUH4XAhs+v1Kyktn5dL2ty5e8cqfDneIN4X4tU/UA34KjNiYfg/0wD5VxCGl+QrZT/trhgjllU9iyEUUvhKOuhdJ8d0sA1LTUJxSrFAggOePESCfCQpjCYkk7X9ATcC/IOIgSJk5J7oUWA=; Expires=Tue, 06 Jul 2021 09:31:39 GMT; Path=/; SameSite=None; Secure","enabled":true},{"key":"X-Powered-By","value":"Express","enabled":true},{"key":"X-Frame-Options","value":"SAMEORIGIN","enabled":true},{"key":"ETag","value":"W/\"2e71-M6lUK4NevYYXb0Xw6s5qWC2xndk\"","enabled":true}],"cookie":[],"responseTime":null,"body":"[\n {\n \"idJurisdiction\": 2,\n \"title\": \"United Kingdom\",\n \"countryCode\": \"UK\",\n \"countryCodeISO\": \"GB\",\n \"description\": \"Covers controlled substances detailed in the 'The Misuse of Drugs Act 1971', 'Misuse of Drugs Regulations 2001', 'UK Dual Use List Materials, Micro-organisms, Toxins', 'UK Human Rights Prohibited Medical Products' and 'UK Controlled Radioactive Sources'. This jurisdiction also includes EU drug precursor legislation\"\n },\n {\n \"idJurisdiction\": 3,\n \"title\": \"United States of America\",\n \"countryCode\": \"USA\",\n \"countryCodeISO\": \"US\",\n \"description\": \"Covers controlled substances and chemical precursors detailed in the 'Controlled Substances Act', 'Automation of Reports and Consolidated Order System' (ARCOS), 'International Traffic in Arms Regulations' (ITAR) and the 'Commerce Control Lists' (CCL)\"\n },\n {\n \"idJurisdiction\": 4,\n \"title\": \"France\",\n \"countryCode\": \"FR\",\n \"countryCodeISO\": \"FR\",\n \"description\": \"Covers controlled substances legislated for by 'Loi no. 70-1320 du 31 décembre 1970' (EN: Law no. 70-1320 of December 31, 1970). The controlled substances are defined by two separate decrees ('Decree of 22 February 1990 establishing the list of substances classified as narcotics' and 'Decree of 22 February 1990 establishing the list of psychotropic substances'). This jurisdiction also includes EU drug precursor legislation\"\n },\n {\n \"idJurisdiction\": 5,\n \"title\": \"Ireland\",\n \"countryCode\": \"IE\",\n \"countryCodeISO\": \"IE\",\n \"description\": \"Covers controlled substances detailed in the 'Misuse of Drugs Act 1977' and 'Misuse of Drugs Regulation 2017'. This jurisdiction also includes EU drug precursor legislation\"\n },\n {\n \"idJurisdiction\": 6,\n \"title\": \"Belgium\",\n \"countryCode\": \"BE\",\n \"countryCodeISO\": \"BE\",\n \"description\": \"Covers controlled substances detailed in the 'Arrêté royal réglementant les substances stupéfiantes, psychotropes et soporifiques' (EN: Royal decree regulating narcotic, psychotropic and soporific substances). This jurisdiction also includes EU drug precursor legislation\"\n },\n {\n \"idJurisdiction\": 7,\n \"title\": \"Denmark\",\n \"countryCode\": \"DK\",\n \"countryCodeISO\": \"DK\",\n \"description\": \"Covers controlled substances detailed in \\\"BEK nr 557 af 31/05/2011 Bekendtgørelse om euforiserende stoffer '' (EN: Executive order no. 557 of 31 May 2001 on Euphoric Substances). This jurisdiction also includes EU drug precursor legislation\"\n },\n {\n \"idJurisdiction\": 8,\n \"title\": \"Germany\",\n \"countryCode\": \"DE\",\n \"countryCodeISO\": \"DE\",\n \"description\": \"Covers controlled substances detailed in the 'Betäubungsmittelgesetz (BtMG)' (EN: Narcotics Act), This jurisdiction also includes EU drug precursor legislation. The 'Neue-Psychoaktive-Stoffe-Gesetz' (EN: New Psychoactive Substances Act) is not covered by CS2 as it does not apply to substances used for legitimate use and research purposes\"\n },\n {\n \"idJurisdiction\": 9,\n \"title\": \"Italy\",\n \"countryCode\": \"IT\",\n \"countryCodeISO\": \"IT\",\n \"description\": \"Covers controlled substances detailed in 'D.P.R. del 9 ottobre 1990, n. 309 Testo unico delle leggi in materia di disciplina degli stupefacenti e sostanze psicotrope, prevenzione, cura e riabilitazione dei relativi stati di tossicodipendenza' (EN: Presidential Decree of 9 October 1990, n. 309 Consolidated Law on the regulation of narcotic drugs and psychotropic substances, prevention, treatment and rehabilitation of the related states of drug addiction). This jurisdiction also includes EU drug precursor legislation\"\n },\n {\n \"idJurisdiction\": 10,\n \"title\": \"Netherlands\",\n \"countryCode\": \"NL\",\n \"countryCodeISO\": \"NL\",\n \"description\": \"Covers controlled substances detailed in the 'OpiumWet' (EN: Opium Act). This jurisdiction also includes EU drug precursor legislation\"\n },\n {\n \"idJurisdiction\": 11,\n \"title\": \"Spain\",\n \"countryCode\": \"ES\",\n \"countryCodeISO\": \"ES\",\n \"description\": \"Covers controlled substances detailed in 'Ley 17/1967, de 8 de abril, por la que se actualizan las normas vigentes sobre estupefacientes y adaptándolas a lo establecido en el convenio de 1961 de las Naciones Unidas' (EN: Law 17/1967, of April 8, which updates current regulations on narcotics and adapting them to the provisions of the 1961 agreement of the United Nations) and 'Real Decreto 2829/1977, de 6 de octubre por el que se regulan las sustancias y preparados medicinales psicotrópicos, así como la fiscalización e inspección de su fabricación, distribución, prescripción y dispensación' (EN: Royal Decree 2829/1977, of October 6, which regulates psychotropic medicinal substances and preparations, as well as the control and inspection of their manufacture, distribution, prescription and dispensation). This jurisdiction also includes EU drug precursor legislation\"\n },\n {\n \"idJurisdiction\": 12,\n \"title\": \"Sweden\",\n \"countryCode\": \"SE\",\n \"countryCodeISO\": \"SE\",\n \"description\": \"Covers controlled substances detailed in the Narkotikastrafflag (1968:64) (EN: Narcotic Drugs Punishments Act 1968:64), 'Förordning (1992:1554) om kontroll av narkotika' (EN: Regulation (1992:1554) on the control of narcotics), 'Läkemedelsverkets föreskrifter (LVFS 2011:9) om kontroll av narkotika' (EN: Medicines Agency's regulations (LVFS 2011: 9) on drug control), 'Lag (1999:42) om förbud mot vissa hälsofarliga varor' (EN: Act (1999: 42) banning certain hazardous goods) and toxic substances regulations published by the Swedish Work Environment Authority (Arbetsmiljöverket). This jurisdiction also includes EU drug precursor legislation\"\n },\n {\n \"idJurisdiction\": 13,\n \"title\": \"Switzerland\",\n \"countryCode\": \"CH\",\n \"countryCodeISO\": \"CH\",\n \"description\": \"Covers controlled substances and chemical precursors detailed in the 'Bundesgesetz über die Betäubungsmittel und die psychotropen Stoffe, (BetmG)' (EN: Federal Law on Narcotic Drugs and Psychotropic Substances 3 October 1951), the 'Verordnung über die Betäubungsmittelkontrolle (BetmKV)' (EN: Regulation on Narcotics Control) and the 'Verordnung des EDI über die Verzeichnisse der Betäubungsmittel, psychotropen Stoffe, Vorläuferstoffe und Hilfschemikalien, BetmVV-EDI' (EN: Ordinance on the lists of narcotic drugs, psychotropic substances, precursors and auxiliary chemicals)\"\n },\n {\n \"idJurisdiction\": 14,\n \"title\": \"Canada\",\n \"countryCode\": \"CA\",\n \"countryCodeISO\": \"CA\",\n \"description\": \"Covers controlled substances and chemical precursors detailed in the 'Controlled Drugs and Substances Act (CSDA)'\"\n },\n {\n \"idJurisdiction\": 10000,\n \"title\": \"UserDefined\",\n \"countryCode\": \"UD\",\n \"countryCodeISO\": null,\n \"description\": null\n },\n {\n \"idJurisdiction\": 15,\n \"title\": \"UN (INCB)\",\n \"countryCode\": \"UN\",\n \"countryCodeISO\": null,\n \"description\": \"Covers controlled substances and chemical precursors detailed in the Red (Precursors), Yellow (Narcotics) and Green (Psychotropics) Lists published by the United Nations International Narcotics Control Board\"\n },\n {\n \"idJurisdiction\": 19,\n \"title\": \"China\",\n \"countryCode\": \"CN\",\n \"countryCodeISO\": \"CN\",\n \"description\": \"Covers the following controlled substance and chemical precursor laws including the 中华人民共和国禁毒法 (EN: Anti-Drug Law of the People's Republic of China), the 在生产中使用麻醉药品和精神药物的法规和前体化学品管理 (EN: Regulations for the Administration of Precursors and Chemicals Used in Production of Narcotic Drugs and Psychotropic Substances) and 非药用类麻醉药品和精神药品列管办法 (EN: Non-medicinal narcotic and psychotropic drugs listed options)\"\n },\n {\n \"idJurisdiction\": 20,\n \"title\": \"Australia Group\",\n \"countryCode\": \"AG\",\n \"countryCodeISO\": null,\n \"description\": \"Covers chemical weapon precursors controlled by the Australia Group. This is an extension to the Chemical Weapons Convention. NOTE: This jurisidction does not cover Australian drug laws.\"\n },\n {\n \"idJurisdiction\": 21,\n \"title\": \"European Union\",\n \"countryCode\": \"EU\",\n \"countryCodeISO\": \"EU\",\n \"description\": \"IMPORTANT NOTE: If you would like to find all controlled substances for an EU country you need to include that country in the selected jurisdictions. This jursisdiction does not include the EU precursor laws, these are instead included with the legislation for each individual EU country. This jurisdiction includes EU legislation that places controls on compounds with military uses (Dual Use and Military lists), compounds that can be used to violate human rights (Human Rights List) and psychoactive substances which are legislated for by the EU\"\n },\n {\n \"idJurisdiction\": 17,\n \"title\": \"India\",\n \"countryCode\": \"IN\",\n \"countryCodeISO\": \"IN\",\n \"description\": \"Covers controlled substances and chemical precursors detailed in the 'Narcotic Drugs and Psychotropic Substances Act 1985 (NDPS)', 'Prevention of Illicit Trafficking in Narcotic Drugs and Psychotropic Substances Act 1988' and the 'Narcotic Drugs and Psychotropic Substance Rules 1985'\"\n },\n {\n \"idJurisdiction\": 18,\n \"title\": \"Chemical Weapons Convention\",\n \"countryCode\": \"CWC\",\n \"countryCodeISO\": null,\n \"description\": \"Covers the substances controlled by the Chemical Weapons Convention treaty administered by the Organisation for the Prohibition of Chemical Weapons (OPCW)\"\n },\n {\n \"idJurisdiction\": 22,\n \"title\": \"Montreal Ozone Protocol\",\n \"countryCode\": \"OZ\",\n \"countryCodeISO\": null,\n \"description\": \"Covers ozone depleting substances detailed by the Montreal Ozone Protol which is administered by the United Nations Environment Programme (UNEP)\"\n },\n {\n \"idJurisdiction\": 23,\n \"title\": \"Austria\",\n \"countryCode\": \"AT\",\n \"countryCodeISO\": \"AT\",\n \"description\": \"Covers controlled substances detailed in the 'Suchtmittelgesetz' (EN: Narcotic Substances Act). This jurisdiction also includes EU drug precursor legislation. The 'Neue-Psychoaktive-Substanzen-Gese (NPSG)' (EN: New Psychoactive Substances Act) is not covered by CS2 as it does not apply to substances used for legitimate use and research purposes\"\n },\n {\n \"idJurisdiction\": 25,\n \"title\": \"Singapore\",\n \"countryCode\": \"SN\",\n \"countryCodeISO\": \"SG\",\n \"description\": \"Covers controlled substances and chemical precursors detailed in the 'Misuse of Drugs Act' and 'Misuse of Drugs Regulations'\"\n },\n {\n \"idJurisdiction\": 26,\n \"title\": \"Mexico\",\n \"countryCode\": \"MX\",\n \"countryCodeISO\": \"MX\",\n \"description\": \"Covers controlled substances detailed in 'Ley General de Salud' (EN: The General Law of Health) and controlled chemical precursors in 'Ley Federal Para El Control De Precursores Químicos, Productos Químicos Esenciales Y Máquinas Para Elaborar Cápsulas, Tabletas Y/O Comprimidos' (EN: Federal Law for the Control of Chemical Precursors, Essential Chemical Products and Machines to Prepare Capsules, Tablets and / or Pills)\"\n },\n {\n \"idJurisdiction\": 29,\n \"title\": \"Finland\",\n \"countryCode\": \"FI\",\n \"countryCodeISO\": \"FI\",\n \"description\": null\n },\n {\n \"idJurisdiction\": 27,\n \"title\": \"Brazil\",\n \"countryCode\": \"BR\",\n \"countryCodeISO\": \"BR\",\n \"description\": \"Covers controlled substances and chemical precursors detailed in 'Portaria No. 344/98' (EN: Ordinance 344/98)\"\n },\n {\n \"idJurisdiction\": 30,\n \"title\": \"Taiwan\",\n \"countryCode\": \"TW\",\n \"countryCodeISO\": \"TW\",\n \"description\": null\n },\n {\n \"idJurisdiction\": 24,\n \"title\": \"Japan\",\n \"countryCode\": \"JP\",\n \"countryCodeISO\": \"JP\",\n \"description\": \"Covers controlled substances and chemical precursors detailed in 麻薬及び向精神薬取締法(EN: The Narcotics and Psychotropics Control Law), 医薬品、医療機器等の品質、有効性及び安全性の確保等に関する法律 (EN: The Pharmaceutical and Medical Device Act), 覚せい剤取締法 (EN: The Stimulants Control Law), あへん法 (EN: The Opium Control Act), 大麻取締法 (EN: The Cannabis Control Law) and the 毒物及び劇物取締法 (EN: Poisonous and Deleterious Substances Control Law)\"\n },\n {\n \"idJurisdiction\": 28,\n \"title\": \"Poland\",\n \"countryCode\": \"PL\",\n \"countryCodeISO\": \"PL\",\n \"description\": \"Covers controlled substances detailed in 'USTAWA - z dnia 29 lipca 2005 r. o przeciwdziałaniu narkomanii' (EN: Act of 29 July 2005 on Counteracting Drug Addiction and its amendments). This jurisdiction also includes EU drug precursor legislation\"\n },\n {\n \"idJurisdiction\": 10001,\n \"title\": \"Adam Test\",\n \"countryCode\": \"ADM\",\n \"countryCodeISO\": null,\n \"description\": \"This is a test\"\n },\n {\n \"idJurisdiction\": 10002,\n \"title\": \"Europe\",\n \"countryCode\": \"EUR\",\n \"countryCodeISO\": null,\n \"description\": \"European system jurisdictions\"\n }\n]"}],"_postman_id":"de4f174b-6a5a-4350-9af6-f802fdeb3869"},{"name":"/controlcodes/list","event":[{"listen":"test","script":{"id":"729b559a-9e85-445d-938f-a9f118fae210","exec":[""],"type":"text/javascript","packages":{}}}],"id":"a698b457-c634-4bd6-9e66-b7d07d9656d7","protocolProfileBehavior":{"disableBodyPruning":true},"request":{"method":"GET","header":[{"key":"x-access-token","value":"{{token}}","description":"

This header needs to have the authenication token obtained from the /authenticate API to allow requests to be sent to this endpoint

\n","type":"text"}],"body":{"mode":"raw","raw":"","options":{"raw":{"language":"json"}}},"url":"https://{{host}}:{{port}}/controlcodes/list?system=true&customer=true","description":"

Get a list of control codes in CS2

\n","urlObject":{"protocol":"https","port":"{{port}}","path":["controlcodes","list"],"host":["{{host}}"],"query":[{"description":{"content":"

Optional. If not provided this defaults to true. This toggles whether to return system control codes.

\n","type":"text/plain"},"key":"system","value":"true"},{"description":{"content":"

Optional. If not provided this defaults to true. This toggles whether to return customer control codes.

\n","type":"text/plain"},"key":"customer","value":"true"}],"variable":[]}},"response":[{"id":"bfa5a0a1-fcc5-4601-8479-6f317689eaeb","name":"/controlcodes/list","originalRequest":{"method":"GET","header":[{"key":"x-access-token","value":"{{token}}","description":"This header needs to have the authenication token obtained from the /owner/authenticate API to allow requests to be sent to this endpoint","type":"text"}],"body":{"mode":"raw","raw":"","options":{"raw":{"language":"json"}}},"url":{"raw":"https://{{host}}:{{port}}/controlcodes/list?system=true&customer=true","protocol":"https","host":["{{host}}"],"port":"{{port}}","path":["controlcodes","list"],"query":[{"key":"system","value":"true","description":"Optional. If not provided this defaults to true. This toggles whether to return system control codes."},{"key":"customer","value":"true","description":"Optional. If not provided this defaults to true. This toggles whether to return customer control codes."}]}},"status":"OK","code":200,"_postman_previewlanguage":"json","header":[{"key":"Date","value":"Tue, 29 Jun 2021 09:32:19 GMT","enabled":true},{"key":"Content-Type","value":"application/json; charset=utf-8","enabled":true},{"key":"Content-Length","value":"78727","enabled":true},{"key":"Connection","value":"keep-alive","enabled":true},{"key":"Set-Cookie","value":"AWSALBTG=/zq57vRvdNU1RDOVYcFBm+Gz2V48s21koMuiQM+3C4XvTbpCVbE3z/NDFp5J+QwCAReirbcavvmK7SvNw43ene470w0kepkLiS5jYN+mZzeCO7+k4f/wi/+rV/Qp08Fhuog6rBSlO8heaB1OziNnveOgb8pw30j6vbiMxgAGSe2vUS+nABQ=; Expires=Tue, 06 Jul 2021 09:32:19 GMT; Path=/","enabled":true},{"key":"Set-Cookie","value":"AWSALBTGCORS=/zq57vRvdNU1RDOVYcFBm+Gz2V48s21koMuiQM+3C4XvTbpCVbE3z/NDFp5J+QwCAReirbcavvmK7SvNw43ene470w0kepkLiS5jYN+mZzeCO7+k4f/wi/+rV/Qp08Fhuog6rBSlO8heaB1OziNnveOgb8pw30j6vbiMxgAGSe2vUS+nABQ=; Expires=Tue, 06 Jul 2021 09:32:19 GMT; Path=/; SameSite=None; Secure","enabled":true},{"key":"X-Powered-By","value":"Express","enabled":true},{"key":"X-Frame-Options","value":"SAMEORIGIN","enabled":true},{"key":"ETag","value":"W/\"13387-yMsxifOenhh1GqH68lOMkrbrcdo\"","enabled":true}],"cookie":[],"responseTime":null,"body":"[\n {\n \"idSysControlledCode\": 97,\n \"codeName\": \"Irish Schedule 1\",\n \"idJurisdiction\": 5,\n \"jurisdictionName\": \"Ireland\",\n \"description\": \"Drugs subject to very strict controls and have little or no use in medicine or industry\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 98,\n \"codeName\": \"Irish Schedule 2\",\n \"idJurisdiction\": 5,\n \"jurisdictionName\": \"Ireland\",\n \"description\": \"Drugs used for scientific purposes which have a high likelihood of their being abused\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 99,\n \"codeName\": \"Irish Schedule 3\",\n \"idJurisdiction\": 5,\n \"jurisdictionName\": \"Ireland\",\n \"description\": \"Controlled medicinal products with a high likelihood of abuse\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 100,\n \"codeName\": \"Irish Schedule 4 pt 1\",\n \"idJurisdiction\": 5,\n \"jurisdictionName\": \"Ireland\",\n \"description\": \"Controlled medicinal products\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 108,\n \"codeName\": \"Irish Schedule 5\",\n \"idJurisdiction\": 5,\n \"jurisdictionName\": \"Ireland\",\n \"description\": \"Controlled drugs exempted from the prohibition on importation and exportation \",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 109,\n \"codeName\": \"Irish Schedule 8 pt1\",\n \"idJurisdiction\": 5,\n \"jurisdictionName\": \"Ireland\",\n \"description\": \"Can be prescribed for pain relief by a nurse in hospital\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 110,\n \"codeName\": \"Irish EU Drug Precursor Category 1\",\n \"idJurisdiction\": 5,\n \"jurisdictionName\": \"Ireland\",\n \"description\": \"EU Drug Precursor Category 1\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 111,\n \"codeName\": \"Irish EU Drug Precursor Category 2A\",\n \"idJurisdiction\": 5,\n \"jurisdictionName\": \"Ireland\",\n \"description\": \"EU Drug Precursor Category 2A\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 112,\n \"codeName\": \"Irish EU Drug Precursor Category 3\",\n \"idJurisdiction\": 5,\n \"jurisdictionName\": \"Ireland\",\n \"description\": \"EU Drug Precursor Category 3\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 113,\n \"codeName\": \"Irish EU Drug Precursor Category 4\",\n \"idJurisdiction\": 5,\n \"jurisdictionName\": \"Ireland\",\n \"description\": \"EU Drug Precursor Category 4\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 114,\n \"codeName\": \"Irish Schedule 4 pt 2\",\n \"idJurisdiction\": 5,\n \"jurisdictionName\": \"Ireland\",\n \"description\": \"Controlled medicinal products\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 175,\n \"codeName\": \"Canadian Schedule VII\",\n \"idJurisdiction\": 14,\n \"jurisdictionName\": \"Canada\",\n \"description\": \"Canadian Schedule VII\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 1176,\n \"codeName\": \"Canadian Schedule VIII\",\n \"idJurisdiction\": 14,\n \"jurisdictionName\": \"Canada\",\n \"description\": \"Canadian Schedule VIII\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 115,\n \"codeName\": \"Irish Schedule 8 pt2\",\n \"idJurisdiction\": 5,\n \"jurisdictionName\": \"Ireland\",\n \"description\": \"Can be prescribed for pain relief by a nurse in hospital\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 116,\n \"codeName\": \"Irish Schedule 8 pt3\",\n \"idJurisdiction\": 5,\n \"jurisdictionName\": \"Ireland\",\n \"description\": \"Can be prescribed for pain relief by a nurse in hospital\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 117,\n \"codeName\": \"Irish Schedule 8 pt4\",\n \"idJurisdiction\": 5,\n \"jurisdictionName\": \"Ireland\",\n \"description\": \"Can be prescribed for pain relief by a nurse in hospital\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 118,\n \"codeName\": \"Irish no schedule given\",\n \"idJurisdiction\": 5,\n \"jurisdictionName\": \"Ireland\",\n \"description\": \"Some substances are controlled in the general text of the legislation but not listed in a named schedule\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 23,\n \"codeName\": \"UK Schedule 1\",\n \"idJurisdiction\": 2,\n \"jurisdictionName\": \"United Kingdom\",\n \"description\": \"Schedule 1 drugs are thought to have no therapeutic value and cannot be lawfully possessed or prescribed. A Home Office license is required for research and significant regulations govern record keeping and storage.\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 24,\n \"codeName\": \"UK Schedule 2\",\n \"idJurisdiction\": 2,\n \"jurisdictionName\": \"United Kingdom\",\n \"description\": \"Schedule 2 drugs can be prescribed and therefore legally possessed and supplied by pharmacists and doctors (possesion or supply is otherwise illegal) and include drugs such as Heroin. Significant regulations govern record keeping and storage requirements for research use. \",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 25,\n \"codeName\": \"UK Schedule 3\",\n \"idJurisdiction\": 2,\n \"jurisdictionName\": \"United Kingdom\",\n \"description\": \"Schedule 3 drugs can be prescribed and therefore legally possessed and supplied by pharmacists and doctors (possession or supply is otherwise illegal). They have less onerous record keeping and storage regulations.\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 26,\n \"codeName\": \"UK Schedule 4\",\n \"idJurisdiction\": 2,\n \"jurisdictionName\": \"United Kingdom\",\n \"description\": \"Schedule 4 contain drugs such as steroids and benzodiazepines. Depending on the substance import / export licenses maybe required as well as a home office permit for scientific use.\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 27,\n \"codeName\": \"UK Schedule 5\",\n \"idJurisdiction\": 2,\n \"jurisdictionName\": \"United Kingdom\",\n \"description\": \"Schedule 5 drugs are sold over the counter and can be legally possessed without a prescription and imported / exported.\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 28,\n \"codeName\": \"UK Class A\",\n \"idJurisdiction\": 2,\n \"jurisdictionName\": \"United Kingdom\",\n \"description\": \"UK Class A\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 29,\n \"codeName\": \"UK Class B\",\n \"idJurisdiction\": 2,\n \"jurisdictionName\": \"United Kingdom\",\n \"description\": \"UK Class B\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 30,\n \"codeName\": \"UK Class C\",\n \"idJurisdiction\": 2,\n \"jurisdictionName\": \"United Kingdom\",\n \"description\": \"UK Class C\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 1,\n \"codeName\": \"UK Temporary Class Drug\",\n \"idJurisdiction\": 2,\n \"jurisdictionName\": \"United Kingdom\",\n \"description\": \"UK TEMPORARY CONTROL\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 2,\n \"codeName\": \"UNKNOWN\",\n \"idJurisdiction\": 2,\n \"jurisdictionName\": \"United Kingdom\",\n \"description\": \"UNKNOWN\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 3,\n \"codeName\": \"UK Schedule 3 Part 2\",\n \"idJurisdiction\": 2,\n \"jurisdictionName\": \"United Kingdom\",\n \"description\": \"Not used\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 4,\n \"codeName\": \"UK Schedule 4 Part 1\",\n \"idJurisdiction\": 2,\n \"jurisdictionName\": \"United Kingdom\",\n \"description\": \"UK Schedule 4 Part 1\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 5,\n \"codeName\": \"UK Schedule 4 Part 2\",\n \"idJurisdiction\": 2,\n \"jurisdictionName\": \"United Kingdom\",\n \"description\": \"UK Schedule 4 Part 2\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 41,\n \"codeName\": \"Test-partA\",\n \"idJurisdiction\": 16,\n \"jurisdictionName\": \"Used for testing\",\n \"description\": \"Test-partA\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 6,\n \"codeName\": \"UN Psychotropics Schedule I \",\n \"idJurisdiction\": 15,\n \"jurisdictionName\": \"UN (INCB)\",\n \"description\": \"UN Psychotropics Schedule I\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 7,\n \"codeName\": \"UN Psychotropics Schedule II\",\n \"idJurisdiction\": 15,\n \"jurisdictionName\": \"UN (INCB)\",\n \"description\": \"UN Psychotropics Schedule II\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 8,\n \"codeName\": \"UN Psychotropics Schedule III\",\n \"idJurisdiction\": 15,\n \"jurisdictionName\": \"UN (INCB)\",\n \"description\": \"UN Psychotropics Schedule III\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 9,\n \"codeName\": \"UN Psychotropics Schedule IV\",\n \"idJurisdiction\": 15,\n \"jurisdictionName\": \"UN (INCB)\",\n \"description\": \"UN Psychotropics Schedule IV\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 21,\n \"codeName\": \"US CSA Schedule I\",\n \"idJurisdiction\": 3,\n \"jurisdictionName\": \"United States of America\",\n \"description\": \"Schedule I drugs, substances, or chemicals are defined as drugs with no currently accepted medical use and a high potential for abuse. Schedule I drugs are the most dangerous drugs of all the drug schedules with potentially severe psychological or physical dependence. Significant controls need to be in place \",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 22,\n \"codeName\": \"US CSA Schedule II\",\n \"idJurisdiction\": 3,\n \"jurisdictionName\": \"United States of America\",\n \"description\": \"Schedule II drugs, substances, or chemicals are defined as drugs with a high potential for abuse, less abuse potential than Schedule I drugs, with use potentially leading to severe psychological or physical dependence. These drugs are also considered dangerous. Significant controls need to be in place\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 31,\n \"codeName\": \"US CSA Schedule III\",\n \"idJurisdiction\": 3,\n \"jurisdictionName\": \"United States of America\",\n \"description\": \"Schedule III drugs, substances, or chemicals are defined as drugs with a moderate to low potential for physical and psychological dependence. Schedule III drugs abuse potential is less than Schedule I and Schedule II drugs but more than Schedule IV. Significant controls generally need to be in place\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 32,\n \"codeName\": \"US CSA Schedule IV\",\n \"idJurisdiction\": 3,\n \"jurisdictionName\": \"United States of America\",\n \"description\": \"Schedule IV drugs, substances, or chemicals are defined as drugs with a low potential for abuse and low risk of dependence. \",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 33,\n \"codeName\": \"US CSA Schedule V\",\n \"idJurisdiction\": 3,\n \"jurisdictionName\": \"United States of America\",\n \"description\": \"Schedule V drugs, substances, or chemicals are defined as drugs with lower potential for abuse than Schedule IV and consist of preparations containing limited quantities of certain narcotics. Schedule V drugs are generally used for antidiarrheal, antitussive, and analgesic purposes.\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 40,\n \"codeName\": \"US CSA Schedule I (temporary)\",\n \"idJurisdiction\": 3,\n \"jurisdictionName\": \"United States of America\",\n \"description\": \"Schedule I drugs, substances, or chemicals are defined as drugs with no currently accepted medical use and a high potential for abuse. Schedule I drugs are the most dangerous drugs of all the drug schedules with potentially severe psychological or physical dependence. Significant controls need to be in place \",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 42,\n \"codeName\": \"US CSA List 1 Regulated Chemical\",\n \"idJurisdiction\": 3,\n \"jurisdictionName\": \"United States of America\",\n \"description\": \"US List 1 Regulated Chemical\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 43,\n \"codeName\": \"US CSA List 2 Regulated Chemical\",\n \"idJurisdiction\": 3,\n \"jurisdictionName\": \"United States of America\",\n \"description\": \"US List 2 Regulated Chemical\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 44,\n \"codeName\": \"UK EU Drug Precursor Category 1\",\n \"idJurisdiction\": 2,\n \"jurisdictionName\": \"United Kingdom\",\n \"description\": \"UK EU Drug Precursor Category 1\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 45,\n \"codeName\": \"UK EU Drug Precursor Category 2B\",\n \"idJurisdiction\": 2,\n \"jurisdictionName\": \"United Kingdom\",\n \"description\": \"UK EU Drug Precursor Category 2B\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 46,\n \"codeName\": \"UK EU Drug Precursor Category 3\",\n \"idJurisdiction\": 2,\n \"jurisdictionName\": \"United Kingdom\",\n \"description\": \"UK EU Drug Precursor Category 3\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 78,\n \"codeName\": \"Spain UN Narcotics List I\",\n \"idJurisdiction\": 11,\n \"jurisdictionName\": \"Spain\",\n \"description\": \"Spain UN Narcotics List I\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 75,\n \"codeName\": \"Spain UN Narcotics List II\",\n \"idJurisdiction\": 11,\n \"jurisdictionName\": \"Spain\",\n \"description\": \"Spain UN Narcotics List II\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 76,\n \"codeName\": \"Spain UN Narcotics List III\",\n \"idJurisdiction\": 11,\n \"jurisdictionName\": \"Spain\",\n \"description\": \"Spain UN Narcotics List III\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 77,\n \"codeName\": \"Spain UN Narcotics List IV\",\n \"idJurisdiction\": 11,\n \"jurisdictionName\": \"Spain\",\n \"description\": \"Spain UN Narcotics List IV\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 79,\n \"codeName\": \"US ARCOS List\",\n \"idJurisdiction\": 3,\n \"jurisdictionName\": \"United States of America\",\n \"description\": \"Substances, which may not be listed in legislation but within US ARCOS system as likely requiring import/export licences and should be considered as controlled\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 80,\n \"codeName\": \"Spain UN Psychotropics List II\",\n \"idJurisdiction\": 11,\n \"jurisdictionName\": \"Spain\",\n \"description\": \"Spain UN Psychotropics List II\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 81,\n \"codeName\": \"Spain UN Psychotropics List III\",\n \"idJurisdiction\": 11,\n \"jurisdictionName\": \"Spain\",\n \"description\": \"Spain UN Psychotropics List III\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 82,\n \"codeName\": \"Spain UN Psychotropics List IV\",\n \"idJurisdiction\": 11,\n \"jurisdictionName\": \"Spain\",\n \"description\": \"Spain UN Psychotropics List IV\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 83,\n \"codeName\": \"Spain UN Psychotropics List I\",\n \"idJurisdiction\": 11,\n \"jurisdictionName\": \"Spain\",\n \"description\": \"Spain UN Psychotropics List I\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 84,\n \"codeName\": \"Spain Psychotropics Annex 2\",\n \"idJurisdiction\": 11,\n \"jurisdictionName\": \"Spain\",\n \"description\": \"Spain Annex substances controlled in addition to UN lists\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 85,\n \"codeName\": \"Swedish List I\",\n \"idJurisdiction\": 12,\n \"jurisdictionName\": \"Sweden\",\n \"description\": \"substances , plant material and fungi that normally do not have medical use\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 86,\n \"codeName\": \"Swedish List II\",\n \"idJurisdiction\": 12,\n \"jurisdictionName\": \"Sweden\",\n \"description\": \"substances , plant material and fungi with medical use\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 87,\n \"codeName\": \"Swedish List III\",\n \"idJurisdiction\": 12,\n \"jurisdictionName\": \"Sweden\",\n \"description\": \"substances , plant material and fungi with medical use\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 88,\n \"codeName\": \"Swedish List IV\",\n \"idJurisdiction\": 12,\n \"jurisdictionName\": \"Sweden\",\n \"description\": \"substances , plant material and fungi with medical use\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 89,\n \"codeName\": \"Swedish List V\",\n \"idJurisdiction\": 12,\n \"jurisdictionName\": \"Sweden\",\n \"description\": \"Swedish List 5\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 90,\n \"codeName\": \"Danish List A\",\n \"idJurisdiction\": 7,\n \"jurisdictionName\": \"Denmark\",\n \"description\": \"Danish List A\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 91,\n \"codeName\": \"Danish List B\",\n \"idJurisdiction\": 7,\n \"jurisdictionName\": \"Denmark\",\n \"description\": \"Danish List B\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 92,\n \"codeName\": \"Danish List C\",\n \"idJurisdiction\": 7,\n \"jurisdictionName\": \"Denmark\",\n \"description\": \"Danish List C\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 93,\n \"codeName\": \"Danish List D\",\n \"idJurisdiction\": 7,\n \"jurisdictionName\": \"Denmark\",\n \"description\": \"Danish List D\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 94,\n \"codeName\": \"Danish List E\",\n \"idJurisdiction\": 7,\n \"jurisdictionName\": \"Denmark\",\n \"description\": \"Danish List E\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 34,\n \"codeName\": \"Swiss Directory A\",\n \"idJurisdiction\": 13,\n \"jurisdictionName\": \"Switzerland\",\n \"description\": \"controlled substances that are subject to all of the control measures; \",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 35,\n \"codeName\": \"Swiss Directory B\",\n \"idJurisdiction\": 13,\n \"jurisdictionName\": \"Switzerland\",\n \"description\": \"controlled substances that are partially exempt from the control measures; \",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 36,\n \"codeName\": \"Swiss Directory C\",\n \"idJurisdiction\": 13,\n \"jurisdictionName\": \"Switzerland\",\n \"description\": \"controlled substances that may be contained in preparations in reduced concentrations and are partially exempt from the control measures; \",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 37,\n \"codeName\": \"Swiss Directory D\",\n \"idJurisdiction\": 13,\n \"jurisdictionName\": \"Switzerland\",\n \"description\": \"illegal controlled substances\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 47,\n \"codeName\": \"Swiss Directory E\",\n \"idJurisdiction\": 13,\n \"jurisdictionName\": \"Switzerland\",\n \"description\": \"Raw Materials and Products with Suspected Similar Narcotics Effect\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 48,\n \"codeName\": \"Swiss Directory F\",\n \"idJurisdiction\": 13,\n \"jurisdictionName\": \"Switzerland\",\n \"description\": \"Precursors\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 49,\n \"codeName\": \"Swiss Directory G\",\n \"idJurisdiction\": 13,\n \"jurisdictionName\": \"Switzerland\",\n \"description\": \"Auxiliary Chemicals\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 50,\n \"codeName\": \"Belgium 1930-art1 (stup)\",\n \"idJurisdiction\": 6,\n \"jurisdictionName\": \"Belgium\",\n \"description\": \"Belgium 1930-art1 (stup)\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 51,\n \"codeName\": \"Belgium 1930-art1bis (stup)\",\n \"idJurisdiction\": 6,\n \"jurisdictionName\": \"Belgium\",\n \"description\": \"Belgium 1930-art1bis (stup)\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 52,\n \"codeName\": \"Belgium 1998-art2 (as-stup)\",\n \"idJurisdiction\": 6,\n \"jurisdictionName\": \"Belgium\",\n \"description\": \"Belgium 1998-art2 (as-stup)\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 53,\n \"codeName\": \"Belgium 1998-art25 (psy)\",\n \"idJurisdiction\": 6,\n \"jurisdictionName\": \"Belgium\",\n \"description\": \"Belgium 1998-art25 (psy)\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 54,\n \"codeName\": \"Belgium 1998-art38 (psy)\",\n \"idJurisdiction\": 6,\n \"jurisdictionName\": \"Belgium\",\n \"description\": \"Belgium 1998-art38 (psy)\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 64,\n \"codeName\": \"Canadian Schedule II\",\n \"idJurisdiction\": 14,\n \"jurisdictionName\": \"Canada\",\n \"description\": \"Canadian Schedule II\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 65,\n \"codeName\": \"Canadian Schedule III\",\n \"idJurisdiction\": 14,\n \"jurisdictionName\": \"Canada\",\n \"description\": \"Canadian Schedule III\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 66,\n \"codeName\": \"Canadian Schedule IV\",\n \"idJurisdiction\": 14,\n \"jurisdictionName\": \"Canada\",\n \"description\": \"Canadian Schedule IV\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 67,\n \"codeName\": \"Canadian Schedule V\",\n \"idJurisdiction\": 14,\n \"jurisdictionName\": \"Canada\",\n \"description\": \"Canadian Schedule V\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 59,\n \"codeName\": \"French Psychotropics Part 1 UN Schedule III\",\n \"idJurisdiction\": 4,\n \"jurisdictionName\": \"France\",\n \"description\": \"This has the contents of Schedule III of the List of Psychotropic Substances under International Control in accordance with the United Nations Convention on Psychotropic Substances of 1971\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 60,\n \"codeName\": \"French Psychotropics Part 1 UN Schedule IV\",\n \"idJurisdiction\": 4,\n \"jurisdictionName\": \"France\",\n \"description\": \"This has the contents of Schedule IV of the List of Psychotropic Substances under International Control in accordance with the United Nations Convention on Psychotropic Substances of 1971\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 61,\n \"codeName\": \"French Psychotropics Part 2\",\n \"idJurisdiction\": 4,\n \"jurisdictionName\": \"France\",\n \"description\": \"Certain preparations of psychotropics.\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 62,\n \"codeName\": \"French Psychotropics Part 3\",\n \"idJurisdiction\": 4,\n \"jurisdictionName\": \"France\",\n \"description\": \"Psychotropics not covered by the List of Psychotropic Substances under International Control in accordance with the United Nations Convention on Psychotropic Substances of 1971.\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 101,\n \"codeName\": \"German Schedule 1\",\n \"idJurisdiction\": 8,\n \"jurisdictionName\": \"Germany\",\n \"description\": \"German Schedule 1\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 102,\n \"codeName\": \"German Schedule 2\",\n \"idJurisdiction\": 8,\n \"jurisdictionName\": \"Germany\",\n \"description\": \"German Schedule 2\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 103,\n \"codeName\": \"German Schedule 3\",\n \"idJurisdiction\": 8,\n \"jurisdictionName\": \"Germany\",\n \"description\": \"German Schedule 3 - not controlled\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 104,\n \"codeName\": \"French Narcotics Annex I\",\n \"idJurisdiction\": 4,\n \"jurisdictionName\": \"France\",\n \"description\": \"Narcotics Annex I: narcotic substances such as heroin, cocaine, cannabis, methadone, opium, etc. Corresponds to Schedule I of the list of narcotic drugs under international control in accordance with the UN Single Convention on Narcotic Drugs 1961.\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 106,\n \"codeName\": \"French Narcotics Annex III\",\n \"idJurisdiction\": 4,\n \"jurisdictionName\": \"France\",\n \"description\": \"Narcotic Annex III: psychotropic substances such as: amphetamines, ecstasy (MDMA), LSD, etc. Corresponds to Schedule I the list of psychotropic drugs under international control in accordance with the UN Convention on Psychotropic Substances of 1971\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 105,\n \"codeName\": \"French Narcotics Annex II\",\n \"idJurisdiction\": 4,\n \"jurisdictionName\": \"France\",\n \"description\": \"Narcotics Annex II: substances like codeine, propiram, etc. Corresponds to Schedule II of the list of narcotics drugs under international control in accordance with the UN Single Convention on Narcotic Drugs, 1961\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 107,\n \"codeName\": \"French Narcotics Annex IV\",\n \"idJurisdiction\": 4,\n \"jurisdictionName\": \"France\",\n \"description\": \"Narcotics Annex IV: substances not controlled at the international level.\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 63,\n \"codeName\": \"Canadian Schedule I\",\n \"idJurisdiction\": 14,\n \"jurisdictionName\": \"Canada\",\n \"description\": \"Canadian Schedule I\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 68,\n \"codeName\": \"Canadian Schedule VI pt1\",\n \"idJurisdiction\": 14,\n \"jurisdictionName\": \"Canada\",\n \"description\": \"Canadian Schedule VI pt1\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 69,\n \"codeName\": \"Italian Table I\",\n \"idJurisdiction\": 9,\n \"jurisdictionName\": \"Italy\",\n \"description\": \"Italian table 1\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 70,\n \"codeName\": \"Italian Table V(a)\",\n \"idJurisdiction\": 9,\n \"jurisdictionName\": \"Italy\",\n \"description\": \"Italian table V(a)\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 71,\n \"codeName\": \"Italian Table V(b)\",\n \"idJurisdiction\": 9,\n \"jurisdictionName\": \"Italy\",\n \"description\": \"Italian table V(b)\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 72,\n \"codeName\": \"Italian Table V(c)\",\n \"idJurisdiction\": 9,\n \"jurisdictionName\": \"Italy\",\n \"description\": \"Italian table V(c)\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 73,\n \"codeName\": \"Italian Table V(d)\",\n \"idJurisdiction\": 9,\n \"jurisdictionName\": \"Italy\",\n \"description\": \"Italian table V(d)\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 74,\n \"codeName\": \"Italian Table V(e)\",\n \"idJurisdiction\": 9,\n \"jurisdictionName\": \"Italy\",\n \"description\": \"Italian table V(e)\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 157,\n \"codeName\": \"German EU Drug Precursor Category 1\",\n \"idJurisdiction\": 8,\n \"jurisdictionName\": \"Germany\",\n \"description\": \"EU Drug Precursor Category 1\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 158,\n \"codeName\": \"German EU Drug Precursor Category 2A\",\n \"idJurisdiction\": 8,\n \"jurisdictionName\": \"Germany\",\n \"description\": \"EU Drug Precursor Category 2A\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 159,\n \"codeName\": \"German EU Drug Precursor Category 2B\",\n \"idJurisdiction\": 8,\n \"jurisdictionName\": \"Germany\",\n \"description\": \"EU Drug Precursor Category 2B\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 160,\n \"codeName\": \"German EU Drug Precursor Category 3\",\n \"idJurisdiction\": 8,\n \"jurisdictionName\": \"Germany\",\n \"description\": \"EU Drug Precursor Category 3\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 161,\n \"codeName\": \"German EU Drug Precursor Category 4\",\n \"idJurisdiction\": 8,\n \"jurisdictionName\": \"Germany\",\n \"description\": \"EU Drug Precursor Category 4\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 162,\n \"codeName\": \"Swedish EU Drug Precursor Category 1\",\n \"idJurisdiction\": 12,\n \"jurisdictionName\": \"Sweden\",\n \"description\": \"EU Drug Precursor Category 1\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 163,\n \"codeName\": \"Swedish EU Drug Precursor Category 2A\",\n \"idJurisdiction\": 12,\n \"jurisdictionName\": \"Sweden\",\n \"description\": \"EU Drug Precursor Category 2A\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 164,\n \"codeName\": \"Swedish EU Drug Precursor Category 2B\",\n \"idJurisdiction\": 12,\n \"jurisdictionName\": \"Sweden\",\n \"description\": \"EU Drug Precursor Category 2B\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 165,\n \"codeName\": \"Swedish EU Drug Precursor Category 3\",\n \"idJurisdiction\": 12,\n \"jurisdictionName\": \"Sweden\",\n \"description\": \"EU Drug Precursor Category 3\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 166,\n \"codeName\": \"Swedish EU Drug Precursor Category 4\",\n \"idJurisdiction\": 12,\n \"jurisdictionName\": \"Sweden\",\n \"description\": \"EU Drug Precursor Category 4\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 168,\n \"codeName\": \"Canadian Schedule VI pt2\",\n \"idJurisdiction\": 14,\n \"jurisdictionName\": \"Canada\",\n \"description\": \"Canadian Schedule VI pt2\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 95,\n \"codeName\": \"Netherlands List 1\",\n \"idJurisdiction\": 10,\n \"jurisdictionName\": \"Netherlands\",\n \"description\": \"Netherlands List 1\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 96,\n \"codeName\": \"Netherlands List 2\",\n \"idJurisdiction\": 10,\n \"jurisdictionName\": \"Netherlands\",\n \"description\": \"Netherlands List 2\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 119,\n \"codeName\": \"UK EU Drug Precursor Category 2A\",\n \"idJurisdiction\": 2,\n \"jurisdictionName\": \"United Kingdom\",\n \"description\": \"UK EU Drug Precursor Category 2A\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 120,\n \"codeName\": \"UK EU Drug Precursor Category 4\",\n \"idJurisdiction\": 2,\n \"jurisdictionName\": \"United Kingdom\",\n \"description\": \"UK EU Drug Precursor Category 4\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 171,\n \"codeName\": \"Italian Table II\",\n \"idJurisdiction\": 9,\n \"jurisdictionName\": \"Italy\",\n \"description\": \"Italian Table II\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 172,\n \"codeName\": \"Italian Table III\",\n \"idJurisdiction\": 9,\n \"jurisdictionName\": \"Italy\",\n \"description\": \"Italian Table III\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 173,\n \"codeName\": \"Italian Table IV\",\n \"idJurisdiction\": 9,\n \"jurisdictionName\": \"Italy\",\n \"description\": \"Italian Table IV\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 174,\n \"codeName\": \"Italian Annex 3a\",\n \"idJurisdiction\": 9,\n \"jurisdictionName\": \"Italy\",\n \"description\": \"Italian Annex 3a\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 126,\n \"codeName\": \"Belgium EU Drug Precursor Category 1\",\n \"idJurisdiction\": 6,\n \"jurisdictionName\": \"Belgium\",\n \"description\": \"EU Drug Precursor Category 1\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 127,\n \"codeName\": \"Belgium EU Drug Precursor Category 2A\",\n \"idJurisdiction\": 6,\n \"jurisdictionName\": \"Belgium\",\n \"description\": \"EU Drug Precursor Category 2A\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 128,\n \"codeName\": \"Belgium EU Drug Precursor Category 2B\",\n \"idJurisdiction\": 6,\n \"jurisdictionName\": \"Belgium\",\n \"description\": \"EU Drug Precursor Category 2B\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 129,\n \"codeName\": \"Belgium EU Drug Precursor Category 3\",\n \"idJurisdiction\": 6,\n \"jurisdictionName\": \"Belgium\",\n \"description\": \"EU Drug Precursor Category 3\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 130,\n \"codeName\": \"Belgium EU Drug Precursor Category 4\",\n \"idJurisdiction\": 6,\n \"jurisdictionName\": \"Belgium\",\n \"description\": \"EU Drug Precursor Category 4\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 131,\n \"codeName\": \"French EU Drug Precursor Category 1\",\n \"idJurisdiction\": 4,\n \"jurisdictionName\": \"France\",\n \"description\": \"EU Drug Precursor Category 1\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 132,\n \"codeName\": \"French EU Drug Precursor Category 2A\",\n \"idJurisdiction\": 4,\n \"jurisdictionName\": \"France\",\n \"description\": \"EU Drug Precursor Category 2A\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 133,\n \"codeName\": \"French EU Drug Precursor Category 2B\",\n \"idJurisdiction\": 4,\n \"jurisdictionName\": \"France\",\n \"description\": \"EU Drug Precursor Category 2B\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 134,\n \"codeName\": \"French EU Drug Precursor Category 3\",\n \"idJurisdiction\": 4,\n \"jurisdictionName\": \"France\",\n \"description\": \"EU Drug Precursor Category 3\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 135,\n \"codeName\": \"French EU Drug Precursor Category 4\",\n \"idJurisdiction\": 4,\n \"jurisdictionName\": \"France\",\n \"description\": \"EU Drug Precursor Category 4\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 136,\n \"codeName\": \"Italian EU Drug Precursor Category 1\",\n \"idJurisdiction\": 9,\n \"jurisdictionName\": \"Italy\",\n \"description\": \"EU Drug Precursor Category 1\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 137,\n \"codeName\": \"Italian EU Drug Precursor Category 2A\",\n \"idJurisdiction\": 9,\n \"jurisdictionName\": \"Italy\",\n \"description\": \"EU Drug Precursor Category 2A\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 138,\n \"codeName\": \"Italian EU Drug Precursor Category 2B\",\n \"idJurisdiction\": 9,\n \"jurisdictionName\": \"Italy\",\n \"description\": \"EU Drug Precursor Category 2B\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 139,\n \"codeName\": \"Italian EU Drug Precursor Category 3\",\n \"idJurisdiction\": 9,\n \"jurisdictionName\": \"Italy\",\n \"description\": \"EU Drug Precursor Category 3\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 140,\n \"codeName\": \"Italian EU Drug Precursor Category 4\",\n \"idJurisdiction\": 9,\n \"jurisdictionName\": \"Italy\",\n \"description\": \"EU Drug Precursor Category 4\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 141,\n \"codeName\": \"Spanish EU Drug Precursor Category 1\",\n \"idJurisdiction\": 11,\n \"jurisdictionName\": \"Spain\",\n \"description\": \"EU Drug Precursor Category 1\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 142,\n \"codeName\": \"Spanish EU Drug Precursor Category 2A\",\n \"idJurisdiction\": 11,\n \"jurisdictionName\": \"Spain\",\n \"description\": \"EU Drug Precursor Category 2A\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 143,\n \"codeName\": \"Spanish EU Drug Precursor Category 2B\",\n \"idJurisdiction\": 11,\n \"jurisdictionName\": \"Spain\",\n \"description\": \"EU Drug Precursor Category 2B\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 144,\n \"codeName\": \"Spanish EU Drug Precursor Category 3\",\n \"idJurisdiction\": 11,\n \"jurisdictionName\": \"Spain\",\n \"description\": \"EU Drug Precursor Category 3\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 145,\n \"codeName\": \"Spanish EU Drug Precursor Category 4\",\n \"idJurisdiction\": 11,\n \"jurisdictionName\": \"Spain\",\n \"description\": \"EU Drug Precursor Category 4\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 146,\n \"codeName\": \"Danish EU Drug Precursor Category 1\",\n \"idJurisdiction\": 7,\n \"jurisdictionName\": \"Denmark\",\n \"description\": \"EU Drug Precursor Category 1\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 147,\n \"codeName\": \"Danish EU Drug Precursor Category 2A\",\n \"idJurisdiction\": 7,\n \"jurisdictionName\": \"Denmark\",\n \"description\": \"EU Drug Precursor Category 2A\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 148,\n \"codeName\": \"Danish EU Drug Precursor Category 2B\",\n \"idJurisdiction\": 7,\n \"jurisdictionName\": \"Denmark\",\n \"description\": \"EU Drug Precursor Category 2B\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 149,\n \"codeName\": \"Danish EU Drug Precursor Category 3\",\n \"idJurisdiction\": 7,\n \"jurisdictionName\": \"Denmark\",\n \"description\": \"EU Drug Precursor Category 3\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 150,\n \"codeName\": \"Danish EU Drug Precursor Category 4\",\n \"idJurisdiction\": 7,\n \"jurisdictionName\": \"Denmark\",\n \"description\": \"EU Drug Precursor Category 4\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 151,\n \"codeName\": \"Netherlands EU Drug Precursor Category 1\",\n \"idJurisdiction\": 10,\n \"jurisdictionName\": \"Netherlands\",\n \"description\": \"EU Drug Precursor Category 1\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 152,\n \"codeName\": \"Netherlands EU Drug Precursor Category 2A\",\n \"idJurisdiction\": 10,\n \"jurisdictionName\": \"Netherlands\",\n \"description\": \"EU Drug Precursor Category 2A\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 153,\n \"codeName\": \"Netherlands EU Drug Precursor Category 2B\",\n \"idJurisdiction\": 10,\n \"jurisdictionName\": \"Netherlands\",\n \"description\": \"EU Drug Precursor Category 2B\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 154,\n \"codeName\": \"Netherlands EU Drug Precursor Category 3\",\n \"idJurisdiction\": 10,\n \"jurisdictionName\": \"Netherlands\",\n \"description\": \"EU Drug Precursor Category 3\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 155,\n \"codeName\": \"Netherlands EU Drug Precursor Category 4\",\n \"idJurisdiction\": 10,\n \"jurisdictionName\": \"Netherlands\",\n \"description\": \"EU Drug Precursor Category 4\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 156,\n \"codeName\": \"Irish EU Drug Precursor Category 2B\",\n \"idJurisdiction\": 5,\n \"jurisdictionName\": \"Ireland\",\n \"description\": \"EU Drug Precursor Category 2B\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 169,\n \"codeName\": \"UN Precursor Table I\",\n \"idJurisdiction\": 15,\n \"jurisdictionName\": \"UN (INCB)\",\n \"description\": \"UN Precursor Table I\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 170,\n \"codeName\": \"UN Precursor Table II\",\n \"idJurisdiction\": 15,\n \"jurisdictionName\": \"UN (INCB)\",\n \"description\": \"UN Precursor Table II\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 176,\n \"codeName\": \"Swedish Hazardous Goods\",\n \"idJurisdiction\": 12,\n \"jurisdictionName\": \"Sweden\",\n \"description\": \"Swedish Hazardous Goods\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 123,\n \"codeName\": \"UN Narcotics Schedule I\",\n \"idJurisdiction\": 15,\n \"jurisdictionName\": \"UN (INCB)\",\n \"description\": \"UN Narcotics Schedule I\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 124,\n \"codeName\": \"UN Narcotics Schedule II\",\n \"idJurisdiction\": 15,\n \"jurisdictionName\": \"UN (INCB)\",\n \"description\": \"UN Narcotics Schedule II\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 125,\n \"codeName\": \"UN Narcotics Schedule III\",\n \"idJurisdiction\": 15,\n \"jurisdictionName\": \"UN (INCB)\",\n \"description\": \"UN Narcotics Schedule III\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 177,\n \"codeName\": \"UN Narcotics Schedule IV\",\n \"idJurisdiction\": 15,\n \"jurisdictionName\": \"UN (INCB)\",\n \"description\": \"UN Narcotics Schedule IV\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 178,\n \"codeName\": \"Indian Schedule A Precursor\",\n \"idJurisdiction\": 17,\n \"jurisdictionName\": \"India\",\n \"description\": \"Indian Schedule A Precursor\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 179,\n \"codeName\": \"Indian Schedule B Precursor\",\n \"idJurisdiction\": 17,\n \"jurisdictionName\": \"India\",\n \"description\": \"Indian Schedule B Precursor\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 180,\n \"codeName\": \"Indian Schedule C Precursor\",\n \"idJurisdiction\": 17,\n \"jurisdictionName\": \"India\",\n \"description\": \"Indian Schedule C Precursor\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 185,\n \"codeName\": \"CWC Schedule 1 A\",\n \"idJurisdiction\": 18,\n \"jurisdictionName\": \"Chemical Weapons Convention\",\n \"description\": \"Chemical Weapons Convention Schedule 1 A - Toxic chemicals\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 186,\n \"codeName\": \"CWC Schedule 1 B\",\n \"idJurisdiction\": 18,\n \"jurisdictionName\": \"Chemical Weapons Convention\",\n \"description\": \"Chemical Weapons Convention Schedule 1 B - Precursors\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 187,\n \"codeName\": \"CWC Schedule 2 A\",\n \"idJurisdiction\": 18,\n \"jurisdictionName\": \"Chemical Weapons Convention\",\n \"description\": \"Chemical Weapons Convention Schedule 2 A - Toxic chemicals\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 188,\n \"codeName\": \"CWC Schedule 2 B\",\n \"idJurisdiction\": 18,\n \"jurisdictionName\": \"Chemical Weapons Convention\",\n \"description\": \"Chemical Weapons Convention Schedule 2 B - Precursors\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 189,\n \"codeName\": \"CWC Schedule 3 A\",\n \"idJurisdiction\": 18,\n \"jurisdictionName\": \"Chemical Weapons Convention\",\n \"description\": \"Chemical Weapons Convention Schedule 3 A - Toxic chemicals\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 190,\n \"codeName\": \"CWC Schedule 3 B\",\n \"idJurisdiction\": 18,\n \"jurisdictionName\": \"Chemical Weapons Convention\",\n \"description\": \"Chemical Weapons Convention Schedule 3 B - Precursors\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 218,\n \"codeName\": \"UK EU Drug Precursor Category 2\",\n \"idJurisdiction\": 2,\n \"jurisdictionName\": \"United Kingdom\",\n \"description\": \"UK EU Drug Precursor Category 2\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 219,\n \"codeName\": \"US CCL RS\",\n \"idJurisdiction\": 3,\n \"jurisdictionName\": \"United States of America\",\n \"description\": \"CCL Regional Stability control code\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 182,\n \"codeName\": \"Indian NDPS Act – Psychotropic \",\n \"idJurisdiction\": 17,\n \"jurisdictionName\": \"India\",\n \"description\": \"Indian NDPS Act – Psychotropic \",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 183,\n \"codeName\": \"Indian NDPS Act – Narcotic \",\n \"idJurisdiction\": 17,\n \"jurisdictionName\": \"India\",\n \"description\": \"Indian NDPS Act – Narcotic \",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 184,\n \"codeName\": \"Indian NDPs Act – Manufactured Narcotic Drug \",\n \"idJurisdiction\": 17,\n \"jurisdictionName\": \"India\",\n \"description\": \"Indian NDPs Act – Manufactured Narcotic Drug \",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 191,\n \"codeName\": \"China Psychotropic Drugs - Category 1\",\n \"idJurisdiction\": 19,\n \"jurisdictionName\": \"China\",\n \"description\": \"精神药品品种目录第一类\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 192,\n \"codeName\": \"China Psychotropic Drugs - Category 2 \",\n \"idJurisdiction\": 19,\n \"jurisdictionName\": \"China\",\n \"description\": \"精神药品品种目录第二类\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 193,\n \"codeName\": \"China Anesthetic Drugs\",\n \"idJurisdiction\": 19,\n \"jurisdictionName\": \"China\",\n \"description\": \"麻醉药品品种目录\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 194,\n \"codeName\": \"China Precursors - Category 1\",\n \"idJurisdiction\": 19,\n \"jurisdictionName\": \"China\",\n \"description\": \"易制毒化学品的分类和品种目录第一类\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 195,\n \"codeName\": \"China Precursors - Category 2\",\n \"idJurisdiction\": 19,\n \"jurisdictionName\": \"China\",\n \"description\": \"易制毒化学品的分类和品种目录第二类\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 196,\n \"codeName\": \"China Precursors - Category 3\",\n \"idJurisdiction\": 19,\n \"jurisdictionName\": \"China\",\n \"description\": \"易制毒化学品的分类和品种目录第一类\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 197,\n \"codeName\": \"US CCL CB1\",\n \"idJurisdiction\": 3,\n \"jurisdictionName\": \"United States of America\",\n \"description\": \"CCL Chemical and Biological Weapons control code\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 198,\n \"codeName\": \"US CCL CB2\",\n \"idJurisdiction\": 3,\n \"jurisdictionName\": \"United States of America\",\n \"description\": \"CCL Chemical and Biological Weapons control code\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 199,\n \"codeName\": \"US CCL CB3\",\n \"idJurisdiction\": 3,\n \"jurisdictionName\": \"United States of America\",\n \"description\": \"CCL Chemical and Biological Weapons control code\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 200,\n \"codeName\": \"US CCL NP1\",\n \"idJurisdiction\": 3,\n \"jurisdictionName\": \"United States of America\",\n \"description\": \"CCL Nuclear non proliferation control code\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 201,\n \"codeName\": \"US CCL NP2\",\n \"idJurisdiction\": 3,\n \"jurisdictionName\": \"United States of America\",\n \"description\": \"CCL Nuclear non proliferation control code\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 202,\n \"codeName\": \"US CCL NS1\",\n \"idJurisdiction\": 3,\n \"jurisdictionName\": \"United States of America\",\n \"description\": \"CCL National Security control code\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 203,\n \"codeName\": \"US CCL NS2\",\n \"idJurisdiction\": 3,\n \"jurisdictionName\": \"United States of America\",\n \"description\": \"CCL National Security control code\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 204,\n \"codeName\": \"US CCL MT1\",\n \"idJurisdiction\": 3,\n \"jurisdictionName\": \"United States of America\",\n \"description\": \"CCL Missile Technology control code\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 205,\n \"codeName\": \"US CCL RS1\",\n \"idJurisdiction\": 3,\n \"jurisdictionName\": \"United States of America\",\n \"description\": \"CCL Regional Security control code\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 206,\n \"codeName\": \"US CCL RS2\",\n \"idJurisdiction\": 3,\n \"jurisdictionName\": \"United States of America\",\n \"description\": \"CCL Regional Security control code\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 207,\n \"codeName\": \"US CCL FC1\",\n \"idJurisdiction\": 3,\n \"jurisdictionName\": \"United States of America\",\n \"description\": \"CCL Firearms Convension control code\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 208,\n \"codeName\": \"US CCL CC1\",\n \"idJurisdiction\": 3,\n \"jurisdictionName\": \"United States of America\",\n \"description\": \"CCL Crime control code\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 209,\n \"codeName\": \"US CCL CC2\",\n \"idJurisdiction\": 3,\n \"jurisdictionName\": \"United States of America\",\n \"description\": \"CCL Crime control code\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 210,\n \"codeName\": \"US CCL CC3\",\n \"idJurisdiction\": 3,\n \"jurisdictionName\": \"United States of America\",\n \"description\": \"CCL Crime control code\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 211,\n \"codeName\": \"US CCL AT1\",\n \"idJurisdiction\": 3,\n \"jurisdictionName\": \"United States of America\",\n \"description\": \"CCL Anti Terrorism control code\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 212,\n \"codeName\": \"US CCL AT2\",\n \"idJurisdiction\": 3,\n \"jurisdictionName\": \"United States of America\",\n \"description\": \"CCL Anti Terrorism control code\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 213,\n \"codeName\": \"US ITAR PT 121 Category V\",\n \"idJurisdiction\": 3,\n \"jurisdictionName\": \"United States of America\",\n \"description\": \"EXPLOSIVES AND ENERGETIC MATERIALS, PROPELLANTS, INCENDIARY AGENTS AND THEIR CONSTITUENTS\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 214,\n \"codeName\": \"US ITAR PT 121 Category XIV\",\n \"idJurisdiction\": 3,\n \"jurisdictionName\": \"United States of America\",\n \"description\": \"TOXICOLOGICAL AGENTS, INCLUDING CHEMICAL AGENTS, BIOLOGICAL AGENTS, AND ASSOCIATED EQUIPMENT\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 215,\n \"codeName\": \"US CCL UN\",\n \"idJurisdiction\": 3,\n \"jurisdictionName\": \"United States of America\",\n \"description\": \"CCL United Nations Embargo control code\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 216,\n \"codeName\": \"US CCL CW\",\n \"idJurisdiction\": 3,\n \"jurisdictionName\": \"United States of America\",\n \"description\": \"CCL Chemical Weapons Convention control code\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 217,\n \"codeName\": \"US CCL AT\",\n \"idJurisdiction\": 3,\n \"jurisdictionName\": \"United States of America\",\n \"description\": \"CCL Anti Terrorism control code\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 227,\n \"codeName\": \"Australia Group CW Precursor\",\n \"idJurisdiction\": 20,\n \"jurisdictionName\": \"Australia Group\",\n \"description\": \"Australia Group Chemical Weapons Precursor\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 228,\n \"codeName\": \"EU Military List ML 7\",\n \"idJurisdiction\": 21,\n \"jurisdictionName\": \"European Union\",\n \"description\": \"European Union Military List ML 7\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 229,\n \"codeName\": \"EU Military List ML 8\",\n \"idJurisdiction\": 21,\n \"jurisdictionName\": \"European Union\",\n \"description\": \"European Union Military List ML 8\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 230,\n \"codeName\": \"Montreal Ozone Annex A, Group I\",\n \"idJurisdiction\": 22,\n \"jurisdictionName\": \"Montreal Ozone Protocol\",\n \"description\": \"Montreal Protocol on Substances that deplete the Ozone Layer Annex A, Group I control code\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 231,\n \"codeName\": \"Montreal Ozone Annex A, Group II\",\n \"idJurisdiction\": 22,\n \"jurisdictionName\": \"Montreal Ozone Protocol\",\n \"description\": \"Montreal Protocol on Substances that deplete the Ozone Layer Annex A, Group II control code\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 233,\n \"codeName\": \"Montreal Ozone Annex B, Group II\",\n \"idJurisdiction\": 22,\n \"jurisdictionName\": \"Montreal Ozone Protocol\",\n \"description\": \"Montreal Protocol on Substances that deplete the Ozone Layer Annex B, Group II control code\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 232,\n \"codeName\": \"Montreal Ozone Annex B, Group I\",\n \"idJurisdiction\": 22,\n \"jurisdictionName\": \"Montreal Ozone Protocol\",\n \"description\": \"Montreal Protocol on Substances that deplete the Ozone Layer Annex B, Group I control code\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 235,\n \"codeName\": \"Montreal Ozone Annex C, Group I\",\n \"idJurisdiction\": 22,\n \"jurisdictionName\": \"Montreal Ozone Protocol\",\n \"description\": \"Montreal Protocol on Substances that deplete the Ozone Layer Annex C, Group I control code\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 236,\n \"codeName\": \"Montreal Ozone Annex C, Group II\",\n \"idJurisdiction\": 22,\n \"jurisdictionName\": \"Montreal Ozone Protocol\",\n \"description\": \"Montreal Protocol on Substances that deplete the Ozone Layer Annex C, Group II control code\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 234,\n \"codeName\": \"Montreal Ozone Annex B, Group III\",\n \"idJurisdiction\": 22,\n \"jurisdictionName\": \"Montreal Ozone Protocol\",\n \"description\": \"Montreal Protocol on Substances that deplete the Ozone Layer Annex B, Group III control code\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 238,\n \"codeName\": \"Montreal Ozone Annex E, Group I\",\n \"idJurisdiction\": 22,\n \"jurisdictionName\": \"Montreal Ozone Protocol\",\n \"description\": \"Montreal Protocol on Substances that deplete the Ozone Layer Annex E, Group I control code\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 237,\n \"codeName\": \"Montreal Ozone Annex C, Group III\",\n \"idJurisdiction\": 22,\n \"jurisdictionName\": \"Montreal Ozone Protocol\",\n \"description\": \"Montreal Protocol on Substances that deplete the Ozone Layer Annex C, Group III control code\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 246,\n \"codeName\": \"French EU Drug Precursor Category 2\",\n \"idJurisdiction\": 4,\n \"jurisdictionName\": \"France\",\n \"description\": \"EU Drug Precursor Category 2\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 264,\n \"codeName\": \"Austria EU Drug Precursor Category 1\",\n \"idJurisdiction\": 23,\n \"jurisdictionName\": \"Austria\",\n \"description\": \"EU Drug Precursor Category 1\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 265,\n \"codeName\": \"Austria EU Drug Precursor Category 2\",\n \"idJurisdiction\": 23,\n \"jurisdictionName\": \"Austria\",\n \"description\": \"EU Drug Precursor Category 2\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 266,\n \"codeName\": \"Austria EU Drug Precursor Category 2A\",\n \"idJurisdiction\": 23,\n \"jurisdictionName\": \"Austria\",\n \"description\": \"EU Drug Precursor Category 2A\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 267,\n \"codeName\": \"Austria EU Drug Precursor Category 3\",\n \"idJurisdiction\": 23,\n \"jurisdictionName\": \"Austria\",\n \"description\": \"EU Drug Precursor Category 3\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 268,\n \"codeName\": \"Austria EU Drug Precursor Category 4\",\n \"idJurisdiction\": 23,\n \"jurisdictionName\": \"Austria\",\n \"description\": \"EU Drug Precursor Category 4\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 269,\n \"codeName\": \"Austria EU Drug Precursor Category 2B\",\n \"idJurisdiction\": 23,\n \"jurisdictionName\": \"Austria\",\n \"description\": \"Austria EU Drug Precursor Category 2B\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 271,\n \"codeName\": \"EU Human Rights List Annex III\",\n \"idJurisdiction\": 21,\n \"jurisdictionName\": \"European Union\",\n \"description\": \"EU Human Rights List Annex III\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 239,\n \"codeName\": \"Swedish Toxic Group A\",\n \"idJurisdiction\": 12,\n \"jurisdictionName\": \"Sweden\",\n \"description\": \"Swedish Toxic Group A\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 240,\n \"codeName\": \"Swedish Toxic Group B\",\n \"idJurisdiction\": 12,\n \"jurisdictionName\": \"Sweden\",\n \"description\": \"Swedish Toxic Group B\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 241,\n \"codeName\": \"Swedish EU Drug Precursor Category 2\",\n \"idJurisdiction\": 12,\n \"jurisdictionName\": \"Sweden\",\n \"description\": \"Swedish EU Drug Precursor Category 2\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 242,\n \"codeName\": \"Belgium EU Drug Precursor Category 2\",\n \"idJurisdiction\": 6,\n \"jurisdictionName\": \"Belgium\",\n \"description\": \"Belgium EU Drug Precursor Category 2\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 243,\n \"codeName\": \"German EU Drug Precursor Category 2\",\n \"idJurisdiction\": 8,\n \"jurisdictionName\": \"Germany\",\n \"description\": \"German EU Drug Precursor Category 2\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 244,\n \"codeName\": \"Danish EU Drug Precursor Category 2\",\n \"idJurisdiction\": 7,\n \"jurisdictionName\": \"Denmark\",\n \"description\": \"Danish EU Drug Precursor Category 2\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 245,\n \"codeName\": \"Irish EU Drug Precursor Category 2\",\n \"idJurisdiction\": 5,\n \"jurisdictionName\": \"Ireland\",\n \"description\": \"Irish EU Drug Precursor Category 2\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 247,\n \"codeName\": \"Netherlands EU Drug Precursor Category 2\",\n \"idJurisdiction\": 10,\n \"jurisdictionName\": \"Netherlands\",\n \"description\": \"Netherlands EU Drug Precursor Category 2\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 248,\n \"codeName\": \"Italian EU Drug Precursor Category 2\",\n \"idJurisdiction\": 9,\n \"jurisdictionName\": \"Italy\",\n \"description\": \"Italian EU Drug Precursor Category 2\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 249,\n \"codeName\": \"Spanish EU Drug Precursor Category 2\",\n \"idJurisdiction\": 11,\n \"jurisdictionName\": \"Spain\",\n \"description\": \"Spanish EU Drug Precursor Category 2\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 250,\n \"codeName\": \"Indian NDPS Rules Schedule I (I Narcotics)\",\n \"idJurisdiction\": 17,\n \"jurisdictionName\": \"India\",\n \"description\": \"Indian NDPS Rules Schedule I (I Narcotics)\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 251,\n \"codeName\": \"Indian NDPS Rules Schedule I (II Psychotrps)\",\n \"idJurisdiction\": 17,\n \"jurisdictionName\": \"India\",\n \"description\": \"Indian NDPS Rules Schedule I (II Psychotrps)\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 252,\n \"codeName\": \"Indian NDPS Rules Schedule II\",\n \"idJurisdiction\": 17,\n \"jurisdictionName\": \"India\",\n \"description\": \"Indian NDPS Rules Schedule II\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 253,\n \"codeName\": \"Indian NDPS Rules Schedule III (Psychotrps)\",\n \"idJurisdiction\": 17,\n \"jurisdictionName\": \"India\",\n \"description\": \"Indian NDPS Rules Schedule III (Psychotrps)\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 254,\n \"codeName\": \"EU Dual Use Items - Category 1C (Materials)\",\n \"idJurisdiction\": 21,\n \"jurisdictionName\": \"European Union\",\n \"description\": \"EU Dual Use Items - Category 1C (Materials)\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 255,\n \"codeName\": \"Austrian Narcotics Annex I.1\",\n \"idJurisdiction\": 23,\n \"jurisdictionName\": \"Austria\",\n \"description\": \"Austrian Narcotics Annex I.1\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 256,\n \"codeName\": \"Austrian Narcotics Annex I.2\",\n \"idJurisdiction\": 23,\n \"jurisdictionName\": \"Austria\",\n \"description\": \"Austrian Narcotics Annex I.2\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 257,\n \"codeName\": \"Austrian Narcotics Annex II\",\n \"idJurisdiction\": 23,\n \"jurisdictionName\": \"Austria\",\n \"description\": \"Austrian Narcotics Annex II\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 258,\n \"codeName\": \"Austrian Narcotics Annex III\",\n \"idJurisdiction\": 23,\n \"jurisdictionName\": \"Austria\",\n \"description\": \"Austrian Narcotics Annex III\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 259,\n \"codeName\": \"Austrian Narcotics Annex IV.1\",\n \"idJurisdiction\": 23,\n \"jurisdictionName\": \"Austria\",\n \"description\": \"Austrian Narcotics Annex IV.1\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 260,\n \"codeName\": \"Austrian Narcotics Annex IV.2\",\n \"idJurisdiction\": 23,\n \"jurisdictionName\": \"Austria\",\n \"description\": \"Austrian Narcotics Annex IV.2\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 261,\n \"codeName\": \"Austrian Narcotics Annex V.1\",\n \"idJurisdiction\": 23,\n \"jurisdictionName\": \"Austria\",\n \"description\": \"Austrian Narcotics Annex V.1\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 262,\n \"codeName\": \"Austrian Narcotics Annex V.2\",\n \"idJurisdiction\": 23,\n \"jurisdictionName\": \"Austria\",\n \"description\": \"Austrian Narcotics Annex V.2\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 263,\n \"codeName\": \"Austrian Psychotropics\",\n \"idJurisdiction\": 23,\n \"jurisdictionName\": \"Austria\",\n \"description\": \"Austrian Psychotropics\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 270,\n \"codeName\": \"UK Dual Use List Materials,Micro-orgs,Toxins\",\n \"idJurisdiction\": 2,\n \"jurisdictionName\": \"United Kingdom\",\n \"description\": \"UK Dual Use List Materials, Micro-organisms and toxins\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 272,\n \"codeName\": \"UK Human Rights – Prohibited Medical Prods\",\n \"idJurisdiction\": 2,\n \"jurisdictionName\": \"United Kingdom\",\n \"description\": \"UK Security and Human Rights - Prohibited Medicinal Products\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 273,\n \"codeName\": \"UK Controlled Radioactive Sources\",\n \"idJurisdiction\": 2,\n \"jurisdictionName\": \"United Kingdom\",\n \"description\": \"UK Radioactive Sources List\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 274,\n \"codeName\": \"China Non-medical Narcotics and Psychotropics\",\n \"idJurisdiction\": 19,\n \"jurisdictionName\": \"China\",\n \"description\": \"非药用类麻醉药品和精神药品管制品种增补目录\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 275,\n \"codeName\": \"Japanese Table I Narcotics\",\n \"idJurisdiction\": 24,\n \"jurisdictionName\": \"Japan\",\n \"description\": \"Narcotics and Psychotropics Control Law - Article 2 Table I Narcotics 第2条表I麻薬 - 麻薬及び向精神薬取締法 \",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 276,\n \"codeName\": \"Japanese Table II Narcotics Plants\",\n \"idJurisdiction\": 24,\n \"jurisdictionName\": \"Japan\",\n \"description\": \"Narcotics and Psychotropics Control Law - Article 2 Table II Narcotics Plants 第2条表II麻薬プラント - 麻薬及び向精神薬取締法 \",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 277,\n \"codeName\": \"Japanese Table III Psychotropics\",\n \"idJurisdiction\": 24,\n \"jurisdictionName\": \"Japan\",\n \"description\": \"Narcotics and Psychotropics Control Law - Article 2 Table III Psychotropics 第2条表III 向精神薬 - 麻薬及び向精神薬取締法 \",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 278,\n \"codeName\": \"Japanese Table IV Drug Raw Materials\",\n \"idJurisdiction\": 24,\n \"jurisdictionName\": \"Japan\",\n \"description\": \"Narcotics and Psychotropics Control Law - Table IV Precursors (Raw Materials) 麻薬原料\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 279,\n \"codeName\": \"Japanese Designated Substance\",\n \"idJurisdiction\": 24,\n \"jurisdictionName\": \"Japan\",\n \"description\": \"Designated substances according to the Pharmaceutical and Medical Device Act. 医薬品、医療機器等の品質、有効性及び安全性の確保等に関する法律指定薬物\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 280,\n \"codeName\": \"Japanese Poisonous Substances\",\n \"idJurisdiction\": 24,\n \"jurisdictionName\": \"Japan\",\n \"description\": \"Poisonous according to the Poisonous and Deleterious Substances Control Law 毒物 - 毒物及び劇物取締法\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 281,\n \"codeName\": \"Japanese Deleterious Substances\",\n \"idJurisdiction\": 24,\n \"jurisdictionName\": \"Japan\",\n \"description\": \"Deleterious Substances according to the Poisonous and Deleterious Substances Control Law 劇物 - 毒物及び劇物取締法\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 282,\n \"codeName\": \"Japanese Specific Poisonous Substances\",\n \"idJurisdiction\": 24,\n \"jurisdictionName\": \"Japan\",\n \"description\": \"Specific Poisonous Substances according to the Poisonous and Deleterious Substances Control Law 特定毒物 - 毒物及び劇物取締法\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 283,\n \"codeName\": \"Japanese Stimulants Raw Materials\",\n \"idJurisdiction\": 24,\n \"jurisdictionName\": \"Japan\",\n \"description\": \"\\rStimulants Raw Material 覚せい剤取締法 \\r\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 284,\n \"codeName\": \"Japanese Table I Narcotics Similar\",\n \"idJurisdiction\": 24,\n \"jurisdictionName\": \"Japan\",\n \"description\": \"Narcotics and Psychotropics Control Law - Article 2 Table I Narcotics 第1条表I麻薬 - 麻薬及び向精神薬取締法 \",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 285,\n \"codeName\": \"Japanese Table III Psychotropics Similar\",\n \"idJurisdiction\": 24,\n \"jurisdictionName\": \"Japan\",\n \"description\": \"Narcotics and Psychotropics Control Law Article 3, Division 1. 麻薬、麻薬原料植物、向精神薬及び麻薬向精神薬原料を指定する政令（第3条関係）第1種\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 286,\n \"codeName\": \"Japanese Article 3 Division 2 Psychotropics\",\n \"idJurisdiction\": 24,\n \"jurisdictionName\": \"Japan\",\n \"description\": \"Not used\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 287,\n \"codeName\": \"Japanese Article 3 Division 3 Psychotropics\",\n \"idJurisdiction\": 24,\n \"jurisdictionName\": \"Japan\",\n \"description\": \"Not used\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 288,\n \"codeName\": \"Japanese Opium Law\",\n \"idJurisdiction\": 24,\n \"jurisdictionName\": \"Japan\",\n \"description\": \"Japanese Opium Law (あへん法)\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 289,\n \"codeName\": \"Japanese Cannabis Control Law\",\n \"idJurisdiction\": 24,\n \"jurisdictionName\": \"Japan\",\n \"description\": \"Japanese Cannabis Control Law (大麻取締法)\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 290,\n \"codeName\": \"Japanese Stimulants Law\",\n \"idJurisdiction\": 24,\n \"jurisdictionName\": \"Japan\",\n \"description\": \"Japanese Stimulants Law 覚せい剤取締法 \\n\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 291,\n \"codeName\": \"US CWC Precursors\",\n \"idJurisdiction\": 3,\n \"jurisdictionName\": \"United States of America\",\n \"description\": \"This is a CS2 generated control code to enable CS2 to flag CWC and Australia Group precursors enacted in US CCL and ITAR legislation as precursors\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 292,\n \"codeName\": \"EU CWC Precursors\",\n \"idJurisdiction\": 21,\n \"jurisdictionName\": \"European Union\",\n \"description\": \"This is a CS2 generated control code to enable CS2 to flag CWC and Australia Group precursors enacted in the EU Military List and EU Dual Use legislation as precursors.\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 293,\n \"codeName\": \"UK 3rd Generation Cannabinoid\",\n \"idJurisdiction\": 2,\n \"jurisdictionName\": \"United Kingdom\",\n \"description\": \"This a CS2 generated control code to enable CS2 to specifically flag 3rd generation cannabinoids, allowing them to be filtered by donwstream systems for special handling\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 294,\n \"codeName\": \"Spanish National Level Narcotic\",\n \"idJurisdiction\": 11,\n \"jurisdictionName\": \"Spain\",\n \"description\": \"These are considered controlled narcotics and are not on the UN Yellow List\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 295,\n \"codeName\": \"Montreal Ozone Annex F, Group I\",\n \"idJurisdiction\": 22,\n \"jurisdictionName\": \"Montreal Ozone Protocol\",\n \"description\": \"Montreal Protocol on Substances that deplete the Ozone Layer Annex F, Group I control code\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 296,\n \"codeName\": \"Montreal Ozone Annex F, Group II\",\n \"idJurisdiction\": 22,\n \"jurisdictionName\": \"Montreal Ozone Protocol\",\n \"description\": \"Montreal Protocol on Substances that deplete the Ozone Layer Annex F, Group II control code\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 297,\n \"codeName\": \"Irish Schedule 8 pt5\",\n \"idJurisdiction\": 5,\n \"jurisdictionName\": \"Ireland\",\n \"description\": \"Drugs for use in mental health or intellectual disbaility\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 298,\n \"codeName\": \"Belgium Annex IA\",\n \"idJurisdiction\": 6,\n \"jurisdictionName\": \"Belgium\",\n \"description\": \"Belgium Annex IA\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 299,\n \"codeName\": \"Belgium Annex IB\",\n \"idJurisdiction\": 6,\n \"jurisdictionName\": \"Belgium\",\n \"description\": \"Belgium Annex IB\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 300,\n \"codeName\": \"Belgium Annex IIA\",\n \"idJurisdiction\": 6,\n \"jurisdictionName\": \"Belgium\",\n \"description\": \"Belgium Annex IIA\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 301,\n \"codeName\": \"Belgium Annex IIB\",\n \"idJurisdiction\": 6,\n \"jurisdictionName\": \"Belgium\",\n \"description\": \"Belgium Annex IIB\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 302,\n \"codeName\": \"Belgium Annex IIC\",\n \"idJurisdiction\": 6,\n \"jurisdictionName\": \"Belgium\",\n \"description\": \"Belgium Annex IIC\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 303,\n \"codeName\": \"Belgium Annex III\",\n \"idJurisdiction\": 6,\n \"jurisdictionName\": \"Belgium\",\n \"description\": \"Belgium Annex III\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 304,\n \"codeName\": \"Belgium Annex IVB\",\n \"idJurisdiction\": 6,\n \"jurisdictionName\": \"Belgium\",\n \"description\": \"Belgium Annex IVB\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 305,\n \"codeName\": \"Belgium Annex IVA\",\n \"idJurisdiction\": 6,\n \"jurisdictionName\": \"Belgium\",\n \"description\": \"Belgium Annex IVA\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 306,\n \"codeName\": \"Belgium Annex IC\",\n \"idJurisdiction\": 6,\n \"jurisdictionName\": \"Belgium\",\n \"description\": \"Belgium Annex IC\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 307,\n \"codeName\": \"Belgium Annex V\",\n \"idJurisdiction\": 6,\n \"jurisdictionName\": \"Belgium\",\n \"description\": \"Belgium Annex V\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 308,\n \"codeName\": \"EU Controlled Psychoactive Substance\",\n \"idJurisdiction\": 21,\n \"jurisdictionName\": \"European Union\",\n \"description\": \"EU Controlled Psychoactive Substance\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 309,\n \"codeName\": \"Singapore Regulations First Schedule\",\n \"idJurisdiction\": 25,\n \"jurisdictionName\": \"Singapore\",\n \"description\": \"Singapore Regulations First Schedule\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 310,\n \"codeName\": \"Singapore Regulations Second Schedule\",\n \"idJurisdiction\": 25,\n \"jurisdictionName\": \"Singapore\",\n \"description\": \"Singapore Regulations Second Schedule\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 311,\n \"codeName\": \"Singapore Regulations Third Schedule\",\n \"idJurisdiction\": 25,\n \"jurisdictionName\": \"Singapore\",\n \"description\": \"Singapore Regulations Third Schedule\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 312,\n \"codeName\": \"Singapore Regulations Fourth Schedule\",\n \"idJurisdiction\": 25,\n \"jurisdictionName\": \"Singapore\",\n \"description\": \"Singapore Regulations Fourth Schedule\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 313,\n \"codeName\": \"Singapore Class A\",\n \"idJurisdiction\": 25,\n \"jurisdictionName\": \"Singapore\",\n \"description\": \"Singapore Class A\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 314,\n \"codeName\": \"Singapore Class B\",\n \"idJurisdiction\": 25,\n \"jurisdictionName\": \"Singapore\",\n \"description\": \"Singapore Class B\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 316,\n \"codeName\": \"Singapore Specified Drug\",\n \"idJurisdiction\": 25,\n \"jurisdictionName\": \"Singapore\",\n \"description\": \"Singapore Specified Drug\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 315,\n \"codeName\": \"Singapore Class C\",\n \"idJurisdiction\": 25,\n \"jurisdictionName\": \"Singapore\",\n \"description\": \"Singapore Class C\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 317,\n \"codeName\": \"Singapore Temporarily Listed Drugs\",\n \"idJurisdiction\": 25,\n \"jurisdictionName\": \"Singapore\",\n \"description\": \"Singapore Temporarily Listed Drugs\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 318,\n \"codeName\": \"Singapore Precursors Part I\",\n \"idJurisdiction\": 25,\n \"jurisdictionName\": \"Singapore\",\n \"description\": \"Singapore Substances useful for Manufacturing Controlled Drugs Part 1\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 319,\n \"codeName\": \"Singapore Precursors Part II\",\n \"idJurisdiction\": 25,\n \"jurisdictionName\": \"Singapore\",\n \"description\": \"Singapore Substances useful for Manufacturing Controlled Drugs Part II\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 320,\n \"codeName\": \"Mexican Narcotics\",\n \"idJurisdiction\": 26,\n \"jurisdictionName\": \"Mexico\",\n \"description\": \"Mexican Narcotic Substances\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 321,\n \"codeName\": \"Mexican Psychotropics Group 1\",\n \"idJurisdiction\": 26,\n \"jurisdictionName\": \"Mexico\",\n \"description\": \"Mexican Psychotropic Substances Group 1\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 322,\n \"codeName\": \"Mexican Psychotropics Group 2\",\n \"idJurisdiction\": 26,\n \"jurisdictionName\": \"Mexico\",\n \"description\": \"Mexican Psychotropic Substances Group 2\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 323,\n \"codeName\": \"Mexican Psychotropics Group 3\",\n \"idJurisdiction\": 26,\n \"jurisdictionName\": \"Mexico\",\n \"description\": \"Mexican Psychotropic Substances Group 3\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 324,\n \"codeName\": \"Mexican Psychotropics Group 4\",\n \"idJurisdiction\": 26,\n \"jurisdictionName\": \"Mexico\",\n \"description\": \"Mexican Psychotropic Substances Group 4\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 325,\n \"codeName\": \"Mexican Psychotropics Group 5\",\n \"idJurisdiction\": 26,\n \"jurisdictionName\": \"Mexico\",\n \"description\": \"Mexican Psychotropic Substances Group 5\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 326,\n \"codeName\": \"Mexican Chemical Precursors List I\",\n \"idJurisdiction\": 26,\n \"jurisdictionName\": \"Mexico\",\n \"description\": \"Mexican Chemical Precursors List I (Chemical Precursors)\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 327,\n \"codeName\": \"Mexican Chemical Precursors List II\",\n \"idJurisdiction\": 26,\n \"jurisdictionName\": \"Mexico\",\n \"description\": \"Mexican Chemical Precursors List II (Essential Chemicals)\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 328,\n \"codeName\": \"Singapore Psychotropic Substance\",\n \"idJurisdiction\": 25,\n \"jurisdictionName\": \"Singapore\",\n \"description\": \"Singapore Psychotropic Substance\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 329,\n \"codeName\": \"Brazilian List A1\",\n \"idJurisdiction\": 27,\n \"jurisdictionName\": \"Brazil\",\n \"description\": \"Brazilian List A1 (Narcotic Substances subject to Revenue Notification A)\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 330,\n \"codeName\": \"Brazilian List A2\",\n \"idJurisdiction\": 27,\n \"jurisdictionName\": \"Brazil\",\n \"description\": \"Brazilian List A2 (Narcotic Substances permitted for use in special concentrations and subject to Revenue Notification A)\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 331,\n \"codeName\": \"Brazilian List A3\",\n \"idJurisdiction\": 27,\n \"jurisdictionName\": \"Brazil\",\n \"description\": \"Brazilian List A3 (Psychotropic Substances subject to Revenue Notification A)\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 332,\n \"codeName\": \"Brazilian List B1\",\n \"idJurisdiction\": 27,\n \"jurisdictionName\": \"Brazil\",\n \"description\": \"Brazilian List B1 (Psychotropic Substances subject to Revenue Notification B)\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 333,\n \"codeName\": \"Brazilian List B2\",\n \"idJurisdiction\": 27,\n \"jurisdictionName\": \"Brazil\",\n \"description\": \"Brazilian List B2 (Anorectic Psychotropic Substances subject to Revenue Notification B)\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 334,\n \"codeName\": \"Brazilian List C1\",\n \"idJurisdiction\": 27,\n \"jurisdictionName\": \"Brazil\",\n \"description\": \"Brazilian List C1 (Other Substances under special control and subject to two-way Special Control Revenue)\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 335,\n \"codeName\": \"Brazilian List C2\",\n \"idJurisdiction\": 27,\n \"jurisdictionName\": \"Brazil\",\n \"description\": \"Brazilian List C2 (Retinoic Substances which are subject to Special Revenue Notification)\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 336,\n \"codeName\": \"Brazilian List C3\",\n \"idJurisdiction\": 27,\n \"jurisdictionName\": \"Brazil\",\n \"description\": \"Brazilian List C3 (Immunosuppressant Substances which are subject to Special Revenue Notification)\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 380,\n \"codeName\": \"Finnish EU Drug Precursor Category 1\",\n \"idJurisdiction\": 29,\n \"jurisdictionName\": \"Finland\",\n \"description\": \"EU Drug Precursor Category 1\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 381,\n \"codeName\": \"Finnish EU Drug Precursor Category 2\",\n \"idJurisdiction\": 29,\n \"jurisdictionName\": \"Finland\",\n \"description\": \"EU Drug Precursor Category 2\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 382,\n \"codeName\": \"Finnish EU Drug Precursor Category 2A\",\n \"idJurisdiction\": 29,\n \"jurisdictionName\": \"Finland\",\n \"description\": \"EU Drug Precursor Category 2A\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 383,\n \"codeName\": \"Finnish EU Drug Precursor Category 2B\",\n \"idJurisdiction\": 29,\n \"jurisdictionName\": \"Finland\",\n \"description\": \"EU Drug Precursor Category 2B\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 384,\n \"codeName\": \"Finnish EU Drug Precursor Category 3\",\n \"idJurisdiction\": 29,\n \"jurisdictionName\": \"Finland\",\n \"description\": \"EU Drug Precursor Category 3\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 385,\n \"codeName\": \"Finnish EU Drug Precursor Category 4\",\n \"idJurisdiction\": 29,\n \"jurisdictionName\": \"Finland\",\n \"description\": \"EU Drug Precursor Category 4\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 353,\n \"codeName\": \"Polish EU Drug Precursor Category 1\",\n \"idJurisdiction\": 28,\n \"jurisdictionName\": \"Poland\",\n \"description\": \"Polish EU Drug Precursor Category 1\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 354,\n \"codeName\": \"Polish EU Drug Precursor Category 2\",\n \"idJurisdiction\": 28,\n \"jurisdictionName\": \"Poland\",\n \"description\": \"Polish EU Drug Precursor Category 2\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 355,\n \"codeName\": \"Polish EU Drug Precursor Category 2A\",\n \"idJurisdiction\": 28,\n \"jurisdictionName\": \"Poland\",\n \"description\": \"Polish EU Drug Precursor Category 2A\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 356,\n \"codeName\": \"Polish EU Drug Precursor Category 2B\",\n \"idJurisdiction\": 28,\n \"jurisdictionName\": \"Poland\",\n \"description\": \"Polish EU Drug Precursor Category 2B\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 357,\n \"codeName\": \"Polish EU Drug Precursor Category 3 \",\n \"idJurisdiction\": 28,\n \"jurisdictionName\": \"Poland\",\n \"description\": \"Polish EU Drug Precursor Category 3\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 358,\n \"codeName\": \"Polish EU Drug Precursor Category 4\",\n \"idJurisdiction\": 28,\n \"jurisdictionName\": \"Poland\",\n \"description\": \"Polish EU Drug Precursor Category 4\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 337,\n \"codeName\": \"Brazilian List C5\",\n \"idJurisdiction\": 27,\n \"jurisdictionName\": \"Brazil\",\n \"description\": \"Brazilian List C5 (Anabolic Substances which are subject to two-way Special Control Revenue)\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 338,\n \"codeName\": \"Brazilian List D1\",\n \"idJurisdiction\": 27,\n \"jurisdictionName\": \"Brazil\",\n \"description\": \"Brazilian List D1 (Precursor Substances for narcotics and/or psychotropics, which are subject to Non-Retention Medical Revenue)\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 339,\n \"codeName\": \"Brazilian List D2\",\n \"idJurisdiction\": 27,\n \"jurisdictionName\": \"Brazil\",\n \"description\": \"Brazilian List D2 (Chemical Inputs in manufacturing and synthesis of narcotics and/or psychotropic substances which are subject to the control of the Ministry of Justice)\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 340,\n \"codeName\": \"Brazilian List E\",\n \"idJurisdiction\": 27,\n \"jurisdictionName\": \"Brazil\",\n \"description\": \"Brazilian List E (Proscribed plants from which narcotics and/or psychotropics originate)\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 341,\n \"codeName\": \"Brazilian List F1\",\n \"idJurisdiction\": 27,\n \"jurisdictionName\": \"Brazil\",\n \"description\": \"Brazilian List F1 (List F is reserved for substances which are prohibited in Brazil. List F1 is for narcotic substances)\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 342,\n \"codeName\": \"Brazilian List F2\",\n \"idJurisdiction\": 27,\n \"jurisdictionName\": \"Brazil\",\n \"description\": \"Brazilian List F2 (List F is reserved for substances which are prohibited in Brazil. List F2a is for psychotropic substances. List F2b and F2c contain the cannabinoid and cathinone Markush definitions, respectively.)\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 343,\n \"codeName\": \"Brazilian List F3\",\n \"idJurisdiction\": 27,\n \"jurisdictionName\": \"Brazil\",\n \"description\": \"Brazilian List F3 (List F is reserved for substances which are prohibited in Brazil. List F3 is reserved for precursor substances)\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 344,\n \"codeName\": \"Brazilian List F4\",\n \"idJurisdiction\": 27,\n \"jurisdictionName\": \"Brazil\",\n \"description\": \"Brazilian List F4 (List F is reserved for substances which are prohibited in Brazil. List F4 is reserved for other substances)\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 361,\n \"codeName\": \"NOT-IN-USE-REUSE THIS IDSYS_CONTROLLEDCODE\",\n \"idJurisdiction\": 19,\n \"jurisdictionName\": \"China\",\n \"description\": \"NOT-IN-USE-REUSE THIS IDSYS_CONTROLLEDCODE - edit all fields including IDJurisdiction\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 362,\n \"codeName\": \"Annex 1 List I\",\n \"idJurisdiction\": 29,\n \"jurisdictionName\": \"Finland\",\n \"description\": \"List of the 1961 Convention on Drugs I (Vuoden 1961 huumausaineyleissopimuksen lista I)\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 363,\n \"codeName\": \"Annex 1 List II\",\n \"idJurisdiction\": 29,\n \"jurisdictionName\": \"Finland\",\n \"description\": \"List of the 1961 Convention on Drugs II (Vuoden 1961 huumausaineyleissopimuksen lista II)\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 364,\n \"codeName\": \"Annex 1 List III\",\n \"idJurisdiction\": 29,\n \"jurisdictionName\": \"Finland\",\n \"description\": \"List of the 1961 Convention on Drugs III (Vuoden 1961 huumausaineyleissopimuksen lista III)\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 365,\n \"codeName\": \"Annex 1 List IV\",\n \"idJurisdiction\": 29,\n \"jurisdictionName\": \"Finland\",\n \"description\": \"List of the 1961 Convention on Drugs IV (Vuoden 1961 huumausaineyleissopimuksen lista IV)\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 366,\n \"codeName\": \"Annex 2 List I\",\n \"idJurisdiction\": 29,\n \"jurisdictionName\": \"Finland\",\n \"description\": \"List of the 1971 Convention on Psychotropic Substances I (Psykotrooppisia aineita koskevan yleissopimuksen lista I)\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 367,\n \"codeName\": \"Annex 2 List II\",\n \"idJurisdiction\": 29,\n \"jurisdictionName\": \"Finland\",\n \"description\": \"List of the 1971 Convention on Psychotropic Substances II (Psykotrooppisia aineita koskevan yleissopimuksen lista II)\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 368,\n \"codeName\": \"Annex 2 List III\",\n \"idJurisdiction\": 29,\n \"jurisdictionName\": \"Finland\",\n \"description\": \"List of the 1971 Convention on Psychotropic Substances III (Psykotrooppisia aineita koskevan yleissopimuksen lista III)\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 369,\n \"codeName\": \"Annex 2 List IV\",\n \"idJurisdiction\": 29,\n \"jurisdictionName\": \"Finland\",\n \"description\": \"List of the 1971 Convention on Psychotropic Substances IV (Psykotrooppisia aineita koskevan yleissopimuksen lista IV)\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 370,\n \"codeName\": \"Annex 3\",\n \"idJurisdiction\": 29,\n \"jurisdictionName\": \"Finland\",\n \"description\": \"Substances subject to surveillance under Council Decisions adopted under Joint Action 97/396 / JHA on new synthetic drugs or Decision 2005/387 / JHA on the exchange, risk assessment and control of new psychoactive substances:\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 371,\n \"codeName\": \"Annex 4\",\n \"idJurisdiction\": 29,\n \"jurisdictionName\": \"Finland\",\n \"description\": \"Annex 4 substances\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 372,\n \"codeName\": \"Psychoactive Substances Appendix\",\n \"idJurisdiction\": 29,\n \"jurisdictionName\": \"Finland\",\n \"description\": \"Substances list under Government Decree on Psychoactive Substances as Banned from the Consumer Market\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 360,\n \"codeName\": \"Polish New Psychotropic Substances\",\n \"idJurisdiction\": 28,\n \"jurisdictionName\": \"Poland\",\n \"description\": \"Polish New Psychotropic Substances (Nowych substancji psychoaktywnych)\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 373,\n \"codeName\": \"Schedule 1 Controlled Drugs \",\n \"idJurisdiction\": 30,\n \"jurisdictionName\": \"Taiwan\",\n \"description\": \"Schedule 1 Controlled Drugs 第一級管制藥品\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 374,\n \"codeName\": \"Schedule 2 Controlled Drugs \",\n \"idJurisdiction\": 30,\n \"jurisdictionName\": \"Taiwan\",\n \"description\": \"Schedule 2 Controlled Drugs 第二級管制藥品\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 375,\n \"codeName\": \"Schedule 3 Controlled Drugs \",\n \"idJurisdiction\": 30,\n \"jurisdictionName\": \"Taiwan\",\n \"description\": \"Schedule 3 Controlled Drugs 第三級管制藥品\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 376,\n \"codeName\": \"Schedule 4 Controlled Drugs \",\n \"idJurisdiction\": 30,\n \"jurisdictionName\": \"Taiwan\",\n \"description\": \"Schedule 4 Controlled Drugs 第四級管制藥品\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 377,\n \"codeName\": \"Schedule 4 Controlled Drug Materials\",\n \"idJurisdiction\": 30,\n \"jurisdictionName\": \"Taiwan\",\n \"description\": \"Schedule 4 Controlled Drug Materials 第四級管制藥品原料藥\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 378,\n \"codeName\": \"Table I – Category A\",\n \"idJurisdiction\": 30,\n \"jurisdictionName\": \"Taiwan\",\n \"description\": \"Table I – Category A 一、甲類\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 379,\n \"codeName\": \"Table 2 – Category B\",\n \"idJurisdiction\": 30,\n \"jurisdictionName\": \"Taiwan\",\n \"description\": \"Table 2 – Category B 二、乙類\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 359,\n \"codeName\": \"EU Human Rights List Annex IV\",\n \"idJurisdiction\": 21,\n \"jurisdictionName\": \"European Union\",\n \"description\": \"EU Human Rights List Annex IV\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 345,\n \"codeName\": \"Polish Narcotic drugs I-N\",\n \"idJurisdiction\": 28,\n \"jurisdictionName\": \"Poland\",\n \"description\": \"Polish Narcotic drugs Group 1 (Środki odurzające grupy I-N)\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 346,\n \"codeName\": \"Polish Narcotic drugs II-N\",\n \"idJurisdiction\": 28,\n \"jurisdictionName\": \"Poland\",\n \"description\": \"Polish Narcotic drugs Group 2 (Środki odurzające grupy II-N)\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 347,\n \"codeName\": \"Polish Narcotic drugs III-N\",\n \"idJurisdiction\": 28,\n \"jurisdictionName\": \"Poland\",\n \"description\": \"Polish Narcotic drugs Group 3 (Środki odurzające grupy III-N)\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 348,\n \"codeName\": \"Polish Narcotic drugs IV-N\",\n \"idJurisdiction\": 28,\n \"jurisdictionName\": \"Poland\",\n \"description\": \"Polish Narcotic drugs Group 4 (Środki odurzające grupy IV-N)\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 349,\n \"codeName\": \"Polish Psychotropic Substances I-P\",\n \"idJurisdiction\": 28,\n \"jurisdictionName\": \"Poland\",\n \"description\": \"Polish Psychotropic Substances group 1 (Substancje psychotropowe grupy I-P)\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 350,\n \"codeName\": \"Polish Psychotropic Substances II-P\",\n \"idJurisdiction\": 28,\n \"jurisdictionName\": \"Poland\",\n \"description\": \"Polish Psychotropic Substances group 2 (Substancje psychotropowe grupy II-P)\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 351,\n \"codeName\": \"Polish Psychotropic Substances III-P\",\n \"idJurisdiction\": 28,\n \"jurisdictionName\": \"Poland\",\n \"description\": \"Polish Psychotropic Substances group 3 (Substancje psychotropowe grupy III-P)\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 352,\n \"codeName\": \"Polish Psychotropic Substances IV-P\",\n \"idJurisdiction\": 28,\n \"jurisdictionName\": \"Poland\",\n \"description\": \"Polish Psychotropic Substances group 4 (Substancje psychotropowe grupy IV-P)\",\n \"idControlledCode\": null\n },\n {\n \"idSysControlledCode\": 386,\n \"codeName\": \"UK 3rd Generation Cannabinoid 2019\",\n \"idJurisdiction\": 2,\n \"jurisdictionName\": \"United Kingdom\",\n \"description\": \"This a CS2 generated control code to enable CS2 to specifically flag 3rd generation cannabinoids as defined by the 2019 amendment, allowing them to be filtered by downstream systems for special handling\",\n \"idControlledCode\": null\n },\n {\n \"idControlledCode\": 141,\n \"codeName\": \"TestCC\",\n \"idJurisdiction\": 2,\n \"jurisdictionName\": \"United Kingdom\",\n \"description\": \"This is a test\",\n \"idSysControlledCode\": null\n },\n {\n \"idControlledCode\": 61,\n \"codeName\": \"Sci UK Test\",\n \"idJurisdiction\": 2,\n \"jurisdictionName\": \"United Kingdom\",\n \"description\": \"Sci test control code for the UK\",\n \"idSysControlledCode\": null\n },\n {\n \"idControlledCode\": 201,\n \"codeName\": \"FR_testCustomerCC\",\n \"idJurisdiction\": 4,\n \"jurisdictionName\": \"France\",\n \"description\": \"testing\",\n \"idSysControlledCode\": null\n },\n {\n \"idControlledCode\": 181,\n \"codeName\": \"UserDefinedCC2\",\n \"idJurisdiction\": 10000,\n \"jurisdictionName\": \"UserDefined\",\n \"description\": \"newUSerDefinedCC_forTestiing multiple customer controls codes per sub2jur \",\n \"idSysControlledCode\": null\n },\n {\n \"idControlledCode\": 121,\n \"codeName\": \"Userdefined Control Code\",\n \"idJurisdiction\": 10000,\n \"jurisdictionName\": \"UserDefined\",\n \"description\": \"this is a test\",\n \"idSysControlledCode\": null\n },\n {\n \"idControlledCode\": 161,\n \"codeName\": \"Adam Test CC 2\",\n \"idJurisdiction\": 10001,\n \"jurisdictionName\": \"Adam Test\",\n \"description\": \"Test control code 2\",\n \"idSysControlledCode\": null\n },\n {\n \"idControlledCode\": 101,\n \"codeName\": \"Adam Test CC\",\n \"idJurisdiction\": 10001,\n \"jurisdictionName\": \"Adam Test\",\n \"description\": \"This is a test control code\",\n \"idSysControlledCode\": null\n }\n]"}],"_postman_id":"a698b457-c634-4bd6-9e66-b7d07d9656d7"},{"name":"/fastlookup/changes","event":[{"listen":"test","script":{"id":"137a05a2-00d6-4bda-b5bc-e23a9023d86d","exec":[""],"type":"text/javascript","packages":{}}}],"id":"27df1b8f-2e54-4ef6-bbd9-4eab111c29f2","protocolProfileBehavior":{"disableBodyPruning":true},"request":{"method":"POST","header":[{"key":"x-access-token","value":"{{token}}","description":"

This header needs to have the authenication token obtained from the /authenticate API to allow requests to be sent to this endpoint

\n","type":"text"}],"body":{"mode":"raw","raw":"{\r\n \"fromDate\": \"2023-01-01\",\r\n \"toDate\": \"2023-06-01\"\r\n}","options":{"raw":{"language":"json"}}},"url":"https://{{host}}:{{port}}/fastlookup/changes","description":"

Return a list of controlled status changes that have occured between the specified dates.

Body parameters

fromDate: string
The date from when to start returning changes in controlled statuses from. Should be in the form yyyy-mm-dd

toDate: string
The date up to which changes in controlled statuses should be returned. Should be in the form yyyy-mm-dd

\n","urlObject":{"protocol":"https","port":"{{port}}","path":["fastlookup","changes"],"host":["{{host}}"],"query":[],"variable":[]}},"response":[],"_postman_id":"27df1b8f-2e54-4ef6-bbd9-4eab111c29f2"}],"id":"9a59a1a4-8a27-4599-9dda-aa16825ce08b","description":"

APIs for Scitegrity's Controlled Substances Squared (CS2) application

\n","_postman_id":"9a59a1a4-8a27-4599-9dda-aa16825ce08b"},{"name":"Dangerous Goods Assessor","item":[{"name":"/dg/webservice","item":[{"name":"/search/run","event":[{"listen":"test","script":{"id":"85fd3ef6-4f1f-4d7e-924c-7a5983c44a0a","exec":["// parse response and set gatewayJobId as environment variable\r","var response = pm.response.json();\r","pm.environment.set(\"jobId\", response.gatewayJobId);"],"type":"text/javascript","packages":{}}}],"id":"f99e07f4-1037-4ae7-b3f1-81930346afd8","protocolProfileBehavior":{"disableBodyPruning":true},"request":{"auth":{"type":"noauth","isInherited":false},"method":"POST","header":[{"key":"x-access-token","value":"{{token}}","description":"

The authentication token obtained from the /authenticate endpoint

\n","type":"text"}],"body":{"mode":"raw","raw":"{\r\n \"fileContent\" : \"O=[N+]([O-])c1cc(cc([N+]([O-])=O)c1O)[N+]([O-])=O POSTMAN_TEST_1\"\r\n}","options":{"raw":{"language":"json"}}},"url":"https://{{host}}:{{port}}/dg/webservice/search/run","description":"

Submit a new job to Scitegrity's Dangerous Goods Assessor providing input compounds in a plain text format (SMILES, InChI). This API call will return a gatewayJobId which can be used to monitor the job and retrieve the results using the /dg/webservice/search/result endpoint. The header field x-access-token must be populated with the value of an active token. Once the job is submitted, the owner of that job will be whomever the token was created by. To obtain a value for x-access-token see GET /authenticate.

Body Parameters

fileContent: String

This is the list of SMILES strings, InChI strings for the compounds you would like to check. This should be in plain text format with each compound on a new line. Optionally, you can provide a compound identifier along with the SMILES/InChI which will be output in the results, add this to the same line after the SMILES/InChI string with a space between the id and SMILES/InChI.

\n","urlObject":{"protocol":"https","port":"{{port}}","path":["dg","webservice","search","run"],"host":["{{host}}"],"query":[],"variable":[]}},"response":[],"_postman_id":"f99e07f4-1037-4ae7-b3f1-81930346afd8"},{"name":"/search/run/b64","event":[{"listen":"test","script":{"id":"6a8e7a8b-2eb0-4bdb-a9e8-17a7de6d83e8","exec":["// parse response and set gatewayJobId as environment variable\r","var response = pm.response.json();\r","pm.environment.set(\"jobId\", response.gatewayJobId);"],"type":"text/javascript","packages":{}}}],"id":"2d3469ad-3204-4786-ae1a-c5676b376faa","protocolProfileBehavior":{"disableBodyPruning":true},"request":{"auth":{"type":"noauth","isInherited":false},"method":"POST","header":[{"key":"x-access-token","value":"{{token}}","description":"

The authentication token obtained from the /authenticate endpoint

\n","type":"text"}],"body":{"mode":"raw","raw":"{\r\n \"fileContent\" : \"
  SciTegic11061411402D

  6  6  0  0  0  0            999 V2000
    4.9992    6.0386    0.0000 O   0  0
    5.7838    5.7839    0.0000 C   0  0
    6.4510    6.2685    0.0000 O   0  0
    7.1185    5.7839    0.0000 C   0  0
    6.8636    4.9992    0.0000 C   0  0
    6.0385    4.9992    0.0000 C   0  0
  1  2  2  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  2  1  0
M  END
> <corporateID>
Example_1

$$$$

  SciTegic11061411402D

 29 32  0  0  0  0            999 V2000
    5.0000    8.8643    0.0000 C   0  0
    5.1714    8.0573    0.0000 O   0  0
    5.9560    7.8023    0.0000 C   0  0
    6.5692    8.3543    0.0000 C   0  0
    7.3538    8.0992    0.0000 C   0  0
    7.5252    7.2923    0.0000 C   0  0
    8.3098    7.0372    0.0000 C   0  0
    8.9230    7.5892    0.0000 C   0  0
    9.7076    7.3342    0.0000 N   0  0
   10.3207    7.8862    0.0000 C   0  0
   10.1493    8.6931    0.0000 O   0  0
   11.1053    7.6311    0.0000 C   0  0
   11.7185    8.1831    0.0000 S   0  0
   12.5031    7.9281    0.0000 C   0  0
   13.1705    8.4129    0.0000 N   0  0
   13.8380    7.9280    0.0000 N   0  0
   13.5830    7.1434    0.0000 C   0  0
   13.9954    6.4290    0.0000 C   0  0
   13.5829    5.7145    0.0000 C   0  0
   13.9954    5.0000    0.0000 C   0  0
   12.7579    5.7145    0.0000 C   0  0
   12.3454    5.0000    0.0000 C   0  0
   11.5204    5.0000    0.0000 C   0  0
   11.1079    5.7145    0.0000 C   0  0
   11.5204    6.4289    0.0000 C   0  0
   12.3454    6.4290    0.0000 C   0  0
   12.7579    7.1434    0.0000 N   0  0
    6.9121    6.7403    0.0000 C   0  0
    6.1275    6.9953    0.0000 C   0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  2  0
 10 12  1  0
 12 13  1  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  2  0
 19 20  1  0
 19 21  1  0
 21 22  2  0
 22 23  1  0
 23 24  2  0
 24 25  1  0
 25 26  2  0
 26 21  1  0
 26 27  1  0
 27 14  1  0
 27 17  1  0
  6 28  1  0
 28 29  2  0
 29  3  1  0
M  END
> <corporateID>
Example_2

$$$$

  SciTegic11061411402D

 22 25  0  0  1  0            999 V2000
    4.1486   -1.0341    0.0000 C   0  0
    4.1487   -1.8528    0.0000 N   0  0
    3.4834   -2.3364    0.0000 C   0  0
    3.7383   -3.1219    0.0000 C   0  0  2  0  0  0
    4.5600   -3.1187    0.0000 C   0  0  1  0  0  0
    4.8143   -2.3364    0.0000 C   0  0
    5.0785   -3.7622    0.0000 C   0  0
    5.8586   -3.5060    0.0000 C   0  0
    6.4698   -4.0602    0.0000 C   0  0
    7.2492   -3.8092    0.0000 Cl  0  0
    6.2974   -4.8653    0.0000 C   0  0
    5.5138   -5.1161    0.0000 C   0  0
    4.9062   -4.5672    0.0000 C   0  0
    4.1649   -4.9279    0.0000 O   0  0
    3.4167   -4.5768    0.0000 C   0  0
    2.8165   -5.1469    0.0000 C   0  0
    2.0205   -4.9057    0.0000 C   0  0
    1.8301   -4.0977    0.0000 C   0  0
    2.4359   -3.5310    0.0000 C   0  0
    3.2263   -3.7689    0.0000 C   0  0
    4.0964   -3.8583    0.0000 H   0  0
    5.3654   -2.9705    0.0000 H   0  0
  1  2  1  0
  2  6  1  0
  2  3  1  0
  3  4  1  0
  4 20  1  0
  4  5  1  0
  5  6  1  0
  5  7  1  0
  7 13  2  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
  9 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  1  0
 14 15  1  0
 15 20  2  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  2  0
 19 20  1  0
  4 21  1  1
  5 22  1  6
M  END
> <corporateID>
Example_3

$$$$

  SciTegic11061411402D

 21 21  0  0  0  0            999 V2000
    2.7361    0.7608    0.0000 C   0  0
    1.9291    0.5892    0.0000 N   0  0
    1.6742   -0.1954    0.0000 C   0  0
    1.3770    1.2023    0.0000 C   0  0
    0.5701    1.0308    0.0000 C   0  0
    0.3151    0.2462    0.0000 C   0  0
    0.8001   -0.4213    0.0000 C   0  0
    0.3151   -1.0887    0.0000 N   0  0
   -0.4696   -0.8338    0.0000 C   0  0
   -1.1840   -1.2464    0.0000 C   0  0
   -1.8985   -0.8338    0.0000 C   0  0
   -1.8985   -0.0088    0.0000 C   0  0
   -2.6130    0.4037    0.0000 O   0  0
   -1.1840    0.4037    0.0000 C   0  0
   -0.4696   -0.0088    0.0000 C   0  0
    4.9142    0.8252    0.0000 O   0  0
    5.2318    0.2751    0.0000 C   0  0
    5.8671    0.2751    0.0000 O   0  0
    4.9142   -0.2751    0.0000 C   0  0
    5.2318   -0.8252    0.0000 O   0  0
    4.2789   -0.2751    0.0000 O   0  0
  1  2  1  0
  2  3  1  0
  2  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  2  0
  6 15  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
  9 15  2  0
 10 11  2  0
 11 12  1  0
 12 13  1  0
 12 14  2  0
 14 15  1  0
 16 17  1  0
 17 18  2  0
 17 19  1  0
 19 20  1  0
 19 21  2  0
M  END
> <corporateID>
Example_4

$$$$

  SciTegic11061411402D

 24 26  0  0  0  0            999 V2000
    4.2867   -1.2375    0.0000 C   0  0
    3.5722   -1.6500    0.0000 C   0  0
    2.8579   -1.2375    0.0000 C   0  0
    2.8579   -0.5775    0.0000 O   0  0
    2.1434   -1.6500    0.0000 N   0  0
    2.1434   -2.4749    0.0000 C   0  0
    1.4289   -2.8874    0.0000 C   0  0
    1.4289   -3.7124    0.0000 C   0  0
    2.1434   -4.1249    0.0000 N   0  0
    2.8579   -3.7124    0.0000 C   0  0
    2.8579   -2.8874    0.0000 C   0  0
    2.1434   -4.9498    0.0000 C   0  0
    2.8579   -5.3623    0.0000 C   0  0
    3.5722   -4.9498    0.0000 C   0  0
    3.8089   -4.1596    0.0000 C   0  0
    4.6337   -4.1405    0.0000 C   0  0
    4.9067   -4.9190    0.0000 C   0  0
    4.2507   -5.4193    0.0000 S   0  0
    1.4289   -1.2375    0.0000 C   0  0
    1.4289   -0.4125    0.0000 C   0  0
    0.7145    0.0000    0.0000 C   0  0
    0.0001   -0.4124    0.0000 C   0  0
    0.0000   -1.2375    0.0000 C   0  0
    0.7145   -1.6500    0.0000 C   0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  3  5  1  0
  5  6  1  0
  5 19  1  0
  6  7  1  0
  6 11  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
  9 12  1  0
 10 11  1  0
 12 13  1  0
 13 14  1  0
 14 15  2  0
 14 18  1  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 19 20  2  0
 19 24  1  0
 20 21  1  0
 21 22  2  0
 22 23  1  0
 23 24  2  0
M  END
> <corporateID>
Example_5

$$$$

  SciTegic11061411402D

 24 26  0  0  0  0            999 V2000
    0.0000   -2.8876    0.0000 C   0  0
    0.7145   -2.4750    0.0000 C   0  0
    0.7145   -1.8151    0.0000 O   0  0
    1.4289   -2.8876    0.0000 N   0  0
    2.1434   -2.4750    0.0000 C   0  0
    2.1434   -1.6500    0.0000 C   0  0
    2.8579   -1.2376    0.0000 C   0  0
    3.5723   -1.6500    0.0000 N   0  0
    3.5723   -2.4750    0.0000 C   0  0
    2.8579   -2.8876    0.0000 C   0  0
    4.2868   -1.2375    0.0000 C   0  0
    5.0013   -1.6500    0.0000 C   0  0
    5.7158   -1.2375    0.0000 C   0  0
    5.7158   -0.4125    0.0000 C   0  0
    6.4302    0.0000    0.0000 C   0  0
    7.1447   -0.4125    0.0000 C   0  0
    7.1447   -1.2375    0.0000 C   0  0
    6.4302   -1.6500    0.0000 C   0  0
    1.4289   -3.7125    0.0000 C   0  0
    0.7145   -4.1251    0.0000 C   0  0
    0.7145   -4.9501    0.0000 C   0  0
    1.4289   -5.3626    0.0000 C   0  0
    2.1434   -4.9501    0.0000 C   0  0
    2.1434   -4.1251    0.0000 C   0  0
  1  2  1  0
  2  3  2  0
  2  4  1  0
  4  5  1  0
  4 19  1  0
  5  6  1  0
  5 10  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  8 11  1  0
  9 10  1  0
 11 12  1  0
 12 13  1  0
 13 14  2  0
 13 18  1  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  2  0
 19 20  2  0
 19 24  1  0
 20 21  1  0
 21 22  2  0
 22 23  1  0
 23 24  2  0
M  END
> <corporateID>
Example_6

$$$$

  SciTegic11061411402D

 22 24  0  0  0  0            999 V2000
   -4.3225   -1.2712    0.0000 C   0  0
   -3.6080   -0.8587    0.0000 C   0  0
   -2.8935   -1.2712    0.0000 C   0  0
   -2.1790   -0.8587    0.0000 C   0  0
   -1.4646   -1.2712    0.0000 C   0  0
   -0.7501   -0.8587    0.0000 N   0  0
   -0.6639   -0.0383    0.0000 C   0  0
    0.1431    0.1333    0.0000 C   0  0
    0.5556   -0.5812    0.0000 C   0  0
    0.0036   -1.1943    0.0000 C   0  0
    1.3761   -0.6674    0.0000 C   0  0
    1.7116   -1.4211    0.0000 O   0  0
    1.8610    0.0000    0.0000 C   0  0
    1.5255    0.7537    0.0000 C   0  0
    2.0104    1.4211    0.0000 C   0  0
    2.8309    1.3349    0.0000 C   0  0
    3.1664    0.5812    0.0000 C   0  0
    3.9869    0.4950    0.0000 C   0  0
    4.3225   -0.2587    0.0000 C   0  0
    3.8375   -0.9261    0.0000 C   0  0
    3.0171   -0.8399    0.0000 C   0  0
    2.6815   -0.0862    0.0000 C   0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
  6 10  1  0
  9 11  1  0
 11 12  2  0
 11 13  1  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  2  0
 21 22  1  0
 13 22  2  0
 17 22  1  0
M  END
> <corporateID>
Example_7

$$$$
\"\r\n}","options":{"raw":{"language":"json"}}},"url":"https://{{host}}:{{port}}/dg/webservice/search/run/b64","description":"

Submit a new job to Scitegrity's Dangerous Goods Assessor providing input compounds in SDF or SMILES file format. This API call will return a gatewayJobId which can be used to monitor the job and retrieve the results using the /dg/webservice/search/result endpoint. Tinit (left-limit onset temperature /C) and Q (exothermic energy in J/g) can be provided as optional data fields in the SDF file for the calculation of Yoshida correlations.

Body Parameters

fileContent: String

Must contain the base64 encoded content of a valid SDF, MOL or SMILES file with the structures you wish to check.

\n","urlObject":{"protocol":"https","port":"{{port}}","path":["dg","webservice","search","run","b64"],"host":["{{host}}"],"query":[],"variable":[]}},"response":[],"_postman_id":"2d3469ad-3204-4786-ae1a-c5676b376faa"},{"name":"/search/status","event":[{"listen":"test","script":{"id":"fd758da2-0fb5-4d32-bb16-4cc182e779d2","exec":[""],"type":"text/javascript","packages":{}}}],"id":"74f5e478-548d-405b-a4c5-cc3e81fc352a","protocolProfileBehavior":{"disableBodyPruning":true},"request":{"method":"POST","header":[{"key":"x-access-token","value":"{{token}}","description":"

The authentication token obtained from the /authenticate endpoint

\n","type":"text"}],"body":{"mode":"raw","raw":"{\r\n \"gatewayJobId\": \"{{jobId}}\"\r\n}","options":{"raw":{"language":"json"}}},"url":"https://{{host}}:{{port}}/dg/webservice/search/status","description":"

Get the status of a submitted Dangerous Gooods Assessor webservice job.

Body Parameters

gatewayJobId: String

The returned jobId provided when the job was started using the above /search/run endpoints.

\n","urlObject":{"protocol":"https","port":"{{port}}","path":["dg","webservice","search","status"],"host":["{{host}}"],"query":[],"variable":[]}},"response":[],"_postman_id":"74f5e478-548d-405b-a4c5-cc3e81fc352a"},{"name":"/search/result","event":[{"listen":"test","script":{"id":"f949f4e5-b2b4-4209-a8c9-f84f8da220bc","exec":[""],"type":"text/javascript","packages":{}}}],"id":"55b779e6-9297-4223-8410-5c9d8cdc6f18","protocolProfileBehavior":{"disableBodyPruning":true},"request":{"method":"POST","header":[{"key":"x-access-token","value":"{{token}}","description":"

The authentication token obtained from the /authenticate endpoint

Get the results of a completed Dangerous Goods Assessor webservice job in JSON format.

Body Parameters

gatewayJobId: String

The returned jobId provided when the job was started using the above /search/run endpoints.

\n","urlObject":{"protocol":"https","port":"{{port}}","path":["dg","webservice","search","result"],"host":["{{host}}"],"query":[],"variable":[]}},"response":[],"_postman_id":"55b779e6-9297-4223-8410-5c9d8cdc6f18"},{"name":"/search/result/sdf","event":[{"listen":"test","script":{"id":"06c59e15-2dd3-4844-857f-16f62b1e459b","exec":[""],"type":"text/javascript","packages":{}}}],"id":"a948bdf9-fe8c-41d7-b7ff-16ad65a3f32c","protocolProfileBehavior":{"disableBodyPruning":true},"request":{"method":"POST","header":[{"key":"x-access-token","value":"{{token}}","description":"

The authentication token obtained from the /authenticate endpoint

Get the results of a completed Dangerous Goods Assessor webservice job in SDF format.

Body Parameters

gatewayJobId: String

The returned jobId provided when the job was started using the above /search/run endpoints.

\n","urlObject":{"protocol":"https","port":"{{port}}","path":["dg","webservice","search","result","sdf"],"host":["{{host}}"],"query":[],"variable":[]}},"response":[],"_postman_id":"a948bdf9-fe8c-41d7-b7ff-16ad65a3f32c"}],"id":"66aaf20b-b264-4b61-a2d4-f2e6dacf6634","description":"

Endpoints to start Dangerous Goods assessment jobs, check the status of these jobs and to get job results.

\n","_postman_id":"66aaf20b-b264-4b61-a2d4-f2e6dacf6634"}],"id":"6631cdd2-b55f-49c9-b497-93ec97635985","description":"

APIs for Scitegrity's Dangerous Goods Assessor (DG) application

\n","_postman_id":"6631cdd2-b55f-49c9-b497-93ec97635985"},{"name":"ExpediChem","item":[{"name":"/expedichem/webservice","item":[{"name":"/search/run","event":[{"listen":"test","script":{"id":"8c4e6c4b-061e-4848-8426-e8d91e202ae9","exec":["// parse response and set gatewayJobId as environment variable\r","var response = pm.response.json();\r","pm.environment.set(\"jobId\", response.gatewayJobId);"],"type":"text/javascript","packages":{}}}],"id":"5181a6b2-42ba-4f75-9595-d3382d3d348a","protocolProfileBehavior":{"disableBodyPruning":true},"request":{"auth":{"type":"noauth","isInherited":false},"method":"POST","header":[{"key":"x-access-token","value":"{{token}}","description":"

The authentication token obtained from the /authenticate endpoint

\n"}],"body":{"mode":"raw","raw":"{\r\n \"selectedSchedules\": [\"US_Export\", \"EU_HS\", \"UK_GT\"],\r\n \"fileContent\" : \"CNCNC\",\r\n \"useFastlookup\": true,\r\n \"fastlookupOnly\": false\r\n}\r\n","options":{"raw":{"language":"json"}}},"url":"https://{{host}}:{{port}}/expedichem/webservice/search/run","description":"

Submit a new job to ExpediChem providing input compounds in a plain text format (SMILES, InChI or a list of compound IDs). This API call will return a gatewayJobId which can be used to monitor the job and retrieve the results using the other endpoints in this collection.

Body parameters

selectedSchedules: string array

A string array of the schedules to assign tariff codes for. If an empty array is provided all ExpediChem schedules are checked. Below is a list of ExpediChem schedules with their allowable input values for this parameter:

\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n

Available Schedules	Allowable webservice input values
HTSUS (US Import)	US_Import
Schedule B (US Export)	US_Export
EU_HS (European Union)	EU_HS
UK_GT (United Kingdom Global Tariff)	UK_GT
CN_HS (China)	CN_HS
CH_HS (Switzerland)	CH_HS
IN_HS (India)	IN_HS
Rest of World	ROW_HS

fileContent: string

This is the list of SMILES strings or InChI strings of the compounds you would like to check. This should be in plain text format with each compound on a new line. Optionally, you can provide a compound identifier along with the SMILES/InChI which will be output in the results, add this to the same line after the SMILES/InChI string with a space between the id and SMILES/InChI. If the useFastlookup parameter is set to true, these identifiers will also be used to get pre-calculated HTS codes from ExpediChem for corporate collection compounds which can improve the performance of webservice calls.

useFastLookup: bool
This parameter is optional. If not provided ExpediChem will use the default set on the server. Whether to check the fastlookup table for precalculated results (recommended). If set to true, precalculated results will be used if present which speeds up the search (recommended). If set to false no precalculated results are used and all compounds are analysed in real time.

fastlookupOnly: bool
This parameter is optional. If not provided ExpediChem will use the default value of false. This parameter selects whether to only check the fastlookup table. If the result is not in the fastlookup table nothing will be returned, however search speed will be 100Ks of compounds per minute. You must provide a corporateID in the same format as used in the fastlookup table, as it will only attempt to do an exact string match of the corporateID (case sensitive).

\n","urlObject":{"protocol":"https","port":"{{port}}","path":["expedichem","webservice","search","run"],"host":["{{host}}"],"query":[],"variable":[]}},"response":[{"id":"bb209891-51ca-46ca-a64a-235273d28838","name":"job started","originalRequest":{"method":"POST","header":[{"key":"x-access-token","value":"{{token}}","description":"The authentication token obtained from the /authenticate endpoint"}],"body":{"mode":"raw","raw":"{\r\n \"selectedSchedules\": [\"US_Export\", \"EU_HS\", \"UK_GT\"],\r\n \"fileContent\" : \"CNCNC\",\r\n \"includeInputData\": true,\r\n \"useFastlookup\": true,\r\n \"fastlookupOnly\": false\r\n}\r\n","options":{"raw":{"language":"json"}}},"url":"https://{{host}}:{{port}}/expedichem/webservice/search/run"},"status":"Created","code":201,"_postman_previewlanguage":"json","header":[{"key":"Date","value":"Thu, 21 Mar 2024 10:01:52 GMT"},{"key":"Content-Type","value":"application/json; charset=utf-8"},{"key":"Content-Length","value":"59"},{"key":"Connection","value":"keep-alive"},{"key":"X-Frame-Options","value":"SAMEORIGIN"},{"key":"Strict-Transport-Security","value":"max-age=63072000; includeSubDomains; preload"},{"key":"ETag","value":"W/\"3b-L+SM/YJyQs4vls5YbocZZU+wOFc\""}],"cookie":[],"responseTime":null,"body":"{\n \"gatewayJobId\": \"GWJ-0a483cc0-e76a-11ee-be0f-75c7d3cea0f6\"\n}"}],"_postman_id":"5181a6b2-42ba-4f75-9595-d3382d3d348a"},{"name":"/search/run/b64","event":[{"listen":"test","script":{"id":"3b5b19e9-89c4-422d-9dfa-c425e3dc8e0c","exec":["// parse response and set gatewayJobId as environment variable\r","var response = pm.response.json();\r","pm.environment.set(\"jobId\", response.gatewayJobId);"],"type":"text/javascript","packages":{}}}],"id":"68948387-90a2-4eff-8008-b5c1d19dd7fc","protocolProfileBehavior":{"disableBodyPruning":true},"request":{"auth":{"type":"noauth","isInherited":false},"method":"POST","header":[{"key":"x-access-token","value":"{{token}}","description":"

The authentication token obtained from the /authenticate endpoint

\n"}],"body":{"mode":"raw","raw":"{\r\n \"selectedSchedules\": [\"US_Export\", \"EU_HS\", \"UK_GT\"],\r\n \"includeInputData\": true,\r\n \"useFastlookup\": true,\r\n \"fastlookupOnly\": false,\r\n \"fileContent\" : \"
  SciTegic11061411402D

  6  6  0  0  0  0            999 V2000
    4.9992    6.0386    0.0000 O   0  0
    5.7838    5.7839    0.0000 C   0  0
    6.4510    6.2685    0.0000 O   0  0
    7.1185    5.7839    0.0000 C   0  0
    6.8636    4.9992    0.0000 C   0  0
    6.0385    4.9992    0.0000 C   0  0
  1  2  2  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  2  1  0
M  END
> <corporateID>
Example_1

$$$$

  SciTegic11061411402D

 29 32  0  0  0  0            999 V2000
    5.0000    8.8643    0.0000 C   0  0
    5.1714    8.0573    0.0000 O   0  0
    5.9560    7.8023    0.0000 C   0  0
    6.5692    8.3543    0.0000 C   0  0
    7.3538    8.0992    0.0000 C   0  0
    7.5252    7.2923    0.0000 C   0  0
    8.3098    7.0372    0.0000 C   0  0
    8.9230    7.5892    0.0000 C   0  0
    9.7076    7.3342    0.0000 N   0  0
   10.3207    7.8862    0.0000 C   0  0
   10.1493    8.6931    0.0000 O   0  0
   11.1053    7.6311    0.0000 C   0  0
   11.7185    8.1831    0.0000 S   0  0
   12.5031    7.9281    0.0000 C   0  0
   13.1705    8.4129    0.0000 N   0  0
   13.8380    7.9280    0.0000 N   0  0
   13.5830    7.1434    0.0000 C   0  0
   13.9954    6.4290    0.0000 C   0  0
   13.5829    5.7145    0.0000 C   0  0
   13.9954    5.0000    0.0000 C   0  0
   12.7579    5.7145    0.0000 C   0  0
   12.3454    5.0000    0.0000 C   0  0
   11.5204    5.0000    0.0000 C   0  0
   11.1079    5.7145    0.0000 C   0  0
   11.5204    6.4289    0.0000 C   0  0
   12.3454    6.4290    0.0000 C   0  0
   12.7579    7.1434    0.0000 N   0  0
    6.9121    6.7403    0.0000 C   0  0
    6.1275    6.9953    0.0000 C   0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  2  0
 10 12  1  0
 12 13  1  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  2  0
 19 20  1  0
 19 21  1  0
 21 22  2  0
 22 23  1  0
 23 24  2  0
 24 25  1  0
 25 26  2  0
 26 21  1  0
 26 27  1  0
 27 14  1  0
 27 17  1  0
  6 28  1  0
 28 29  2  0
 29  3  1  0
M  END
> <corporateID>
Example_2

$$$$

  SciTegic11061411402D

 22 25  0  0  1  0            999 V2000
    4.1486   -1.0341    0.0000 C   0  0
    4.1487   -1.8528    0.0000 N   0  0
    3.4834   -2.3364    0.0000 C   0  0
    3.7383   -3.1219    0.0000 C   0  0  2  0  0  0
    4.5600   -3.1187    0.0000 C   0  0  1  0  0  0
    4.8143   -2.3364    0.0000 C   0  0
    5.0785   -3.7622    0.0000 C   0  0
    5.8586   -3.5060    0.0000 C   0  0
    6.4698   -4.0602    0.0000 C   0  0
    7.2492   -3.8092    0.0000 Cl  0  0
    6.2974   -4.8653    0.0000 C   0  0
    5.5138   -5.1161    0.0000 C   0  0
    4.9062   -4.5672    0.0000 C   0  0
    4.1649   -4.9279    0.0000 O   0  0
    3.4167   -4.5768    0.0000 C   0  0
    2.8165   -5.1469    0.0000 C   0  0
    2.0205   -4.9057    0.0000 C   0  0
    1.8301   -4.0977    0.0000 C   0  0
    2.4359   -3.5310    0.0000 C   0  0
    3.2263   -3.7689    0.0000 C   0  0
    4.0964   -3.8583    0.0000 H   0  0
    5.3654   -2.9705    0.0000 H   0  0
  1  2  1  0
  2  6  1  0
  2  3  1  0
  3  4  1  0
  4 20  1  0
  4  5  1  0
  5  6  1  0
  5  7  1  0
  7 13  2  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
  9 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  1  0
 14 15  1  0
 15 20  2  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  2  0
 19 20  1  0
  4 21  1  1
  5 22  1  6
M  END
> <corporateID>
Example_3

$$$$

  SciTegic11061411402D

 21 21  0  0  0  0            999 V2000
    2.7361    0.7608    0.0000 C   0  0
    1.9291    0.5892    0.0000 N   0  0
    1.6742   -0.1954    0.0000 C   0  0
    1.3770    1.2023    0.0000 C   0  0
    0.5701    1.0308    0.0000 C   0  0
    0.3151    0.2462    0.0000 C   0  0
    0.8001   -0.4213    0.0000 C   0  0
    0.3151   -1.0887    0.0000 N   0  0
   -0.4696   -0.8338    0.0000 C   0  0
   -1.1840   -1.2464    0.0000 C   0  0
   -1.8985   -0.8338    0.0000 C   0  0
   -1.8985   -0.0088    0.0000 C   0  0
   -2.6130    0.4037    0.0000 O   0  0
   -1.1840    0.4037    0.0000 C   0  0
   -0.4696   -0.0088    0.0000 C   0  0
    4.9142    0.8252    0.0000 O   0  0
    5.2318    0.2751    0.0000 C   0  0
    5.8671    0.2751    0.0000 O   0  0
    4.9142   -0.2751    0.0000 C   0  0
    5.2318   -0.8252    0.0000 O   0  0
    4.2789   -0.2751    0.0000 O   0  0
  1  2  1  0
  2  3  1  0
  2  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  2  0
  6 15  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
  9 15  2  0
 10 11  2  0
 11 12  1  0
 12 13  1  0
 12 14  2  0
 14 15  1  0
 16 17  1  0
 17 18  2  0
 17 19  1  0
 19 20  1  0
 19 21  2  0
M  END
> <corporateID>
Example_4

$$$$

  SciTegic11061411402D

 24 26  0  0  0  0            999 V2000
    4.2867   -1.2375    0.0000 C   0  0
    3.5722   -1.6500    0.0000 C   0  0
    2.8579   -1.2375    0.0000 C   0  0
    2.8579   -0.5775    0.0000 O   0  0
    2.1434   -1.6500    0.0000 N   0  0
    2.1434   -2.4749    0.0000 C   0  0
    1.4289   -2.8874    0.0000 C   0  0
    1.4289   -3.7124    0.0000 C   0  0
    2.1434   -4.1249    0.0000 N   0  0
    2.8579   -3.7124    0.0000 C   0  0
    2.8579   -2.8874    0.0000 C   0  0
    2.1434   -4.9498    0.0000 C   0  0
    2.8579   -5.3623    0.0000 C   0  0
    3.5722   -4.9498    0.0000 C   0  0
    3.8089   -4.1596    0.0000 C   0  0
    4.6337   -4.1405    0.0000 C   0  0
    4.9067   -4.9190    0.0000 C   0  0
    4.2507   -5.4193    0.0000 S   0  0
    1.4289   -1.2375    0.0000 C   0  0
    1.4289   -0.4125    0.0000 C   0  0
    0.7145    0.0000    0.0000 C   0  0
    0.0001   -0.4124    0.0000 C   0  0
    0.0000   -1.2375    0.0000 C   0  0
    0.7145   -1.6500    0.0000 C   0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  3  5  1  0
  5  6  1  0
  5 19  1  0
  6  7  1  0
  6 11  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
  9 12  1  0
 10 11  1  0
 12 13  1  0
 13 14  1  0
 14 15  2  0
 14 18  1  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 19 20  2  0
 19 24  1  0
 20 21  1  0
 21 22  2  0
 22 23  1  0
 23 24  2  0
M  END
> <corporateID>
Example_5

$$$$

  SciTegic11061411402D

 24 26  0  0  0  0            999 V2000
    0.0000   -2.8876    0.0000 C   0  0
    0.7145   -2.4750    0.0000 C   0  0
    0.7145   -1.8151    0.0000 O   0  0
    1.4289   -2.8876    0.0000 N   0  0
    2.1434   -2.4750    0.0000 C   0  0
    2.1434   -1.6500    0.0000 C   0  0
    2.8579   -1.2376    0.0000 C   0  0
    3.5723   -1.6500    0.0000 N   0  0
    3.5723   -2.4750    0.0000 C   0  0
    2.8579   -2.8876    0.0000 C   0  0
    4.2868   -1.2375    0.0000 C   0  0
    5.0013   -1.6500    0.0000 C   0  0
    5.7158   -1.2375    0.0000 C   0  0
    5.7158   -0.4125    0.0000 C   0  0
    6.4302    0.0000    0.0000 C   0  0
    7.1447   -0.4125    0.0000 C   0  0
    7.1447   -1.2375    0.0000 C   0  0
    6.4302   -1.6500    0.0000 C   0  0
    1.4289   -3.7125    0.0000 C   0  0
    0.7145   -4.1251    0.0000 C   0  0
    0.7145   -4.9501    0.0000 C   0  0
    1.4289   -5.3626    0.0000 C   0  0
    2.1434   -4.9501    0.0000 C   0  0
    2.1434   -4.1251    0.0000 C   0  0
  1  2  1  0
  2  3  2  0
  2  4  1  0
  4  5  1  0
  4 19  1  0
  5  6  1  0
  5 10  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  8 11  1  0
  9 10  1  0
 11 12  1  0
 12 13  1  0
 13 14  2  0
 13 18  1  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  2  0
 19 20  2  0
 19 24  1  0
 20 21  1  0
 21 22  2  0
 22 23  1  0
 23 24  2  0
M  END
> <corporateID>
Example_6

$$$$

  SciTegic11061411402D

 22 24  0  0  0  0            999 V2000
   -4.3225   -1.2712    0.0000 C   0  0
   -3.6080   -0.8587    0.0000 C   0  0
   -2.8935   -1.2712    0.0000 C   0  0
   -2.1790   -0.8587    0.0000 C   0  0
   -1.4646   -1.2712    0.0000 C   0  0
   -0.7501   -0.8587    0.0000 N   0  0
   -0.6639   -0.0383    0.0000 C   0  0
    0.1431    0.1333    0.0000 C   0  0
    0.5556   -0.5812    0.0000 C   0  0
    0.0036   -1.1943    0.0000 C   0  0
    1.3761   -0.6674    0.0000 C   0  0
    1.7116   -1.4211    0.0000 O   0  0
    1.8610    0.0000    0.0000 C   0  0
    1.5255    0.7537    0.0000 C   0  0
    2.0104    1.4211    0.0000 C   0  0
    2.8309    1.3349    0.0000 C   0  0
    3.1664    0.5812    0.0000 C   0  0
    3.9869    0.4950    0.0000 C   0  0
    4.3225   -0.2587    0.0000 C   0  0
    3.8375   -0.9261    0.0000 C   0  0
    3.0171   -0.8399    0.0000 C   0  0
    2.6815   -0.0862    0.0000 C   0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
  6 10  1  0
  9 11  1  0
 11 12  2  0
 11 13  1  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  2  0
 21 22  1  0
 13 22  2  0
 17 22  1  0
M  END
> <corporateID>
Example_7

$$$$
\"\r\n}\r\n","options":{"raw":{"language":"json"}}},"url":"https://{{host}}:{{port}}/expedichem/webservice/search/run/b64","description":"

Submit a new job to ExpediChem providing input compounds in SDF/MOL file format. This API call will return a gatewayJobId which can be used to monitor the job and retrieve the results using the other endpoints in this collection.

Body parameters

selectedSchedules: string array

\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n

Available Schedules	Allowable webservice input values
HTSUS (US Import)	US_Import
Schedule B (US Export)	US_Export
EU_HS (European Union)	EU_HS
UK_GT (United Kingdom Global Tariff)	UK_GT
CN_HS (China)	CN_HS
CH_HS (Switzerland)	CH_HS
IN_HS (India)	IN_HS
Rest of World	ROW_HS

fileContent: string

Must contain the base64 encoded content of a valid SDF/MOL file, containing the structures you wish to check. You can also provide identifiers for compounds (e.g. SCIT-1, SCIT-2) using a field named 'corporateId'. Scitegrity recommends to avoid using integers as IDs and instead use a string such as input1, input2 etc. If the useFastlookup parameter is set to true, these identifiers will also be used to get pre-calculated HTS codes from ExpediChem for corporate collection compounds which can improve the performance of webservice calls.

\n","urlObject":{"protocol":"https","port":"{{port}}","path":["expedichem","webservice","search","run","b64"],"host":["{{host}}"],"query":[],"variable":[]}},"response":[{"id":"0bb10ae4-b67e-472a-861f-deffc983e3ac","name":"job started","originalRequest":{"method":"POST","header":[{"key":"x-access-token","value":"{{token}}","description":"The authentication token obtained from the /authenticate endpoint"}],"body":{"mode":"raw","raw":"{\r\n \"selectedSchedules\": [\"US_Export\", \"EU_HS\", \"UK_GT\"],\r\n \"includeInputData\": true,\r\n \"useFastlookup\": true,\r\n \"fastlookupOnly\": false,\r\n \"fileContent\" : \"
  SciTegic11061411402D

  6  6  0  0  0  0            999 V2000
    4.9992    6.0386    0.0000 O   0  0
    5.7838    5.7839    0.0000 C   0  0
    6.4510    6.2685    0.0000 O   0  0
    7.1185    5.7839    0.0000 C   0  0
    6.8636    4.9992    0.0000 C   0  0
    6.0385    4.9992    0.0000 C   0  0
  1  2  2  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  2  1  0
M  END
> <corporateID>
Example_1

$$$$

  SciTegic11061411402D

 29 32  0  0  0  0            999 V2000
    5.0000    8.8643    0.0000 C   0  0
    5.1714    8.0573    0.0000 O   0  0
    5.9560    7.8023    0.0000 C   0  0
    6.5692    8.3543    0.0000 C   0  0
    7.3538    8.0992    0.0000 C   0  0
    7.5252    7.2923    0.0000 C   0  0
    8.3098    7.0372    0.0000 C   0  0
    8.9230    7.5892    0.0000 C   0  0
    9.7076    7.3342    0.0000 N   0  0
   10.3207    7.8862    0.0000 C   0  0
   10.1493    8.6931    0.0000 O   0  0
   11.1053    7.6311    0.0000 C   0  0
   11.7185    8.1831    0.0000 S   0  0
   12.5031    7.9281    0.0000 C   0  0
   13.1705    8.4129    0.0000 N   0  0
   13.8380    7.9280    0.0000 N   0  0
   13.5830    7.1434    0.0000 C   0  0
   13.9954    6.4290    0.0000 C   0  0
   13.5829    5.7145    0.0000 C   0  0
   13.9954    5.0000    0.0000 C   0  0
   12.7579    5.7145    0.0000 C   0  0
   12.3454    5.0000    0.0000 C   0  0
   11.5204    5.0000    0.0000 C   0  0
   11.1079    5.7145    0.0000 C   0  0
   11.5204    6.4289    0.0000 C   0  0
   12.3454    6.4290    0.0000 C   0  0
   12.7579    7.1434    0.0000 N   0  0
    6.9121    6.7403    0.0000 C   0  0
    6.1275    6.9953    0.0000 C   0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  2  0
 10 12  1  0
 12 13  1  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  2  0
 19 20  1  0
 19 21  1  0
 21 22  2  0
 22 23  1  0
 23 24  2  0
 24 25  1  0
 25 26  2  0
 26 21  1  0
 26 27  1  0
 27 14  1  0
 27 17  1  0
  6 28  1  0
 28 29  2  0
 29  3  1  0
M  END
> <corporateID>
Example_2

$$$$

  SciTegic11061411402D

 22 25  0  0  1  0            999 V2000
    4.1486   -1.0341    0.0000 C   0  0
    4.1487   -1.8528    0.0000 N   0  0
    3.4834   -2.3364    0.0000 C   0  0
    3.7383   -3.1219    0.0000 C   0  0  2  0  0  0
    4.5600   -3.1187    0.0000 C   0  0  1  0  0  0
    4.8143   -2.3364    0.0000 C   0  0
    5.0785   -3.7622    0.0000 C   0  0
    5.8586   -3.5060    0.0000 C   0  0
    6.4698   -4.0602    0.0000 C   0  0
    7.2492   -3.8092    0.0000 Cl  0  0
    6.2974   -4.8653    0.0000 C   0  0
    5.5138   -5.1161    0.0000 C   0  0
    4.9062   -4.5672    0.0000 C   0  0
    4.1649   -4.9279    0.0000 O   0  0
    3.4167   -4.5768    0.0000 C   0  0
    2.8165   -5.1469    0.0000 C   0  0
    2.0205   -4.9057    0.0000 C   0  0
    1.8301   -4.0977    0.0000 C   0  0
    2.4359   -3.5310    0.0000 C   0  0
    3.2263   -3.7689    0.0000 C   0  0
    4.0964   -3.8583    0.0000 H   0  0
    5.3654   -2.9705    0.0000 H   0  0
  1  2  1  0
  2  6  1  0
  2  3  1  0
  3  4  1  0
  4 20  1  0
  4  5  1  0
  5  6  1  0
  5  7  1  0
  7 13  2  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
  9 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  1  0
 14 15  1  0
 15 20  2  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  2  0
 19 20  1  0
  4 21  1  1
  5 22  1  6
M  END
> <corporateID>
Example_3

$$$$

  SciTegic11061411402D

 21 21  0  0  0  0            999 V2000
    2.7361    0.7608    0.0000 C   0  0
    1.9291    0.5892    0.0000 N   0  0
    1.6742   -0.1954    0.0000 C   0  0
    1.3770    1.2023    0.0000 C   0  0
    0.5701    1.0308    0.0000 C   0  0
    0.3151    0.2462    0.0000 C   0  0
    0.8001   -0.4213    0.0000 C   0  0
    0.3151   -1.0887    0.0000 N   0  0
   -0.4696   -0.8338    0.0000 C   0  0
   -1.1840   -1.2464    0.0000 C   0  0
   -1.8985   -0.8338    0.0000 C   0  0
   -1.8985   -0.0088    0.0000 C   0  0
   -2.6130    0.4037    0.0000 O   0  0
   -1.1840    0.4037    0.0000 C   0  0
   -0.4696   -0.0088    0.0000 C   0  0
    4.9142    0.8252    0.0000 O   0  0
    5.2318    0.2751    0.0000 C   0  0
    5.8671    0.2751    0.0000 O   0  0
    4.9142   -0.2751    0.0000 C   0  0
    5.2318   -0.8252    0.0000 O   0  0
    4.2789   -0.2751    0.0000 O   0  0
  1  2  1  0
  2  3  1  0
  2  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  2  0
  6 15  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
  9 15  2  0
 10 11  2  0
 11 12  1  0
 12 13  1  0
 12 14  2  0
 14 15  1  0
 16 17  1  0
 17 18  2  0
 17 19  1  0
 19 20  1  0
 19 21  2  0
M  END
> <corporateID>
Example_4

$$$$

  SciTegic11061411402D

 24 26  0  0  0  0            999 V2000
    4.2867   -1.2375    0.0000 C   0  0
    3.5722   -1.6500    0.0000 C   0  0
    2.8579   -1.2375    0.0000 C   0  0
    2.8579   -0.5775    0.0000 O   0  0
    2.1434   -1.6500    0.0000 N   0  0
    2.1434   -2.4749    0.0000 C   0  0
    1.4289   -2.8874    0.0000 C   0  0
    1.4289   -3.7124    0.0000 C   0  0
    2.1434   -4.1249    0.0000 N   0  0
    2.8579   -3.7124    0.0000 C   0  0
    2.8579   -2.8874    0.0000 C   0  0
    2.1434   -4.9498    0.0000 C   0  0
    2.8579   -5.3623    0.0000 C   0  0
    3.5722   -4.9498    0.0000 C   0  0
    3.8089   -4.1596    0.0000 C   0  0
    4.6337   -4.1405    0.0000 C   0  0
    4.9067   -4.9190    0.0000 C   0  0
    4.2507   -5.4193    0.0000 S   0  0
    1.4289   -1.2375    0.0000 C   0  0
    1.4289   -0.4125    0.0000 C   0  0
    0.7145    0.0000    0.0000 C   0  0
    0.0001   -0.4124    0.0000 C   0  0
    0.0000   -1.2375    0.0000 C   0  0
    0.7145   -1.6500    0.0000 C   0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  3  5  1  0
  5  6  1  0
  5 19  1  0
  6  7  1  0
  6 11  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
  9 12  1  0
 10 11  1  0
 12 13  1  0
 13 14  1  0
 14 15  2  0
 14 18  1  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 19 20  2  0
 19 24  1  0
 20 21  1  0
 21 22  2  0
 22 23  1  0
 23 24  2  0
M  END
> <corporateID>
Example_5

$$$$

  SciTegic11061411402D

 24 26  0  0  0  0            999 V2000
    0.0000   -2.8876    0.0000 C   0  0
    0.7145   -2.4750    0.0000 C   0  0
    0.7145   -1.8151    0.0000 O   0  0
    1.4289   -2.8876    0.0000 N   0  0
    2.1434   -2.4750    0.0000 C   0  0
    2.1434   -1.6500    0.0000 C   0  0
    2.8579   -1.2376    0.0000 C   0  0
    3.5723   -1.6500    0.0000 N   0  0
    3.5723   -2.4750    0.0000 C   0  0
    2.8579   -2.8876    0.0000 C   0  0
    4.2868   -1.2375    0.0000 C   0  0
    5.0013   -1.6500    0.0000 C   0  0
    5.7158   -1.2375    0.0000 C   0  0
    5.7158   -0.4125    0.0000 C   0  0
    6.4302    0.0000    0.0000 C   0  0
    7.1447   -0.4125    0.0000 C   0  0
    7.1447   -1.2375    0.0000 C   0  0
    6.4302   -1.6500    0.0000 C   0  0
    1.4289   -3.7125    0.0000 C   0  0
    0.7145   -4.1251    0.0000 C   0  0
    0.7145   -4.9501    0.0000 C   0  0
    1.4289   -5.3626    0.0000 C   0  0
    2.1434   -4.9501    0.0000 C   0  0
    2.1434   -4.1251    0.0000 C   0  0
  1  2  1  0
  2  3  2  0
  2  4  1  0
  4  5  1  0
  4 19  1  0
  5  6  1  0
  5 10  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  8 11  1  0
  9 10  1  0
 11 12  1  0
 12 13  1  0
 13 14  2  0
 13 18  1  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  2  0
 19 20  2  0
 19 24  1  0
 20 21  1  0
 21 22  2  0
 22 23  1  0
 23 24  2  0
M  END
> <corporateID>
Example_6

$$$$

  SciTegic11061411402D

 22 24  0  0  0  0            999 V2000
   -4.3225   -1.2712    0.0000 C   0  0
   -3.6080   -0.8587    0.0000 C   0  0
   -2.8935   -1.2712    0.0000 C   0  0
   -2.1790   -0.8587    0.0000 C   0  0
   -1.4646   -1.2712    0.0000 C   0  0
   -0.7501   -0.8587    0.0000 N   0  0
   -0.6639   -0.0383    0.0000 C   0  0
    0.1431    0.1333    0.0000 C   0  0
    0.5556   -0.5812    0.0000 C   0  0
    0.0036   -1.1943    0.0000 C   0  0
    1.3761   -0.6674    0.0000 C   0  0
    1.7116   -1.4211    0.0000 O   0  0
    1.8610    0.0000    0.0000 C   0  0
    1.5255    0.7537    0.0000 C   0  0
    2.0104    1.4211    0.0000 C   0  0
    2.8309    1.3349    0.0000 C   0  0
    3.1664    0.5812    0.0000 C   0  0
    3.9869    0.4950    0.0000 C   0  0
    4.3225   -0.2587    0.0000 C   0  0
    3.8375   -0.9261    0.0000 C   0  0
    3.0171   -0.8399    0.0000 C   0  0
    2.6815   -0.0862    0.0000 C   0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
  6 10  1  0
  9 11  1  0
 11 12  2  0
 11 13  1  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  2  0
 21 22  1  0
 13 22  2  0
 17 22  1  0
M  END
> <corporateID>
Example_7

$$$$
\"\r\n}\r\n","options":{"raw":{"language":"json"}}},"url":"https://{{host}}:{{port}}/expedichem/webservice/search/run/b64"},"status":"Created","code":201,"_postman_previewlanguage":"json","header":[{"key":"Date","value":"Thu, 21 Mar 2024 10:02:20 GMT"},{"key":"Content-Type","value":"application/json; charset=utf-8"},{"key":"Content-Length","value":"59"},{"key":"Connection","value":"keep-alive"},{"key":"X-Frame-Options","value":"SAMEORIGIN"},{"key":"Strict-Transport-Security","value":"max-age=63072000; includeSubDomains; preload"},{"key":"ETag","value":"W/\"3b-y6LoVLo3gPtkEHK1AjAxvxzxVIY\""}],"cookie":[],"responseTime":null,"body":"{\n \"gatewayJobId\": \"GWJ-1afbc000-e76a-11ee-be0f-75c7d3cea0f6\"\n}"}],"_postman_id":"68948387-90a2-4eff-8008-b5c1d19dd7fc"},{"name":"/search/status","id":"7c3b7250-d262-4e02-a90e-f23b5e262b84","protocolProfileBehavior":{"disableBodyPruning":true},"request":{"method":"POST","header":[{"key":"x-access-token","value":"{{token}}","description":"

The authentication token obtained from the /authenticate endpoint

\n"}],"body":{"mode":"raw","raw":"{\r\n \"gatewayJobId\": \"{{jobId}}\"\r\n}","options":{"raw":{"language":"json"}}},"url":"https://{{host}}:{{port}}/expedichem/webservice/search/status","description":"

Get the status of a submitted ExpediChem webservice job.

\n","urlObject":{"protocol":"https","port":"{{port}}","path":["expedichem","webservice","search","status"],"host":["{{host}}"],"query":[],"variable":[]}},"response":[{"id":"d92aa1b3-305f-4f70-93e5-ee0dee4007ee","name":"job running","originalRequest":{"method":"POST","header":[{"key":"x-access-token","value":"{{token}}","description":"The authentication token obtained from the /authenticate endpoint"}],"body":{"mode":"raw","raw":"{\r\n \"gatewayJobId\": \"{{jobId}}\"\r\n}","options":{"raw":{"language":"json"}}},"url":"https://{{host}}:{{port}}/expedichem/webservice/search/status"},"status":"OK","code":200,"_postman_previewlanguage":"json","header":[{"key":"Date","value":"Thu, 21 Mar 2024 10:03:00 GMT"},{"key":"Content-Type","value":"application/json; charset=utf-8"},{"key":"Content-Length","value":"100"},{"key":"Connection","value":"keep-alive"},{"key":"X-Frame-Options","value":"SAMEORIGIN"},{"key":"Strict-Transport-Security","value":"max-age=63072000; includeSubDomains; preload"},{"key":"ETag","value":"W/\"64-FH3hXf1fJDa/6XIoIgX1ab4Fan4\""}],"cookie":[],"responseTime":null,"body":"{\n \"jobStatus\": \"running\",\n \"protocol\": \"search_EC\",\n \"updatedAt\": \"2024-03-21T10:03:01.791Z\",\n \"message\": null\n}"},{"id":"81cc8e05-ae56-4e0e-8b37-1796437d8254","name":"job complete","originalRequest":{"method":"POST","header":[{"key":"x-access-token","value":"{{token}}","description":"The authentication token obtained from the /authenticate endpoint"}],"body":{"mode":"raw","raw":"{\r\n \"gatewayJobId\": \"{{jobId}}\"\r\n}","options":{"raw":{"language":"json"}}},"url":"https://{{host}}:{{port}}/expedichem/webservice/search/status"},"status":"OK","code":200,"_postman_previewlanguage":"json","header":[{"key":"Date","value":"Thu, 21 Mar 2024 10:03:24 GMT"},{"key":"Content-Type","value":"application/json; charset=utf-8"},{"key":"Content-Length","value":"145"},{"key":"Connection","value":"keep-alive"},{"key":"X-Frame-Options","value":"SAMEORIGIN"},{"key":"Strict-Transport-Security","value":"max-age=63072000; includeSubDomains; preload"},{"key":"ETag","value":"W/\"91-b7DFMGjeap3+vGN7YU2LbLabgb0\""}],"cookie":[],"responseTime":null,"body":"{\n \"jobStatus\": \"complete\",\n \"protocol\": \"search_EC\",\n \"updatedAt\": \"2024-03-21T10:03:24.591Z\",\n \"message\": \"ExpediChem search complete - preparing results\"\n}"}],"_postman_id":"7c3b7250-d262-4e02-a90e-f23b5e262b84"},{"name":"/search/result","id":"67635890-ebea-4a81-bd94-ba7316c64281","protocolProfileBehavior":{"disableBodyPruning":true},"request":{"method":"POST","header":[{"key":"x-access-token","value":"{{token}}","description":"

The authentication token obtained from the /authenticate endpoint

Get the results of a completed ExpediChem webservice job in JSON format.

\n","urlObject":{"protocol":"https","port":"{{port}}","path":["expedichem","webservice","search","result"],"host":["{{host}}"],"query":[],"variable":[]}},"response":[{"id":"0233aca7-64e5-4f1f-9432-ae7fcf03813b","name":"job result JSON","originalRequest":{"method":"POST","header":[{"key":"x-access-token","value":"{{token}}","description":"The authentication token obtained from the /authenticate endpoint"}],"body":{"mode":"raw","raw":"{\r\n \"gatewayJobId\": \"{{jobId}}\"\r\n}","options":{"raw":{"language":"json"}}},"url":"https://{{host}}:{{port}}/expedichem/webservice/search/result"},"status":"OK","code":200,"_postman_previewlanguage":"json","header":[{"key":"Date","value":"Thu, 21 Mar 2024 10:03:45 GMT"},{"key":"Content-Type","value":"application/json; charset=utf-8"},{"key":"Content-Length","value":"8534"},{"key":"Connection","value":"keep-alive"},{"key":"X-Frame-Options","value":"SAMEORIGIN"},{"key":"Strict-Transport-Security","value":"max-age=63072000; includeSubDomains; preload"},{"key":"ETag","value":"W/\"2156-DauN3NmIKQTfcY94jYxOGgnZgPg\""}],"cookie":[],"responseTime":null,"body":"{\n \"jobStatus\": \"complete\",\n \"jobResult\": {\n \"records\": [\n {\n \"corporateId\": \"Example_1\",\n \"country\": \"SCHB\",\n \"tariffCode\": \"2932.20.6000\",\n \"description\": \"- Heterocyclic compounds with oxygen hetero-atom(s) only:\\n- - Lactones:\\n- - - Other:\\n- - - - Other\",\n \"comments\": \"\",\n \"linkToSchedule\": \"https://www.census.gov/foreign-trade/schedules/b/2024/c29.pdf\"\n },\n {\n \"corporateId\": \"Example_1\",\n \"country\": \"EU\",\n \"tariffCode\": \"2932.20.2000\",\n \"generalDuty\": \"6.50%\",\n \"description\": \"- Heterocyclic compounds with oxygen hetero-atom(s) only:\\n- - Lactones:\\n- - - gamma-Butyrolactone\",\n \"comments\": \"\",\n \"linkToSchedule\": \"https://ec.europa.eu/taxation_customs/dds2/taric/measures.jsp?Lang=en&SimDate=20240321&Taric=2932202000\"\n },\n {\n \"corporateId\": \"Example_1\",\n \"country\": \"UK\",\n \"tariffCode\": \"2932.20.2000\",\n \"generalDuty\": \"6%\",\n \"description\": \"- Heterocyclic compounds with oxygen hetero-atom(s) only:\\n- - Lactones:\\n- - - gamma-Butyrolactone\",\n \"comments\": \"\",\n \"linkToSchedule\": \"https://www.trade-tariff.service.gov.uk/commodities/2932202000?day=21&month=3&year=2024\"\n },\n {\n \"corporateId\": \"Example_2\",\n \"country\": \"SCHB\",\n \"tariffCode\": \"2933.99.8350\",\n \"description\": \"- Heterocyclic compounds with nitrogen hetero-atom(s) only:\\n- - Other:\\n- - - Other:\\n- - - - Aromatic or modified aromatic:\\n- - - - - Other:\\n- - - - - - Other\",\n \"comments\": \"\",\n \"linkToSchedule\": \"https://www.census.gov/foreign-trade/schedules/b/2024/c29.pdf\"\n },\n {\n \"corporateId\": \"Example_2\",\n \"country\": \"EU\",\n \"tariffCode\": \"2933.99.8090\",\n \"generalDuty\": \"6.50%\",\n \"description\": \"- Heterocyclic compounds with nitrogen hetero-atom(s) only:\\n- - Other:\\n- - - Other:\\n- - - - Other:\\n- - - - - Other\",\n \"comments\": \"\",\n \"linkToSchedule\": \"https://ec.europa.eu/taxation_customs/dds2/taric/measures.jsp?Lang=en&SimDate=20240321&Taric=2933998090\"\n },\n {\n \"corporateId\": \"Example_2\",\n \"country\": \"UK\",\n \"tariffCode\": \"2933.99.8090\",\n \"generalDuty\": \"Free\",\n \"description\": \"- Heterocyclic compounds with nitrogen hetero-atom(s) only:\\n- - Other:\\n- - - Other:\\n- - - - Other:\\n- - - - - Other\",\n \"comments\": \"\",\n \"linkToSchedule\": \"https://www.trade-tariff.service.gov.uk/commodities/2933998090?day=21&month=3&year=2024\"\n },\n {\n \"corporateId\": \"Example_3\",\n \"country\": \"SCHB\",\n \"tariffCode\": \"2934.99.0005\",\n \"description\": \"- Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds:\\n- - Other:\\n- - - Other\",\n \"comments\": \"\",\n \"linkToSchedule\": \"https://www.census.gov/foreign-trade/schedules/b/2024/c29.pdf\"\n },\n {\n \"corporateId\": \"Example_3\",\n \"country\": \"EU\",\n \"tariffCode\": \"2934.99.9090\",\n \"generalDuty\": \"6.50%\",\n \"description\": \"- Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds:\\n- - Other:\\n- - - Other:\\n- - - - Other:\\n- - - - - Other\",\n \"comments\": \"INFORMATION - Stereochemistry is inexplicit or could not be exactly matched. This compound is a stereomatch to a compound in the pharmaceutical appendix; however, we have not altered the rate of duty due, since we cannot explicitly match it. You could be eligible for zero duty. Being more explicit with stereochemistry may provide a better match.\\n\",\n \"linkToSchedule\": \"https://ec.europa.eu/taxation_customs/dds2/taric/measures.jsp?Lang=en&SimDate=20240321&Taric=2934999090\"\n },\n {\n \"corporateId\": \"Example_3\",\n \"country\": \"UK\",\n \"tariffCode\": \"2934.99.9090\",\n \"generalDuty\": \"6%\",\n \"description\": \"- Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds:\\n- - Other:\\n- - - Other:\\n- - - - Other:\\n- - - - - Other\",\n \"comments\": \"INFORMATION - Stereochemistry is inexplicit or could not be exactly matched. This compound is a stereomatch to a compound in the pharmaceutical appendix; however, we have not altered the rate of duty due, since we cannot explicitly match it. You could be eligible for zero duty. Being more explicit with stereochemistry may provide a better match.\\n\",\n \"linkToSchedule\": \"https://www.trade-tariff.service.gov.uk/commodities/2934999090?day=21&month=3&year=2024\"\n },\n {\n \"corporateId\": \"Example_4\",\n \"country\": \"SCHB\",\n \"tariffCode\": \"2933.99.8350\",\n \"description\": \"- Heterocyclic compounds with nitrogen hetero-atom(s) only:\\n- - Other:\\n- - - Other:\\n- - - - Aromatic or modified aromatic:\\n- - - - - Other:\\n- - - - - - Other\",\n \"comments\": \"\",\n \"linkToSchedule\": \"https://www.census.gov/foreign-trade/schedules/b/2024/c29.pdf\"\n },\n {\n \"corporateId\": \"Example_4\",\n \"country\": \"EU\",\n \"tariffCode\": \"2933.99.8090\",\n \"generalDuty\": \"6.50%\",\n \"description\": \"- Heterocyclic compounds with nitrogen hetero-atom(s) only:\\n- - Other:\\n- - - Other:\\n- - - - Other:\\n- - - - - Other\",\n \"comments\": \"\",\n \"linkToSchedule\": \"https://ec.europa.eu/taxation_customs/dds2/taric/measures.jsp?Lang=en&SimDate=20240321&Taric=2933998090\"\n },\n {\n \"corporateId\": \"Example_4\",\n \"country\": \"UK\",\n \"tariffCode\": \"2933.99.8090\",\n \"generalDuty\": \"Free\",\n \"description\": \"- Heterocyclic compounds with nitrogen hetero-atom(s) only:\\n- - Other:\\n- - - Other:\\n- - - - Other:\\n- - - - - Other\",\n \"comments\": \"\",\n \"linkToSchedule\": \"https://www.trade-tariff.service.gov.uk/commodities/2933998090?day=21&month=3&year=2024\"\n },\n {\n \"corporateId\": \"Example_5\",\n \"country\": \"SCHB\",\n \"tariffCode\": \"2934.92.0000\",\n \"description\": \"- Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds:\\n- - Other:\\n- - - Other fentanyls and their derivatives\",\n \"comments\": \"\",\n \"linkToSchedule\": \"https://www.census.gov/foreign-trade/schedules/b/2024/c29.pdf\"\n },\n {\n \"corporateId\": \"Example_5\",\n \"country\": \"EU\",\n \"tariffCode\": \"2934.92.0000\",\n \"generalDuty\": \"6.50%\",\n \"description\": \"- Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds:\\n- - Other:\\n- - - Other fentanyls and their derivatives\",\n \"comments\": \"\",\n \"linkToSchedule\": \"https://ec.europa.eu/taxation_customs/dds2/taric/measures.jsp?Lang=en&SimDate=20240321&Taric=2934920000\"\n },\n {\n \"corporateId\": \"Example_5\",\n \"country\": \"UK\",\n \"tariffCode\": \"2934.92.0000\",\n \"generalDuty\": \"6%\",\n \"description\": \"- Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds:\\n- - Other:\\n- - - Other fentanyls and their derivatives\",\n \"comments\": \"\",\n \"linkToSchedule\": \"https://www.trade-tariff.service.gov.uk/commodities/2934920000?day=21&month=3&year=2024\"\n },\n {\n \"corporateId\": \"Example_6\",\n \"country\": \"SCHB\",\n \"tariffCode\": \"2933.34.0000\",\n \"description\": \"- Heterocyclic compounds with nitrogen hetero-atom(s) only:\\n- - Compounds containing an unfused pyridine ring (whether or not hydrogenated) in the structure:\\n- - - Other fentanyls and their derivatives\",\n \"comments\": \"\",\n \"linkToSchedule\": \"https://www.census.gov/foreign-trade/schedules/b/2024/c29.pdf\"\n },\n {\n \"corporateId\": \"Example_6\",\n \"country\": \"EU\",\n \"tariffCode\": \"2933.34.0000\",\n \"generalDuty\": \"6.50%\",\n \"description\": \"- Heterocyclic compounds with nitrogen hetero-atom(s) only:\\n- - Compounds containing an unfused pyridine ring (whether or not hydrogenated) in the structure:\\n- - - Other fentanyls and their derivatives\",\n \"comments\": \"\",\n \"linkToSchedule\": \"https://ec.europa.eu/taxation_customs/dds2/taric/measures.jsp?Lang=en&SimDate=20240321&Taric=2933340000\"\n },\n {\n \"corporateId\": \"Example_6\",\n \"country\": \"UK\",\n \"tariffCode\": \"2933.34.0000\",\n \"generalDuty\": \"Free\",\n \"description\": \"- Heterocyclic compounds with nitrogen hetero-atom(s) only:\\n- - Compounds containing an unfused pyridine ring (whether or not hydrogenated) in the structure:\\n- - - Other fentanyls and their derivatives\",\n \"comments\": \"\",\n \"linkToSchedule\": \"https://www.trade-tariff.service.gov.uk/commodities/2933340000?day=21&month=3&year=2024\"\n },\n {\n \"corporateId\": \"Example_7\",\n \"country\": \"SCHB\",\n \"tariffCode\": \"2933.99.8350\",\n \"description\": \"- Heterocyclic compounds with nitrogen hetero-atom(s) only:\\n- - Other:\\n- - - Other:\\n- - - - Aromatic or modified aromatic:\\n- - - - - Other:\\n- - - - - - Other\",\n \"comments\": \"\",\n \"linkToSchedule\": \"https://www.census.gov/foreign-trade/schedules/b/2024/c29.pdf\"\n },\n {\n \"corporateId\": \"Example_7\",\n \"country\": \"EU\",\n \"tariffCode\": \"2933.99.8090\",\n \"generalDuty\": \"6.50%\",\n \"description\": \"- Heterocyclic compounds with nitrogen hetero-atom(s) only:\\n- - Other:\\n- - - Other:\\n- - - - Other:\\n- - - - - Other\",\n \"comments\": \"\",\n \"linkToSchedule\": \"https://ec.europa.eu/taxation_customs/dds2/taric/measures.jsp?Lang=en&SimDate=20240321&Taric=2933998090\"\n },\n {\n \"corporateId\": \"Example_7\",\n \"country\": \"UK\",\n \"tariffCode\": \"2933.99.8090\",\n \"generalDuty\": \"Free\",\n \"description\": \"- Heterocyclic compounds with nitrogen hetero-atom(s) only:\\n- - Other:\\n- - - Other:\\n- - - - Other:\\n- - - - - Other\",\n \"comments\": \"\",\n \"linkToSchedule\": \"https://www.trade-tariff.service.gov.uk/commodities/2933998090?day=21&month=3&year=2024\"\n }\n ]\n },\n \"searchQuery\": \"selectedSchedules=US_Export&selectedSchedules=EU_HS&selectedSchedules=UK_GT&includeInputData=true&useFastlookup=true&fastlookupOnly=false\"\n}"}],"_postman_id":"67635890-ebea-4a81-bd94-ba7316c64281"},{"name":"/search/result/sdf","id":"2152471b-8c0a-41e0-9f83-44c6d7c8fd5f","protocolProfileBehavior":{"disableBodyPruning":true},"request":{"method":"POST","header":[{"key":"x-access-token","value":"{{token}}","description":"

The authentication token obtained from the /authenticate endpoint

Get the results of a completed ExpediChem webservice job in SDF format.

\n","urlObject":{"protocol":"https","port":"{{port}}","path":["expedichem","webservice","search","result","sdf"],"host":["{{host}}"],"query":[],"variable":[]}},"response":[{"id":"7f6ebfa8-d742-4308-b6ed-88745c7d57b0","name":"job result sdf","originalRequest":{"method":"POST","header":[{"key":"x-access-token","value":"{{token}}","description":"The authentication token obtained from the /authenticate endpoint"}],"body":{"mode":"raw","raw":"{\r\n \"gatewayJobId\": \"{{jobId}}\"\r\n}","options":{"raw":{"language":"json"}}},"url":"https://{{host}}:{{port}}/expedichem/webservice/search/result/sdf"},"status":"OK","code":200,"_postman_previewlanguage":"raw","header":[{"key":"Date","value":"Thu, 21 Mar 2024 10:04:10 GMT"},{"key":"Content-Type","value":"chemical/x-mdl-sdfile"},{"key":"Content-Length","value":"10613"},{"key":"Connection","value":"keep-alive"},{"key":"X-Frame-Options","value":"SAMEORIGIN"},{"key":"Strict-Transport-Security","value":"max-age=63072000; includeSubDomains; preload"},{"key":"Cache-Control","value":"no-cache"},{"key":"Content-Disposition","value":"attachment; filename=results.sdf"},{"key":"ETag","value":"W/\"2975-jsqR+JKCPl0iZ/28IoCAfNsgrRs\""}],"cookie":[],"responseTime":null,"body":"\r\n SciTegic03212410032D\r\n\r\n 0 0 0 0 0 0 999 V2000\r\nM END\r\n> \r\nExample_1\r\n\r\n> \r\nSCHB\r\n\r\n> \r\n2932.20.6000\r\n\r\n> \r\n- Heterocyclic compounds with oxygen hetero-atom(s) only:\r\n- - Lactones:\r\n- - - Other:\r\n- - - - Other\r\n\r\n> \r\n.\r\n\r\n> \r\nhttps://www.census.gov/foreign-trade/schedules/b/2024/c29.pdf\r\n\r\n$$$$\r\n\r\n SciTegic03212410032D\r\n\r\n 0 0 0 0 0 0 999 V2000\r\nM END\r\n> \r\nExample_1\r\n\r\n> \r\nEU\r\n\r\n> \r\n2932.20.2000\r\n\r\n> \r\n6.50%\r\n\r\n> \r\n- Heterocyclic compounds with oxygen hetero-atom(s) only:\r\n- - Lactones:\r\n- - - gamma-Butyrolactone\r\n\r\n> \r\n.\r\n\r\n> \r\nhttps://ec.europa.eu/taxation_customs/dds2/taric/measures.jsp?Lang=en&SimDate=20240321&Taric=2932202000\r\n\r\n$$$$\r\n\r\n SciTegic03212410032D\r\n\r\n 0 0 0 0 0 0 999 V2000\r\nM END\r\n> \r\nExample_1\r\n\r\n> \r\nUK\r\n\r\n> \r\n2932.20.2000\r\n\r\n> \r\n6%\r\n\r\n> \r\n- Heterocyclic compounds with oxygen hetero-atom(s) only:\r\n- - Lactones:\r\n- - - gamma-Butyrolactone\r\n\r\n> \r\n.\r\n\r\n> \r\nhttps://www.trade-tariff.service.gov.uk/commodities/2932202000?day=21&month=3&year=2024\r\n\r\n$$$$\r\n\r\n SciTegic03212410032D\r\n\r\n 0 0 0 0 0 0 999 V2000\r\nM END\r\n> \r\nExample_2\r\n\r\n> \r\nSCHB\r\n\r\n> \r\n2933.99.8350\r\n\r\n> \r\n- Heterocyclic compounds with nitrogen hetero-atom(s) only:\r\n- - Other:\r\n- - - Other:\r\n- - - - Aromatic or modified aromatic:\r\n- - - - - Other:\r\n- - - - - - Other\r\n\r\n> \r\n.\r\n\r\n> \r\nhttps://www.census.gov/foreign-trade/schedules/b/2024/c29.pdf\r\n\r\n$$$$\r\n\r\n SciTegic03212410032D\r\n\r\n 0 0 0 0 0 0 999 V2000\r\nM END\r\n> \r\nExample_2\r\n\r\n> \r\nEU\r\n\r\n> \r\n2933.99.8090\r\n\r\n> \r\n6.50%\r\n\r\n> \r\n- Heterocyclic compounds with nitrogen hetero-atom(s) only:\r\n- - Other:\r\n- - - Other:\r\n- - - - Other:\r\n- - - - - Other\r\n\r\n> \r\n.\r\n\r\n> \r\nhttps://ec.europa.eu/taxation_customs/dds2/taric/measures.jsp?Lang=en&SimDate=20240321&Taric=2933998090\r\n\r\n$$$$\r\n\r\n SciTegic03212410032D\r\n\r\n 0 0 0 0 0 0 999 V2000\r\nM END\r\n> \r\nExample_2\r\n\r\n> \r\nUK\r\n\r\n> \r\n2933.99.8090\r\n\r\n> \r\nFree\r\n\r\n> \r\n- Heterocyclic compounds with nitrogen hetero-atom(s) only:\r\n- - Other:\r\n- - - Other:\r\n- - - - Other:\r\n- - - - - Other\r\n\r\n> \r\n.\r\n\r\n> \r\nhttps://www.trade-tariff.service.gov.uk/commodities/2933998090?day=21&month=3&year=2024\r\n\r\n$$$$\r\n\r\n SciTegic03212410032D\r\n\r\n 0 0 0 0 0 0 999 V2000\r\nM END\r\n> \r\nExample_3\r\n\r\n> \r\nSCHB\r\n\r\n> \r\n2934.99.0005\r\n\r\n> \r\n- Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds:\r\n- - Other:\r\n- - - Other\r\n\r\n> \r\n.\r\n\r\n> \r\nhttps://www.census.gov/foreign-trade/schedules/b/2024/c29.pdf\r\n\r\n$$$$\r\n\r\n SciTegic03212410032D\r\n\r\n 0 0 0 0 0 0 999 V2000\r\nM END\r\n> \r\nExample_3\r\n\r\n> \r\nEU\r\n\r\n> \r\n2934.99.9090\r\n\r\n> \r\n6.50%\r\n\r\n> \r\n- Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds:\r\n- - Other:\r\n- - - Other:\r\n- - - - Other:\r\n- - - - - Other\r\n\r\n> \r\nINFORMATION - Stereochemistry is inexplicit or could not be exactly matched. This compound is a stereomatch to a compound in the pharmaceutical appendix; however, we have not altered the rate of duty\r\n due, since we cannot explicitly match it. You could be eligible for zero duty. Being more explicit with stereochemistry may provide a better match.\r\n\r\n> \r\nhttps://ec.europa.eu/taxation_customs/dds2/taric/measures.jsp?Lang=en&SimDate=20240321&Taric=2934999090\r\n\r\n$$$$\r\n\r\n SciTegic03212410032D\r\n\r\n 0 0 0 0 0 0 999 V2000\r\nM END\r\n> \r\nExample_3\r\n\r\n> \r\nUK\r\n\r\n> \r\n2934.99.9090\r\n\r\n> \r\n6%\r\n\r\n> \r\n- Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds:\r\n- - Other:\r\n- - - Other:\r\n- - - - Other:\r\n- - - - - Other\r\n\r\n> \r\nINFORMATION - Stereochemistry is inexplicit or could not be exactly matched. This compound is a stereomatch to a compound in the pharmaceutical appendix; however, we have not altered the rate of duty\r\n due, since we cannot explicitly match it. You could be eligible for zero duty. Being more explicit with stereochemistry may provide a better match.\r\n\r\n> \r\nhttps://www.trade-tariff.service.gov.uk/commodities/2934999090?day=21&month=3&year=2024\r\n\r\n$$$$\r\n\r\n SciTegic03212410032D\r\n\r\n 0 0 0 0 0 0 999 V2000\r\nM END\r\n> \r\nExample_4\r\n\r\n> \r\nSCHB\r\n\r\n> \r\n2933.99.8350\r\n\r\n> \r\n- Heterocyclic compounds with nitrogen hetero-atom(s) only:\r\n- - Other:\r\n- - - Other:\r\n- - - - Aromatic or modified aromatic:\r\n- - - - - Other:\r\n- - - - - - Other\r\n\r\n> \r\n.\r\n\r\n> \r\nhttps://www.census.gov/foreign-trade/schedules/b/2024/c29.pdf\r\n\r\n$$$$\r\n\r\n SciTegic03212410032D\r\n\r\n 0 0 0 0 0 0 999 V2000\r\nM END\r\n> \r\nExample_4\r\n\r\n> \r\nEU\r\n\r\n> \r\n2933.99.8090\r\n\r\n> \r\n6.50%\r\n\r\n> \r\n- Heterocyclic compounds with nitrogen hetero-atom(s) only:\r\n- - Other:\r\n- - - Other:\r\n- - - - Other:\r\n- - - - - Other\r\n\r\n> \r\n.\r\n\r\n> \r\nhttps://ec.europa.eu/taxation_customs/dds2/taric/measures.jsp?Lang=en&SimDate=20240321&Taric=2933998090\r\n\r\n$$$$\r\n\r\n SciTegic03212410032D\r\n\r\n 0 0 0 0 0 0 999 V2000\r\nM END\r\n> \r\nExample_4\r\n\r\n> \r\nUK\r\n\r\n> \r\n2933.99.8090\r\n\r\n> \r\nFree\r\n\r\n> \r\n- Heterocyclic compounds with nitrogen hetero-atom(s) only:\r\n- - Other:\r\n- - - Other:\r\n- - - - Other:\r\n- - - - - Other\r\n\r\n> \r\n.\r\n\r\n> \r\nhttps://www.trade-tariff.service.gov.uk/commodities/2933998090?day=21&month=3&year=2024\r\n\r\n$$$$\r\n\r\n SciTegic03212410032D\r\n\r\n 0 0 0 0 0 0 999 V2000\r\nM END\r\n> \r\nExample_5\r\n\r\n> \r\nSCHB\r\n\r\n> \r\n2934.92.0000\r\n\r\n> \r\n- Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds:\r\n- - Other:\r\n- - - Other fentanyls and their derivatives\r\n\r\n> \r\n.\r\n\r\n> \r\nhttps://www.census.gov/foreign-trade/schedules/b/2024/c29.pdf\r\n\r\n$$$$\r\n\r\n SciTegic03212410032D\r\n\r\n 0 0 0 0 0 0 999 V2000\r\nM END\r\n> \r\nExample_5\r\n\r\n> \r\nEU\r\n\r\n> \r\n2934.92.0000\r\n\r\n> \r\n6.50%\r\n\r\n> \r\n- Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds:\r\n- - Other:\r\n- - - Other fentanyls and their derivatives\r\n\r\n> \r\n.\r\n\r\n> \r\nhttps://ec.europa.eu/taxation_customs/dds2/taric/measures.jsp?Lang=en&SimDate=20240321&Taric=2934920000\r\n\r\n$$$$\r\n\r\n SciTegic03212410032D\r\n\r\n 0 0 0 0 0 0 999 V2000\r\nM END\r\n> \r\nExample_5\r\n\r\n> \r\nUK\r\n\r\n> \r\n2934.92.0000\r\n\r\n> \r\n6%\r\n\r\n> \r\n- Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds:\r\n- - Other:\r\n- - - Other fentanyls and their derivatives\r\n\r\n> \r\n.\r\n\r\n> \r\nhttps://www.trade-tariff.service.gov.uk/commodities/2934920000?day=21&month=3&year=2024\r\n\r\n$$$$\r\n\r\n SciTegic03212410032D\r\n\r\n 0 0 0 0 0 0 999 V2000\r\nM END\r\n> \r\nExample_6\r\n\r\n> \r\nSCHB\r\n\r\n> \r\n2933.34.0000\r\n\r\n> \r\n- Heterocyclic compounds with nitrogen hetero-atom(s) only:\r\n- - Compounds containing an unfused pyridine ring (whether or not hydrogenated) in the structure:\r\n- - - Other fentanyls and their derivatives\r\n\r\n> \r\n.\r\n\r\n> \r\nhttps://www.census.gov/foreign-trade/schedules/b/2024/c29.pdf\r\n\r\n$$$$\r\n\r\n SciTegic03212410032D\r\n\r\n 0 0 0 0 0 0 999 V2000\r\nM END\r\n> \r\nExample_6\r\n\r\n> \r\nEU\r\n\r\n> \r\n2933.34.0000\r\n\r\n> \r\n6.50%\r\n\r\n> \r\n- Heterocyclic compounds with nitrogen hetero-atom(s) only:\r\n- - Compounds containing an unfused pyridine ring (whether or not hydrogenated) in the structure:\r\n- - - Other fentanyls and their derivatives\r\n\r\n> \r\n.\r\n\r\n> \r\nhttps://ec.europa.eu/taxation_customs/dds2/taric/measures.jsp?Lang=en&SimDate=20240321&Taric=2933340000\r\n\r\n$$$$\r\n\r\n SciTegic03212410032D\r\n\r\n 0 0 0 0 0 0 999 V2000\r\nM END\r\n> \r\nExample_6\r\n\r\n> \r\nUK\r\n\r\n> \r\n2933.34.0000\r\n\r\n> \r\nFree\r\n\r\n> \r\n- Heterocyclic compounds with nitrogen hetero-atom(s) only:\r\n- - Compounds containing an unfused pyridine ring (whether or not hydrogenated) in the structure:\r\n- - - Other fentanyls and their derivatives\r\n\r\n> \r\n.\r\n\r\n> \r\nhttps://www.trade-tariff.service.gov.uk/commodities/2933340000?day=21&month=3&year=2024\r\n\r\n$$$$\r\n\r\n SciTegic03212410032D\r\n\r\n 0 0 0 0 0 0 999 V2000\r\nM END\r\n> \r\nExample_7\r\n\r\n> \r\nSCHB\r\n\r\n> \r\n2933.99.8350\r\n\r\n> \r\n- Heterocyclic compounds with nitrogen hetero-atom(s) only:\r\n- - Other:\r\n- - - Other:\r\n- - - - Aromatic or modified aromatic:\r\n- - - - - Other:\r\n- - - - - - Other\r\n\r\n> \r\n.\r\n\r\n> \r\nhttps://www.census.gov/foreign-trade/schedules/b/2024/c29.pdf\r\n\r\n$$$$\r\n\r\n SciTegic03212410032D\r\n\r\n 0 0 0 0 0 0 999 V2000\r\nM END\r\n> \r\nExample_7\r\n\r\n> \r\nEU\r\n\r\n> \r\n2933.99.8090\r\n\r\n> \r\n6.50%\r\n\r\n> \r\n- Heterocyclic compounds with nitrogen hetero-atom(s) only:\r\n- - Other:\r\n- - - Other:\r\n- - - - Other:\r\n- - - - - Other\r\n\r\n> \r\n.\r\n\r\n> \r\nhttps://ec.europa.eu/taxation_customs/dds2/taric/measures.jsp?Lang=en&SimDate=20240321&Taric=2933998090\r\n\r\n$$$$\r\n\r\n SciTegic03212410032D\r\n\r\n 0 0 0 0 0 0 999 V2000\r\nM END\r\n> \r\nExample_7\r\n\r\n> \r\nUK\r\n\r\n> \r\n2933.99.8090\r\n\r\n> \r\nFree\r\n\r\n> \r\n- Heterocyclic compounds with nitrogen hetero-atom(s) only:\r\n- - Other:\r\n- - - Other:\r\n- - - - Other:\r\n- - - - - Other\r\n\r\n> \r\n.\r\n\r\n> \r\nhttps://www.trade-tariff.service.gov.uk/commodities/2933998090?day=21&month=3&year=2024\r\n\r\n$$$$\r\n"}],"_postman_id":"2152471b-8c0a-41e0-9f83-44c6d7c8fd5f"}],"id":"8b7ba982-2a1a-469a-9f3d-7676b75d75cc","_postman_id":"8b7ba982-2a1a-469a-9f3d-7676b75d75cc","description":""},{"name":"/expedichem/fastlookup","item":[{"name":"/refresh/run","event":[{"listen":"test","script":{"id":"9b5f7f93-b3f8-4836-ba1b-93f1b2389b6d","exec":["// parse response and set gatewayJobId as environment variable\r","var response = pm.response.json();\r","pm.environment.set(\"jobId\", response.gatewayJobId);"],"type":"text/javascript","packages":{}}}],"id":"e3ffb104-f256-42da-b488-8b32cec690b4","protocolProfileBehavior":{"disableBodyPruning":true},"request":{"method":"POST","header":[{"key":"x-access-token","value":"{{token}}","description":"

The authentication token obtained from the /authenticate endpoint

\n"}],"body":{"mode":"raw","raw":"{\r\n \"fileContent\" : \"
  SciTegic11061411402D

  6  6  0  0  0  0            999 V2000
    4.9992    6.0386    0.0000 O   0  0
    5.7838    5.7839    0.0000 C   0  0
    6.4510    6.2685    0.0000 O   0  0
    7.1185    5.7839    0.0000 C   0  0
    6.8636    4.9992    0.0000 C   0  0
    6.0385    4.9992    0.0000 C   0  0
  1  2  2  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  2  1  0
M  END
> <corporateID>
Example_1

$$$$

  SciTegic11061411402D

 29 32  0  0  0  0            999 V2000
    5.0000    8.8643    0.0000 C   0  0
    5.1714    8.0573    0.0000 O   0  0
    5.9560    7.8023    0.0000 C   0  0
    6.5692    8.3543    0.0000 C   0  0
    7.3538    8.0992    0.0000 C   0  0
    7.5252    7.2923    0.0000 C   0  0
    8.3098    7.0372    0.0000 C   0  0
    8.9230    7.5892    0.0000 C   0  0
    9.7076    7.3342    0.0000 N   0  0
   10.3207    7.8862    0.0000 C   0  0
   10.1493    8.6931    0.0000 O   0  0
   11.1053    7.6311    0.0000 C   0  0
   11.7185    8.1831    0.0000 S   0  0
   12.5031    7.9281    0.0000 C   0  0
   13.1705    8.4129    0.0000 N   0  0
   13.8380    7.9280    0.0000 N   0  0
   13.5830    7.1434    0.0000 C   0  0
   13.9954    6.4290    0.0000 C   0  0
   13.5829    5.7145    0.0000 C   0  0
   13.9954    5.0000    0.0000 C   0  0
   12.7579    5.7145    0.0000 C   0  0
   12.3454    5.0000    0.0000 C   0  0
   11.5204    5.0000    0.0000 C   0  0
   11.1079    5.7145    0.0000 C   0  0
   11.5204    6.4289    0.0000 C   0  0
   12.3454    6.4290    0.0000 C   0  0
   12.7579    7.1434    0.0000 N   0  0
    6.9121    6.7403    0.0000 C   0  0
    6.1275    6.9953    0.0000 C   0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  2  0
 10 12  1  0
 12 13  1  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  2  0
 19 20  1  0
 19 21  1  0
 21 22  2  0
 22 23  1  0
 23 24  2  0
 24 25  1  0
 25 26  2  0
 26 21  1  0
 26 27  1  0
 27 14  1  0
 27 17  1  0
  6 28  1  0
 28 29  2  0
 29  3  1  0
M  END
> <corporateID>
Example_2

$$$$

  SciTegic11061411402D

 22 25  0  0  1  0            999 V2000
    4.1486   -1.0341    0.0000 C   0  0
    4.1487   -1.8528    0.0000 N   0  0
    3.4834   -2.3364    0.0000 C   0  0
    3.7383   -3.1219    0.0000 C   0  0  2  0  0  0
    4.5600   -3.1187    0.0000 C   0  0  1  0  0  0
    4.8143   -2.3364    0.0000 C   0  0
    5.0785   -3.7622    0.0000 C   0  0
    5.8586   -3.5060    0.0000 C   0  0
    6.4698   -4.0602    0.0000 C   0  0
    7.2492   -3.8092    0.0000 Cl  0  0
    6.2974   -4.8653    0.0000 C   0  0
    5.5138   -5.1161    0.0000 C   0  0
    4.9062   -4.5672    0.0000 C   0  0
    4.1649   -4.9279    0.0000 O   0  0
    3.4167   -4.5768    0.0000 C   0  0
    2.8165   -5.1469    0.0000 C   0  0
    2.0205   -4.9057    0.0000 C   0  0
    1.8301   -4.0977    0.0000 C   0  0
    2.4359   -3.5310    0.0000 C   0  0
    3.2263   -3.7689    0.0000 C   0  0
    4.0964   -3.8583    0.0000 H   0  0
    5.3654   -2.9705    0.0000 H   0  0
  1  2  1  0
  2  6  1  0
  2  3  1  0
  3  4  1  0
  4 20  1  0
  4  5  1  0
  5  6  1  0
  5  7  1  0
  7 13  2  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
  9 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  1  0
 14 15  1  0
 15 20  2  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  2  0
 19 20  1  0
  4 21  1  1
  5 22  1  6
M  END
> <corporateID>
Example_3

$$$$

  SciTegic11061411402D

 21 21  0  0  0  0            999 V2000
    2.7361    0.7608    0.0000 C   0  0
    1.9291    0.5892    0.0000 N   0  0
    1.6742   -0.1954    0.0000 C   0  0
    1.3770    1.2023    0.0000 C   0  0
    0.5701    1.0308    0.0000 C   0  0
    0.3151    0.2462    0.0000 C   0  0
    0.8001   -0.4213    0.0000 C   0  0
    0.3151   -1.0887    0.0000 N   0  0
   -0.4696   -0.8338    0.0000 C   0  0
   -1.1840   -1.2464    0.0000 C   0  0
   -1.8985   -0.8338    0.0000 C   0  0
   -1.8985   -0.0088    0.0000 C   0  0
   -2.6130    0.4037    0.0000 O   0  0
   -1.1840    0.4037    0.0000 C   0  0
   -0.4696   -0.0088    0.0000 C   0  0
    4.9142    0.8252    0.0000 O   0  0
    5.2318    0.2751    0.0000 C   0  0
    5.8671    0.2751    0.0000 O   0  0
    4.9142   -0.2751    0.0000 C   0  0
    5.2318   -0.8252    0.0000 O   0  0
    4.2789   -0.2751    0.0000 O   0  0
  1  2  1  0
  2  3  1  0
  2  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  2  0
  6 15  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
  9 15  2  0
 10 11  2  0
 11 12  1  0
 12 13  1  0
 12 14  2  0
 14 15  1  0
 16 17  1  0
 17 18  2  0
 17 19  1  0
 19 20  1  0
 19 21  2  0
M  END
> <corporateID>
Example_4

$$$$

  SciTegic11061411402D

 24 26  0  0  0  0            999 V2000
    4.2867   -1.2375    0.0000 C   0  0
    3.5722   -1.6500    0.0000 C   0  0
    2.8579   -1.2375    0.0000 C   0  0
    2.8579   -0.5775    0.0000 O   0  0
    2.1434   -1.6500    0.0000 N   0  0
    2.1434   -2.4749    0.0000 C   0  0
    1.4289   -2.8874    0.0000 C   0  0
    1.4289   -3.7124    0.0000 C   0  0
    2.1434   -4.1249    0.0000 N   0  0
    2.8579   -3.7124    0.0000 C   0  0
    2.8579   -2.8874    0.0000 C   0  0
    2.1434   -4.9498    0.0000 C   0  0
    2.8579   -5.3623    0.0000 C   0  0
    3.5722   -4.9498    0.0000 C   0  0
    3.8089   -4.1596    0.0000 C   0  0
    4.6337   -4.1405    0.0000 C   0  0
    4.9067   -4.9190    0.0000 C   0  0
    4.2507   -5.4193    0.0000 S   0  0
    1.4289   -1.2375    0.0000 C   0  0
    1.4289   -0.4125    0.0000 C   0  0
    0.7145    0.0000    0.0000 C   0  0
    0.0001   -0.4124    0.0000 C   0  0
    0.0000   -1.2375    0.0000 C   0  0
    0.7145   -1.6500    0.0000 C   0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  3  5  1  0
  5  6  1  0
  5 19  1  0
  6  7  1  0
  6 11  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
  9 12  1  0
 10 11  1  0
 12 13  1  0
 13 14  1  0
 14 15  2  0
 14 18  1  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 19 20  2  0
 19 24  1  0
 20 21  1  0
 21 22  2  0
 22 23  1  0
 23 24  2  0
M  END
> <corporateID>
Example_5

$$$$

  SciTegic11061411402D

 24 26  0  0  0  0            999 V2000
    0.0000   -2.8876    0.0000 C   0  0
    0.7145   -2.4750    0.0000 C   0  0
    0.7145   -1.8151    0.0000 O   0  0
    1.4289   -2.8876    0.0000 N   0  0
    2.1434   -2.4750    0.0000 C   0  0
    2.1434   -1.6500    0.0000 C   0  0
    2.8579   -1.2376    0.0000 C   0  0
    3.5723   -1.6500    0.0000 N   0  0
    3.5723   -2.4750    0.0000 C   0  0
    2.8579   -2.8876    0.0000 C   0  0
    4.2868   -1.2375    0.0000 C   0  0
    5.0013   -1.6500    0.0000 C   0  0
    5.7158   -1.2375    0.0000 C   0  0
    5.7158   -0.4125    0.0000 C   0  0
    6.4302    0.0000    0.0000 C   0  0
    7.1447   -0.4125    0.0000 C   0  0
    7.1447   -1.2375    0.0000 C   0  0
    6.4302   -1.6500    0.0000 C   0  0
    1.4289   -3.7125    0.0000 C   0  0
    0.7145   -4.1251    0.0000 C   0  0
    0.7145   -4.9501    0.0000 C   0  0
    1.4289   -5.3626    0.0000 C   0  0
    2.1434   -4.9501    0.0000 C   0  0
    2.1434   -4.1251    0.0000 C   0  0
  1  2  1  0
  2  3  2  0
  2  4  1  0
  4  5  1  0
  4 19  1  0
  5  6  1  0
  5 10  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  8 11  1  0
  9 10  1  0
 11 12  1  0
 12 13  1  0
 13 14  2  0
 13 18  1  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  2  0
 19 20  2  0
 19 24  1  0
 20 21  1  0
 21 22  2  0
 22 23  1  0
 23 24  2  0
M  END
> <corporateID>
Example_6

$$$$

  SciTegic11061411402D

 22 24  0  0  0  0            999 V2000
   -4.3225   -1.2712    0.0000 C   0  0
   -3.6080   -0.8587    0.0000 C   0  0
   -2.8935   -1.2712    0.0000 C   0  0
   -2.1790   -0.8587    0.0000 C   0  0
   -1.4646   -1.2712    0.0000 C   0  0
   -0.7501   -0.8587    0.0000 N   0  0
   -0.6639   -0.0383    0.0000 C   0  0
    0.1431    0.1333    0.0000 C   0  0
    0.5556   -0.5812    0.0000 C   0  0
    0.0036   -1.1943    0.0000 C   0  0
    1.3761   -0.6674    0.0000 C   0  0
    1.7116   -1.4211    0.0000 O   0  0
    1.8610    0.0000    0.0000 C   0  0
    1.5255    0.7537    0.0000 C   0  0
    2.0104    1.4211    0.0000 C   0  0
    2.8309    1.3349    0.0000 C   0  0
    3.1664    0.5812    0.0000 C   0  0
    3.9869    0.4950    0.0000 C   0  0
    4.3225   -0.2587    0.0000 C   0  0
    3.8375   -0.9261    0.0000 C   0  0
    3.0171   -0.8399    0.0000 C   0  0
    2.6815   -0.0862    0.0000 C   0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
  6 10  1  0
  9 11  1  0
 11 12  2  0
 11 13  1  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  2  0
 21 22  1  0
 13 22  2  0
 17 22  1  0
M  END
> <corporateID>
Example_7

$$$$
\"\r\n}","options":{"raw":{"language":"json"}}},"url":"https://{{host}}:{{port}}/expedichem/fastlookup/refresh/run","description":"

Send a batch of compounds to the ExpediChem fastlookup webservice to be populated in the ExpediChem fastlookup table. This API call will return a gatewayJobId which can be used to monitor the job and retrieve the ExpediChem results using the /expedichem/fastlookup/refresh/result endpoint.

The header field x-access-token must be populated with the value of an active token. Once the job is submitted, the owner of that job will be whomever the token was created by. To obtain a value for x-access-token use the /authenticate enpoint in this collection.

fileContent: String

This is required and must contain the base64 encoded content of a valid SD file. The SD file needs to contain a field named CorporateID which contains the identifier of the compound (e.g. SCITEGRITY-123) and can optionally include a FastlookupIdSource field which can be used to denote the source of the compound (e.g. CorporateDB1). NOTE: DO NOT USE INTEGERS FOR CORPORATEIDS - this can cause issues where users unintentionally use precalculated results when using an integer index for their file of compounds - always prefix or postfix this with a label (i.e. use COMP123 as corporateId not 123).

\n","urlObject":{"protocol":"https","port":"{{port}}","path":["expedichem","fastlookup","refresh","run"],"host":["{{host}}"],"query":[],"variable":[]}},"response":[{"id":"8faf2795-d996-4f5b-a75e-a60cb4538fbe","name":"job submitted","originalRequest":{"method":"POST","header":[{"key":"x-access-token","value":"{{token}}","description":"The authentication token obtained from the /authenticate endpoint"}],"body":{"mode":"raw","raw":"{\r\n \"fileContent\" : \"
  SciTegic11061411402D

  6  6  0  0  0  0            999 V2000
    4.9992    6.0386    0.0000 O   0  0
    5.7838    5.7839    0.0000 C   0  0
    6.4510    6.2685    0.0000 O   0  0
    7.1185    5.7839    0.0000 C   0  0
    6.8636    4.9992    0.0000 C   0  0
    6.0385    4.9992    0.0000 C   0  0
  1  2  2  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  2  1  0
M  END
> <corporateID>
Example_1

$$$$

  SciTegic11061411402D

 29 32  0  0  0  0            999 V2000
    5.0000    8.8643    0.0000 C   0  0
    5.1714    8.0573    0.0000 O   0  0
    5.9560    7.8023    0.0000 C   0  0
    6.5692    8.3543    0.0000 C   0  0
    7.3538    8.0992    0.0000 C   0  0
    7.5252    7.2923    0.0000 C   0  0
    8.3098    7.0372    0.0000 C   0  0
    8.9230    7.5892    0.0000 C   0  0
    9.7076    7.3342    0.0000 N   0  0
   10.3207    7.8862    0.0000 C   0  0
   10.1493    8.6931    0.0000 O   0  0
   11.1053    7.6311    0.0000 C   0  0
   11.7185    8.1831    0.0000 S   0  0
   12.5031    7.9281    0.0000 C   0  0
   13.1705    8.4129    0.0000 N   0  0
   13.8380    7.9280    0.0000 N   0  0
   13.5830    7.1434    0.0000 C   0  0
   13.9954    6.4290    0.0000 C   0  0
   13.5829    5.7145    0.0000 C   0  0
   13.9954    5.0000    0.0000 C   0  0
   12.7579    5.7145    0.0000 C   0  0
   12.3454    5.0000    0.0000 C   0  0
   11.5204    5.0000    0.0000 C   0  0
   11.1079    5.7145    0.0000 C   0  0
   11.5204    6.4289    0.0000 C   0  0
   12.3454    6.4290    0.0000 C   0  0
   12.7579    7.1434    0.0000 N   0  0
    6.9121    6.7403    0.0000 C   0  0
    6.1275    6.9953    0.0000 C   0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  2  0
 10 12  1  0
 12 13  1  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  2  0
 19 20  1  0
 19 21  1  0
 21 22  2  0
 22 23  1  0
 23 24  2  0
 24 25  1  0
 25 26  2  0
 26 21  1  0
 26 27  1  0
 27 14  1  0
 27 17  1  0
  6 28  1  0
 28 29  2  0
 29  3  1  0
M  END
> <corporateID>
Example_2

$$$$

  SciTegic11061411402D

 22 25  0  0  1  0            999 V2000
    4.1486   -1.0341    0.0000 C   0  0
    4.1487   -1.8528    0.0000 N   0  0
    3.4834   -2.3364    0.0000 C   0  0
    3.7383   -3.1219    0.0000 C   0  0  2  0  0  0
    4.5600   -3.1187    0.0000 C   0  0  1  0  0  0
    4.8143   -2.3364    0.0000 C   0  0
    5.0785   -3.7622    0.0000 C   0  0
    5.8586   -3.5060    0.0000 C   0  0
    6.4698   -4.0602    0.0000 C   0  0
    7.2492   -3.8092    0.0000 Cl  0  0
    6.2974   -4.8653    0.0000 C   0  0
    5.5138   -5.1161    0.0000 C   0  0
    4.9062   -4.5672    0.0000 C   0  0
    4.1649   -4.9279    0.0000 O   0  0
    3.4167   -4.5768    0.0000 C   0  0
    2.8165   -5.1469    0.0000 C   0  0
    2.0205   -4.9057    0.0000 C   0  0
    1.8301   -4.0977    0.0000 C   0  0
    2.4359   -3.5310    0.0000 C   0  0
    3.2263   -3.7689    0.0000 C   0  0
    4.0964   -3.8583    0.0000 H   0  0
    5.3654   -2.9705    0.0000 H   0  0
  1  2  1  0
  2  6  1  0
  2  3  1  0
  3  4  1  0
  4 20  1  0
  4  5  1  0
  5  6  1  0
  5  7  1  0
  7 13  2  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
  9 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  1  0
 14 15  1  0
 15 20  2  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  2  0
 19 20  1  0
  4 21  1  1
  5 22  1  6
M  END
> <corporateID>
Example_3

$$$$

  SciTegic11061411402D

 21 21  0  0  0  0            999 V2000
    2.7361    0.7608    0.0000 C   0  0
    1.9291    0.5892    0.0000 N   0  0
    1.6742   -0.1954    0.0000 C   0  0
    1.3770    1.2023    0.0000 C   0  0
    0.5701    1.0308    0.0000 C   0  0
    0.3151    0.2462    0.0000 C   0  0
    0.8001   -0.4213    0.0000 C   0  0
    0.3151   -1.0887    0.0000 N   0  0
   -0.4696   -0.8338    0.0000 C   0  0
   -1.1840   -1.2464    0.0000 C   0  0
   -1.8985   -0.8338    0.0000 C   0  0
   -1.8985   -0.0088    0.0000 C   0  0
   -2.6130    0.4037    0.0000 O   0  0
   -1.1840    0.4037    0.0000 C   0  0
   -0.4696   -0.0088    0.0000 C   0  0
    4.9142    0.8252    0.0000 O   0  0
    5.2318    0.2751    0.0000 C   0  0
    5.8671    0.2751    0.0000 O   0  0
    4.9142   -0.2751    0.0000 C   0  0
    5.2318   -0.8252    0.0000 O   0  0
    4.2789   -0.2751    0.0000 O   0  0
  1  2  1  0
  2  3  1  0
  2  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  2  0
  6 15  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
  9 15  2  0
 10 11  2  0
 11 12  1  0
 12 13  1  0
 12 14  2  0
 14 15  1  0
 16 17  1  0
 17 18  2  0
 17 19  1  0
 19 20  1  0
 19 21  2  0
M  END
> <corporateID>
Example_4

$$$$

  SciTegic11061411402D

 24 26  0  0  0  0            999 V2000
    4.2867   -1.2375    0.0000 C   0  0
    3.5722   -1.6500    0.0000 C   0  0
    2.8579   -1.2375    0.0000 C   0  0
    2.8579   -0.5775    0.0000 O   0  0
    2.1434   -1.6500    0.0000 N   0  0
    2.1434   -2.4749    0.0000 C   0  0
    1.4289   -2.8874    0.0000 C   0  0
    1.4289   -3.7124    0.0000 C   0  0
    2.1434   -4.1249    0.0000 N   0  0
    2.8579   -3.7124    0.0000 C   0  0
    2.8579   -2.8874    0.0000 C   0  0
    2.1434   -4.9498    0.0000 C   0  0
    2.8579   -5.3623    0.0000 C   0  0
    3.5722   -4.9498    0.0000 C   0  0
    3.8089   -4.1596    0.0000 C   0  0
    4.6337   -4.1405    0.0000 C   0  0
    4.9067   -4.9190    0.0000 C   0  0
    4.2507   -5.4193    0.0000 S   0  0
    1.4289   -1.2375    0.0000 C   0  0
    1.4289   -0.4125    0.0000 C   0  0
    0.7145    0.0000    0.0000 C   0  0
    0.0001   -0.4124    0.0000 C   0  0
    0.0000   -1.2375    0.0000 C   0  0
    0.7145   -1.6500    0.0000 C   0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  3  5  1  0
  5  6  1  0
  5 19  1  0
  6  7  1  0
  6 11  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
  9 12  1  0
 10 11  1  0
 12 13  1  0
 13 14  1  0
 14 15  2  0
 14 18  1  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 19 20  2  0
 19 24  1  0
 20 21  1  0
 21 22  2  0
 22 23  1  0
 23 24  2  0
M  END
> <corporateID>
Example_5

$$$$

  SciTegic11061411402D

 24 26  0  0  0  0            999 V2000
    0.0000   -2.8876    0.0000 C   0  0
    0.7145   -2.4750    0.0000 C   0  0
    0.7145   -1.8151    0.0000 O   0  0
    1.4289   -2.8876    0.0000 N   0  0
    2.1434   -2.4750    0.0000 C   0  0
    2.1434   -1.6500    0.0000 C   0  0
    2.8579   -1.2376    0.0000 C   0  0
    3.5723   -1.6500    0.0000 N   0  0
    3.5723   -2.4750    0.0000 C   0  0
    2.8579   -2.8876    0.0000 C   0  0
    4.2868   -1.2375    0.0000 C   0  0
    5.0013   -1.6500    0.0000 C   0  0
    5.7158   -1.2375    0.0000 C   0  0
    5.7158   -0.4125    0.0000 C   0  0
    6.4302    0.0000    0.0000 C   0  0
    7.1447   -0.4125    0.0000 C   0  0
    7.1447   -1.2375    0.0000 C   0  0
    6.4302   -1.6500    0.0000 C   0  0
    1.4289   -3.7125    0.0000 C   0  0
    0.7145   -4.1251    0.0000 C   0  0
    0.7145   -4.9501    0.0000 C   0  0
    1.4289   -5.3626    0.0000 C   0  0
    2.1434   -4.9501    0.0000 C   0  0
    2.1434   -4.1251    0.0000 C   0  0
  1  2  1  0
  2  3  2  0
  2  4  1  0
  4  5  1  0
  4 19  1  0
  5  6  1  0
  5 10  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  8 11  1  0
  9 10  1  0
 11 12  1  0
 12 13  1  0
 13 14  2  0
 13 18  1  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  2  0
 19 20  2  0
 19 24  1  0
 20 21  1  0
 21 22  2  0
 22 23  1  0
 23 24  2  0
M  END
> <corporateID>
Example_6

$$$$

  SciTegic11061411402D

 22 24  0  0  0  0            999 V2000
   -4.3225   -1.2712    0.0000 C   0  0
   -3.6080   -0.8587    0.0000 C   0  0
   -2.8935   -1.2712    0.0000 C   0  0
   -2.1790   -0.8587    0.0000 C   0  0
   -1.4646   -1.2712    0.0000 C   0  0
   -0.7501   -0.8587    0.0000 N   0  0
   -0.6639   -0.0383    0.0000 C   0  0
    0.1431    0.1333    0.0000 C   0  0
    0.5556   -0.5812    0.0000 C   0  0
    0.0036   -1.1943    0.0000 C   0  0
    1.3761   -0.6674    0.0000 C   0  0
    1.7116   -1.4211    0.0000 O   0  0
    1.8610    0.0000    0.0000 C   0  0
    1.5255    0.7537    0.0000 C   0  0
    2.0104    1.4211    0.0000 C   0  0
    2.8309    1.3349    0.0000 C   0  0
    3.1664    0.5812    0.0000 C   0  0
    3.9869    0.4950    0.0000 C   0  0
    4.3225   -0.2587    0.0000 C   0  0
    3.8375   -0.9261    0.0000 C   0  0
    3.0171   -0.8399    0.0000 C   0  0
    2.6815   -0.0862    0.0000 C   0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
  6 10  1  0
  9 11  1  0
 11 12  2  0
 11 13  1  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  2  0
 21 22  1  0
 13 22  2  0
 17 22  1  0
M  END
> <corporateID>
Example_7

$$$$
\"\r\n}","options":{"raw":{"language":"json"}}},"url":"https://{{host}}:{{port}}/expedichem/fastlookup/refresh/run"},"status":"Created","code":201,"_postman_previewlanguage":"json","header":[{"key":"Date","value":"Thu, 04 Jan 2024 16:37:07 GMT"},{"key":"Content-Type","value":"application/json; charset=utf-8"},{"key":"Content-Length","value":"59"},{"key":"Connection","value":"keep-alive"},{"key":"X-Frame-Options","value":"SAMEORIGIN"},{"key":"Strict-Transport-Security","value":"max-age=63072000; includeSubDomains; preload"},{"key":"ETag","value":"W/\"3b-AtmLP4blewkxWhFgIIA2SKjxt4k\""}],"cookie":[],"responseTime":null,"body":"{\n \"gatewayJobId\": \"GWJ-8043d8d0-ab1f-11ee-a98f-9506d165b82d\"\n}"}],"_postman_id":"e3ffb104-f256-42da-b488-8b32cec690b4"},{"name":"/refresh/result","id":"e6f75a01-ff98-4f43-9fe1-9b927eb91ccc","protocolProfileBehavior":{"disableBodyPruning":true},"request":{"method":"POST","header":[{"key":"x-access-token","value":"{{token}}","description":"

The authentication token obtained from the /authenticate endpoint

Retrieve the results of a previously submitted fastlookup job. If the job is still running the request will show the status of the job. If the job has completed the ExpediChem results will be returned in the response.

This is a protected route. The value of the header field x-access-token must match an active token, issued to the owner of the job

Look at the example completed job to see the format of ExpediChem results returned

\n","urlObject":{"protocol":"https","port":"{{port}}","path":["expedichem","fastlookup","refresh","result"],"host":["{{host}}"],"query":[],"variable":[]}},"response":[{"id":"45b2eae1-74a2-4bcf-bb06-327f77e568c4","name":"job running","originalRequest":{"method":"POST","header":[{"key":"x-access-token","value":"{{token}}","description":"The authentication token obtained from the /authenticate endpoint"}],"body":{"mode":"raw","raw":"{\r\n \"gatewayJobId\": \"{{jobId}}\"\r\n}","options":{"raw":{"language":"json"}}},"url":"https://{{host}}:{{port}}/expedichem/fastlookup/refresh/result"},"status":"OK","code":200,"_postman_previewlanguage":"json","header":[{"key":"Date","value":"Thu, 04 Jan 2024 16:37:28 GMT"},{"key":"Content-Type","value":"application/json; charset=utf-8"},{"key":"Content-Length","value":"113"},{"key":"Connection","value":"keep-alive"},{"key":"X-Frame-Options","value":"SAMEORIGIN"},{"key":"Strict-Transport-Security","value":"max-age=63072000; includeSubDomains; preload"},{"key":"ETag","value":"W/\"71-4lQFlIaGuf5EGqCbrpnS+0tsQ70\""}],"cookie":[],"responseTime":null,"body":"{\n \"jobStatus\": \"running\",\n \"jobResult\": null,\n \"updatedAt\": \"2024-01-04T16:37:29.540Z\",\n \"queryString\": null,\n \"message\": null\n}"},{"id":"d66d74c0-f2be-4d7e-9b50-b4bdbb82a416","name":"job complete","originalRequest":{"method":"POST","header":[{"key":"x-access-token","value":"{{token}}","description":"The authentication token obtained from the /authenticate endpoint"}],"body":{"mode":"raw","raw":"{\r\n \"gatewayJobId\": \"{{jobId}}\"\r\n}","options":{"raw":{"language":"json"}}},"url":"https://{{host}}:{{port}}/expedichem/fastlookup/refresh/result"},"status":"OK","code":200,"_postman_previewlanguage":"json","header":[{"key":"Date","value":"Thu, 04 Jan 2024 16:37:52 GMT"},{"key":"Content-Type","value":"application/json; charset=utf-8"},{"key":"Content-Length","value":"19465"},{"key":"Connection","value":"keep-alive"},{"key":"X-Frame-Options","value":"SAMEORIGIN"},{"key":"Strict-Transport-Security","value":"max-age=63072000; includeSubDomains; preload"},{"key":"ETag","value":"W/\"4c09-gWSL+JIkrzAn/qVD0kYXMFjtX+A\""}],"cookie":[],"responseTime":null,"body":"{\n \"jobStatus\": \"complete\",\n \"jobResult\": {\n \"records\": [\n {\n \"corporateId\": \"EXAMPLE_1\",\n \"country\": \"USHTS\",\n \"tariffCode\": \"2932.20.5010\",\n \"description\": \"- Heterocyclic compounds with oxygen hetero-atom(s) only:\\n- - Lactones:\\n- - - Other:\\n- - - - Other:\\n- - - - - Butyrolactone\",\n \"duty\": \"3.7%\",\n \"specialRate\": \"Free(A,AU,BH,CA,CL,CO,D,E,IL,JO,K,KR,MA,MX,OM,P,PA,PE,S,SG)\",\n \"rate2\": \"25%\",\n \"comments\": null,\n \"htsFastlookupSource\": \"notDefinedRefresh\",\n \"checkStatus\": \"Completed\"\n },\n {\n \"corporateId\": \"EXAMPLE_1\",\n \"country\": \"SCHB\",\n \"tariffCode\": \"2932.20.6000\",\n \"description\": \"- Heterocyclic compounds with oxygen hetero-atom(s) only:\\n- - Lactones:\\n- - - Other:\\n- - - - Other\",\n \"duty\": null,\n \"specialRate\": null,\n \"rate2\": null,\n \"comments\": null,\n \"htsFastlookupSource\": \"notDefinedRefresh\",\n \"checkStatus\": \"Completed\"\n },\n {\n \"corporateId\": \"EXAMPLE_1\",\n \"country\": \"EU\",\n \"tariffCode\": \"2932.20.2000\",\n \"description\": \"- Heterocyclic compounds with oxygen hetero-atom(s) only:\\n- - Lactones:\\n- - - gamma-Butyrolactone\",\n \"duty\": \"6.50%\",\n \"specialRate\": null,\n \"rate2\": null,\n \"comments\": null,\n \"htsFastlookupSource\": \"notDefinedRefresh\",\n \"checkStatus\": \"Completed\"\n },\n {\n \"corporateId\": \"EXAMPLE_1\",\n \"country\": \"CN\",\n \"tariffCode\": \"2932.20.9031\",\n \"description\": \"- Heterocyclic compounds with oxygen hetero-atom(s) only:\\n- - ³-Butyrolactone\",\n \"duty\": \"6.50%\",\n \"specialRate\": \"Free (AS,KR,AU,IS,CR,PE,CL,GE,HK,MO,LD), 1.3% (CH), 5% (PK)\",\n \"rate2\": \"20%\",\n \"comments\": null,\n \"htsFastlookupSource\": \"notDefinedRefresh\",\n \"checkStatus\": \"Completed\"\n },\n {\n \"corporateId\": \"EXAMPLE_1\",\n \"country\": \"UK\",\n \"tariffCode\": \"2932.20.2000\",\n \"description\": \"- Heterocyclic compounds with oxygen hetero-atom(s) only:\\n- - Lactones:\\n- - - gamma-Butyrolactone\",\n \"duty\": \"6%\",\n \"specialRate\": null,\n \"rate2\": null,\n \"comments\": null,\n \"htsFastlookupSource\": \"notDefinedRefresh\",\n \"checkStatus\": \"Completed\"\n },\n {\n \"corporateId\": \"EXAMPLE_1\",\n \"country\": \"CH\",\n \"tariffCode\": \"2932.20.00\",\n \"description\": \"- Heterocyclic compounds with oxygen hetero-atom(s) only:\\n- - Lactones\",\n \"duty\": \"Free\",\n \"specialRate\": null,\n \"rate2\": null,\n \"comments\": null,\n \"htsFastlookupSource\": \"notDefinedRefresh\",\n \"checkStatus\": \"Completed\"\n },\n {\n \"corporateId\": \"EXAMPLE_1\",\n \"country\": \"ROW\",\n \"tariffCode\": \"2932.20\",\n \"description\": null,\n \"duty\": null,\n \"specialRate\": null,\n \"rate2\": null,\n \"comments\": null,\n \"htsFastlookupSource\": \"notDefinedRefresh\",\n \"checkStatus\": \"Completed\"\n },\n {\n \"corporateId\": \"EXAMPLE_2\",\n \"country\": \"ROW\",\n \"tariffCode\": \"2933.99\",\n \"description\": null,\n \"duty\": null,\n \"specialRate\": null,\n \"rate2\": null,\n \"comments\": null,\n \"htsFastlookupSource\": \"notDefinedRefresh\",\n \"checkStatus\": \"Completed\"\n },\n {\n \"corporateId\": \"EXAMPLE_2\",\n \"country\": \"CH\",\n \"tariffCode\": \"2933.99.80\",\n \"description\": \"- Heterocyclic compounds with nitrogen hetero-atom(s) only:\\n- - Other:\\n- - - Other:\\n- - - - Other\",\n \"duty\": \"1%\",\n \"specialRate\": null,\n \"rate2\": null,\n \"comments\": null,\n \"htsFastlookupSource\": \"notDefinedRefresh\",\n \"checkStatus\": \"Completed\"\n },\n {\n \"corporateId\": \"EXAMPLE_2\",\n \"country\": \"CN\",\n \"tariffCode\": \"2933.99.0099\",\n \"description\": \"- Heterocyclic compounds with nitrogen hetero-atom(s) only:\\n- - Other heterocyclic compounds containing nitrogen hetero-atom(s) only\",\n \"duty\": \"6.50%\",\n \"specialRate\": \"Free (AS,KR,AU,IS,CR,PE,CL,GE,HK,MO,LD), 3.7% (CH), 5% (PK)\",\n \"rate2\": \"20%\",\n \"comments\": \"If anti-cancer drug then use code 2933.99.0092\",\n \"htsFastlookupSource\": \"notDefinedRefresh\",\n \"checkStatus\": \"Completed\"\n },\n {\n \"corporateId\": \"EXAMPLE_2\",\n \"country\": \"UK\",\n \"tariffCode\": \"2933.99.8090\",\n \"description\": \"- Heterocyclic compounds with nitrogen hetero-atom(s) only:\\n- - Other:\\n- - - Other:\\n- - - - Other:\\n- - - - - Other\",\n \"duty\": \"Free\",\n \"specialRate\": null,\n \"rate2\": null,\n \"comments\": null,\n \"htsFastlookupSource\": \"notDefinedRefresh\",\n \"checkStatus\": \"Completed\"\n },\n {\n \"corporateId\": \"EXAMPLE_2\",\n \"country\": \"EU\",\n \"tariffCode\": \"2933.99.8090\",\n \"description\": \"- Heterocyclic compounds with nitrogen hetero-atom(s) only:\\n- - Other:\\n- - - Other:\\n- - - - Other:\\n- - - - - Other\",\n \"duty\": \"6.50%\",\n \"specialRate\": null,\n \"rate2\": null,\n \"comments\": null,\n \"htsFastlookupSource\": \"notDefinedRefresh\",\n \"checkStatus\": \"Completed\"\n },\n {\n \"corporateId\": \"EXAMPLE_2\",\n \"country\": \"SCHB\",\n \"tariffCode\": \"2933.99.8350\",\n \"description\": \"- Heterocyclic compounds with nitrogen hetero-atom(s) only:\\n- - Other:\\n- - - Other:\\n- - - - Aromatic or modified aromatic:\\n- - - - - Other:\\n- - - - - - Other\",\n \"duty\": null,\n \"specialRate\": null,\n \"rate2\": null,\n \"comments\": null,\n \"htsFastlookupSource\": \"notDefinedRefresh\",\n \"checkStatus\": \"Completed\"\n },\n {\n \"corporateId\": \"EXAMPLE_2\",\n \"country\": \"USHTS\",\n \"tariffCode\": \"2933.99.7900\",\n \"description\": \"- Heterocyclic compounds with nitrogen hetero-atom(s) only:\\n- - Other:\\n- - - Other:\\n- - - - Aromatic or modified aromatic:\\n- - - - - Other:\\n- - - - - - Other:\\n- - - - - - - Products described in additional U.S. note 3 to section VI\",\n \"duty\": \"6.5%\",\n \"specialRate\": \"Free(A+,AU,BH,CA,CL,CO,D,E,IL,JO,K,KR,L,MA,MX,OM,P,PA,PE,S,SG)\",\n \"rate2\": \"15.4¢/kg + 52%\",\n \"comments\": null,\n \"htsFastlookupSource\": \"notDefinedRefresh\",\n \"checkStatus\": \"Completed\"\n },\n {\n \"corporateId\": \"EXAMPLE_3\",\n \"country\": \"USHTS\",\n \"tariffCode\": \"2934.99.3900\",\n \"description\": \"- Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds:\\n- - Other:\\n- - - Other:\\n- - - - Aromatic or modified aromatic\\n- - - - - Other:\\n- - - - - - Other:\\n- - - - - - - Products described in additional U.S. note 3 to section VI\",\n \"duty\": \"6.5%\",\n \"specialRate\": \"Free(A+,AU,BH,CA,CL,CO,D,E,IL,JO,K,KR,L,MA,MX,OM,P,PA,PE,S,SG)\",\n \"rate2\": \"15.4¢/kg + 52%\",\n \"comments\": \"INFORMATION: Pharmaceutical Appendix Stereomatch - Stereochemistry is inexplicit or could not be exactly matched. This compound is a stereomatch to a compound in the pharmaceutical appendix - you could be eligible for zero duty. Being more explicit with stereochemistry may provide a better match.\\n\",\n \"htsFastlookupSource\": \"notDefinedRefresh\",\n \"checkStatus\": \"Completed\"\n },\n {\n \"corporateId\": \"EXAMPLE_3\",\n \"country\": \"SCHB\",\n \"tariffCode\": \"2934.99.0005\",\n \"description\": \"- Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds:\\n- - Other:\\n- - - Other\",\n \"duty\": null,\n \"specialRate\": null,\n \"rate2\": null,\n \"comments\": null,\n \"htsFastlookupSource\": \"notDefinedRefresh\",\n \"checkStatus\": \"Completed\"\n },\n {\n \"corporateId\": \"EXAMPLE_3\",\n \"country\": \"EU\",\n \"tariffCode\": \"2934.99.9090\",\n \"description\": \"- Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds:\\n- - Other:\\n- - - Other:\\n- - - - Other:\\n- - - - - Other\",\n \"duty\": \"6.50%\",\n \"specialRate\": null,\n \"rate2\": null,\n \"comments\": \"INFORMATION - Stereochemistry is inexplicit or could not be exactly matched. This compound is a stereomatch to a compound in the pharmaceutical appendix; however, we have not altered the rate of duty due, since we cannot explicitly match it. You could be eligible for zero duty. Being more explicit with stereochemistry may provide a better match.\\n\",\n \"htsFastlookupSource\": \"notDefinedRefresh\",\n \"checkStatus\": \"Completed\"\n },\n {\n \"corporateId\": \"EXAMPLE_3\",\n \"country\": \"CN\",\n \"tariffCode\": \"2934.99.9099\",\n \"description\": \"- Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds:\\n- - Other heterocyclic compounds (tax numbers resulting from the separation of anticancer drug raw materials)\",\n \"duty\": \"6.50%\",\n \"specialRate\": \"Free (AS,KR,AU,CH,IS,CR,PE,CL,GE,HK,MO,LD), 5% (PK)\",\n \"rate2\": \"30%\",\n \"comments\": \"If anti-cancer drug then use code 2934.99.9091, else if nucleotide food additive, then use code 2934.99.9001\",\n \"htsFastlookupSource\": \"notDefinedRefresh\",\n \"checkStatus\": \"Completed\"\n },\n {\n \"corporateId\": \"EXAMPLE_3\",\n \"country\": \"UK\",\n \"tariffCode\": \"2934.99.9090\",\n \"description\": \"- Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds:\\n- - Other:\\n- - - Other:\\n- - - - Other:\\n- - - - - Other\",\n \"duty\": \"6%\",\n \"specialRate\": null,\n \"rate2\": null,\n \"comments\": \"INFORMATION - Stereochemistry is inexplicit or could not be exactly matched. This compound is a stereomatch to a compound in the pharmaceutical appendix; however, we have not altered the rate of duty due, since we cannot explicitly match it. You could be eligible for zero duty. Being more explicit with stereochemistry may provide a better match.\\n\",\n \"htsFastlookupSource\": \"notDefinedRefresh\",\n \"checkStatus\": \"Completed\"\n },\n {\n \"corporateId\": \"EXAMPLE_3\",\n \"country\": \"CH\",\n \"tariffCode\": \"2934.99.99\",\n \"description\": \"- Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds:\\n- - Other:\\n- - - Other:\\n- - - - Other:\\n- - - - - Other\",\n \"duty\": \"Free\",\n \"specialRate\": null,\n \"rate2\": null,\n \"comments\": \"INFORMATION - Stereochemistry is inexplicit or could not be exactly matched. This compound is a stereomatch to a compound in the pharmaceutical appendix; however, we have not altered the rate of duty/code due, since we cannot explicitly match it. You could be eligible for zero duty. Being more explicit with stereochemistry may provide a better match.\\n\",\n \"htsFastlookupSource\": \"notDefinedRefresh\",\n \"checkStatus\": \"Completed\"\n },\n {\n \"corporateId\": \"EXAMPLE_3\",\n \"country\": \"ROW\",\n \"tariffCode\": \"2934.99\",\n \"description\": null,\n \"duty\": null,\n \"specialRate\": null,\n \"rate2\": null,\n \"comments\": \"PHARMACEUTICAL APPENDIX - you may be eligible for free duty\",\n \"htsFastlookupSource\": \"notDefinedRefresh\",\n \"checkStatus\": \"Completed\"\n },\n {\n \"corporateId\": \"EXAMPLE_4\",\n \"country\": \"ROW\",\n \"tariffCode\": \"2933.99\",\n \"description\": null,\n \"duty\": null,\n \"specialRate\": null,\n \"rate2\": null,\n \"comments\": null,\n \"htsFastlookupSource\": \"notDefinedRefresh\",\n \"checkStatus\": \"Completed\"\n },\n {\n \"corporateId\": \"EXAMPLE_4\",\n \"country\": \"CH\",\n \"tariffCode\": \"2933.99.80\",\n \"description\": \"- Heterocyclic compounds with nitrogen hetero-atom(s) only:\\n- - Other:\\n- - - Other:\\n- - - - Other\",\n \"duty\": \"1%\",\n \"specialRate\": null,\n \"rate2\": null,\n \"comments\": null,\n \"htsFastlookupSource\": \"notDefinedRefresh\",\n \"checkStatus\": \"Completed\"\n },\n {\n \"corporateId\": \"EXAMPLE_4\",\n \"country\": \"UK\",\n \"tariffCode\": \"2933.99.8090\",\n \"description\": \"- Heterocyclic compounds with nitrogen hetero-atom(s) only:\\n- - Other:\\n- - - Other:\\n- - - - Other:\\n- - - - - Other\",\n \"duty\": \"Free\",\n \"specialRate\": null,\n \"rate2\": null,\n \"comments\": null,\n \"htsFastlookupSource\": \"notDefinedRefresh\",\n \"checkStatus\": \"Completed\"\n },\n {\n \"corporateId\": \"EXAMPLE_4\",\n \"country\": \"CN\",\n \"tariffCode\": \"2933.99.0099\",\n \"description\": \"- Heterocyclic compounds with nitrogen hetero-atom(s) only:\\n- - Other heterocyclic compounds containing nitrogen hetero-atom(s) only\",\n \"duty\": \"6.50%\",\n \"specialRate\": \"Free (AS,KR,AU,IS,CR,PE,CL,GE,HK,MO,LD), 3.7% (CH), 5% (PK)\",\n \"rate2\": \"20%\",\n \"comments\": \"If anti-cancer drug then use code 2933.99.0092\",\n \"htsFastlookupSource\": \"notDefinedRefresh\",\n \"checkStatus\": \"Completed\"\n },\n {\n \"corporateId\": \"EXAMPLE_4\",\n \"country\": \"EU\",\n \"tariffCode\": \"2933.99.8090\",\n \"description\": \"- Heterocyclic compounds with nitrogen hetero-atom(s) only:\\n- - Other:\\n- - - Other:\\n- - - - Other:\\n- - - - - Other\",\n \"duty\": \"6.50%\",\n \"specialRate\": null,\n \"rate2\": null,\n \"comments\": null,\n \"htsFastlookupSource\": \"notDefinedRefresh\",\n \"checkStatus\": \"Completed\"\n },\n {\n \"corporateId\": \"EXAMPLE_4\",\n \"country\": \"SCHB\",\n \"tariffCode\": \"2933.99.8350\",\n \"description\": \"- Heterocyclic compounds with nitrogen hetero-atom(s) only:\\n- - Other:\\n- - - Other:\\n- - - - Aromatic or modified aromatic:\\n- - - - - Other:\\n- - - - - - Other\",\n \"duty\": null,\n \"specialRate\": null,\n \"rate2\": null,\n \"comments\": null,\n \"htsFastlookupSource\": \"notDefinedRefresh\",\n \"checkStatus\": \"Completed\"\n },\n {\n \"corporateId\": \"EXAMPLE_4\",\n \"country\": \"USHTS\",\n \"tariffCode\": \"2933.99.7900\",\n \"description\": \"- Heterocyclic compounds with nitrogen hetero-atom(s) only:\\n- - Other:\\n- - - Other:\\n- - - - Aromatic or modified aromatic:\\n- - - - - Other:\\n- - - - - - Other:\\n- - - - - - - Products described in additional U.S. note 3 to section VI\",\n \"duty\": \"6.5%\",\n \"specialRate\": \"Free(A+,AU,BH,CA,CL,CO,D,E,IL,JO,K,KR,L,MA,MX,OM,P,PA,PE,S,SG)\",\n \"rate2\": \"15.4¢/kg + 52%\",\n \"comments\": null,\n \"htsFastlookupSource\": \"notDefinedRefresh\",\n \"checkStatus\": \"Completed\"\n },\n {\n \"corporateId\": \"EXAMPLE_5\",\n \"country\": \"USHTS\",\n \"tariffCode\": \"2934.92.0000\",\n \"description\": \"- Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds:\\n- - Other:\\n- - - Other fentanyls and their derivatives\",\n \"duty\": \"6.5%\",\n \"specialRate\": \"Free(A,AU,BH,CA,CL,CO,D,E,IL,JO,K,KR,MA,MX,OM,P,PA,PE,S,SG)\",\n \"rate2\": \"30.5%\",\n \"comments\": null,\n \"htsFastlookupSource\": \"notDefinedRefresh\",\n \"checkStatus\": \"Completed\"\n },\n {\n \"corporateId\": \"EXAMPLE_5\",\n \"country\": \"SCHB\",\n \"tariffCode\": \"2934.92.0000\",\n \"description\": \"- Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds:\\n- - Other:\\n- - - Other fentanyls and their derivatives\",\n \"duty\": null,\n \"specialRate\": null,\n \"rate2\": null,\n \"comments\": null,\n \"htsFastlookupSource\": \"notDefinedRefresh\",\n \"checkStatus\": \"Completed\"\n },\n {\n \"corporateId\": \"EXAMPLE_5\",\n \"country\": \"EU\",\n \"tariffCode\": \"2934.92.0000\",\n \"description\": \"- Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds:\\n- - Other:\\n- - - Other fentanyls and their derivatives\",\n \"duty\": \"6.50%\",\n \"specialRate\": null,\n \"rate2\": null,\n \"comments\": null,\n \"htsFastlookupSource\": \"notDefinedRefresh\",\n \"checkStatus\": \"Completed\"\n },\n {\n \"corporateId\": \"EXAMPLE_5\",\n \"country\": \"CN\",\n \"tariffCode\": \"2934.92.0010\",\n \"description\": \"- Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds:\\n- - Thiofentanyl, Alpha-Methyl Thiofentanyl, 3-Methyl Thiofentanyl and their salts\",\n \"duty\": \"6.50%\",\n \"specialRate\": null,\n \"rate2\": \"20%\",\n \"comments\": null,\n \"htsFastlookupSource\": \"notDefinedRefresh\",\n \"checkStatus\": \"Completed\"\n },\n {\n \"corporateId\": \"EXAMPLE_5\",\n \"country\": \"UK\",\n \"tariffCode\": \"2934.92.0000\",\n \"description\": \"- Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds:\\n- - Other:\\n- - - Other fentanyls and their derivatives\",\n \"duty\": \"6%\",\n \"specialRate\": null,\n \"rate2\": null,\n \"comments\": null,\n \"htsFastlookupSource\": \"notDefinedRefresh\",\n \"checkStatus\": \"Completed\"\n },\n {\n \"corporateId\": \"EXAMPLE_5\",\n \"country\": \"CH\",\n \"tariffCode\": \"2934.92.00\",\n \"description\": \"- Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds:\\n- - Other:\\n- - - Other fentanyls and their derivatives\",\n \"duty\": \"Free\",\n \"specialRate\": null,\n \"rate2\": null,\n \"comments\": null,\n \"htsFastlookupSource\": \"notDefinedRefresh\",\n \"checkStatus\": \"Completed\"\n },\n {\n \"corporateId\": \"EXAMPLE_5\",\n \"country\": \"ROW\",\n \"tariffCode\": \"2934.92\",\n \"description\": null,\n \"duty\": null,\n \"specialRate\": null,\n \"rate2\": null,\n \"comments\": null,\n \"htsFastlookupSource\": \"notDefinedRefresh\",\n \"checkStatus\": \"Completed\"\n },\n {\n \"corporateId\": \"EXAMPLE_6\",\n \"country\": \"ROW\",\n \"tariffCode\": \"2933.34\",\n \"description\": null,\n \"duty\": null,\n \"specialRate\": null,\n \"rate2\": null,\n \"comments\": null,\n \"htsFastlookupSource\": \"notDefinedRefresh\",\n \"checkStatus\": \"Completed\"\n },\n {\n \"corporateId\": \"EXAMPLE_6\",\n \"country\": \"CH\",\n \"tariffCode\": \"2933.34.00\",\n \"description\": \"- Heterocyclic compounds with nitrogen hetero-atom(s) only:\\n- - Compounds containing an unfused pyridine ring (whether or not hydrogenated) in the structure:\\n- - - Other fentanyls and their derivatives\",\n \"duty\": \"Free\",\n \"specialRate\": null,\n \"rate2\": null,\n \"comments\": null,\n \"htsFastlookupSource\": \"notDefinedRefresh\",\n \"checkStatus\": \"Completed\"\n },\n {\n \"corporateId\": \"EXAMPLE_6\",\n \"country\": \"UK\",\n \"tariffCode\": \"2933.34.0000\",\n \"description\": \"- Heterocyclic compounds with nitrogen hetero-atom(s) only:\\n- - Compounds containing an unfused pyridine ring (whether or not hydrogenated) in the structure:\\n- - - Other fentanyls and their derivatives\",\n \"duty\": \"Free\",\n \"specialRate\": null,\n \"rate2\": null,\n \"comments\": null,\n \"htsFastlookupSource\": \"notDefinedRefresh\",\n \"checkStatus\": \"Completed\"\n },\n {\n \"corporateId\": \"EXAMPLE_6\",\n \"country\": \"CN\",\n \"tariffCode\": \"2933.34.0090\",\n \"description\": \"- Heterocyclic compounds with nitrogen hetero-atom(s) only:\\n- - Other fentanyls and their derivatives\",\n \"duty\": \"6.50%\",\n \"specialRate\": null,\n \"rate2\": \"20%\",\n \"comments\": null,\n \"htsFastlookupSource\": \"notDefinedRefresh\",\n \"checkStatus\": \"Completed\"\n },\n {\n \"corporateId\": \"EXAMPLE_6\",\n \"country\": \"EU\",\n \"tariffCode\": \"2933.34.0000\",\n \"description\": \"- Heterocyclic compounds with nitrogen hetero-atom(s) only:\\n- - Compounds containing an unfused pyridine ring (whether or not hydrogenated) in the structure:\\n- - - Other fentanyls and their derivatives\",\n \"duty\": \"6.50%\",\n \"specialRate\": null,\n \"rate2\": null,\n \"comments\": null,\n \"htsFastlookupSource\": \"notDefinedRefresh\",\n \"checkStatus\": \"Completed\"\n },\n {\n \"corporateId\": \"EXAMPLE_6\",\n \"country\": \"SCHB\",\n \"tariffCode\": \"2933.34.0000\",\n \"description\": \"- Heterocyclic compounds with nitrogen hetero-atom(s) only:\\n- - Compounds containing an unfused pyridine ring (whether or not hydrogenated) in the structure:\\n- - - Other fentanyls and their derivatives\",\n \"duty\": null,\n \"specialRate\": null,\n \"rate2\": null,\n \"comments\": null,\n \"htsFastlookupSource\": \"notDefinedRefresh\",\n \"checkStatus\": \"Completed\"\n },\n {\n \"corporateId\": \"EXAMPLE_6\",\n \"country\": \"USHTS\",\n \"tariffCode\": \"2933.34.0000\",\n \"description\": \"- Heterocyclic compounds with nitrogen hetero-atom(s) only:\\n- - Compounds containing an unfused pyridine ring (whether or not hydrogenated) in the structure:\\n- - - Other fentanyls and their derivatives\",\n \"duty\": \"6.5%\",\n \"specialRate\": \"Free(A+,AU,BH,CA,CL,CO,D,E,IL,JO,K,KR,MA,MX,OM,P,PA,PE,S,SG)\",\n \"rate2\": \"15.4¢/kg + 52%\",\n \"comments\": null,\n \"htsFastlookupSource\": \"notDefinedRefresh\",\n \"checkStatus\": \"Completed\"\n },\n {\n \"corporateId\": \"EXAMPLE_7\",\n \"country\": \"USHTS\",\n \"tariffCode\": \"2933.99.7900\",\n \"description\": \"- Heterocyclic compounds with nitrogen hetero-atom(s) only:\\n- - Other:\\n- - - Other:\\n- - - - Aromatic or modified aromatic:\\n- - - - - Other:\\n- - - - - - Other:\\n- - - - - - - Products described in additional U.S. note 3 to section VI\",\n \"duty\": \"6.5%\",\n \"specialRate\": \"Free(A+,AU,BH,CA,CL,CO,D,E,IL,JO,K,KR,L,MA,MX,OM,P,PA,PE,S,SG)\",\n \"rate2\": \"15.4¢/kg + 52%\",\n \"comments\": null,\n \"htsFastlookupSource\": \"notDefinedRefresh\",\n \"checkStatus\": \"Completed\"\n },\n {\n \"corporateId\": \"EXAMPLE_7\",\n \"country\": \"SCHB\",\n \"tariffCode\": \"2933.99.8350\",\n \"description\": \"- Heterocyclic compounds with nitrogen hetero-atom(s) only:\\n- - Other:\\n- - - Other:\\n- - - - Aromatic or modified aromatic:\\n- - - - - Other:\\n- - - - - - Other\",\n \"duty\": null,\n \"specialRate\": null,\n \"rate2\": null,\n \"comments\": null,\n \"htsFastlookupSource\": \"notDefinedRefresh\",\n \"checkStatus\": \"Completed\"\n },\n {\n \"corporateId\": \"EXAMPLE_7\",\n \"country\": \"EU\",\n \"tariffCode\": \"2933.99.8090\",\n \"description\": \"- Heterocyclic compounds with nitrogen hetero-atom(s) only:\\n- - Other:\\n- - - Other:\\n- - - - Other:\\n- - - - - Other\",\n \"duty\": \"6.50%\",\n \"specialRate\": null,\n \"rate2\": null,\n \"comments\": null,\n \"htsFastlookupSource\": \"notDefinedRefresh\",\n \"checkStatus\": \"Completed\"\n },\n {\n \"corporateId\": \"EXAMPLE_7\",\n \"country\": \"UK\",\n \"tariffCode\": \"2933.99.8090\",\n \"description\": \"- Heterocyclic compounds with nitrogen hetero-atom(s) only:\\n- - Other:\\n- - - Other:\\n- - - - Other:\\n- - - - - Other\",\n \"duty\": \"Free\",\n \"specialRate\": null,\n \"rate2\": null,\n \"comments\": null,\n \"htsFastlookupSource\": \"notDefinedRefresh\",\n \"checkStatus\": \"Completed\"\n },\n {\n \"corporateId\": \"EXAMPLE_7\",\n \"country\": \"CH\",\n \"tariffCode\": \"2933.99.80\",\n \"description\": \"- Heterocyclic compounds with nitrogen hetero-atom(s) only:\\n- - Other:\\n- - - Other:\\n- - - - Other\",\n \"duty\": \"1%\",\n \"specialRate\": null,\n \"rate2\": null,\n \"comments\": null,\n \"htsFastlookupSource\": \"notDefinedRefresh\",\n \"checkStatus\": \"Completed\"\n },\n {\n \"corporateId\": \"EXAMPLE_7\",\n \"country\": \"ROW\",\n \"tariffCode\": \"2933.99\",\n \"description\": null,\n \"duty\": null,\n \"specialRate\": null,\n \"rate2\": null,\n \"comments\": null,\n \"htsFastlookupSource\": \"notDefinedRefresh\",\n \"checkStatus\": \"Completed\"\n },\n {\n \"corporateId\": \"EXAMPLE_7\",\n \"country\": \"CN\",\n \"tariffCode\": \"2933.99.0099\",\n \"description\": \"- Heterocyclic compounds with nitrogen hetero-atom(s) only:\\n- - Other heterocyclic compounds containing nitrogen hetero-atom(s) only\",\n \"duty\": \"6.50%\",\n \"specialRate\": \"Free (AS,KR,AU,IS,CR,PE,CL,GE,HK,MO,LD), 3.7% (CH), 5% (PK)\",\n \"rate2\": \"20%\",\n \"comments\": \"If anti-cancer drug then use code 2933.99.0092\",\n \"htsFastlookupSource\": \"notDefinedRefresh\",\n \"checkStatus\": \"Completed\"\n }\n ]\n },\n \"searchQuery\": \"\"\n}"}],"_postman_id":"e6f75a01-ff98-4f43-9fe1-9b927eb91ccc"}],"id":"a5094e6a-30c4-4a71-b723-d9de9777a9a1","_postman_id":"a5094e6a-30c4-4a71-b723-d9de9777a9a1","description":""}],"id":"62aec981-4705-48c4-876e-6cbc847dd421","description":"

APIs for Scitegrity's ExpediChem tariff coding application

\n","_postman_id":"62aec981-4705-48c4-876e-6cbc847dd421"},{"name":"/authenticate","event":[{"listen":"test","script":{"id":"94a9d19b-b5a6-4c57-9c18-7f5a93ad8524","exec":["// Set token in environment variable to be used by other calls\r","const jsonData = pm.response.json();\r","pm.environment.set('token', jsonData.token);"],"type":"text/javascript","packages":{}}}],"id":"e105400a-6c05-4e54-aebe-91879b0b72f7","protocolProfileBehavior":{"disableBodyPruning":true},"request":{"auth":{"type":"basic","basic":{"basicConfig":[{"key":"username","value":"{{username}}"},{"key":"password","value":"{{password}}"}]},"isInherited":false},"method":"GET","header":[],"url":"https://{{host}}:{{port}}/authenticate","description":"

/authenticate

Used to authenticate with provided service account credentials. Provides a jsonWebToken, used to authenticate requests to /job, /controlcodes and /jurisdiction end-points

\n","urlObject":{"protocol":"https","port":"{{port}}","path":["authenticate"],"host":["{{host}}"],"query":[],"variable":[]}},"response":[],"_postman_id":"e105400a-6c05-4e54-aebe-91879b0b72f7"},{"name":"/authenticate","event":[{"listen":"test","script":{"id":"1287f9be-e6e2-4d72-9ac1-22e8e029f5fa","exec":["// Set token in environment variable to be used by other calls","const jsonData = pm.response.json();","pm.environment.set('token', jsonData.token);"],"type":"text/javascript","packages":{}}}],"id":"a1c66597-52d4-4ac1-a062-73caaf928cc5","protocolProfileBehavior":{"disableBodyPruning":true},"request":{"method":"POST","header":[],"body":{"mode":"raw","raw":"{\r\n\t\"username\": \"{{username}}\",\r\n\t\"password\": \"{{password}}\"\r\n}","options":{"raw":{"language":"json"}}},"url":"https://{{host}}:{{port}}/authenticate","description":"

/authenticate

Used to authenticate with provided service account credentials. Provides a jsonWebToken, used to authenticate requests to /job, /controlcodes and /jurisdiction end-points

\n","urlObject":{"protocol":"https","port":"{{port}}","path":["authenticate"],"host":["{{host}}"],"query":[],"variable":[]}},"response":[],"_postman_id":"a1c66597-52d4-4ac1-a062-73caaf928cc5"}],"event":[{"listen":"prerequest","script":{"id":"d3d4c081-56ec-473d-8ca8-13d3c87b8abf","type":"text/javascript","exec":[""]}},{"listen":"test","script":{"id":"409a07f5-4122-4ae9-a399-51d9e055cae9","type":"text/javascript","exec":[""]}}]}